id,rna_value_breast,study_id,Log2FoldChangeValue,Contrast,Log_RNA_Value_Breast
ENSG00000175471,1500.0,,,,7.313886831633462
ENSG00000104321,5.0,E-GEOD-52194,5.4,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',1.791759469228055
ENSG00000221716,8.0,,,,2.1972245773362196
ENSG00000140396,2680.0,,,,7.893945138235959
ENSG00000164778,9.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',2.302585092994046
ENSG00000113073,5.0,,,,1.791759469228055
ENSG00000244474,0.0,,,,0.0
ENSG00000128652,69.0,,,,4.248495242049359
ENSG00000134955,383.0,,,,5.950642552587727
ENSG00000160716,13.0,,,,2.6390573296152584
ENSG00000189079,1553.0,,,,7.348587530927593
ENSG00000136931,3.0,,,,1.3862943611198906
ENSG00000196420,7.0,,,,2.0794415416798357
ENSG00000111012,56.0,,,,4.04305126783455
ENSG00000142065,417.0,,,,6.035481432524756
ENSG00000127364,46.0,,,,3.8501476017100584
ENSG00000068097,666.0,,,,6.502790045915623
ENSG00000157330,2.0,,,,1.0986122886681098
ENSG00000112246,161.0,,,,5.087596335232384
ENSG00000132740,1271.0,,,,7.148345743900068
ENSG00000178795,4.0,,,,1.6094379124341003
ENSG00000234741,9247.0,,,,9.13216259091216
ENSG00000128656,501.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',6.218600119691729
ENSG00000128656,501.0,E-GEOD-20086,1.1,'breast cancer' vs 'normal',6.218600119691729
ENSG00000022556,83.0,,,,4.430816798843313
ENSG00000100387,1719.0,,,,7.450079569807499
ENSG00000205592,3.0,E-GEOD-52194,5.7,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.3862943611198906
ENSG00000205592,3.0,E-GEOD-52194,6.2,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',1.3862943611198906
ENSG00000109101,8.0,,,,2.1972245773362196
ENSG00000111247,60.0,E-GEOD-54002,1.7,'breast cancer' vs 'normal',4.110873864173311
ENSG00000111247,60.0,E-GEOD-31138,2.2,'invasive ductal carcinoma' vs 'normal',4.110873864173311
ENSG00000111247,60.0,E-GEOD-10780,1.4,'breast carcinoma' vs 'normal',4.110873864173311
ENSG00000111247,60.0,E-GEOD-38959,1.8,'breast cancer; breast' vs 'normal; breast',4.110873864173311
ENSG00000112116,0.0,,,,0.0
ENSG00000254703,96.0,,,,4.574710978503383
ENSG00000164794,2.0,,,,1.0986122886681098
ENSG00000201098,0.0,E-GEOD-52194,9.6,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000201098,0.0,E-GEOD-52194,10.3,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',0.0
ENSG00000201098,0.0,E-GEOD-52194,10.0,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000101144,71.0,,,,4.276666119016055
ENSG00000267272,285.0,,,,5.655991810819852
ENSG00000255986,94.0,,,,4.553876891600541
ENSG00000122644,1319.0,E-GEOD-38959,-1.9,'breast cancer; breast' vs 'normal; breast',7.1853870155804165
ENSG00000114204,4.0,,,,1.6094379124341003
ENSG00000277734,262.0,E-GEOD-44408,2.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.572154032177765
ENSG00000249395,5.0,E-GEOD-52194,6.1,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',1.791759469228055
ENSG00000137273,125.0,,,,4.836281906951478
ENSG00000196167,265.0,E-MTAB-779,-1.2,'breast carcinoma' vs 'normal',5.583496308781699
ENSG00000196167,265.0,E-GEOD-7377,2.6,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',5.583496308781699
ENSG00000273820,136.0,,,,4.919980925828125
ENSG00000180806,396.0,,,,5.983936280687191
ENSG00000049167,264.0,,,,5.579729825986222
ENSG00000186594,2360.0,,,,7.766840537085513
ENSG00000101457,906.0,,,,6.810142450115136
ENSG00000204520,1494.0,,,,7.3098814858247865
ENSG00000175879,858.0,E-GEOD-54002,1.8,'breast cancer' vs 'normal',6.755768921984255
ENSG00000104972,147.0,E-GEOD-44408,1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.997212273764115
ENSG00000198719,1420.0,,,,7.259116128097101
ENSG00000233725,5.0,,,,1.791759469228055
ENSG00000120075,97.0,,,,4.584967478670572
ENSG00000115738,3210.0,,,,8.074337694089515
ENSG00000159625,1.0,,,,0.6931471805599453
ENSG00000100296,1716.0,,,,7.448333860897476
ENSG00000074219,2066.0,,,,7.633853559681768
ENSG00000187135,0.0,,,,0.0
ENSG00000230176,1.0,,,,0.6931471805599453
ENSG00000174429,8.0,,,,2.1972245773362196
ENSG00000105568,9232.0,,,,9.130539301772627
ENSG00000130700,1.0,,,,0.6931471805599453
ENSG00000090932,1.0,,,,0.6931471805599453
ENSG00000005812,3378.0,,,,8.12533508671429
ENSG00000187474,186.0,,,,5.231108616854587
ENSG00000167767,259.0,,,,5.560681631015528
ENSG00000233893,0.0,,,,0.0
ENSG00000154134,1282.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',7.1569563646156364
ENSG00000154134,1282.0,E-GEOD-38959,-2.1,'breast cancer; breast' vs 'normal; breast',7.1569563646156364
ENSG00000134827,72.0,E-GEOD-54002,-3.9,'breast cancer' vs 'normal',4.290459441148391
ENSG00000118193,16.0,E-GEOD-52194,5.4,'triple-negative breast cancer; breast carcinoma' vs 'normal',2.833213344056216
ENSG00000118193,16.0,E-GEOD-52194,5.3,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',2.833213344056216
ENSG00000118193,16.0,E-GEOD-54002,3.1,'breast cancer' vs 'normal',2.833213344056216
ENSG00000243977,5.0,,,,1.791759469228055
ENSG00000228789,10.0,,,,2.3978952727983707
ENSG00000162398,4.0,,,,1.6094379124341003
ENSG00000186567,436.0,,,,6.07993319509559
ENSG00000171303,267.0,,,,5.5909869805108565
ENSG00000108179,2078.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',7.639642287858013
ENSG00000176124,102.0,,,,4.634728988229636
ENSG00000204262,5711.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',8.65032450401942
ENSG00000204262,5711.0,E-GEOD-10780,1.4,'breast carcinoma' vs 'normal',8.65032450401942
ENSG00000204262,5711.0,E-GEOD-54002,3.0,'breast cancer' vs 'normal',8.65032450401942
ENSG00000204262,5711.0,E-GEOD-44408,-2.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.65032450401942
ENSG00000129422,5549.0,E-GEOD-44408,-1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.62155320674048
ENSG00000272578,138.0,,,,4.9344739331306915
ENSG00000237945,101.0,,,,4.624972813284271
ENSG00000223784,2.0,,,,1.0986122886681098
ENSG00000151893,3044.0,,,,8.021256180143997
ENSG00000163288,1.0,E-GEOD-68086,-5.3,'breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000246223,52.0,,,,3.970291913552122
ENSG00000080224,8.0,,,,2.1972245773362196
ENSG00000163083,3329.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',8.110727582974489
ENSG00000163083,3329.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',8.110727582974489
ENSG00000163083,3329.0,E-MTAB-779,-1.7,'breast carcinoma' vs 'normal',8.110727582974489
ENSG00000163083,3329.0,E-GEOD-20086,1.4,'breast cancer' vs 'normal',8.110727582974489
ENSG00000163083,3329.0,E-GEOD-38959,-2.1,'breast cancer; breast' vs 'normal; breast',8.110727582974489
ENSG00000186297,0.0,E-GEOD-52194,5.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000186297,0.0,E-GEOD-20086,-3.0,'breast cancer' vs 'normal',0.0
ENSG00000186297,0.0,E-GEOD-68086,-5.8,'breast carcinoma' vs 'normal',0.0
ENSG00000168785,478.0,,,,6.171700597410915
ENSG00000198791,2281.0,,,,7.732807530422021
ENSG00000166823,225.0,,,,5.420534999272286
ENSG00000196876,82.0,,,,4.418840607796598
ENSG00000228253,83330.0,,,,11.330575907784267
ENSG00000250366,2.0,,,,1.0986122886681098
ENSG00000126883,3524.0,,,,8.16763571524637
ENSG00000277258,1476.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.29776828253138
ENSG00000225968,107.0,,,,4.68213122712422
ENSG00000120616,2296.0,,,,7.739359202689098
ENSG00000148377,1.0,,,,0.6931471805599453
ENSG00000152270,1273.0,,,,7.149916836132109
ENSG00000143816,264.0,,,,5.579729825986222
ENSG00000008517,842.0,E-GEOD-44408,1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.736966958001855
ENSG00000229558,5.0,,,,1.791759469228055
ENSG00000010319,5725.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',8.65277248565806
ENSG00000010319,5725.0,E-GEOD-38959,-1.4,'breast cancer; breast' vs 'normal; breast',8.65277248565806
ENSG00000010319,5725.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',8.65277248565806
ENSG00000104313,22.0,,,,3.1354942159291497
ENSG00000177519,7.0,,,,2.0794415416798357
ENSG00000161055,60.0,E-GEOD-54002,-2.1,'breast cancer' vs 'normal',4.110873864173311
ENSG00000161055,60.0,E-GEOD-38959,-1.5,'breast cancer; breast' vs 'normal; breast',4.110873864173311
ENSG00000161055,60.0,E-GEOD-10780,-2.0,'breast carcinoma' vs 'normal',4.110873864173311
ENSG00000161055,60.0,E-GEOD-52194,-8.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',4.110873864173311
ENSG00000161055,60.0,E-GEOD-52194,-5.2,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',4.110873864173311
ENSG00000178732,4.0,,,,1.6094379124341003
ENSG00000133124,1.0,,,,0.6931471805599453
ENSG00000104889,347.0,,,,5.8522024797744745
ENSG00000102878,1536.0,,,,7.337587743538596
ENSG00000183773,50.0,,,,3.9318256327243257
ENSG00000109674,3.0,E-GEOD-54002,1.8,'breast cancer' vs 'normal',1.3862943611198906
ENSG00000106952,50.0,,,,3.9318256327243257
ENSG00000233608,1558.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',7.351799869057777
ENSG00000233608,1558.0,E-GEOD-20086,-1.3,'breast cancer' vs 'normal',7.351799869057777
ENSG00000080854,80.0,,,,4.394449154672439
ENSG00000158014,20.0,,,,3.044522437723423
ENSG00000125845,417.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.035481432524756
ENSG00000125845,417.0,E-GEOD-52194,-4.9,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',6.035481432524756
ENSG00000182379,26.0,,,,3.295836866004329
ENSG00000279050,5.0,,,,1.791759469228055
ENSG00000115602,715.0,,,,6.573680166960646
ENSG00000173530,560.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',6.329720905522696
ENSG00000173530,560.0,E-GEOD-52194,-5.5,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',6.329720905522696
ENSG00000173530,560.0,E-GEOD-52194,-5.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',6.329720905522696
ENSG00000161649,5718.0,E-MTAB-779,-1.9,'breast carcinoma' vs 'normal',8.651549243915316
ENSG00000161649,5718.0,E-GEOD-52194,-5.2,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',8.651549243915316
ENSG00000161649,5718.0,E-GEOD-10780,-1.8,'breast carcinoma' vs 'normal',8.651549243915316
ENSG00000206561,184.0,,,,5.220355825078324
ENSG00000241684,243.0,E-GEOD-54002,-2.5,'breast cancer' vs 'normal',5.497168225293202
ENSG00000241684,243.0,E-GEOD-31138,-3.2,'invasive ductal carcinoma' vs 'normal',5.497168225293202
ENSG00000184845,13.0,,,,2.6390573296152584
ENSG00000229637,0.0,,,,0.0
ENSG00000230838,0.0,,,,0.0
ENSG00000248859,0.0,,,,0.0
ENSG00000132964,562.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',6.333279628139691
ENSG00000111186,171.0,,,,5.147494476813453
ENSG00000172461,16.0,,,,2.833213344056216
ENSG00000104044,16.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',2.833213344056216
ENSG00000168936,2137.0,,,,7.6676260915849905
ENSG00000104059,10.0,,,,2.3978952727983707
ENSG00000198734,76.0,,,,4.343805421853684
ENSG00000110324,957.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.86484777797086
ENSG00000227124,316.0,,,,5.75890177387728
ENSG00000152457,374.0,,,,5.926926025970411
ENSG00000166407,2.0,,,,1.0986122886681098
ENSG00000143196,11281.0,,,,9.330963814299922
ENSG00000167074,1549.0,,,,7.346010209913293
ENSG00000085382,937.0,,,,6.843749949006225
ENSG00000120937,5.0,,,,1.791759469228055
ENSG00000249917,2.0,,,,1.0986122886681098
ENSG00000206384,170.0,E-MTAB-779,-1.8,'breast carcinoma' vs 'normal',5.14166355650266
ENSG00000206384,170.0,E-GEOD-10780,-1.9,'breast carcinoma' vs 'normal',5.14166355650266
ENSG00000133740,369.0,,,,5.91350300563827
ENSG00000174306,3267.0,E-MTAB-779,-1.2,'breast carcinoma' vs 'normal',8.091933455979893
ENSG00000148704,0.0,E-GEOD-52194,4.9,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',0.0
ENSG00000148704,0.0,E-GEOD-52194,5.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000156427,57.0,,,,4.060443010546419
ENSG00000156509,14.0,,,,2.70805020110221
ENSG00000271447,464.0,,,,6.142037405587356
ENSG00000108001,1375.0,,,,7.226936018493289
ENSG00000167977,880.0,,,,6.78105762593618
ENSG00000169618,19.0,,,,2.995732273553991
ENSG00000113263,212.0,E-GEOD-44408,3.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.3612921657094255
ENSG00000174038,5.0,E-GEOD-68086,-4.9,'breast carcinoma' vs 'normal',1.791759469228055
ENSG00000103510,2418.0,,,,7.791109510610028
ENSG00000156925,0.0,,,,0.0
ENSG00000169194,3.0,,,,1.3862943611198906
ENSG00000166342,28.0,,,,3.367295829986474
ENSG00000197992,16.0,,,,2.833213344056216
ENSG00000251442,22.0,,,,3.1354942159291497
ENSG00000148482,2.0,,,,1.0986122886681098
ENSG00000233016,2043.0,,,,7.622663951323595
ENSG00000169442,156.0,E-GEOD-44408,2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.056245805348308
ENSG00000172139,13.0,,,,2.6390573296152584
ENSG00000145451,7.0,,,,2.0794415416798357
ENSG00000147082,24.0,,,,3.2188758248682006
ENSG00000240520,2.0,,,,1.0986122886681098
ENSG00000167984,183.0,,,,5.214935757608986
ENSG00000165269,6458.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',8.773229786032473
ENSG00000117425,335.0,,,,5.817111159963204
ENSG00000116521,2378.0,,,,7.774435510302958
ENSG00000135976,525.0,,,,6.26530121273771
ENSG00000100911,3195.0,,,,8.069655306886165
ENSG00000226856,3.0,,,,1.3862943611198906
ENSG00000197959,330.0,,,,5.802118375377063
ENSG00000151012,66.0,E-GEOD-31138,2.4,'invasive ductal carcinoma' vs 'normal',4.204692619390966
ENSG00000151012,66.0,E-GEOD-7377,1.8,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',4.204692619390966
ENSG00000122176,5688.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',8.646289764750648
ENSG00000122176,5688.0,E-GEOD-38959,-1.5,'breast cancer; breast' vs 'normal; breast',8.646289764750648
ENSG00000246430,91.0,,,,4.5217885770490405
ENSG00000258366,77.0,,,,4.356708826689592
ENSG00000116473,3587.0,,,,8.185350223178686
ENSG00000204610,0.0,E-GEOD-52194,5.5,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000259156,0.0,,,,0.0
ENSG00000176204,4.0,,,,1.6094379124341003
ENSG00000196917,722.0,E-GEOD-38959,-2.5,'breast cancer; breast' vs 'normal; breast',6.583409222158765
ENSG00000143878,31402.0,E-GEOD-44408,-1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',10.35465870873383
ENSG00000187266,803.0,,,,6.6895992691789665
ENSG00000138741,24.0,,,,3.2188758248682006
ENSG00000202566,3.0,,,,1.3862943611198906
ENSG00000162976,1303.0,,,,7.1731917424865985
ENSG00000233521,8.0,,,,2.1972245773362196
ENSG00000249669,1738.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',7.461065514354283
ENSG00000249669,1738.0,E-GEOD-54002,-3.2,'breast cancer' vs 'normal',7.461065514354283
ENSG00000249669,1738.0,E-GEOD-38959,-4.0,'breast cancer; breast' vs 'normal; breast',7.461065514354283
ENSG00000142627,1524.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',7.329749689041512
ENSG00000142627,1524.0,E-GEOD-7377,-1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.329749689041512
ENSG00000142627,1524.0,E-GEOD-52194,-4.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',7.329749689041512
ENSG00000099910,948.0,,,,6.855408798609928
ENSG00000187720,701.0,E-GEOD-38959,-3.4,'breast cancer; breast' vs 'normal; breast',6.553933404025811
ENSG00000242366,0.0,E-GEOD-68086,-5.5,'breast carcinoma' vs 'normal',0.0
ENSG00000112309,137.0,,,,4.927253685157205
ENSG00000212907,63739.0,,,,11.062567587971328
ENSG00000167461,919.0,,,,6.824373670043086
ENSG00000133142,4194.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.341648618901306
ENSG00000159110,723.0,,,,6.584791392385716
ENSG00000185432,7418.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',8.911799556189527
ENSG00000185432,7418.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',8.911799556189527
ENSG00000185432,7418.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',8.911799556189527
ENSG00000254709,48.0,,,,3.8918202981106265
ENSG00000154342,2.0,,,,1.0986122886681098
ENSG00000160588,541.0,E-GEOD-54002,-1.4,'breast cancer' vs 'normal',6.295266001439646
ENSG00000075420,5324.0,,,,8.580167990577626
ENSG00000143919,196.0,,,,5.2832037287379885
ENSG00000179101,0.0,,,,0.0
ENSG00000205221,1044.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',6.951772164398911
ENSG00000205221,1044.0,E-GEOD-38959,-1.4,'breast cancer; breast' vs 'normal; breast',6.951772164398911
ENSG00000205221,1044.0,E-GEOD-20086,-1.9,'breast cancer' vs 'normal',6.951772164398911
ENSG00000280997,2.0,,,,1.0986122886681098
ENSG00000105428,0.0,,,,0.0
ENSG00000138798,202.0,E-GEOD-54002,-2.1,'breast cancer' vs 'normal',5.313205979041787
ENSG00000138798,202.0,E-GEOD-7377,-3.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',5.313205979041787
ENSG00000249231,0.0,,,,0.0
ENSG00000168505,0.0,,,,0.0
ENSG00000168032,103.0,,,,4.6443908991413725
ENSG00000233818,10.0,,,,2.3978952727983707
ENSG00000132429,17.0,,,,2.8903717578961645
ENSG00000258441,1100.0,,,,7.00397413672268
ENSG00000171889,1.0,,,,0.6931471805599453
ENSG00000174442,343.0,,,,5.840641657373398
ENSG00000285972,0.0,,,,0.0
ENSG00000177426,2312.0,,,,7.746300662231439
ENSG00000149654,6.0,,,,1.9459101490553132
ENSG00000115461,39539.0,,,,10.585068096724608
ENSG00000160224,11.0,,,,2.4849066497880004
ENSG00000181374,48.0,E-GEOD-68086,-5.1,'breast carcinoma' vs 'normal',3.8918202981106265
ENSG00000152580,1046.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',6.953684210870537
ENSG00000152580,1046.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',6.953684210870537
ENSG00000148842,508.0,,,,6.2324480165505225
ENSG00000198785,41.0,,,,3.7376696182833684
ENSG00000133105,3.0,,,,1.3862943611198906
ENSG00000004838,54.0,,,,4.007333185232471
ENSG00000075886,12.0,,,,2.5649493574615367
ENSG00000119138,12034.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',9.395574350217172
ENSG00000119138,12034.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',9.395574350217172
ENSG00000241566,0.0,,,,0.0
ENSG00000207607,0.0,,,,0.0
ENSG00000113327,0.0,E-GEOD-52194,5.2,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000118495,3580.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',8.183397369998433
ENSG00000118495,3580.0,E-GEOD-54002,-2.9,'breast cancer' vs 'normal',8.183397369998433
ENSG00000118495,3580.0,E-GEOD-10780,-1.7,'breast carcinoma' vs 'normal',8.183397369998433
ENSG00000118495,3580.0,E-GEOD-7377,-3.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.183397369998433
ENSG00000113318,615.0,,,,6.423246963533519
ENSG00000182165,288.0,,,,5.666426688112432
ENSG00000130844,1635.0,,,,7.400009517162692
ENSG00000138039,27.0,,,,3.332204510175204
ENSG00000266714,10471.0,,,,9.256460307589736
ENSG00000198355,6392.0,,,,8.762958920766726
ENSG00000168418,6.0,E-GEOD-52194,5.6,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.9459101490553132
ENSG00000185483,258.0,,,,5.556828061699537
ENSG00000254369,58.0,E-GEOD-38959,-3.7,'breast cancer; breast' vs 'normal; breast',4.07753744390572
ENSG00000162576,7714.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.950921764797261
ENSG00000213401,0.0,E-GEOD-52194,4.9,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000241721,0.0,,,,0.0
ENSG00000156970,37.0,E-GEOD-54002,2.6,'breast cancer' vs 'normal',3.6375861597263857
ENSG00000156970,37.0,E-GEOD-10780,1.6,'breast carcinoma' vs 'normal',3.6375861597263857
ENSG00000177133,96.0,,,,4.574710978503383
ENSG00000160973,7.0,,,,2.0794415416798357
ENSG00000159248,0.0,,,,0.0
ENSG00000212296,4.0,,,,1.6094379124341003
ENSG00000140612,5457.0,,,,8.604837701268284
ENSG00000175691,188.0,,,,5.241747015059643
ENSG00000119048,3742.0,,,,8.22764270790443
ENSG00000051341,33.0,E-GEOD-54002,1.7,'breast cancer' vs 'normal',3.5263605246161616
ENSG00000051341,33.0,E-GEOD-52194,5.1,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',3.5263605246161616
ENSG00000169469,6.0,,,,1.9459101490553132
ENSG00000250742,651.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',6.480044561926653
ENSG00000183888,34.0,E-MTAB-779,1.9,'breast carcinoma' vs 'normal',3.5553480614894135
ENSG00000183888,34.0,E-GEOD-38959,-2.2,'breast cancer; breast' vs 'normal; breast',3.5553480614894135
ENSG00000229927,3.0,,,,1.3862943611198906
ENSG00000198885,250.0,,,,5.5254529391317835
ENSG00000007314,3082.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',8.03365842788615
ENSG00000238097,1.0,,,,0.6931471805599453
ENSG00000183032,26.0,,,,3.295836866004329
ENSG00000143297,38.0,E-GEOD-52194,5.2,'triple-negative breast cancer; breast carcinoma' vs 'normal',3.6635616461296463
ENSG00000143297,38.0,E-GEOD-52194,6.0,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',3.6635616461296463
ENSG00000185551,6135.0,,,,8.721928343047091
ENSG00000241644,525.0,,,,6.26530121273771
ENSG00000136110,0.0,,,,0.0
ENSG00000258839,262.0,,,,5.572154032177765
ENSG00000181274,369.0,,,,5.91350300563827
ENSG00000064995,1309.0,,,,7.177782416195197
ENSG00000173334,1703.0,,,,7.440733707389261
ENSG00000198223,299.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.703782474656201
ENSG00000136688,0.0,,,,0.0
ENSG00000124721,2.0,E-GEOD-52194,5.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000116001,4970.0,,,,8.511376306094673
ENSG00000163823,185.0,,,,5.225746673713202
ENSG00000186897,4.0,,,,1.6094379124341003
ENSG00000125813,2.0,,,,1.0986122886681098
ENSG00000169071,484.0,,,,6.184148890937483
ENSG00000135919,629.0,,,,6.4457198193855785
ENSG00000169933,6.0,,,,1.9459101490553132
ENSG00000116032,73.0,,,,4.30406509320417
ENSG00000198797,23.0,,,,3.1780538303479458
ENSG00000231234,12.0,,,,2.5649493574615367
ENSG00000159199,1355.0,,,,7.212294468500341
ENSG00000171241,53.0,,,,3.9889840465642745
ENSG00000121067,2599.0,,,,7.8632667240095735
ENSG00000200816,0.0,,,,0.0
ENSG00000132581,1315.0,,,,7.182352111885263
ENSG00000117148,0.0,E-GEOD-68086,-5.5,'breast carcinoma' vs 'normal',0.0
ENSG00000117148,0.0,E-GEOD-52194,6.8,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000117148,0.0,E-GEOD-52194,5.7,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',0.0
ENSG00000111875,460.0,E-GEOD-31138,2.8,'invasive ductal carcinoma' vs 'normal',6.133398042996649
ENSG00000163492,48.0,,,,3.8918202981106265
ENSG00000178184,445.0,,,,6.100318952020064
ENSG00000255774,0.0,E-GEOD-52194,4.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000170577,91.0,E-GEOD-54002,1.7,'breast cancer' vs 'normal',4.5217885770490405
ENSG00000251562,28025.0,E-GEOD-52194,5.3,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',10.240887929730164
ENSG00000251562,28025.0,E-GEOD-52194,5.0,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',10.240887929730164
ENSG00000213246,2155.0,,,,7.6760099320288875
ENSG00000071991,157.0,,,,5.062595033026967
ENSG00000205795,75.0,,,,4.330733340286331
ENSG00000171119,18.0,,,,2.9444389791664403
ENSG00000170209,50.0,,,,3.9318256327243257
ENSG00000169679,34.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',3.5553480614894135
ENSG00000169679,34.0,E-GEOD-54002,2.8,'breast cancer' vs 'normal',3.5553480614894135
ENSG00000159261,6.0,E-GEOD-68086,-5.2,'breast carcinoma' vs 'normal',1.9459101490553132
ENSG00000168404,1311.0,,,,7.179307969504034
ENSG00000143801,739.0,,,,6.606650186198215
ENSG00000139842,4630.0,,,,8.440528106480752
ENSG00000198089,1560.0,,,,7.353081920515432
ENSG00000110900,177.0,,,,5.181783550292085
ENSG00000244242,268.0,,,,5.594711379601839
ENSG00000108688,0.0,,,,0.0
ENSG00000158089,76.0,,,,4.343805421853684
ENSG00000160193,383.0,,,,5.950642552587727
ENSG00000109099,9710.0,E-MTAB-779,-1.2,'breast carcinoma' vs 'normal',9.181014542594355
ENSG00000132386,25312.0,,,,10.139073376740225
ENSG00000175611,144.0,,,,4.976733742420574
ENSG00000225614,198.0,,,,5.293304824724492
ENSG00000275152,57.0,,,,4.060443010546419
ENSG00000276293,4086.0,,,,8.315566483564277
ENSG00000185129,1645.0,,,,7.406103381237015
ENSG00000166250,3473.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',8.153061946801051
ENSG00000166250,3473.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',8.153061946801051
ENSG00000166250,3473.0,E-GEOD-10780,-1.7,'breast carcinoma' vs 'normal',8.153061946801051
ENSG00000109466,1336.0,,,,7.198183577101943
ENSG00000091181,6.0,,,,1.9459101490553132
ENSG00000106178,6.0,,,,1.9459101490553132
ENSG00000225950,106.0,,,,4.672828834461906
ENSG00000189430,6.0,,,,1.9459101490553132
ENSG00000117215,3.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',1.3862943611198906
ENSG00000117215,3.0,E-GEOD-52194,5.3,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',1.3862943611198906
ENSG00000270641,152.0,,,,5.030437921392435
ENSG00000182963,773.0,E-GEOD-54002,2.0,'breast cancer' vs 'normal',6.651571873589727
ENSG00000164093,50.0,,,,3.9318256327243257
ENSG00000136235,9890.0,E-GEOD-31138,2.5,'invasive ductal carcinoma' vs 'normal',9.199380531739841
ENSG00000145423,6285.0,E-GEOD-54002,2.4,'breast cancer' vs 'normal',8.746080217357513
ENSG00000166349,45.0,,,,3.828641396489095
ENSG00000157557,7545.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.928772900524256
ENSG00000157557,7545.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',8.928772900524256
ENSG00000157557,7545.0,E-GEOD-52194,-4.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',8.928772900524256
ENSG00000143164,3368.0,,,,8.122371243406553
ENSG00000253409,0.0,,,,0.0
ENSG00000129566,2778.0,,,,7.929846429742503
ENSG00000166148,1242.0,,,,7.1252830915107115
ENSG00000141639,53.0,,,,3.9889840465642745
ENSG00000225783,185.0,,,,5.225746673713202
ENSG00000181634,29.0,,,,3.4011973816621555
ENSG00000245105,99.0,,,,4.605170185988092
ENSG00000137872,636.0,E-GEOD-68086,-5.2,'breast carcinoma' vs 'normal',6.456769655572163
ENSG00000137872,636.0,E-GEOD-10780,-1.8,'breast carcinoma' vs 'normal',6.456769655572163
ENSG00000137872,636.0,E-GEOD-38959,-2.1,'breast cancer; breast' vs 'normal; breast',6.456769655572163
ENSG00000113083,2689.0,E-GEOD-54002,1.7,'breast cancer' vs 'normal',7.897296472595885
ENSG00000113083,2689.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',7.897296472595885
ENSG00000113083,2689.0,E-GEOD-31138,3.5,'invasive ductal carcinoma' vs 'normal',7.897296472595885
ENSG00000125965,27.0,,,,3.332204510175204
ENSG00000075223,2198.0,E-GEOD-38959,-1.4,'breast cancer; breast' vs 'normal; breast',7.695757990554761
ENSG00000075223,2198.0,E-GEOD-44408,-4.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.695757990554761
ENSG00000150275,1.0,,,,0.6931471805599453
ENSG00000182111,11.0,,,,2.4849066497880004
ENSG00000173391,42.0,E-GEOD-44408,-1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.7612001156935624
ENSG00000173391,42.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',3.7612001156935624
ENSG00000170689,24.0,,,,3.2188758248682006
ENSG00000181847,28.0,,,,3.367295829986474
ENSG00000162891,2.0,,,,1.0986122886681098
ENSG00000249532,15.0,,,,2.772588722239781
ENSG00000185156,10.0,,,,2.3978952727983707
ENSG00000002745,4.0,,,,1.6094379124341003
ENSG00000253438,10.0,,,,2.3978952727983707
ENSG00000107831,4.0,,,,1.6094379124341003
ENSG00000259706,7.0,,,,2.0794415416798357
ENSG00000120675,1261.0,,,,7.140453043101158
ENSG00000204642,2894.0,E-GEOD-44408,1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.970740390007095
ENSG00000143126,963.0,E-GEOD-44408,-2.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.871091294610546
ENSG00000106538,4754.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',8.46695197497949
ENSG00000236824,204.0,,,,5.3230099791384085
ENSG00000269858,1167.0,,,,7.0630481633881725
ENSG00000285219,0.0,,,,0.0
ENSG00000266256,17.0,,,,2.8903717578961645
ENSG00000264575,86.0,,,,4.465908118654584
ENSG00000278709,48.0,,,,3.8918202981106265
ENSG00000163364,201.0,E-GEOD-54002,2.6,'breast cancer' vs 'normal',5.308267697401205
ENSG00000181234,1010.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',6.918695219020472
ENSG00000181234,1010.0,E-GEOD-52194,-5.1,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',6.918695219020472
ENSG00000176208,204.0,,,,5.3230099791384085
ENSG00000256870,1.0,E-GEOD-68086,-5.1,'breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000184058,514.0,,,,6.244166900663736
ENSG00000274736,52.0,,,,3.970291913552122
ENSG00000180332,3.0,,,,1.3862943611198906
ENSG00000166323,24.0,,,,3.2188758248682006
ENSG00000130766,933.0,,,,6.839476438228843
ENSG00000153885,1195.0,,,,7.086737934510577
ENSG00000125538,16.0,E-GEOD-44408,1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',2.833213344056216
ENSG00000151834,68.0,,,,4.23410650459726
ENSG00000188107,59.0,,,,4.0943445622221
ENSG00000128165,59.0,,,,4.0943445622221
ENSG00000163394,1.0,E-GEOD-68086,-4.8,'breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000163394,1.0,E-GEOD-52194,5.3,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000163394,1.0,E-GEOD-52194,4.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000235576,6.0,,,,1.9459101490553132
ENSG00000122641,144.0,E-GEOD-54002,2.1,'breast cancer' vs 'normal',4.976733742420574
ENSG00000122641,144.0,E-MTAB-779,1.9,'breast carcinoma' vs 'normal',4.976733742420574
ENSG00000122641,144.0,E-GEOD-10780,2.6,'breast carcinoma' vs 'normal',4.976733742420574
ENSG00000122641,144.0,E-GEOD-44408,-2.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.976733742420574
ENSG00000122641,144.0,E-GEOD-31138,6.3,'invasive ductal carcinoma' vs 'normal',4.976733742420574
ENSG00000115488,0.0,,,,0.0
ENSG00000172156,1.0,,,,0.6931471805599453
ENSG00000166821,911.0,E-GEOD-44408,-1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.815639990074331
ENSG00000134545,12.0,,,,2.5649493574615367
ENSG00000128606,287.0,,,,5.662960480135946
ENSG00000170891,115.0,,,,4.7535901911063645
ENSG00000249346,8.0,,,,2.1972245773362196
ENSG00000135801,1314.0,,,,7.181591944611865
ENSG00000160185,20.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.044522437723423
ENSG00000006638,150.0,,,,5.017279836814924
ENSG00000251301,15.0,,,,2.772588722239781
ENSG00000131668,6.0,,,,1.9459101490553132
ENSG00000042781,16.0,,,,2.833213344056216
ENSG00000109991,3.0,,,,1.3862943611198906
ENSG00000203688,4.0,,,,1.6094379124341003
ENSG00000129521,454.0,,,,6.12029741895095
ENSG00000257167,31.0,,,,3.4657359027997265
ENSG00000258791,1.0,,,,0.6931471805599453
ENSG00000181467,845.0,E-GEOD-31138,3.7,'invasive ductal carcinoma' vs 'normal',6.740519359606223
ENSG00000080031,69.0,,,,4.248495242049359
ENSG00000124827,1.0,,,,0.6931471805599453
ENSG00000119403,1307.0,,,,7.176254532017144
ENSG00000164458,0.0,,,,0.0
ENSG00000131831,2582.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',7.8567067930958405
ENSG00000131831,2582.0,E-GEOD-38959,-2.3,'breast cancer; breast' vs 'normal; breast',7.8567067930958405
ENSG00000198695,31845.0,,,,10.368667064416371
ENSG00000112761,33.0,,,,3.5263605246161616
ENSG00000142675,753.0,E-GEOD-44408,-1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.625392368007956
ENSG00000062282,4337.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',8.37516869138682
ENSG00000062282,4337.0,E-MTAB-779,-1.9,'breast carcinoma' vs 'normal',8.37516869138682
ENSG00000170162,1.0,,,,0.6931471805599453
ENSG00000144354,141.0,E-GEOD-38959,1.9,'breast cancer; breast' vs 'normal; breast',4.955827057601261
ENSG00000115009,5.0,E-GEOD-52194,-4.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',1.791759469228055
ENSG00000115009,5.0,E-GEOD-44408,3.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',1.791759469228055
ENSG00000047936,1.0,E-GEOD-68086,-4.8,'breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000047936,1.0,E-GEOD-52194,6.9,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000123600,675.0,,,,6.516193076042964
ENSG00000156885,8.0,,,,2.1972245773362196
ENSG00000156804,6178.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',8.72891172506098
ENSG00000156804,6178.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',8.72891172506098
ENSG00000148219,267.0,,,,5.5909869805108565
ENSG00000198838,483.0,E-GEOD-31138,-2.4,'invasive ductal carcinoma' vs 'normal',6.182084906716632
ENSG00000198838,483.0,E-GEOD-54002,-2.3,'breast cancer' vs 'normal',6.182084906716632
ENSG00000157890,16.0,E-GEOD-68086,-5.1,'breast carcinoma' vs 'normal',2.833213344056216
ENSG00000197375,1119.0,E-GEOD-44408,-1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.02108396428914
ENSG00000139549,23.0,,,,3.1780538303479458
ENSG00000165457,460.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.133398042996649
ENSG00000145888,1.0,,,,0.6931471805599453
ENSG00000129451,93.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',4.543294782270004
ENSG00000228630,6.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',1.9459101490553132
ENSG00000228630,6.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',1.9459101490553132
ENSG00000169427,2.0,,,,1.0986122886681098
ENSG00000183715,11.0,,,,2.4849066497880004
ENSG00000004846,165.0,,,,5.111987788356544
ENSG00000211934,14.0,,,,2.70805020110221
ENSG00000170915,295.0,,,,5.69035945432406
ENSG00000139618,103.0,,,,4.6443908991413725
ENSG00000211891,0.0,,,,0.0
ENSG00000243961,30.0,,,,3.4339872044851463
ENSG00000144048,1013.0,,,,6.921658184151129
ENSG00000213886,6.0,,,,1.9459101490553132
ENSG00000163599,33.0,E-GEOD-44408,1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.5263605246161616
ENSG00000093072,1036.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.9440872082295275
ENSG00000093072,1036.0,E-GEOD-25407,2.2,'breast cancer' vs 'normal',6.9440872082295275
ENSG00000210082,213833.0,,,,12.272955292057766
ENSG00000158022,49.0,,,,3.912023005428146
ENSG00000205809,2.0,,,,1.0986122886681098
ENSG00000224652,17.0,,,,2.8903717578961645
ENSG00000135111,3780.0,E-GEOD-38959,-1.4,'breast cancer; breast' vs 'normal; breast',8.237743803890933
ENSG00000203999,24.0,,,,3.2188758248682006
ENSG00000230223,0.0,,,,0.0
ENSG00000156395,2.0,E-GEOD-52194,5.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000183780,53.0,E-GEOD-54002,-2.2,'breast cancer' vs 'normal',3.9889840465642745
ENSG00000276365,0.0,,,,0.0
ENSG00000280916,3.0,,,,1.3862943611198906
ENSG00000123496,9.0,,,,2.302585092994046
ENSG00000238121,27.0,,,,3.332204510175204
ENSG00000204859,1353.0,,,,7.21081845347222
ENSG00000105989,53.0,,,,3.9889840465642745
ENSG00000123297,632.0,,,,6.450470422144176
ENSG00000119729,5411.0,,,,8.59637398929068
ENSG00000198786,118997.0,,,,11.686861965229744
ENSG00000229417,10.0,,,,2.3978952727983707
ENSG00000163357,83.0,E-GEOD-68086,-5.2,'breast carcinoma' vs 'normal',4.430816798843313
ENSG00000127318,0.0,,,,0.0
ENSG00000141480,1814.0,E-GEOD-44408,1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.503840746698951
ENSG00000211448,115.0,,,,4.7535901911063645
ENSG00000122420,735.0,,,,6.601230118728877
ENSG00000204091,0.0,,,,0.0
ENSG00000112146,3923.0,,,,8.274866820685254
ENSG00000153982,54.0,,,,4.007333185232471
ENSG00000130511,1970.0,,,,7.58629630715272
ENSG00000228544,104.0,,,,4.653960350157523
ENSG00000116285,11978.0,,,,9.39091039573133
ENSG00000116016,26901.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',10.199955912268527
ENSG00000184983,1675.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',7.424165281042028
ENSG00000184983,1675.0,E-GEOD-31138,2.7,'invasive ductal carcinoma' vs 'normal',7.424165281042028
ENSG00000224137,0.0,,,,0.0
ENSG00000233791,6.0,,,,1.9459101490553132
ENSG00000102924,95.0,,,,4.564348191467836
ENSG00000133116,333.0,,,,5.811140992976701
ENSG00000108511,176.0,,,,5.176149732573829
ENSG00000142224,0.0,,,,0.0
ENSG00000196932,78.0,E-GEOD-54002,-1.4,'breast cancer' vs 'normal',4.3694478524670215
ENSG00000211897,180.0,E-GEOD-52194,5.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',5.198497031265826
ENSG00000150594,2314.0,,,,7.747164966520335
ENSG00000029559,0.0,E-GEOD-52194,5.3,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000029559,0.0,E-GEOD-52194,4.7,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000043355,4.0,E-GEOD-54002,1.4,'breast cancer' vs 'normal',1.6094379124341003
ENSG00000267795,80.0,E-MTAB-779,2.1,'breast carcinoma' vs 'normal',4.394449154672439
ENSG00000100368,669.0,E-GEOD-44408,2.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.507277712385012
ENSG00000229124,113.0,,,,4.736198448394496
ENSG00000174371,12.0,,,,2.5649493574615367
ENSG00000135903,94.0,,,,4.553876891600541
ENSG00000254726,96.0,E-GEOD-38959,1.6,'breast cancer; breast' vs 'normal; breast',4.574710978503383
ENSG00000164849,547.0,E-GEOD-31138,-2.0,'invasive ductal carcinoma' vs 'normal',6.306275286948016
ENSG00000147535,1526.0,,,,7.3310603052186325
ENSG00000254838,164.0,,,,5.10594547390058
ENSG00000105426,5592.0,,,,8.629271094821588
ENSG00000248360,414.0,E-GEOD-38959,-1.4,'breast cancer; breast' vs 'normal; breast',6.028278520230698
ENSG00000091106,84.0,,,,4.442651256490317
ENSG00000198829,67.0,,,,4.219507705176107
ENSG00000139793,4186.0,,,,8.339739766019143
ENSG00000099364,638.0,,,,6.459904454377535
ENSG00000106128,1.0,,,,0.6931471805599453
ENSG00000123685,145.0,,,,4.983606621708336
ENSG00000224271,0.0,E-GEOD-52194,5.3,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',0.0
ENSG00000224271,0.0,E-GEOD-52194,4.7,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000133937,206.0,,,,5.332718793265369
ENSG00000163217,0.0,,,,0.0
ENSG00000185904,59.0,,,,4.0943445622221
ENSG00000125148,16110.0,E-GEOD-52194,-4.9,'triple-negative breast cancer; breast carcinoma' vs 'normal',9.687257547490987
ENSG00000125148,16110.0,E-GEOD-52194,-6.0,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',9.687257547490987
ENSG00000125148,16110.0,E-GEOD-52194,-5.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',9.687257547490987
ENSG00000179774,4.0,,,,1.6094379124341003
ENSG00000198019,12.0,,,,2.5649493574615367
ENSG00000234912,352.0,,,,5.8664680569332965
ENSG00000176692,91.0,E-GEOD-52194,-5.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',4.5217885770490405
ENSG00000075415,15319.0,,,,9.636914443294582
ENSG00000249859,516.0,,,,6.248042874508429
ENSG00000198854,2.0,,,,1.0986122886681098
ENSG00000215644,6.0,,,,1.9459101490553132
ENSG00000124657,0.0,,,,0.0
ENSG00000186919,9.0,,,,2.302585092994046
ENSG00000175482,787.0,,,,6.669498089857879
ENSG00000230712,8.0,,,,2.1972245773362196
ENSG00000178977,122.0,,,,4.812184355372417
ENSG00000168412,0.0,,,,0.0
ENSG00000156374,517.0,,,,6.249975242259483
ENSG00000213186,68.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',4.23410650459726
ENSG00000213186,68.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',4.23410650459726
ENSG00000012817,3568.0,E-GEOD-68086,-7.4,'breast carcinoma' vs 'normal',8.18004072349016
ENSG00000135116,26.0,,,,3.295836866004329
ENSG00000136514,94.0,,,,4.553876891600541
ENSG00000145777,95.0,E-GEOD-54002,-2.3,'breast cancer' vs 'normal',4.564348191467836
ENSG00000145777,95.0,E-GEOD-68086,-5.1,'breast carcinoma' vs 'normal',4.564348191467836
ENSG00000162733,6587.0,E-MTAB-779,-1.7,'breast carcinoma' vs 'normal',8.79300509129753
ENSG00000162733,6587.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',8.79300509129753
ENSG00000066279,23.0,E-MTAB-779,1.8,'breast carcinoma' vs 'normal',3.1780538303479458
ENSG00000066279,23.0,E-GEOD-52194,5.3,'triple-negative breast cancer; breast carcinoma' vs 'normal',3.1780538303479458
ENSG00000066279,23.0,E-GEOD-54002,3.7,'breast cancer' vs 'normal',3.1780538303479458
ENSG00000066279,23.0,E-GEOD-10780,2.0,'breast carcinoma' vs 'normal',3.1780538303479458
ENSG00000066279,23.0,E-GEOD-31138,3.5,'invasive ductal carcinoma' vs 'normal',3.1780538303479458
ENSG00000066279,23.0,E-GEOD-38959,2.3,'breast cancer; breast' vs 'normal; breast',3.1780538303479458
ENSG00000066279,23.0,E-GEOD-52194,5.9,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',3.1780538303479458
ENSG00000188937,0.0,,,,0.0
ENSG00000278910,1.0,,,,0.6931471805599453
ENSG00000147257,4115.0,E-GEOD-20086,-1.7,'breast cancer' vs 'normal',8.32263709695394
ENSG00000147257,4115.0,E-GEOD-10780,-2.0,'breast carcinoma' vs 'normal',8.32263709695394
ENSG00000147257,4115.0,E-MTAB-779,-2.1,'breast carcinoma' vs 'normal',8.32263709695394
ENSG00000197119,3308.0,,,,8.104401307921613
ENSG00000182257,42.0,,,,3.7612001156935624
ENSG00000117525,4015.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',8.298041661371565
ENSG00000117525,4015.0,E-GEOD-54002,-2.3,'breast cancer' vs 'normal',8.298041661371565
ENSG00000130600,9378.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',9.146228426508939
ENSG00000130600,9378.0,E-GEOD-54002,2.1,'breast cancer' vs 'normal',9.146228426508939
ENSG00000130600,9378.0,E-GEOD-20086,-2.1,'breast cancer' vs 'normal',9.146228426508939
ENSG00000107187,0.0,,,,0.0
ENSG00000143457,1066.0,E-GEOD-31138,2.1,'invasive ductal carcinoma' vs 'normal',6.9726062513017535
ENSG00000162761,18.0,,,,2.9444389791664403
ENSG00000165197,699.0,E-GEOD-31138,-3.0,'invasive ductal carcinoma' vs 'normal',6.551080335043404
ENSG00000165197,699.0,E-GEOD-38959,-1.7,'breast cancer; breast' vs 'normal; breast',6.551080335043404
ENSG00000165197,699.0,E-GEOD-52194,-5.4,'triple-negative breast cancer; breast carcinoma' vs 'normal',6.551080335043404
ENSG00000165197,699.0,E-MTAB-779,-2.7,'breast carcinoma' vs 'normal',6.551080335043404
ENSG00000165197,699.0,E-GEOD-10780,-2.6,'breast carcinoma' vs 'normal',6.551080335043404
ENSG00000165197,699.0,E-GEOD-52194,-5.2,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',6.551080335043404
ENSG00000173404,1.0,,,,0.6931471805599453
ENSG00000141542,790.0,,,,6.673297967767654
ENSG00000204403,60.0,,,,4.110873864173311
ENSG00000057468,27.0,,,,3.332204510175204
ENSG00000122584,0.0,E-GEOD-52194,5.0,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000146005,30.0,,,,3.4339872044851463
ENSG00000183117,17.0,,,,2.8903717578961645
ENSG00000134259,94.0,,,,4.553876891600541
ENSG00000117281,30.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.4339872044851463
ENSG00000187140,6.0,,,,1.9459101490553132
ENSG00000110713,5316.0,,,,8.57866451350434
ENSG00000072315,1.0,,,,0.6931471805599453
ENSG00000174886,1476.0,,,,7.29776828253138
ENSG00000257315,332.0,,,,5.808142489980444
ENSG00000109756,2984.0,,,,8.001355025826703
ENSG00000169894,212.0,,,,5.3612921657094255
ENSG00000197261,526.0,E-GEOD-54002,1.6,'breast cancer' vs 'normal',6.267200548541362
ENSG00000213420,85.0,,,,4.454347296253507
ENSG00000281406,9.0,,,,2.302585092994046
ENSG00000105146,95.0,,,,4.564348191467836
ENSG00000126895,361.0,,,,5.8916442118257715
ENSG00000070985,2.0,,,,1.0986122886681098
ENSG00000211677,743.0,,,,6.612041034833092
ENSG00000172183,588.0,,,,6.3784261836515865
ENSG00000135409,4.0,,,,1.6094379124341003
ENSG00000250682,1.0,,,,0.6931471805599453
ENSG00000276600,221.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',5.402677381872279
ENSG00000123500,8.0,E-GEOD-52194,5.5,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',2.1972245773362196
ENSG00000123500,8.0,E-GEOD-54002,4.3,'breast cancer' vs 'normal',2.1972245773362196
ENSG00000123500,8.0,E-GEOD-20086,2.7,'breast cancer' vs 'normal',2.1972245773362196
ENSG00000123500,8.0,E-GEOD-10780,3.2,'breast carcinoma' vs 'normal',2.1972245773362196
ENSG00000123500,8.0,E-MTAB-779,2.6,'breast carcinoma' vs 'normal',2.1972245773362196
ENSG00000123500,8.0,E-GEOD-52194,6.4,'triple-negative breast cancer; breast carcinoma' vs 'normal',2.1972245773362196
ENSG00000123500,8.0,E-GEOD-52194,6.3,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',2.1972245773362196
ENSG00000123500,8.0,E-GEOD-44408,-4.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',2.1972245773362196
ENSG00000099822,8.0,,,,2.1972245773362196
ENSG00000252316,0.0,E-GEOD-52194,6.9,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000252316,0.0,E-GEOD-52194,8.6,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',0.0
ENSG00000252316,0.0,E-GEOD-52194,6.7,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000106484,1760.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',7.473637108496206
ENSG00000106484,1760.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',7.473637108496206
ENSG00000141750,2742.0,E-GEOD-52194,-4.8,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',7.916807490937603
ENSG00000141750,2742.0,E-GEOD-54002,-2.3,'breast cancer' vs 'normal',7.916807490937603
ENSG00000141750,2742.0,E-MTAB-779,-2.1,'breast carcinoma' vs 'normal',7.916807490937603
ENSG00000141750,2742.0,E-GEOD-52194,-5.7,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',7.916807490937603
ENSG00000270751,2.0,E-GEOD-52194,5.4,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000007923,1306.0,,,,7.175489713624222
ENSG00000102802,3369.0,E-MTAB-779,-1.8,'breast carcinoma' vs 'normal',8.122668023346407
ENSG00000102802,3369.0,E-GEOD-68086,-5.2,'breast carcinoma' vs 'normal',8.122668023346407
ENSG00000179674,0.0,E-GEOD-68086,-4.9,'breast carcinoma' vs 'normal',0.0
ENSG00000144331,189.0,,,,5.247024072160486
ENSG00000211599,0.0,,,,0.0
ENSG00000280165,1.0,,,,0.6931471805599453
ENSG00000231690,18.0,,,,2.9444389791664403
ENSG00000088986,3447.0,E-GEOD-31138,2.8,'invasive ductal carcinoma' vs 'normal',8.145549631783584
ENSG00000146070,63.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.1588830833596715
ENSG00000146070,63.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',4.1588830833596715
ENSG00000167131,0.0,,,,0.0
ENSG00000223573,70.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',4.2626798770413155
ENSG00000223573,70.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',4.2626798770413155
ENSG00000196366,6.0,,,,1.9459101490553132
ENSG00000212694,935.0,,,,6.841615476477592
ENSG00000181652,107.0,,,,4.68213122712422
ENSG00000108813,20.0,,,,3.044522437723423
ENSG00000196689,16.0,,,,2.833213344056216
ENSG00000049249,14.0,E-GEOD-44408,2.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',2.70805020110221
ENSG00000160505,0.0,,,,0.0
ENSG00000204832,10.0,E-GEOD-54002,1.7,'breast cancer' vs 'normal',2.3978952727983707
ENSG00000204832,10.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',2.3978952727983707
ENSG00000204832,10.0,E-GEOD-52194,5.4,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',2.3978952727983707
ENSG00000168214,5884.0,,,,8.680162019694377
ENSG00000108306,1392.0,E-GEOD-38959,-1.4,'breast cancer; breast' vs 'normal; breast',7.239214973779806
ENSG00000147488,5.0,E-GEOD-52194,5.0,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',1.791759469228055
ENSG00000147488,5.0,E-GEOD-52194,4.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',1.791759469228055
ENSG00000147488,5.0,E-GEOD-52194,5.6,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.791759469228055
ENSG00000136295,2188.0,E-GEOD-38959,1.7,'breast cancer; breast' vs 'normal; breast',7.691200097522863
ENSG00000139926,2064.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',7.632885505395133
ENSG00000139926,2064.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',7.632885505395133
ENSG00000138623,173.0,,,,5.159055299214529
ENSG00000110218,519.0,,,,6.253828811575473
ENSG00000137648,9.0,E-GEOD-52194,5.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',2.302585092994046
ENSG00000137648,9.0,E-GEOD-52194,5.0,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',2.302585092994046
ENSG00000152104,3679.0,E-GEOD-54002,-2.0,'breast cancer' vs 'normal',8.210668031162976
ENSG00000152104,3679.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',8.210668031162976
ENSG00000180957,3298.0,,,,8.101374671228582
ENSG00000169439,4177.0,,,,8.33758794211651
ENSG00000171105,3927.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.275885669474356
ENSG00000196345,182.0,,,,5.209486152841421
ENSG00000186998,113.0,,,,4.736198448394496
ENSG00000166106,2532.0,,,,7.837159650001675
ENSG00000136381,2891.0,,,,7.969703583278656
ENSG00000147231,135.0,E-GEOD-54002,-2.3,'breast cancer' vs 'normal',4.912654885736052
ENSG00000153707,187.0,E-GEOD-20086,1.2,'breast cancer' vs 'normal',5.236441962829949
ENSG00000142599,12879.0,,,,9.463430999658344
ENSG00000155011,181.0,,,,5.204006687076795
ENSG00000213190,319.0,,,,5.768320995793772
ENSG00000154783,2391.0,,,,7.779885115070522
ENSG00000148337,5612.0,,,,8.6328406149422
ENSG00000170525,15144.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',9.625425723461337
ENSG00000196182,3501.0,,,,8.161089512845797
ENSG00000103942,1140.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.039660349862076
ENSG00000115904,3460.0,,,,8.149312843635345
ENSG00000196422,842.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.736966958001855
ENSG00000221926,374.0,,,,5.926926025970411
ENSG00000183172,1703.0,,,,7.440733707389261
ENSG00000167644,47.0,,,,3.871201010907891
ENSG00000183023,297.0,,,,5.697093486505405
ENSG00000164934,1153.0,,,,7.050989447068045
ENSG00000156463,377.0,E-GEOD-54002,-1.9,'breast cancer' vs 'normal',5.934894195619588
ENSG00000108932,186.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',5.231108616854587
ENSG00000136878,1904.0,,,,7.552237287560802
ENSG00000214087,1218.0,,,,7.105786129481271
ENSG00000102970,3.0,,,,1.3862943611198906
ENSG00000091039,3122.0,,,,8.046549357283078
ENSG00000112379,549.0,,,,6.309918278226516
ENSG00000152467,11.0,,,,2.4849066497880004
ENSG00000105397,5304.0,,,,8.576405051048084
ENSG00000108395,888.0,,,,6.790097235513905
ENSG00000058063,2789.0,,,,7.933796874815411
ENSG00000120694,2323.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',7.751045117971802
ENSG00000170485,922.0,,,,6.827629234502852
ENSG00000110002,1660.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',7.415175109613295
ENSG00000102038,1771.0,E-GEOD-54002,-1.4,'breast cancer' vs 'normal',7.4798641311650265
ENSG00000125249,1381.0,,,,7.231287004327616
ENSG00000072133,175.0,,,,5.170483995038151
ENSG00000138382,1036.0,,,,6.9440872082295275
ENSG00000179958,743.0,,,,6.612041034833092
ENSG00000121957,518.0,E-GEOD-54002,1.9,'breast cancer' vs 'normal',6.251903883165888
ENSG00000166484,1591.0,,,,7.3727463664043285
ENSG00000100399,95.0,,,,4.564348191467836
ENSG00000187210,318.0,,,,5.765191102784844
ENSG00000196482,64.0,,,,4.174387269895637
ENSG00000133316,1101.0,,,,7.004881989712859
ENSG00000121851,1421.0,,,,7.259819610363186
ENSG00000187288,10185.0,E-MTAB-779,-2.5,'breast carcinoma' vs 'normal',9.22876950744455
ENSG00000187288,10185.0,E-GEOD-10780,-1.8,'breast carcinoma' vs 'normal',9.22876950744455
ENSG00000125650,97.0,,,,4.584967478670572
ENSG00000144647,757.0,,,,6.630683385642372
ENSG00000145860,3025.0,E-GEOD-54002,-2.5,'breast cancer' vs 'normal',8.014996894348302
ENSG00000161955,281.0,,,,5.641907070938114
ENSG00000147852,1155.0,E-MTAB-779,-2.1,'breast carcinoma' vs 'normal',7.052721049232323
ENSG00000094755,1705.0,E-GEOD-54002,-6.0,'breast cancer' vs 'normal',7.441906728051625
ENSG00000094755,1705.0,E-GEOD-10780,-2.7,'breast carcinoma' vs 'normal',7.441906728051625
ENSG00000094755,1705.0,E-GEOD-52194,-5.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',7.441906728051625
ENSG00000094755,1705.0,E-GEOD-7377,-2.4,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.441906728051625
ENSG00000239857,146.0,,,,4.990432586778736
ENSG00000162819,1593.0,,,,7.374001859350161
ENSG00000155545,1034.0,,,,6.942156705699469
ENSG00000125995,1034.0,,,,6.942156705699469
ENSG00000169692,8234.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',9.016148642611741
ENSG00000142871,16907.0,E-GEOD-54002,-2.1,'breast cancer' vs 'normal',9.73554216168668
ENSG00000142871,16907.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',9.73554216168668
ENSG00000142871,16907.0,E-GEOD-52194,-5.2,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',9.73554216168668
ENSG00000183317,43.0,,,,3.784189633918261
ENSG00000090238,4715.0,,,,8.458716261657262
ENSG00000211460,2229.0,,,,7.709756864454165
ENSG00000180340,83.0,,,,4.430816798843313
ENSG00000184451,119.0,,,,4.787491742782046
ENSG00000120334,170.0,,,,5.14166355650266
ENSG00000139154,1521.0,,,,7.3277805384216315
ENSG00000162676,42.0,,,,3.7612001156935624
ENSG00000175938,524.0,,,,6.263398262591624
ENSG00000134874,622.0,,,,6.434546518787453
ENSG00000139915,2.0,,,,1.0986122886681098
ENSG00000111371,3833.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',8.251663923605589
ENSG00000134333,22950.0,,,,10.041116787524166
ENSG00000185920,722.0,E-GEOD-54002,-2.2,'breast cancer' vs 'normal',6.583409222158765
ENSG00000185920,722.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',6.583409222158765
ENSG00000112115,0.0,,,,0.0
ENSG00000132128,4226.0,,,,8.34924780056679
ENSG00000214530,1207.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',7.0967213784947605
ENSG00000214530,1207.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',7.0967213784947605
ENSG00000205517,1202.0,,,,7.0925737159746784
ENSG00000178982,6140.0,,,,8.722742874329398
ENSG00000168389,162.0,E-GEOD-52194,-4.7,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',5.093750200806762
ENSG00000175906,255.0,,,,5.545177444479562
ENSG00000111667,2454.0,,,,7.805882040228621
ENSG00000254122,295.0,,,,5.69035945432406
ENSG00000106366,2064.0,E-GEOD-52194,-4.7,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',7.632885505395133
ENSG00000165244,94.0,E-GEOD-54002,1.4,'breast cancer' vs 'normal',4.553876891600541
ENSG00000165244,94.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',4.553876891600541
ENSG00000165886,751.0,,,,6.62273632394984
ENSG00000165071,139.0,E-GEOD-54002,-3.5,'breast cancer' vs 'normal',4.941642422609304
ENSG00000111799,11792.0,E-GEOD-54002,2.0,'breast cancer' vs 'normal',9.37526141408997
ENSG00000143322,1987.0,,,,7.59488438721652
ENSG00000186174,3562.0,,,,8.178358165605836
ENSG00000174944,170.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',5.14166355650266
ENSG00000174944,170.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',5.14166355650266
ENSG00000174944,170.0,E-GEOD-44408,2.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.14166355650266
ENSG00000169562,12.0,,,,2.5649493574615367
ENSG00000114770,2349.0,,,,7.762170607138205
ENSG00000151790,3.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',1.3862943611198906
ENSG00000151790,3.0,E-GEOD-54002,2.0,'breast cancer' vs 'normal',1.3862943611198906
ENSG00000135632,1253.0,,,,7.134093721192866
ENSG00000102900,1436.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',7.270312886079025
ENSG00000183486,1791.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.491087593534876
ENSG00000011114,1714.0,E-GEOD-7377,1.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.44716835960004
ENSG00000158856,1364.0,,,,7.21890970761906
ENSG00000172987,251.0,,,,5.529429087511423
ENSG00000165792,2728.0,,,,7.911690520708339
ENSG00000128917,1557.0,,,,7.351158226430694
ENSG00000144711,3822.0,,,,8.248790733696413
ENSG00000136982,139.0,,,,4.941642422609304
ENSG00000157388,148.0,,,,5.003946305945459
ENSG00000198740,1728.0,,,,7.455298485683291
ENSG00000146904,464.0,,,,6.142037405587356
ENSG00000156603,454.0,,,,6.12029741895095
ENSG00000069493,839.0,E-GEOD-44408,2.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.733401891837359
ENSG00000102471,866.0,,,,6.7650389767805414
ENSG00000176920,59.0,,,,4.0943445622221
ENSG00000113249,8.0,,,,2.1972245773362196
ENSG00000175894,11.0,,,,2.4849066497880004
ENSG00000173040,546.0,,,,6.304448802421981
ENSG00000108375,255.0,,,,5.545177444479562
ENSG00000121481,712.0,,,,6.569481420414296
ENSG00000126091,835.0,,,,6.728628613084702
ENSG00000163939,2964.0,,,,7.994632311431825
ENSG00000120696,271.0,,,,5.605802066295998
ENSG00000256061,35.0,,,,3.58351893845611
ENSG00000092978,655.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',6.486160788944089
ENSG00000144642,2914.0,E-GEOD-54002,-2.6,'breast cancer' vs 'normal',7.977625098784593
ENSG00000144642,2914.0,E-MTAB-779,-1.7,'breast carcinoma' vs 'normal',7.977625098784593
ENSG00000144642,2914.0,E-GEOD-10780,-2.4,'breast carcinoma' vs 'normal',7.977625098784593
ENSG00000144642,2914.0,E-GEOD-38959,-1.9,'breast cancer; breast' vs 'normal; breast',7.977625098784593
ENSG00000137193,3626.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',8.196161139282902
ENSG00000071246,833.0,,,,6.726233402358747
ENSG00000156103,179.0,E-GEOD-31138,1.9,'invasive ductal carcinoma' vs 'normal',5.19295685089021
ENSG00000101825,781.0,E-GEOD-44408,-2.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.661854740545311
ENSG00000144426,773.0,,,,6.651571873589727
ENSG00000260027,513.0,E-GEOD-54002,1.6,'breast cancer' vs 'normal',6.2422232654551655
ENSG00000124942,113488.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',11.639461194907346
ENSG00000124942,113488.0,E-GEOD-38959,-1.3,'breast cancer; breast' vs 'normal; breast',11.639461194907346
ENSG00000148484,4642.0,,,,8.443115988019922
ENSG00000123545,540.0,,,,6.293419278846481
ENSG00000140749,107.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.68213122712422
ENSG00000169359,1319.0,,,,7.1853870155804165
ENSG00000106261,4570.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',8.427487278331744
ENSG00000124089,0.0,,,,0.0
ENSG00000269335,874.0,,,,6.774223886357614
ENSG00000133627,352.0,,,,5.8664680569332965
ENSG00000172336,677.0,,,,6.519147287940395
ENSG00000154258,5236.0,E-GEOD-10780,-2.0,'breast carcinoma' vs 'normal',8.563504094279487
ENSG00000154258,5236.0,E-GEOD-31138,-3.3,'invasive ductal carcinoma' vs 'normal',8.563504094279487
ENSG00000112159,3192.0,,,,8.068716192714781
ENSG00000054277,97.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',4.584967478670572
ENSG00000129437,20.0,,,,3.044522437723423
ENSG00000151718,1357.0,,,,7.213768308118642
ENSG00000129167,127.0,,,,4.852030263919617
ENSG00000123610,204.0,E-GEOD-54002,2.1,'breast cancer' vs 'normal',5.3230099791384085
ENSG00000123610,204.0,E-GEOD-31138,4.5,'invasive ductal carcinoma' vs 'normal',5.3230099791384085
ENSG00000123610,204.0,E-GEOD-120774,1.2,'coronary artery disease' vs 'normal' in 'subcutaneous adipose tissue',5.3230099791384085
ENSG00000175356,1601.0,E-GEOD-38959,-2.3,'breast cancer; breast' vs 'normal; breast',7.379008127628304
ENSG00000175356,1601.0,E-GEOD-7377,2.6,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.379008127628304
ENSG00000117569,1945.0,,,,7.57353126274595
ENSG00000125571,1.0,,,,0.6931471805599453
ENSG00000116580,3060.0,,,,8.026496938945412
ENSG00000185608,897.0,,,,6.8001700683022
ENSG00000007968,30.0,E-GEOD-38959,1.9,'breast cancer; breast' vs 'normal; breast',3.4339872044851463
ENSG00000129667,1693.0,,,,7.434847875211999
ENSG00000136943,32.0,E-GEOD-38959,1.5,'breast cancer; breast' vs 'normal; breast',3.4965075614664802
ENSG00000168811,21.0,,,,3.091042453358316
ENSG00000176170,1252.0,,,,7.133295954896068
ENSG00000100196,422.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',6.0473721790462776
ENSG00000100196,422.0,E-GEOD-44408,-1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.0473721790462776
ENSG00000132481,1114.0,,,,7.016609683894219
ENSG00000157214,1601.0,,,,7.379008127628304
ENSG00000171033,147.0,,,,4.997212273764115
ENSG00000165949,3531.0,E-GEOD-54002,3.7,'breast cancer' vs 'normal',8.16961956172385
ENSG00000165949,3531.0,E-GEOD-38959,2.7,'breast cancer; breast' vs 'normal; breast',8.16961956172385
ENSG00000159231,238.0,,,,5.476463551931511
ENSG00000131435,1476.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',7.29776828253138
ENSG00000131435,1476.0,E-GEOD-54002,-2.3,'breast cancer' vs 'normal',7.29776828253138
ENSG00000169814,785.0,,,,6.666956792429207
ENSG00000154217,1485.0,,,,7.303843225277705
ENSG00000042445,6453.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.772455372611907
ENSG00000213281,1536.0,,,,7.337587743538596
ENSG00000137491,1846.0,,,,7.52131798019924
ENSG00000145147,1070.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',6.976348070447749
ENSG00000198252,954.0,E-GEOD-31138,1.9,'invasive ductal carcinoma' vs 'normal',6.86171134048073
ENSG00000175931,1749.0,,,,7.4673710669175595
ENSG00000101844,578.0,,,,6.361302477572996
ENSG00000129562,3642.0,,,,8.200562797008564
ENSG00000087460,34684.0,,,,10.454062595819401
ENSG00000164938,2301.0,,,,7.741533589281828
ENSG00000164048,1006.0,,,,6.914730892718563
ENSG00000125735,218.0,,,,5.389071729816501
ENSG00000125731,718.0,,,,6.577861357721047
ENSG00000164609,2155.0,,,,7.6760099320288875
ENSG00000106723,3421.0,,,,8.137980454452139
ENSG00000177427,491.0,,,,6.198478716492308
ENSG00000186469,1556.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',7.350516171833998
ENSG00000188822,25.0,,,,3.258096538021482
ENSG00000165072,1194.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',7.085901464365611
ENSG00000165072,1194.0,E-GEOD-54002,-4.1,'breast cancer' vs 'normal',7.085901464365611
ENSG00000165072,1194.0,E-GEOD-10780,-2.7,'breast carcinoma' vs 'normal',7.085901464365611
ENSG00000163874,1548.0,E-GEOD-52194,-4.9,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',7.3453648404168685
ENSG00000163874,1548.0,E-GEOD-52194,-5.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',7.3453648404168685
ENSG00000163874,1548.0,E-GEOD-52194,-4.9,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',7.3453648404168685
ENSG00000159147,582.0,E-GEOD-54002,1.4,'breast cancer' vs 'normal',6.368187186350492
ENSG00000159147,582.0,E-GEOD-31138,2.2,'invasive ductal carcinoma' vs 'normal',6.368187186350492
ENSG00000159147,582.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',6.368187186350492
ENSG00000184007,10328.0,E-GEOD-7377,1.7,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',9.242710752006634
ENSG00000080293,14.0,E-GEOD-52194,5.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',2.70805020110221
ENSG00000108506,671.0,,,,6.51025834052315
ENSG00000177374,1383.0,,,,7.232733136177615
ENSG00000103522,12.0,E-GEOD-44408,2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',2.5649493574615367
ENSG00000143363,1049.0,,,,6.956545443151569
ENSG00000047644,2716.0,,,,7.907283609426348
ENSG00000169248,3.0,E-GEOD-54002,2.1,'breast cancer' vs 'normal',1.3862943611198906
ENSG00000169248,3.0,E-GEOD-10780,1.7,'breast carcinoma' vs 'normal',1.3862943611198906
ENSG00000169248,3.0,E-GEOD-38959,2.1,'breast cancer; breast' vs 'normal; breast',1.3862943611198906
ENSG00000108587,2005.0,,,,7.603897968521881
ENSG00000075089,876.0,,,,6.776506992372183
ENSG00000068001,3983.0,,,,8.290041618704489
ENSG00000115590,148.0,,,,5.003946305945459
ENSG00000111885,6626.0,,,,8.798907492088226
ENSG00000138073,3061.0,,,,8.026823576217629
ENSG00000239697,1700.0,,,,7.438971592395862
ENSG00000106799,1980.0,E-GEOD-31138,2.1,'invasive ductal carcinoma' vs 'normal',7.591357046698551
ENSG00000088386,20.0,,,,3.044522437723423
ENSG00000175895,993.0,E-MTAB-779,1.2,'breast carcinoma' vs 'normal',6.901737206656574
ENSG00000175895,993.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.901737206656574
ENSG00000175895,993.0,E-GEOD-31138,3.1,'invasive ductal carcinoma' vs 'normal',6.901737206656574
ENSG00000183018,1982.0,,,,7.592366128519796
ENSG00000011105,3155.0,E-GEOD-7377,1.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.057060681965766
ENSG00000205213,1249.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',7.1308988302963465
ENSG00000205213,1249.0,E-GEOD-54002,-2.5,'breast cancer' vs 'normal',7.1308988302963465
ENSG00000102230,17.0,,,,2.8903717578961645
ENSG00000083444,4435.0,,,,8.397508348470257
ENSG00000175497,4.0,E-GEOD-68086,-5.0,'breast carcinoma' vs 'normal',1.6094379124341003
ENSG00000120471,10.0,,,,2.3978952727983707
ENSG00000204308,1485.0,,,,7.303843225277705
ENSG00000153234,1080.0,,,,6.985641817639208
ENSG00000121281,275.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.62040086571715
ENSG00000121281,275.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',5.62040086571715
ENSG00000147912,275.0,,,,5.62040086571715
ENSG00000198001,1551.0,,,,7.347299700743164
ENSG00000070269,955.0,,,,6.862757913051401
ENSG00000005801,852.0,,,,6.748759547491679
ENSG00000151151,543.0,,,,6.298949246855942
ENSG00000109079,3243.0,,,,8.084562415235304
ENSG00000123104,2147.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',7.672292455628756
ENSG00000123104,2147.0,E-GEOD-31138,2.7,'invasive ductal carcinoma' vs 'normal',7.672292455628756
ENSG00000100300,4835.0,,,,8.483843211734683
ENSG00000172817,178.0,E-GEOD-54002,-2.4,'breast cancer' vs 'normal',5.187385805840755
ENSG00000111664,166.0,,,,5.117993812416755
ENSG00000089327,4665.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.448057452581375
ENSG00000089327,4665.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',8.448057452581375
ENSG00000009724,218.0,,,,5.389071729816501
ENSG00000156976,19087.0,,,,9.856815144337697
ENSG00000090661,1126.0,,,,7.027314514039777
ENSG00000143499,1382.0,E-GEOD-31138,2.5,'invasive ductal carcinoma' vs 'normal',7.232010331664759
ENSG00000140743,1146.0,,,,7.044905117129371
ENSG00000135842,4943.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',8.505929999137527
ENSG00000135842,4943.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',8.505929999137527
ENSG00000135842,4943.0,E-GEOD-38959,-1.6,'breast cancer; breast' vs 'normal; breast',8.505929999137527
ENSG00000167995,535.0,,,,6.284134161070802
ENSG00000198183,0.0,,,,0.0
ENSG00000183963,7734.0,,,,8.953510763007166
ENSG00000104723,1191.0,,,,7.083387847625295
ENSG00000198087,1789.0,,,,7.489970898834801
ENSG00000164828,11285.0,,,,9.331318298529085
ENSG00000105641,16.0,,,,2.833213344056216
ENSG00000244617,129.0,,,,4.867534450455582
ENSG00000198901,357.0,,,,5.8805329864007
ENSG00000138180,23.0,E-MTAB-779,1.6,'breast carcinoma' vs 'normal',3.1780538303479458
ENSG00000138180,23.0,E-GEOD-54002,3.6,'breast cancer' vs 'normal',3.1780538303479458
ENSG00000138180,23.0,E-GEOD-10780,1.8,'breast carcinoma' vs 'normal',3.1780538303479458
ENSG00000138180,23.0,E-GEOD-31138,3.6,'invasive ductal carcinoma' vs 'normal',3.1780538303479458
ENSG00000138180,23.0,E-GEOD-38959,2.8,'breast cancer; breast' vs 'normal; breast',3.1780538303479458
ENSG00000141577,827.0,,,,6.71901315438526
ENSG00000063660,2643.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.880048200971577
ENSG00000175920,27.0,E-MTAB-779,2.0,'breast carcinoma' vs 'normal',3.332204510175204
ENSG00000007062,459.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',6.131226489483141
ENSG00000007062,459.0,E-GEOD-54002,-4.1,'breast cancer' vs 'normal',6.131226489483141
ENSG00000007062,459.0,E-GEOD-10780,-1.7,'breast carcinoma' vs 'normal',6.131226489483141
ENSG00000007062,459.0,E-GEOD-52194,-5.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',6.131226489483141
ENSG00000007062,459.0,E-GEOD-7377,-2.8,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.131226489483141
ENSG00000129757,3132.0,E-GEOD-54002,-2.2,'breast cancer' vs 'normal',8.049746290952191
ENSG00000129757,3132.0,E-GEOD-10780,-1.9,'breast carcinoma' vs 'normal',8.049746290952191
ENSG00000152056,58.0,,,,4.07753744390572
ENSG00000205581,5331.0,,,,8.5814816812986
ENSG00000160221,33.0,,,,3.5263605246161616
ENSG00000163106,70.0,,,,4.2626798770413155
ENSG00000171631,60.0,,,,4.110873864173311
ENSG00000004897,2910.0,,,,7.976251943745623
ENSG00000109180,4268.0,,,,8.359134886757962
ENSG00000157423,25.0,,,,3.258096538021482
ENSG00000186132,262.0,E-GEOD-31138,3.1,'invasive ductal carcinoma' vs 'normal',5.572154032177765
ENSG00000175470,1779.0,,,,7.484368643286131
ENSG00000154639,179.0,E-GEOD-44408,-2.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.19295685089021
ENSG00000120907,175.0,,,,5.170483995038151
ENSG00000049618,4162.0,,,,8.333991247194975
ENSG00000196954,3524.0,E-GEOD-44408,1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.16763571524637
ENSG00000160803,2241.0,,,,7.715123603632105
ENSG00000116670,914.0,,,,6.818924065275521
ENSG00000054219,369.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',5.91350300563827
ENSG00000054219,369.0,E-GEOD-44408,2.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.91350300563827
ENSG00000054219,369.0,E-GEOD-54002,-3.2,'breast cancer' vs 'normal',5.91350300563827
ENSG00000069020,2709.0,,,,7.904703913873747
ENSG00000173801,6981.0,E-GEOD-44408,-1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.851090687664982
ENSG00000165480,11.0,,,,2.4849066497880004
ENSG00000272398,4037.0,,,,8.303504798872783
ENSG00000172116,37.0,,,,3.6375861597263857
ENSG00000102225,3924.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.275121630216509
ENSG00000103091,2395.0,,,,7.78155595923534
ENSG00000122565,5096.0,,,,8.536407410340042
ENSG00000135439,161.0,,,,5.087596335232384
ENSG00000188389,33.0,,,,3.5263605246161616
ENSG00000121152,52.0,E-GEOD-54002,1.7,'breast cancer' vs 'normal',3.970291913552122
ENSG00000121152,52.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',3.970291913552122
ENSG00000137124,885.0,,,,6.786716950605081
ENSG00000105717,109.0,,,,4.700480365792417
ENSG00000172809,11870.0,,,,9.381853730053534
ENSG00000138069,7091.0,,,,8.866722667194098
ENSG00000180210,2.0,,,,1.0986122886681098
ENSG00000187772,0.0,E-GEOD-52194,6.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000197580,130.0,,,,4.875197323201151
ENSG00000051180,38.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',3.6635616461296463
ENSG00000051180,38.0,E-GEOD-54002,1.7,'breast cancer' vs 'normal',3.6635616461296463
ENSG00000051180,38.0,E-GEOD-38959,2.2,'breast cancer; breast' vs 'normal; breast',3.6635616461296463
ENSG00000135744,154.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',5.043425116919247
ENSG00000142583,197.0,,,,5.288267030694535
ENSG00000132334,1681.0,E-GEOD-44408,1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.427738840532894
ENSG00000132334,1681.0,E-GEOD-20086,1.1,'breast cancer' vs 'normal',7.427738840532894
ENSG00000107789,566.0,,,,6.340359303727752
ENSG00000196562,4453.0,,,,8.401557847817314
ENSG00000162775,450.0,E-GEOD-31138,2.6,'invasive ductal carcinoma' vs 'normal',6.111467339502679
ENSG00000167080,109.0,,,,4.700480365792417
ENSG00000117984,14728.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',9.597573618489543
ENSG00000164078,188.0,,,,5.241747015059643
ENSG00000120156,1460.0,,,,7.2868764117507
ENSG00000089250,9.0,,,,2.302585092994046
ENSG00000119042,422.0,,,,6.0473721790462776
ENSG00000134765,15.0,,,,2.772588722239781
ENSG00000204209,2541.0,,,,7.8407064517494
ENSG00000104081,546.0,,,,6.304448802421981
ENSG00000173611,620.0,,,,6.431331081933479
ENSG00000143368,2254.0,,,,7.720905251936779
ENSG00000137218,398.0,,,,5.988961416889864
ENSG00000160683,2.0,E-GEOD-44408,1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',1.0986122886681098
ENSG00000117054,2097.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.6487397889562425
ENSG00000134308,9425.0,,,,9.151227107483676
ENSG00000175084,1333.0,,,,7.195937226475569
ENSG00000100342,2558.0,,,,7.847371836159788
ENSG00000170454,0.0,,,,0.0
ENSG00000114125,1986.0,,,,7.594381242551817
ENSG00000183960,59.0,E-GEOD-54002,-2.5,'breast cancer' vs 'normal',4.0943445622221
ENSG00000198408,13135.0,,,,9.48311183169221
ENSG00000052802,815.0,,,,6.704414354964107
ENSG00000100764,1217.0,,,,7.1049654482698426
ENSG00000204264,2325.0,,,,7.75190533307861
ENSG00000091972,651.0,E-GEOD-31138,2.4,'invasive ductal carcinoma' vs 'normal',6.480044561926653
ENSG00000091972,651.0,E-GEOD-54002,-2.7,'breast cancer' vs 'normal',6.480044561926653
ENSG00000091972,651.0,E-GEOD-38959,-1.7,'breast cancer; breast' vs 'normal; breast',6.480044561926653
ENSG00000091972,651.0,E-GEOD-20086,1.2,'breast cancer' vs 'normal',6.480044561926653
ENSG00000198890,368.0,,,,5.910796644040527
ENSG00000087884,762.0,,,,6.637258031284457
ENSG00000172379,195.0,,,,5.278114659230517
ENSG00000116106,827.0,,,,6.71901315438526
ENSG00000158517,49.0,,,,3.912023005428146
ENSG00000182979,4155.0,,,,8.332308352219117
ENSG00000115641,3213.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',8.075271546297458
ENSG00000204348,1181.0,,,,7.074963197966044
ENSG00000121068,1826.0,,,,7.510430556378006
ENSG00000171115,2047.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',7.6246189861593985
ENSG00000169398,4289.0,,,,8.364042011922063
ENSG00000145907,5871.0,,,,8.677950570294351
ENSG00000100632,2266.0,,,,7.726212650507529
ENSG00000274641,0.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',0.0
ENSG00000274641,0.0,E-GEOD-38959,1.8,'breast cancer; breast' vs 'normal; breast',0.0
ENSG00000274641,0.0,E-GEOD-52194,8.9,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000274641,0.0,E-GEOD-52194,8.9,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',0.0
ENSG00000274641,0.0,E-GEOD-52194,8.0,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000132932,27.0,E-GEOD-52194,4.7,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',3.332204510175204
ENSG00000132932,27.0,E-GEOD-68086,-5.1,'breast carcinoma' vs 'normal',3.332204510175204
ENSG00000124299,2963.0,,,,7.994294986415977
ENSG00000158195,9729.0,,,,9.18296917518005
ENSG00000035403,11343.0,,,,9.336444248771908
ENSG00000118113,9.0,,,,2.302585092994046
ENSG00000187556,4.0,,,,1.6094379124341003
ENSG00000102786,1733.0,,,,7.458186157340487
ENSG00000149136,5757.0,,,,8.65834547117212
ENSG00000143321,7845.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',8.967759126769497
ENSG00000125445,1672.0,,,,7.422373700986824
ENSG00000259384,10.0,,,,2.3978952727983707
ENSG00000132185,6.0,,,,1.9459101490553132
ENSG00000136231,22.0,E-GEOD-52194,5.3,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',3.1354942159291497
ENSG00000136231,22.0,E-GEOD-52194,8.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',3.1354942159291497
ENSG00000106462,356.0,E-GEOD-54002,1.9,'breast cancer' vs 'normal',5.877735781779639
ENSG00000106462,356.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',5.877735781779639
ENSG00000106462,356.0,E-GEOD-10780,1.4,'breast carcinoma' vs 'normal',5.877735781779639
ENSG00000106462,356.0,E-GEOD-38959,1.8,'breast cancer; breast' vs 'normal; breast',5.877735781779639
ENSG00000106462,356.0,E-GEOD-31138,3.4,'invasive ductal carcinoma' vs 'normal',5.877735781779639
ENSG00000186652,27.0,,,,3.332204510175204
ENSG00000100749,374.0,,,,5.926926025970411
ENSG00000137672,411.0,,,,6.021023349349527
ENSG00000198648,1062.0,,,,6.968850378341948
ENSG00000171540,0.0,,,,0.0
ENSG00000033050,2226.0,,,,7.708410667257367
ENSG00000101213,124.0,,,,4.8283137373023015
ENSG00000170471,3433.0,,,,8.141481041457421
ENSG00000167754,225.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',5.420534999272286
ENSG00000167754,225.0,E-GEOD-54002,-3.3,'breast cancer' vs 'normal',5.420534999272286
ENSG00000171759,6.0,,,,1.9459101490553132
ENSG00000197930,2101.0,,,,7.650644551436897
ENSG00000077984,133.0,E-GEOD-44408,1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.897839799950911
ENSG00000186106,699.0,,,,6.551080335043404
ENSG00000126262,72.0,,,,4.290459441148391
ENSG00000164307,2744.0,,,,7.917536353943631
ENSG00000175606,896.0,E-GEOD-31138,2.2,'invasive ductal carcinoma' vs 'normal',6.799055862058796
ENSG00000175606,896.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',6.799055862058796
ENSG00000184650,1.0,,,,0.6931471805599453
ENSG00000182511,2192.0,,,,7.693025748417888
ENSG00000129151,102.0,E-GEOD-54002,-5.4,'breast cancer' vs 'normal',4.634728988229636
ENSG00000129151,102.0,E-MTAB-779,-2.0,'breast carcinoma' vs 'normal',4.634728988229636
ENSG00000129151,102.0,E-GEOD-10780,-1.7,'breast carcinoma' vs 'normal',4.634728988229636
ENSG00000135414,380.0,,,,5.942799375126701
ENSG00000165280,12423.0,,,,9.427385364828522
ENSG00000160862,11864.0,E-GEOD-7377,1.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',9.381348168869865
ENSG00000160862,11864.0,E-GEOD-38959,-2.4,'breast cancer; breast' vs 'normal; breast',9.381348168869865
ENSG00000160862,11864.0,E-GEOD-44408,-6.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.381348168869865
ENSG00000088247,5447.0,,,,8.60300384782935
ENSG00000071553,4523.0,,,,8.41715183723601
ENSG00000175387,4175.0,E-GEOD-31138,2.4,'invasive ductal carcinoma' vs 'normal',8.337109129562474
ENSG00000261701,12.0,,,,2.5649493574615367
ENSG00000014257,40.0,,,,3.713572066704308
ENSG00000144749,4512.0,E-GEOD-38959,-1.7,'breast cancer; breast' vs 'normal; breast',8.414717399827001
ENSG00000144749,4512.0,E-GEOD-20086,1.2,'breast cancer' vs 'normal',8.414717399827001
ENSG00000070367,2170.0,,,,7.682943169878292
ENSG00000135222,0.0,E-GEOD-52194,-7.6,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000135222,0.0,E-GEOD-52194,-7.9,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',0.0
ENSG00000135222,0.0,E-GEOD-52194,-8.9,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000083290,1462.0,,,,7.288244401020124
ENSG00000076928,7580.0,,,,8.933400396056303
ENSG00000069849,3981.0,E-GEOD-38959,1.9,'breast cancer; breast' vs 'normal; breast',8.289539484624141
ENSG00000128604,330.0,,,,5.802118375377063
ENSG00000196159,1399.0,,,,7.24422751560335
ENSG00000133687,4626.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',8.439663988907
ENSG00000133687,4626.0,E-GEOD-54002,-2.6,'breast cancer' vs 'normal',8.439663988907
ENSG00000133687,4626.0,E-GEOD-10780,-1.8,'breast carcinoma' vs 'normal',8.439663988907
ENSG00000133687,4626.0,E-GEOD-38959,-1.9,'breast cancer; breast' vs 'normal; breast',8.439663988907
ENSG00000206538,2513.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',7.829630389150193
ENSG00000206538,2513.0,E-MTAB-779,-1.7,'breast carcinoma' vs 'normal',7.829630389150193
ENSG00000130726,8269.0,,,,9.020389788017736
ENSG00000186654,933.0,,,,6.839476438228843
ENSG00000137693,5552.0,E-GEOD-44408,-1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.622093601241607
ENSG00000137693,5552.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',8.622093601241607
ENSG00000068697,14852.0,,,,9.605957144029533
ENSG00000113558,9279.0,,,,9.135616825780247
ENSG00000130940,1201.0,,,,7.091742115095153
ENSG00000128610,0.0,,,,0.0
ENSG00000086827,835.0,,,,6.728628613084702
ENSG00000159023,1870.0,,,,7.534228326274089
ENSG00000164270,2.0,E-GEOD-52194,4.9,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000124151,3725.0,,,,8.223090551161533
ENSG00000185264,0.0,,,,0.0
ENSG00000129810,12.0,,,,2.5649493574615367
ENSG00000151655,19.0,,,,2.995732273553991
ENSG00000178662,150.0,E-GEOD-54002,-2.0,'breast cancer' vs 'normal',5.017279836814924
ENSG00000178662,150.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',5.017279836814924
ENSG00000178662,150.0,E-GEOD-38959,-1.6,'breast cancer; breast' vs 'normal; breast',5.017279836814924
ENSG00000170989,7119.0,E-GEOD-44408,1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.87066300440602
ENSG00000170989,7119.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',8.87066300440602
ENSG00000115596,132.0,,,,4.890349128221754
ENSG00000145321,2.0,,,,1.0986122886681098
ENSG00000144290,3.0,,,,1.3862943611198906
ENSG00000002330,1089.0,,,,6.993932975223189
ENSG00000138029,7038.0,,,,8.85922139360813
ENSG00000166816,575.0,,,,6.3561076606958915
ENSG00000111262,24.0,,,,3.2188758248682006
ENSG00000161526,3471.0,,,,8.15248607578024
ENSG00000165997,1296.0,,,,7.167809184316444
ENSG00000168769,1708.0,,,,7.443663683115591
ENSG00000166963,1173.0,,,,7.068172000388042
ENSG00000062038,504.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',6.22455842927536
ENSG00000148834,2406.0,,,,7.786136437783072
ENSG00000133104,4248.0,,,,8.354438940114811
ENSG00000159200,2803.0,E-GEOD-10780,-1.5,'breast carcinoma' vs 'normal',7.938802248154481
ENSG00000159200,2803.0,E-GEOD-54002,-2.9,'breast cancer' vs 'normal',7.938802248154481
ENSG00000159200,2803.0,E-GEOD-52194,-5.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',7.938802248154481
ENSG00000186204,576.0,E-GEOD-31138,-1.7,'invasive ductal carcinoma' vs 'normal',6.3578422665081
ENSG00000139112,8937.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',9.098067129493398
ENSG00000168610,16585.0,,,,9.71631424501115
ENSG00000138279,6109.0,,,,8.71768205216564
ENSG00000177697,14371.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.573037148233409
ENSG00000177697,14371.0,E-GEOD-7377,1.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',9.573037148233409
ENSG00000183971,4.0,,,,1.6094379124341003
ENSG00000196776,4140.0,,,,8.328692583545568
ENSG00000128272,19827.0,,,,9.894850359140465
ENSG00000108684,2.0,,,,1.0986122886681098
ENSG00000158290,3410.0,,,,8.134760782418645
ENSG00000090006,9831.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',9.19339765124587
ENSG00000100354,2152.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',7.674617497364363
ENSG00000138449,3535.0,E-GEOD-31138,2.2,'invasive ductal carcinoma' vs 'normal',8.170751423757535
ENSG00000138449,3535.0,E-GEOD-38959,-1.7,'breast cancer; breast' vs 'normal; breast',8.170751423757535
ENSG00000138449,3535.0,E-GEOD-20086,-2.1,'breast cancer' vs 'normal',8.170751423757535
ENSG00000138449,3535.0,E-GEOD-7377,2.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.170751423757535
ENSG00000126351,3981.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',8.289539484624141
ENSG00000156127,165.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',5.111987788356544
ENSG00000140044,1993.0,,,,7.597897950521784
ENSG00000169344,2.0,,,,1.0986122886681098
ENSG00000064886,425.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.054439346269371
ENSG00000040633,1169.0,E-GEOD-31138,1.9,'invasive ductal carcinoma' vs 'normal',7.064759027791802
ENSG00000118231,0.0,,,,0.0
ENSG00000186716,3446.0,,,,8.145259566516865
ENSG00000132872,1.0,,,,0.6931471805599453
ENSG00000167468,13797.0,,,,9.532278933106054
ENSG00000173894,144.0,E-GEOD-54002,2.0,'breast cancer' vs 'normal',4.976733742420574
ENSG00000113722,9.0,,,,2.302585092994046
ENSG00000103044,333.0,E-GEOD-10780,-1.6,'breast carcinoma' vs 'normal',5.811140992976701
ENSG00000103044,333.0,E-GEOD-54002,-3.7,'breast cancer' vs 'normal',5.811140992976701
ENSG00000197747,9397.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',9.14825217966276
ENSG00000164305,899.0,,,,6.802394763324311
ENSG00000224389,193.0,,,,5.267858159063328
ENSG00000049540,7262.0,,,,8.890548245606167
ENSG00000175793,317.0,E-GEOD-31138,2.3,'invasive ductal carcinoma' vs 'normal',5.762051382780177
ENSG00000161956,731.0,,,,6.595780513961311
ENSG00000164615,2017.0,,,,7.609862200913554
ENSG00000150540,2024.0,E-GEOD-7377,1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.613324979540639
ENSG00000111245,79.0,,,,4.382026634673881
ENSG00000134640,0.0,E-GEOD-52194,5.7,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000106003,725.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',6.587550014824796
ENSG00000170242,4285.0,,,,8.363109176033522
ENSG00000126581,2284.0,,,,7.734121303328305
ENSG00000064199,94.0,,,,4.553876891600541
ENSG00000102967,730.0,,,,6.594413459749778
ENSG00000180739,28.0,,,,3.367295829986474
ENSG00000104738,922.0,E-GEOD-10780,1.4,'breast carcinoma' vs 'normal',6.827629234502852
ENSG00000104738,922.0,E-GEOD-31138,2.7,'invasive ductal carcinoma' vs 'normal',6.827629234502852
ENSG00000104738,922.0,E-GEOD-38959,1.7,'breast cancer; breast' vs 'normal; breast',6.827629234502852
ENSG00000186081,10396.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',9.249272581977971
ENSG00000186081,10396.0,E-GEOD-38959,-1.5,'breast cancer; breast' vs 'normal; breast',9.249272581977971
ENSG00000186081,10396.0,E-GEOD-54002,-4.6,'breast cancer' vs 'normal',9.249272581977971
ENSG00000186081,10396.0,E-GEOD-10780,-2.9,'breast carcinoma' vs 'normal',9.249272581977971
ENSG00000186081,10396.0,E-GEOD-52194,-6.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',9.249272581977971
ENSG00000112276,294.0,,,,5.68697535633982
ENSG00000116661,338.0,,,,5.82600010738045
ENSG00000176108,880.0,,,,6.78105762593618
ENSG00000175592,223.0,E-GEOD-52194,-7.8,'triple-negative breast cancer; breast carcinoma' vs 'normal',5.4116460518550396
ENSG00000175592,223.0,E-GEOD-52194,-8.2,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',5.4116460518550396
ENSG00000175592,223.0,E-GEOD-52194,-8.7,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',5.4116460518550396
ENSG00000155380,835.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',6.728628613084702
ENSG00000117676,1000.0,,,,6.90875477931522
ENSG00000106278,100.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',4.61512051684126
ENSG00000106278,100.0,E-GEOD-54002,-4.1,'breast cancer' vs 'normal',4.61512051684126
ENSG00000160307,873.0,E-GEOD-54002,-2.8,'breast cancer' vs 'normal',6.773080375655535
ENSG00000160307,873.0,E-GEOD-10780,-1.5,'breast carcinoma' vs 'normal',6.773080375655535
ENSG00000120341,28.0,,,,3.367295829986474
ENSG00000100906,9513.0,E-GEOD-52194,-4.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',9.160519676992227
ENSG00000114737,2215.0,E-MTAB-779,1.7,'breast carcinoma' vs 'normal',7.703459047867175
ENSG00000067082,20711.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',9.938468521431373
ENSG00000092871,640.0,,,,6.46302945692067
ENSG00000152684,1195.0,,,,7.086737934510577
ENSG00000138207,4334.0,E-GEOD-10780,-2.9,'breast carcinoma' vs 'normal',8.374476889214643
ENSG00000138207,4334.0,E-MTAB-779,-3.3,'breast carcinoma' vs 'normal',8.374476889214643
ENSG00000101115,14.0,,,,2.70805020110221
ENSG00000074621,595.0,,,,6.39024066706535
ENSG00000064205,3966.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',8.28576542051433
ENSG00000101438,0.0,,,,0.0
ENSG00000162704,5148.0,,,,8.546557800046141
ENSG00000130005,514.0,,,,6.244166900663736
ENSG00000176153,45.0,,,,3.828641396489095
ENSG00000105894,415.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',6.030685260261263
ENSG00000105894,415.0,E-GEOD-54002,-5.6,'breast cancer' vs 'normal',6.030685260261263
ENSG00000105894,415.0,E-GEOD-10780,-3.0,'breast carcinoma' vs 'normal',6.030685260261263
ENSG00000105894,415.0,E-GEOD-38959,-3.3,'breast cancer; breast' vs 'normal; breast',6.030685260261263
ENSG00000081479,264.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',5.579729825986222
ENSG00000081479,264.0,E-GEOD-54002,-2.3,'breast cancer' vs 'normal',5.579729825986222
ENSG00000081479,264.0,E-GEOD-7377,1.6,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',5.579729825986222
ENSG00000166579,3463.0,,,,8.150179269682326
ENSG00000090863,8522.0,,,,9.050523670522297
ENSG00000159958,44.0,,,,3.8066624897703196
ENSG00000113749,68.0,,,,4.23410650459726
ENSG00000143549,10582.0,,,,9.267004219093725
ENSG00000164904,1851.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',7.524021415206125
ENSG00000158825,116.0,,,,4.762173934797756
ENSG00000105058,2674.0,,,,7.891704659330107
ENSG00000162407,12237.0,E-MTAB-779,-1.8,'breast carcinoma' vs 'normal',9.412301144022486
ENSG00000162407,12237.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',9.412301144022486
ENSG00000162407,12237.0,E-GEOD-20086,-1.1,'breast cancer' vs 'normal',9.412301144022486
ENSG00000105974,19920.0,E-GEOD-31138,-1.8,'invasive ductal carcinoma' vs 'normal',9.899529730681785
ENSG00000105974,19920.0,E-GEOD-54002,-2.5,'breast cancer' vs 'normal',9.899529730681785
ENSG00000105974,19920.0,E-MTAB-779,-2.4,'breast carcinoma' vs 'normal',9.899529730681785
ENSG00000105974,19920.0,E-GEOD-10780,-2.0,'breast carcinoma' vs 'normal',9.899529730681785
ENSG00000132471,9145.0,,,,9.121071904218
ENSG00000016082,2.0,,,,1.0986122886681098
ENSG00000205076,3.0,,,,1.3862943611198906
ENSG00000116729,2133.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.665753431861699
ENSG00000116729,2133.0,E-GEOD-54002,-2.6,'breast cancer' vs 'normal',7.665753431861699
ENSG00000116729,2133.0,E-GEOD-10780,-1.8,'breast carcinoma' vs 'normal',7.665753431861699
ENSG00000135164,5112.0,,,,8.53954159508
ENSG00000267467,0.0,,,,0.0
ENSG00000119711,1546.0,,,,7.344072850573066
ENSG00000136457,177.0,,,,5.181783550292085
ENSG00000113575,4223.0,,,,8.348537825386098
ENSG00000155008,902.0,,,,6.805722553416985
ENSG00000134318,5505.0,,,,8.613593685702552
ENSG00000162972,462.0,,,,6.137727054086234
ENSG00000198300,629.0,E-GEOD-54002,-2.9,'breast cancer' vs 'normal',6.4457198193855785
ENSG00000198300,629.0,E-GEOD-10780,-2.0,'breast carcinoma' vs 'normal',6.4457198193855785
ENSG00000134627,252.0,,,,5.53338948872752
ENSG00000164047,6.0,E-GEOD-38959,1.6,'breast cancer; breast' vs 'normal; breast',1.9459101490553132
ENSG00000164047,6.0,E-GEOD-52194,5.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.9459101490553132
ENSG00000164047,6.0,E-GEOD-52194,5.2,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',1.9459101490553132
ENSG00000125414,45.0,,,,3.828641396489095
ENSG00000124257,54.0,,,,4.007333185232471
ENSG00000175600,92.0,E-GEOD-20086,1.4,'breast cancer' vs 'normal',4.532599493153256
ENSG00000136352,1.0,,,,0.6931471805599453
ENSG00000106992,365.0,,,,5.902633333401366
ENSG00000124275,1567.0,,,,7.357556200910353
ENSG00000109610,4616.0,E-MTAB-779,-2.6,'breast carcinoma' vs 'normal',8.43750042250699
ENSG00000106392,1074.0,,,,6.980075940561763
ENSG00000125675,108.0,E-GEOD-31138,-1.8,'invasive ductal carcinoma' vs 'normal',4.6913478822291435
ENSG00000157404,1922.0,E-GEOD-54002,-5.5,'breast cancer' vs 'normal',7.56164174558878
ENSG00000157404,1922.0,E-MTAB-779,-2.2,'breast carcinoma' vs 'normal',7.56164174558878
ENSG00000157404,1922.0,E-GEOD-10780,-2.6,'breast carcinoma' vs 'normal',7.56164174558878
ENSG00000157404,1922.0,E-GEOD-38959,-2.4,'breast cancer; breast' vs 'normal; breast',7.56164174558878
ENSG00000157404,1922.0,E-GEOD-7377,-2.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.56164174558878
ENSG00000112499,0.0,E-GEOD-52194,4.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000112499,0.0,E-GEOD-52194,5.7,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000140443,4144.0,E-GEOD-38959,-1.7,'breast cancer; breast' vs 'normal; breast',8.329658067569396
ENSG00000163681,2733.0,,,,7.913521017283895
ENSG00000126453,384.0,,,,5.953243334287785
ENSG00000177666,32948.0,,,,10.402716190456456
ENSG00000159202,3813.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',8.246433786160365
ENSG00000134248,2345.0,,,,7.76046702921342
ENSG00000284770,0.0,,,,0.0
ENSG00000150316,1871.0,,,,7.534762657037537
ENSG00000140092,8274.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',9.020994200245264
ENSG00000140092,8274.0,E-MTAB-779,-1.9,'breast carcinoma' vs 'normal',9.020994200245264
ENSG00000205220,513.0,,,,6.2422232654551655
ENSG00000134480,1834.0,,,,7.51479976048867
ENSG00000179399,2.0,,,,1.0986122886681098
ENSG00000100373,2.0,,,,1.0986122886681098
ENSG00000074370,1287.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.160845906664299
ENSG00000165841,0.0,,,,0.0
ENSG00000015285,359.0,,,,5.886104031450156
ENSG00000113302,0.0,,,,0.0
ENSG00000168702,148.0,,,,5.003946305945459
ENSG00000116962,17377.0,E-GEOD-54002,1.9,'breast cancer' vs 'normal',9.762960317399152
ENSG00000122986,197.0,,,,5.288267030694535
ENSG00000173531,685.0,,,,6.530877627725885
ENSG00000105401,10170.0,,,,9.227295812625597
ENSG00000164404,33.0,,,,3.5263605246161616
ENSG00000099958,107.0,,,,4.68213122712422
ENSG00000160746,1757.0,,,,7.471932078245122
ENSG00000169876,0.0,E-GEOD-52194,6.7,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000169876,0.0,E-GEOD-52194,5.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000178295,394.0,,,,5.978885764901122
ENSG00000130816,2819.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.944492163932159
ENSG00000172638,3896.0,,,,8.26796230533871
ENSG00000105409,17.0,,,,2.8903717578961645
ENSG00000126457,4005.0,,,,8.295548516225763
ENSG00000161958,32.0,,,,3.4965075614664802
ENSG00000068796,712.0,,,,6.569481420414296
ENSG00000101017,1299.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.170119543449628
ENSG00000119421,1101.0,,,,7.004881989712859
ENSG00000181192,1229.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',7.114769448366463
ENSG00000181192,1229.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',7.114769448366463
ENSG00000144891,2280.0,E-GEOD-10780,-1.6,'breast carcinoma' vs 'normal',7.732369222284388
ENSG00000050555,189.0,,,,5.247024072160486
ENSG00000104695,3914.0,,,,8.272570608424903
ENSG00000113580,4540.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',8.420902531097951
ENSG00000113580,4540.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',8.420902531097951
ENSG00000113580,4540.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',8.420902531097951
ENSG00000181104,1133.0,,,,7.033506484287697
ENSG00000085224,3919.0,,,,8.273846932784508
ENSG00000061938,4689.0,,,,8.453187861440325
ENSG00000106511,1537.0,E-GEOD-44408,1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.338238150065589
ENSG00000106511,1537.0,E-GEOD-10780,-1.9,'breast carcinoma' vs 'normal',7.338238150065589
ENSG00000106511,1537.0,E-GEOD-31138,-4.0,'invasive ductal carcinoma' vs 'normal',7.338238150065589
ENSG00000102854,11.0,,,,2.4849066497880004
ENSG00000165125,175.0,,,,5.170483995038151
ENSG00000187134,2471.0,,,,7.812782818577581
ENSG00000136205,3804.0,,,,8.244071270295786
ENSG00000162616,1471.0,,,,7.294377299288821
ENSG00000158714,135.0,,,,4.912654885736052
ENSG00000015520,45.0,,,,3.828641396489095
ENSG00000110721,1642.0,,,,7.404279118037268
ENSG00000173517,4063.0,,,,8.309922989258318
ENSG00000113889,2.0,E-GEOD-68086,-5.1,'breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000096384,39223.0,,,,10.577044083331069
ENSG00000092068,2951.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',7.990238185720363
ENSG00000092068,2951.0,E-GEOD-31138,2.6,'invasive ductal carcinoma' vs 'normal',7.990238185720363
ENSG00000092068,2951.0,E-GEOD-7377,1.8,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.990238185720363
ENSG00000084110,43.0,,,,3.784189633918261
ENSG00000137033,1180.0,E-MTAB-779,-1.9,'breast carcinoma' vs 'normal',7.074116816197362
ENSG00000137033,1180.0,E-GEOD-31138,-2.7,'invasive ductal carcinoma' vs 'normal',7.074116816197362
ENSG00000137033,1180.0,E-GEOD-38959,-1.6,'breast cancer; breast' vs 'normal; breast',7.074116816197362
ENSG00000137033,1180.0,E-GEOD-44408,2.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.074116816197362
ENSG00000137033,1180.0,E-GEOD-54002,-4.2,'breast cancer' vs 'normal',7.074116816197362
ENSG00000137033,1180.0,E-GEOD-10780,-1.9,'breast carcinoma' vs 'normal',7.074116816197362
ENSG00000164754,7310.0,,,,8.897135342293316
ENSG00000070808,21.0,,,,3.091042453358316
ENSG00000130707,5792.0,E-GEOD-38959,1.5,'breast cancer; breast' vs 'normal; breast',8.664405571096625
ENSG00000020633,392.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',5.973809611869261
ENSG00000020633,392.0,E-GEOD-44408,2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.973809611869261
ENSG00000108055,2580.0,,,,7.855932199718614
ENSG00000162618,4850.0,,,,8.486940148245216
ENSG00000105464,50.0,E-MTAB-779,1.6,'breast carcinoma' vs 'normal',3.9318256327243257
ENSG00000052841,4590.0,,,,8.431853144249223
ENSG00000090530,436.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',6.07993319509559
ENSG00000111796,46.0,E-GEOD-44408,2.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.8501476017100584
ENSG00000011376,719.0,,,,6.579251212010101
ENSG00000128591,1674.0,,,,7.423568444259167
ENSG00000123124,3299.0,,,,8.101677747454572
ENSG00000136869,1888.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.543802867501509
ENSG00000109062,1613.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.3864708488298945
ENSG00000109062,1613.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',7.3864708488298945
ENSG00000109062,1613.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.3864708488298945
ENSG00000111704,16.0,,,,2.833213344056216
ENSG00000141582,674.0,E-GEOD-31138,2.7,'invasive ductal carcinoma' vs 'normal',6.51471269087253
ENSG00000107902,580.0,,,,6.364750756851911
ENSG00000167770,3090.0,,,,8.036249942132116
ENSG00000010278,5527.0,E-GEOD-44408,-2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.617581365447506
ENSG00000100345,61927.0,,,,11.03372769888455
ENSG00000079246,10350.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',9.24483841238375
ENSG00000143155,1328.0,,,,7.192182058713246
ENSG00000166888,14165.0,E-GEOD-38959,-1.4,'breast cancer; breast' vs 'normal; breast',9.558600006313569
ENSG00000277443,3871.0,E-GEOD-31138,1.9,'invasive ductal carcinoma' vs 'normal',8.261526448396468
ENSG00000278588,0.0,E-GEOD-38959,1.9,'breast cancer; breast' vs 'normal; breast',0.0
ENSG00000278588,0.0,E-GEOD-52194,8.2,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000278588,0.0,E-GEOD-52194,8.9,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',0.0
ENSG00000278588,0.0,E-GEOD-52194,6.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000008853,984.0,,,,6.892641641172089
ENSG00000137699,1608.0,E-GEOD-54002,-3.3,'breast cancer' vs 'normal',7.3833681469923835
ENSG00000137699,1608.0,E-GEOD-10780,-1.8,'breast carcinoma' vs 'normal',7.3833681469923835
ENSG00000165553,0.0,E-GEOD-52194,4.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000055917,5475.0,,,,8.60813018640834
ENSG00000044115,16899.0,E-GEOD-44408,-1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.735068900911164
ENSG00000101255,488.0,,,,6.192362489474872
ENSG00000164985,2699.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.90100705199242
ENSG00000188906,1181.0,,,,7.074963197966044
ENSG00000136573,22.0,E-GEOD-44408,2.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.1354942159291497
ENSG00000086696,80.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',4.394449154672439
ENSG00000185974,0.0,,,,0.0
ENSG00000058091,1273.0,,,,7.149916836132109
ENSG00000198752,5055.0,,,,8.528330935826693
ENSG00000184349,637.0,E-GEOD-54002,-2.2,'breast cancer' vs 'normal',6.45833828334479
ENSG00000099860,7172.0,E-GEOD-52194,-5.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',8.878079256126435
ENSG00000099860,7172.0,E-GEOD-52194,-5.1,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',8.878079256126435
ENSG00000099860,7172.0,E-GEOD-52194,-4.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',8.878079256126435
ENSG00000115339,535.0,E-GEOD-20086,2.4,'breast cancer' vs 'normal',6.284134161070802
ENSG00000130427,3.0,E-GEOD-52194,5.2,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',1.3862943611198906
ENSG00000100151,1786.0,,,,7.488293515159428
ENSG00000167531,0.0,E-GEOD-52194,-5.5,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',0.0
ENSG00000167531,0.0,E-GEOD-52194,-7.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000135097,37.0,,,,3.6375861597263857
ENSG00000196557,1661.0,,,,7.415776975415394
ENSG00000198646,2611.0,,,,7.867871490396322
ENSG00000170962,1943.0,E-GEOD-54002,-2.6,'breast cancer' vs 'normal',7.572502985020384
ENSG00000170962,1943.0,E-GEOD-10780,-1.7,'breast carcinoma' vs 'normal',7.572502985020384
ENSG00000129250,8297.0,,,,9.023769800892813
ENSG00000142178,215.0,,,,5.375278407684165
ENSG00000229117,30482.0,,,,10.324924430153992
ENSG00000109084,290.0,,,,5.673323267171493
ENSG00000185187,1466.0,,,,7.2909747781429814
ENSG00000119655,5939.0,,,,8.68946441235669
ENSG00000100979,5033.0,,,,8.523970175695261
ENSG00000105880,16.0,,,,2.833213344056216
ENSG00000234745,37976.0,,,,10.544735992304938
ENSG00000163482,1722.0,,,,7.45182223652793
ENSG00000138639,972.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.880384082186005
ENSG00000121060,3030.0,,,,8.016647877057803
ENSG00000121671,3887.0,,,,8.265650165580329
ENSG00000165917,20.0,,,,3.044522437723423
ENSG00000007047,1627.0,,,,7.395107546562485
ENSG00000171124,20.0,E-GEOD-68086,-5.3,'breast carcinoma' vs 'normal',3.044522437723423
ENSG00000178585,1395.0,,,,7.241366283322318
ENSG00000111700,0.0,,,,0.0
ENSG00000079785,4139.0,,,,8.32845106681936
ENSG00000176887,5.0,E-GEOD-38959,2.8,'breast cancer; breast' vs 'normal; breast',1.791759469228055
ENSG00000169704,2.0,,,,1.0986122886681098
ENSG00000168439,3654.0,,,,8.203851372183879
ENSG00000112033,2239.0,,,,7.7142311448490855
ENSG00000186458,25.0,E-GEOD-68086,-5.1,'breast carcinoma' vs 'normal',3.258096538021482
ENSG00000126432,4354.0,,,,8.379079889286603
ENSG00000081800,0.0,E-GEOD-52194,5.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000179218,13186.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',9.486986774807699
ENSG00000111877,872.0,E-GEOD-31138,2.2,'invasive ductal carcinoma' vs 'normal',6.771935555839602
ENSG00000064270,91.0,E-GEOD-7377,1.4,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',4.5217885770490405
ENSG00000110719,6716.0,,,,8.812396905266864
ENSG00000105825,279.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',5.634789603169249
ENSG00000105825,279.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',5.634789603169249
ENSG00000105825,279.0,E-GEOD-52194,-5.9,'triple-negative breast cancer; breast carcinoma' vs 'normal',5.634789603169249
ENSG00000002834,7273.0,E-GEOD-7377,1.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.892061625546935
ENSG00000100312,75.0,,,,4.330733340286331
ENSG00000135547,382.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',5.948034989180646
ENSG00000142168,6381.0,,,,8.76123680683819
ENSG00000004799,37845.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',10.541280572963995
ENSG00000004799,37845.0,E-GEOD-31138,-2.8,'invasive ductal carcinoma' vs 'normal',10.541280572963995
ENSG00000004799,37845.0,E-GEOD-54002,-3.2,'breast cancer' vs 'normal',10.541280572963995
ENSG00000004799,37845.0,E-GEOD-10780,-2.1,'breast carcinoma' vs 'normal',10.541280572963995
ENSG00000004799,37845.0,E-MTAB-779,-2.4,'breast carcinoma' vs 'normal',10.541280572963995
ENSG00000004799,37845.0,E-GEOD-38959,-3.0,'breast cancer; breast' vs 'normal; breast',10.541280572963995
ENSG00000144355,5.0,,,,1.791759469228055
ENSG00000115539,559.0,,,,6.327936783729195
ENSG00000108106,310.0,,,,5.739792912179234
ENSG00000065029,2437.0,,,,7.798933310041217
ENSG00000080371,3560.0,,,,8.177796683277778
ENSG00000133265,1162.0,,,,7.0587581525186645
ENSG00000134917,77.0,,,,4.356708826689592
ENSG00000005471,59.0,E-GEOD-44408,2.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.0943445622221
ENSG00000196748,1.0,,,,0.6931471805599453
ENSG00000133661,25.0,,,,3.258096538021482
ENSG00000227345,672.0,,,,6.511745329644728
ENSG00000204435,1722.0,,,,7.45182223652793
ENSG00000134375,1651.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',7.409741954080923
ENSG00000134375,1651.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',7.409741954080923
ENSG00000140538,939.0,,,,6.84587987526405
ENSG00000067113,3892.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',8.266935347610456
ENSG00000067113,3892.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',8.266935347610456
ENSG00000067113,3892.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',8.266935347610456
ENSG00000157227,12730.0,,,,9.451795243061646
ENSG00000145384,0.0,,,,0.0
ENSG00000112742,22.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',3.1354942159291497
ENSG00000112742,22.0,E-GEOD-54002,2.4,'breast cancer' vs 'normal',3.1354942159291497
ENSG00000112742,22.0,E-GEOD-10780,1.7,'breast carcinoma' vs 'normal',3.1354942159291497
ENSG00000204315,159.0,,,,5.075173815233827
ENSG00000110244,1.0,,,,0.6931471805599453
ENSG00000129235,626.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',6.440946540632921
ENSG00000129235,626.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.440946540632921
ENSG00000156453,2348.0,,,,7.761744984658913
ENSG00000134760,23.0,E-GEOD-54002,-2.3,'breast cancer' vs 'normal',3.1780538303479458
ENSG00000131828,3056.0,,,,8.025189321890835
ENSG00000101200,2.0,,,,1.0986122886681098
ENSG00000134538,0.0,,,,0.0
ENSG00000107164,2568.0,,,,7.851271997109883
ENSG00000112280,6.0,,,,1.9459101490553132
ENSG00000100146,0.0,E-GEOD-10780,-1.7,'breast carcinoma' vs 'normal',0.0
ENSG00000100146,0.0,E-GEOD-52194,-5.7,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000100604,10.0,,,,2.3978952727983707
ENSG00000169242,3126.0,E-GEOD-31138,1.6,'invasive ductal carcinoma' vs 'normal',8.047829357457841
ENSG00000169242,3126.0,E-GEOD-44408,-2.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.047829357457841
ENSG00000197323,2874.0,,,,7.963807953231451
ENSG00000214078,5002.0,,,,8.517793011488205
ENSG00000102683,60.0,E-GEOD-52194,4.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',4.110873864173311
ENSG00000102879,851.0,E-GEOD-44408,2.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.747586526829315
ENSG00000171310,645.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.470799503782602
ENSG00000127838,1359.0,,,,7.215239978730097
ENSG00000092208,292.0,,,,5.680172609017068
ENSG00000169241,1081.0,,,,6.9865664594064265
ENSG00000133818,1184.0,,,,7.077498053569231
ENSG00000105650,84.0,,,,4.442651256490317
ENSG00000102316,6767.0,E-GEOD-44408,-1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.81996090128606
ENSG00000102316,6767.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.81996090128606
ENSG00000203805,1.0,E-GEOD-54002,1.6,'breast cancer' vs 'normal',0.6931471805599453
ENSG00000203805,1.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000203805,1.0,E-GEOD-52194,5.8,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000203805,1.0,E-GEOD-52194,5.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000175216,3075.0,,,,8.031385330625534
ENSG00000125618,199.0,,,,5.298317366548036
ENSG00000123983,2760.0,,,,7.923348211930154
ENSG00000102981,91.0,,,,4.5217885770490405
ENSG00000143924,2701.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.9017475185201445
ENSG00000143924,2701.0,E-GEOD-7377,-1.6,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.9017475185201445
ENSG00000136167,2371.0,E-GEOD-44408,1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.771488760117616
ENSG00000169567,5491.0,,,,8.61104776688786
ENSG00000140459,99.0,,,,4.605170185988092
ENSG00000186834,2062.0,,,,7.631916513071252
ENSG00000197561,107.0,,,,4.68213122712422
ENSG00000085063,23943.0,,,,10.083473049532534
ENSG00000143185,3.0,,,,1.3862943611198906
ENSG00000105509,13.0,,,,2.6390573296152584
ENSG00000095777,10.0,,,,2.3978952727983707
ENSG00000180530,2634.0,E-GEOD-7377,2.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.876638460975463
ENSG00000095794,938.0,,,,6.844815479208263
ENSG00000119772,1414.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',7.254884810077338
ENSG00000064225,556.0,E-GEOD-54002,-2.0,'breast cancer' vs 'normal',6.322565239927284
ENSG00000031081,2502.0,,,,7.8252452914317745
ENSG00000143369,1633.0,E-GEOD-31138,2.1,'invasive ductal carcinoma' vs 'normal',7.3987862754199485
ENSG00000143369,1633.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',7.3987862754199485
ENSG00000143369,1633.0,E-GEOD-54002,2.2,'breast cancer' vs 'normal',7.3987862754199485
ENSG00000162849,46.0,,,,3.8501476017100584
ENSG00000077463,636.0,,,,6.456769655572163
ENSG00000100519,3051.0,,,,8.023552392404348
ENSG00000196754,53.0,,,,3.9889840465642745
ENSG00000006451,1845.0,,,,7.520776415062797
ENSG00000070031,2.0,,,,1.0986122886681098
ENSG00000111716,11664.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',9.36434818445553
ENSG00000111716,11664.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',9.36434818445553
ENSG00000111716,11664.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',9.36434818445553
ENSG00000164749,10.0,,,,2.3978952727983707
ENSG00000135454,146.0,,,,4.990432586778736
ENSG00000151779,1748.0,,,,7.466799475018602
ENSG00000116030,2606.0,,,,7.865955413933502
ENSG00000240065,841.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.7357800142423265
ENSG00000137868,54.0,,,,4.007333185232471
ENSG00000110435,1299.0,,,,7.170119543449628
ENSG00000111181,26.0,,,,3.295836866004329
ENSG00000114547,29.0,,,,3.4011973816621555
ENSG00000135447,4787.0,E-MTAB-779,-3.0,'breast carcinoma' vs 'normal',8.473868066677865
ENSG00000135447,4787.0,E-GEOD-10780,-1.9,'breast carcinoma' vs 'normal',8.473868066677865
ENSG00000108423,372.0,,,,5.921578419643816
ENSG00000051382,1443.0,,,,7.275172319452771
ENSG00000101079,1391.0,,,,7.238496840894365
ENSG00000144848,1864.0,,,,7.5310163320779155
ENSG00000151692,1577.0,E-GEOD-7377,-1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.363913501405819
ENSG00000166266,1716.0,,,,7.448333860897476
ENSG00000049246,1244.0,,,,7.126890808898808
ENSG00000125931,54.0,E-GEOD-52194,-5.3,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',4.007333185232471
ENSG00000125931,54.0,E-GEOD-52194,-6.3,'triple-negative breast cancer; breast carcinoma' vs 'normal',4.007333185232471
ENSG00000125931,54.0,E-GEOD-52194,-6.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',4.007333185232471
ENSG00000066405,33.0,,,,3.5263605246161616
ENSG00000115353,501.0,E-GEOD-31138,-3.1,'invasive ductal carcinoma' vs 'normal',6.218600119691729
ENSG00000104432,68.0,E-GEOD-44408,2.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.23410650459726
ENSG00000104432,68.0,E-GEOD-20086,-1.3,'breast cancer' vs 'normal',4.23410650459726
ENSG00000171885,18.0,,,,2.9444389791664403
ENSG00000145623,5030.0,,,,8.523374050491318
ENSG00000203867,188.0,E-GEOD-68086,-4.8,'breast carcinoma' vs 'normal',5.241747015059643
ENSG00000070915,2.0,E-GEOD-52194,5.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000133742,12.0,E-GEOD-52194,4.9,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',2.5649493574615367
ENSG00000133742,12.0,E-GEOD-52194,6.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',2.5649493574615367
ENSG00000133742,12.0,E-GEOD-52194,6.4,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',2.5649493574615367
ENSG00000117632,1441.0,E-GEOD-38959,2.1,'breast cancer; breast' vs 'normal; breast',7.273786317844895
ENSG00000145494,1348.0,,,,7.207118856207756
ENSG00000136010,679.0,,,,6.522092798170152
ENSG00000124490,5.0,,,,1.791759469228055
ENSG00000122406,41144.0,,,,10.624857692039813
ENSG00000186529,16.0,,,,2.833213344056216
ENSG00000182175,2627.0,E-GEOD-10780,-1.6,'breast carcinoma' vs 'normal',7.873978379604501
ENSG00000182175,2627.0,E-MTAB-779,-1.8,'breast carcinoma' vs 'normal',7.873978379604501
ENSG00000182175,2627.0,E-GEOD-7377,-2.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.873978379604501
ENSG00000166333,470.0,,,,6.154858094016418
ENSG00000170248,7854.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.96890555068972
ENSG00000087586,71.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',4.276666119016055
ENSG00000087586,71.0,E-GEOD-54002,2.9,'breast cancer' vs 'normal',4.276666119016055
ENSG00000087586,71.0,E-GEOD-31138,4.3,'invasive ductal carcinoma' vs 'normal',4.276666119016055
ENSG00000087586,71.0,E-GEOD-38959,2.0,'breast cancer; breast' vs 'normal; breast',4.276666119016055
ENSG00000127585,93.0,,,,4.543294782270004
ENSG00000196428,1660.0,E-GEOD-31138,2.0,'invasive ductal carcinoma' vs 'normal',7.415175109613295
ENSG00000174373,1755.0,,,,7.470793774195062
ENSG00000182179,3558.0,,,,8.177234885510194
ENSG00000168542,21393.0,E-GEOD-44408,-1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.970865787866076
ENSG00000168542,21393.0,E-GEOD-38959,1.5,'breast cancer; breast' vs 'normal; breast',9.970865787866076
ENSG00000168542,21393.0,E-GEOD-54002,3.5,'breast cancer' vs 'normal',9.970865787866076
ENSG00000118777,189.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',5.247024072160486
ENSG00000125755,4292.0,,,,8.36474106822456
ENSG00000244509,1128.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.029087564149662
ENSG00000147419,1596.0,,,,7.3758821482150125
ENSG00000167653,31.0,,,,3.4657359027997265
ENSG00000153179,1914.0,,,,7.557472901614746
ENSG00000141378,534.0,,,,6.282266746896006
ENSG00000112981,47.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',3.871201010907891
ENSG00000107099,1490.0,,,,7.307202314764738
ENSG00000060688,1187.0,,,,7.080026499922591
ENSG00000065518,2726.0,,,,7.910957382845589
ENSG00000160691,9547.0,,,,9.16408698745872
ENSG00000099331,5305.0,,,,8.576593534697684
ENSG00000137440,13.0,E-GEOD-54002,-2.4,'breast cancer' vs 'normal',2.6390573296152584
ENSG00000137440,13.0,E-GEOD-52194,-5.7,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',2.6390573296152584
ENSG00000186318,1840.0,,,,7.518064181233078
ENSG00000003400,960.0,,,,6.8679744089702925
ENSG00000077782,12920.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',9.46660917372222
ENSG00000171793,821.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',6.71174039505618
ENSG00000018510,1681.0,,,,7.427738840532894
ENSG00000140525,473.0,E-GEOD-54002,1.8,'breast cancer' vs 'normal',6.161207321695077
ENSG00000140525,473.0,E-GEOD-38959,2.2,'breast cancer; breast' vs 'normal; breast',6.161207321695077
ENSG00000171914,2827.0,,,,7.947325027016463
ENSG00000172845,4910.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',8.499232866039245
ENSG00000151422,1166.0,,,,7.062191632286556
ENSG00000128271,12.0,,,,2.5649493574615367
ENSG00000084444,517.0,E-GEOD-31138,3.9,'invasive ductal carcinoma' vs 'normal',6.249975242259483
ENSG00000156413,17.0,,,,2.8903717578961645
ENSG00000025772,958.0,,,,6.8658910748834385
ENSG00000213619,1698.0,,,,7.4377951216719325
ENSG00000164258,1491.0,,,,7.307872780763706
ENSG00000142945,59.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',4.0943445622221
ENSG00000142945,59.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',4.0943445622221
ENSG00000142945,59.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',4.0943445622221
ENSG00000142945,59.0,E-GEOD-54002,2.4,'breast cancer' vs 'normal',4.0943445622221
ENSG00000122585,2.0,E-GEOD-52194,6.5,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000164879,249.0,E-GEOD-54002,-2.8,'breast cancer' vs 'normal',5.521460917862246
ENSG00000138814,2593.0,,,,7.860956364876389
ENSG00000171533,190.0,,,,5.25227342804663
ENSG00000163348,1639.0,,,,7.402451520818244
ENSG00000155495,0.0,,,,0.0
ENSG00000172037,16597.0,,,,9.717037485158393
ENSG00000074842,2066.0,,,,7.633853559681768
ENSG00000166068,1758.0,E-GEOD-31138,3.9,'invasive ductal carcinoma' vs 'normal',7.472500744737558
ENSG00000125966,73.0,,,,4.30406509320417
ENSG00000080298,935.0,,,,6.841615476477592
ENSG00000053254,5594.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',8.629628620746026
ENSG00000053254,5594.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',8.629628620746026
ENSG00000054654,11493.0,,,,9.349580439067687
ENSG00000064666,6474.0,,,,8.775703886567738
ENSG00000158186,3167.0,E-GEOD-54002,-1.9,'breast cancer' vs 'normal',8.060855752934316
ENSG00000186832,277.0,E-GEOD-52194,-6.3,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',5.627621113690637
ENSG00000158106,1008.0,,,,6.9167150203536085
ENSG00000184481,1648.0,,,,7.407924322559599
ENSG00000108946,13186.0,E-GEOD-31138,3.3,'invasive ductal carcinoma' vs 'normal',9.486986774807699
ENSG00000102195,0.0,,,,0.0
ENSG00000111537,1.0,,,,0.6931471805599453
ENSG00000213022,0.0,,,,0.0
ENSG00000053900,2097.0,,,,7.6487397889562425
ENSG00000159197,8.0,,,,2.1972245773362196
ENSG00000023228,3186.0,,,,8.066835314417336
ENSG00000066379,481.0,,,,6.1779441140506
ENSG00000046604,3145.0,E-GEOD-44408,-3.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.053887083618223
ENSG00000171209,0.0,,,,0.0
ENSG00000112902,1094.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',6.9985096422506015
ENSG00000112902,1094.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',6.9985096422506015
ENSG00000112902,1094.0,E-GEOD-54002,-2.8,'breast cancer' vs 'normal',6.9985096422506015
ENSG00000204231,3983.0,,,,8.290041618704489
ENSG00000148180,91826.0,E-GEOD-10780,-1.5,'breast carcinoma' vs 'normal',11.427661651011524
ENSG00000148180,91826.0,E-MTAB-779,-1.9,'breast carcinoma' vs 'normal',11.427661651011524
ENSG00000104728,2404.0,,,,7.785305182539862
ENSG00000160255,1453.0,E-GEOD-44408,1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.282073658093465
ENSG00000160255,1453.0,E-MTAB-779,1.9,'breast carcinoma' vs 'normal',7.282073658093465
ENSG00000160255,1453.0,E-GEOD-20086,1.2,'breast cancer' vs 'normal',7.282073658093465
ENSG00000104805,13926.0,,,,9.541584681053092
ENSG00000135052,1791.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',7.491087593534876
ENSG00000135052,1791.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.491087593534876
ENSG00000135052,1791.0,E-GEOD-44408,-3.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.491087593534876
ENSG00000108786,303.0,,,,5.717027701406222
ENSG00000186340,5522.0,E-GEOD-54002,2.9,'breast cancer' vs 'normal',8.616676469901188
ENSG00000186340,5522.0,E-GEOD-44408,-3.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.616676469901188
ENSG00000087303,1001.0,E-GEOD-54002,2.9,'breast cancer' vs 'normal',6.90975328164481
ENSG00000198851,115.0,E-GEOD-44408,2.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.7535901911063645
ENSG00000162595,105.0,E-GEOD-54002,-2.1,'breast cancer' vs 'normal',4.663439094112067
ENSG00000128654,935.0,,,,6.841615476477592
ENSG00000134046,4700.0,E-GEOD-7377,1.4,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.45553053102413
ENSG00000137944,1306.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.175489713624222
ENSG00000160007,3372.0,,,,8.12355783506165
ENSG00000172995,6.0,E-GEOD-52194,5.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.9459101490553132
ENSG00000100852,2882.0,,,,7.9665866976384025
ENSG00000168329,55.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',4.02535169073515
ENSG00000168329,55.0,E-GEOD-54002,-3.4,'breast cancer' vs 'normal',4.02535169073515
ENSG00000168329,55.0,E-GEOD-38959,-2.7,'breast cancer; breast' vs 'normal; breast',4.02535169073515
ENSG00000069974,1321.0,E-GEOD-44408,1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.186901020411631
ENSG00000167207,161.0,,,,5.087596335232384
ENSG00000159763,472.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',6.159095388491933
ENSG00000159763,472.0,E-GEOD-54002,-2.2,'breast cancer' vs 'normal',6.159095388491933
ENSG00000159763,472.0,E-GEOD-38959,-4.5,'breast cancer; breast' vs 'normal; breast',6.159095388491933
ENSG00000162614,1904.0,,,,7.552237287560802
ENSG00000142453,1976.0,,,,7.589335823170617
ENSG00000134042,60.0,,,,4.110873864173311
ENSG00000240583,16425.0,E-MTAB-779,-1.7,'breast carcinoma' vs 'normal',9.706620724300137
ENSG00000240583,16425.0,E-GEOD-10780,-1.5,'breast carcinoma' vs 'normal',9.706620724300137
ENSG00000197272,3.0,,,,1.3862943611198906
ENSG00000065328,109.0,E-GEOD-54002,1.6,'breast cancer' vs 'normal',4.700480365792417
ENSG00000065328,109.0,E-GEOD-52194,4.9,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',4.700480365792417
ENSG00000111670,2028.0,,,,7.615298339825815
ENSG00000173039,6318.0,,,,8.751316246773456
ENSG00000082556,2.0,E-GEOD-52194,5.7,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000196839,697.0,,,,6.548219102762372
ENSG00000177030,1169.0,,,,7.064759027791802
ENSG00000171552,4150.0,,,,8.33110454805304
ENSG00000196338,77.0,,,,4.356708826689592
ENSG00000169093,1844.0,,,,7.520234556474628
ENSG00000109061,102.0,,,,4.634728988229636
ENSG00000103460,73.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',4.30406509320417
ENSG00000103460,73.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',4.30406509320417
ENSG00000103460,73.0,E-GEOD-44408,-3.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.30406509320417
ENSG00000141736,3767.0,,,,8.234299635696253
ENSG00000176485,5789.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',8.663887570567042
ENSG00000065618,1932.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',7.566828479208331
ENSG00000065618,1932.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',7.566828479208331
ENSG00000065618,1932.0,E-GEOD-38959,-3.4,'breast cancer; breast' vs 'normal; breast',7.566828479208331
ENSG00000118046,3547.0,,,,8.17413934342947
ENSG00000163625,3106.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.041412909393047
ENSG00000144339,10.0,,,,2.3978952727983707
ENSG00000198431,3108.0,,,,8.042056410058754
ENSG00000131142,1.0,,,,0.6931471805599453
ENSG00000140675,8.0,,,,2.1972245773362196
ENSG00000160179,1456.0,,,,7.284134806195205
ENSG00000109046,15189.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',9.628392595589819
ENSG00000114757,31.0,,,,3.4657359027997265
ENSG00000118503,2633.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.876258882303226
ENSG00000118503,2633.0,E-GEOD-52194,-5.1,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',7.876258882303226
ENSG00000162267,150.0,,,,5.017279836814924
ENSG00000278540,2333.0,E-GEOD-44408,-1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.755338812846501
ENSG00000169860,125.0,,,,4.836281906951478
ENSG00000166681,2216.0,,,,7.7039102096163115
ENSG00000106105,2929.0,,,,7.982757702011113
ENSG00000134247,1443.0,,,,7.275172319452771
ENSG00000165609,1829.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',7.512071245835466
ENSG00000162654,1110.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',7.01301578963963
ENSG00000081248,4.0,E-GEOD-52194,6.5,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.6094379124341003
ENSG00000081248,4.0,E-GEOD-52194,5.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',1.6094379124341003
ENSG00000141012,1031.0,,,,6.939253946041508
ENSG00000090020,1637.0,,,,7.401231264413015
ENSG00000013364,7939.0,,,,8.979668554241181
ENSG00000100362,3.0,,,,1.3862943611198906
ENSG00000163930,4070.0,,,,8.31164394850298
ENSG00000100603,3105.0,,,,8.041091003708633
ENSG00000119125,10.0,E-GEOD-52194,5.2,'triple-negative breast cancer; breast carcinoma' vs 'normal',2.3978952727983707
ENSG00000119125,10.0,E-GEOD-52194,4.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',2.3978952727983707
ENSG00000011347,681.0,,,,6.525029657843462
ENSG00000140521,2978.0,,,,7.999342952713282
ENSG00000115355,1580.0,,,,7.365812837209472
ENSG00000005884,2995.0,,,,8.005033344637111
ENSG00000018236,229.0,,,,5.438079308923196
ENSG00000137806,614.0,,,,6.421622267806518
ENSG00000145920,5.0,E-GEOD-52194,4.9,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',1.791759469228055
ENSG00000145920,5.0,E-GEOD-52194,6.4,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.791759469228055
ENSG00000106571,1650.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.409136443920128
ENSG00000106571,1650.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',7.409136443920128
ENSG00000197408,1.0,E-GEOD-52194,5.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000167759,9.0,,,,2.302585092994046
ENSG00000075131,150.0,E-GEOD-38959,1.6,'breast cancer; breast' vs 'normal; breast',5.017279836814924
ENSG00000068305,3749.0,,,,8.229511118964457
ENSG00000198691,80.0,,,,4.394449154672439
ENSG00000080815,2555.0,,,,7.846198815497425
ENSG00000162298,3850.0,,,,8.25608813381491
ENSG00000166986,4081.0,,,,8.31434234336979
ENSG00000010327,10266.0,,,,9.236690147298965
ENSG00000121578,889.0,,,,6.7912214627261855
ENSG00000076554,792.0,E-GEOD-44408,-1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.675823221634848
ENSG00000076554,792.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',6.675823221634848
ENSG00000076554,792.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.675823221634848
ENSG00000076554,792.0,E-GEOD-10780,1.4,'breast carcinoma' vs 'normal',6.675823221634848
ENSG00000171557,20.0,,,,3.044522437723423
ENSG00000104714,1432.0,,,,7.267525427828172
ENSG00000101076,2.0,E-GEOD-52194,6.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000101076,2.0,E-GEOD-52194,5.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000131778,1549.0,,,,7.346010209913293
ENSG00000198074,21.0,,,,3.091042453358316
ENSG00000163285,4.0,,,,1.6094379124341003
ENSG00000141316,0.0,,,,0.0
ENSG00000106927,18.0,,,,2.9444389791664403
ENSG00000171094,14.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',2.70805020110221
ENSG00000196361,2.0,,,,1.0986122886681098
ENSG00000012048,217.0,,,,5.384495062789089
ENSG00000167548,6286.0,,,,8.74623928838306
ENSG00000106211,14920.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.610524895640422
ENSG00000106211,14920.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',9.610524895640422
ENSG00000106211,14920.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',9.610524895640422
ENSG00000104969,3231.0,,,,8.080856419640986
ENSG00000154473,3092.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.03689677268507
ENSG00000169379,474.0,,,,6.163314804034641
ENSG00000189143,1490.0,E-GEOD-44408,-2.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.307202314764738
ENSG00000157224,1072.0,,,,6.9782137426306985
ENSG00000179950,4539.0,,,,8.420682291035394
ENSG00000026652,837.0,,,,6.731018100482083
ENSG00000116133,6820.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',8.82776136765472
ENSG00000116133,6820.0,E-GEOD-44408,-3.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.82776136765472
ENSG00000095637,10401.0,E-GEOD-10780,-1.5,'breast carcinoma' vs 'normal',9.249753374333018
ENSG00000095637,10401.0,E-GEOD-20086,1.2,'breast cancer' vs 'normal',9.249753374333018
ENSG00000095637,10401.0,E-MTAB-779,-2.7,'breast carcinoma' vs 'normal',9.249753374333018
ENSG00000168743,931.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',6.837332814685591
ENSG00000168743,931.0,E-MTAB-779,1.7,'breast carcinoma' vs 'normal',6.837332814685591
ENSG00000069535,2805.0,E-GEOD-54002,-1.9,'breast cancer' vs 'normal',7.939515260662406
ENSG00000069535,2805.0,E-MTAB-779,-1.7,'breast carcinoma' vs 'normal',7.939515260662406
ENSG00000069535,2805.0,E-GEOD-38959,-1.7,'breast cancer; breast' vs 'normal; breast',7.939515260662406
ENSG00000091704,167.0,,,,5.123963979403259
ENSG00000148840,2542.0,,,,7.841099765422119
ENSG00000120729,56.0,,,,4.04305126783455
ENSG00000018625,2423.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',7.793174347189205
ENSG00000018625,2423.0,E-GEOD-68086,-5.4,'breast carcinoma' vs 'normal',7.793174347189205
ENSG00000164850,495.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',6.206575926724928
ENSG00000163519,21.0,E-GEOD-44408,3.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.091042453358316
ENSG00000173821,9307.0,,,,9.138629524422182
ENSG00000135932,4289.0,,,,8.364042011922063
ENSG00000150938,11281.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',9.330963814299922
ENSG00000150938,11281.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',9.330963814299922
ENSG00000120265,2608.0,,,,7.866722285136729
ENSG00000131019,14.0,,,,2.70805020110221
ENSG00000101367,4069.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',8.311398278436641
ENSG00000157500,2605.0,,,,7.8655717576847906
ENSG00000185567,1763.0,,,,7.475339236566737
ENSG00000177463,3608.0,,,,8.19118600464279
ENSG00000166851,122.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',4.812184355372417
ENSG00000166851,122.0,E-GEOD-38959,1.5,'breast cancer; breast' vs 'normal; breast',4.812184355372417
ENSG00000196586,3348.0,E-GEOD-31138,3.0,'invasive ductal carcinoma' vs 'normal',8.116417072794205
ENSG00000196586,3348.0,E-GEOD-44408,-2.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.116417072794205
ENSG00000107796,22659.0,E-GEOD-54002,-2.8,'breast cancer' vs 'normal',10.028356534581997
ENSG00000107796,22659.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',10.028356534581997
ENSG00000107796,22659.0,E-GEOD-38959,-2.6,'breast cancer; breast' vs 'normal; breast',10.028356534581997
ENSG00000140945,1411.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',7.252762418053187
ENSG00000143416,5428.0,E-GEOD-44408,-1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.599510233905452
ENSG00000049768,23.0,,,,3.1780538303479458
ENSG00000065154,4171.0,E-GEOD-31138,3.0,'invasive ductal carcinoma' vs 'normal',8.336150816120663
ENSG00000104859,4205.0,,,,8.344267356262645
ENSG00000268940,0.0,,,,0.0
ENSG00000234289,85.0,,,,4.454347296253507
ENSG00000167768,158.0,,,,5.0689042022202315
ENSG00000123106,1041.0,,,,6.948897222313312
ENSG00000128849,776.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',6.655440350367647
ENSG00000134769,870.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',6.769641976852503
ENSG00000112739,5678.0,,,,8.644530439877432
ENSG00000006071,104.0,E-GEOD-52194,-4.8,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',4.653960350157523
ENSG00000129009,3840.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.253488028345904
ENSG00000140937,1073.0,,,,6.97914527506881
ENSG00000129691,1918.0,,,,7.5595594960077
ENSG00000197165,32.0,,,,3.4965075614664802
ENSG00000169710,45683.0,E-GEOD-54002,1.7,'breast cancer' vs 'normal',10.729503406170497
ENSG00000169710,45683.0,E-GEOD-44408,-2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',10.729503406170497
ENSG00000130035,49.0,,,,3.912023005428146
ENSG00000139679,2220.0,E-GEOD-31138,2.5,'invasive ductal carcinoma' vs 'normal',7.7057128238944275
ENSG00000141499,368.0,,,,5.910796644040527
ENSG00000162374,3.0,E-GEOD-52194,5.4,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.3862943611198906
ENSG00000087206,2020.0,,,,7.611347717403621
ENSG00000255974,31.0,,,,3.4657359027997265
ENSG00000167460,22980.0,,,,10.042423066556905
ENSG00000184863,5430.0,,,,8.599878558034845
ENSG00000007171,27.0,,,,3.332204510175204
ENSG00000125740,816.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',6.705639094860003
ENSG00000125740,816.0,E-GEOD-38959,-1.4,'breast cancer; breast' vs 'normal; breast',6.705639094860003
ENSG00000125740,816.0,E-GEOD-54002,-4.0,'breast cancer' vs 'normal',6.705639094860003
ENSG00000125740,816.0,E-GEOD-10780,-2.2,'breast carcinoma' vs 'normal',6.705639094860003
ENSG00000125740,816.0,E-GEOD-31138,-3.5,'invasive ductal carcinoma' vs 'normal',6.705639094860003
ENSG00000125740,816.0,E-GEOD-52194,-7.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',6.705639094860003
ENSG00000125740,816.0,E-GEOD-52194,-5.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',6.705639094860003
ENSG00000102054,4170.0,,,,8.335911094196945
ENSG00000110697,1054.0,,,,6.961296045910167
ENSG00000170315,11400.0,,,,9.34145634983372
ENSG00000105514,621.0,,,,6.432940092739179
ENSG00000075391,2760.0,,,,7.923348211930154
ENSG00000102362,1845.0,,,,7.520776415062797
ENSG00000166839,474.0,,,,6.163314804034641
ENSG00000172292,747.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.617402977974478
ENSG00000172292,747.0,E-GEOD-31138,3.2,'invasive ductal carcinoma' vs 'normal',6.617402977974478
ENSG00000108349,7807.0,,,,8.962904128092928
ENSG00000005379,1241.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',7.124478262493424
ENSG00000046653,897.0,E-GEOD-54002,-3.4,'breast cancer' vs 'normal',6.8001700683022
ENSG00000046653,897.0,E-GEOD-10780,-2.3,'breast carcinoma' vs 'normal',6.8001700683022
ENSG00000197045,2047.0,E-GEOD-7377,1.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.6246189861593985
ENSG00000105327,272.0,,,,5.60947179518496
ENSG00000166886,1215.0,,,,7.103322062526113
ENSG00000099795,2245.0,,,,7.716906135298388
ENSG00000150867,1689.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.432483807917119
ENSG00000118257,2026.0,E-GEOD-20086,1.2,'breast cancer' vs 'normal',7.614312146452
ENSG00000118257,2026.0,E-GEOD-31138,4.5,'invasive ductal carcinoma' vs 'normal',7.614312146452
ENSG00000108840,4669.0,,,,8.448914350662942
ENSG00000163694,1341.0,E-GEOD-44408,-1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.201916317531627
ENSG00000198157,259.0,,,,5.560681631015528
ENSG00000173198,276.0,,,,5.6240175061873385
ENSG00000213927,0.0,,,,0.0
ENSG00000100600,3277.0,,,,8.094988759303774
ENSG00000091136,16672.0,,,,9.721545923560459
ENSG00000132846,1043.0,,,,6.950814768442584
ENSG00000183742,389.0,,,,5.966146739123692
ENSG00000129625,6427.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',8.768418726857403
ENSG00000129625,6427.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.768418726857403
ENSG00000139547,53.0,,,,3.9889840465642745
ENSG00000101158,4037.0,,,,8.303504798872783
ENSG00000181072,1.0,E-GEOD-52194,5.4,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000076356,1867.0,E-GEOD-31138,2.5,'invasive ductal carcinoma' vs 'normal',7.532623618788788
ENSG00000163006,91.0,,,,4.5217885770490405
ENSG00000101745,3187.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.067149039910106
ENSG00000042286,2671.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',7.890582534656536
ENSG00000134852,1630.0,,,,7.396948602621014
ENSG00000157103,84.0,,,,4.442651256490317
ENSG00000198276,2721.0,,,,7.909122183211411
ENSG00000069329,3760.0,,,,8.232440158470336
ENSG00000130640,3551.0,,,,8.17526610411206
ENSG00000101152,2736.0,,,,7.914617709040679
ENSG00000111291,10.0,,,,2.3978952727983707
ENSG00000164182,571.0,,,,6.349138991379798
ENSG00000129194,87.0,,,,4.477336814478207
ENSG00000067798,461.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',6.135564891081739
ENSG00000067798,461.0,E-GEOD-38959,-1.6,'breast cancer; breast' vs 'normal; breast',6.135564891081739
ENSG00000122484,1106.0,,,,7.009408932708637
ENSG00000141968,242.0,E-GEOD-44408,2.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.493061443340548
ENSG00000167751,16.0,,,,2.833213344056216
ENSG00000124104,1619.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',7.3901814282264295
ENSG00000129450,112.0,,,,4.727387818712341
ENSG00000214435,7.0,,,,2.0794415416798357
ENSG00000102468,27.0,,,,3.332204510175204
ENSG00000136810,3279.0,,,,8.09559870137819
ENSG00000135929,1815.0,,,,7.504391559161238
ENSG00000139514,1350.0,,,,7.208600337960199
ENSG00000067066,4543.0,E-GEOD-38959,-1.3,'breast cancer; breast' vs 'normal; breast',8.421562960400987
ENSG00000153820,6.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',1.9459101490553132
ENSG00000153820,6.0,E-GEOD-7377,-1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',1.9459101490553132
ENSG00000151276,2254.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',7.720905251936779
ENSG00000112658,4145.0,,,,8.329899292995725
ENSG00000109758,20.0,,,,3.044522437723423
ENSG00000102760,2458.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',7.807510042216193
ENSG00000102760,2458.0,E-GEOD-54002,-2.3,'breast cancer' vs 'normal',7.807510042216193
ENSG00000102760,2458.0,E-GEOD-7377,-2.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.807510042216193
ENSG00000136928,2.0,E-GEOD-52194,6.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000184831,189.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',5.247024072160486
ENSG00000165392,913.0,,,,6.81783057145415
ENSG00000184144,15.0,,,,2.772588722239781
ENSG00000166233,4120.0,,,,8.323851131338817
ENSG00000082781,8868.0,E-GEOD-44408,-2.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.090317329376452
ENSG00000132746,492.0,E-GEOD-7377,2.9,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.20050917404269
ENSG00000124391,1.0,,,,0.6931471805599453
ENSG00000125266,1886.0,E-GEOD-20086,1.2,'breast cancer' vs 'normal',7.54274354536855
ENSG00000022355,0.0,,,,0.0
ENSG00000123360,1330.0,,,,7.193685818395112
ENSG00000186871,20.0,,,,3.044522437723423
ENSG00000254087,1277.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.15305163493748
ENSG00000254087,1277.0,E-GEOD-31138,2.0,'invasive ductal carcinoma' vs 'normal',7.15305163493748
ENSG00000254087,1277.0,E-GEOD-54002,-1.9,'breast cancer' vs 'normal',7.15305163493748
ENSG00000105447,1441.0,,,,7.273786317844895
ENSG00000073849,2553.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.845416036592485
ENSG00000078269,1254.0,E-GEOD-31138,3.3,'invasive ductal carcinoma' vs 'normal',7.134890851565884
ENSG00000242689,22.0,,,,3.1354942159291497
ENSG00000136938,6691.0,,,,8.808668062106715
ENSG00000101654,2136.0,,,,7.667158255319148
ENSG00000198034,50362.0,,,,10.827012057472162
ENSG00000156802,634.0,E-GEOD-54002,2.0,'breast cancer' vs 'normal',6.453624998892692
ENSG00000156802,634.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',6.453624998892692
ENSG00000156802,634.0,E-GEOD-38959,1.6,'breast cancer; breast' vs 'normal; breast',6.453624998892692
ENSG00000172819,1829.0,,,,7.512071245835466
ENSG00000099960,31.0,,,,3.4657359027997265
ENSG00000141232,4057.0,,,,8.30844552038576
ENSG00000188827,465.0,,,,6.144185634125646
ENSG00000164506,1376.0,,,,7.227662498728654
ENSG00000156650,2113.0,,,,7.656337166430183
ENSG00000090382,663.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',6.498282149476434
ENSG00000090382,663.0,E-GEOD-20086,2.4,'breast cancer' vs 'normal',6.498282149476434
ENSG00000090382,663.0,E-GEOD-7377,1.7,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.498282149476434
ENSG00000117318,4205.0,,,,8.344267356262645
ENSG00000243147,1359.0,,,,7.215239978730097
ENSG00000153015,833.0,,,,6.726233402358747
ENSG00000103197,5825.0,,,,8.67008593751938
ENSG00000160209,4509.0,E-GEOD-44408,-1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.414052432496725
ENSG00000137843,5.0,,,,1.791759469228055
ENSG00000144161,613.0,,,,6.419994928147142
ENSG00000213445,2366.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.769378609513984
ENSG00000167258,2647.0,,,,7.881559917056899
ENSG00000167740,973.0,E-GEOD-7377,1.4,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.881411303642535
ENSG00000122218,8538.0,,,,9.052399183907607
ENSG00000100162,21.0,E-GEOD-54002,1.6,'breast cancer' vs 'normal',3.091042453358316
ENSG00000172262,1194.0,,,,7.085901464365611
ENSG00000116604,5601.0,,,,8.630878955820053
ENSG00000167315,3417.0,,,,8.136810863675537
ENSG00000137098,106.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',4.672828834461906
ENSG00000102858,3606.0,,,,8.19063168090354
ENSG00000198931,2946.0,,,,7.988542982737695
ENSG00000110497,1632.0,,,,7.398174092970465
ENSG00000130414,5626.0,,,,8.635331719433278
ENSG00000129467,6715.0,E-GEOD-31138,-2.3,'invasive ductal carcinoma' vs 'normal',8.812248018197431
ENSG00000129467,6715.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',8.812248018197431
ENSG00000079805,7096.0,,,,8.867427438524983
ENSG00000165410,2625.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',7.873217054862741
ENSG00000171757,135.0,,,,4.912654885736052
ENSG00000077232,4031.0,E-GEOD-7377,1.6,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.302017809751204
ENSG00000008283,1654.0,,,,7.411556287811163
ENSG00000150054,541.0,E-GEOD-7377,1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.295266001439646
ENSG00000149357,3570.0,,,,8.18060094759445
ENSG00000198467,17709.0,E-GEOD-54002,-2.1,'breast cancer' vs 'normal',9.781884730776879
ENSG00000198467,17709.0,E-GEOD-38959,-1.4,'breast cancer; breast' vs 'normal; breast',9.781884730776879
ENSG00000198467,17709.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',9.781884730776879
ENSG00000184956,40.0,E-GEOD-31138,-4.3,'invasive ductal carcinoma' vs 'normal',3.713572066704308
ENSG00000117594,265.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',5.583496308781699
ENSG00000188677,2348.0,,,,7.761744984658913
ENSG00000113140,53146.0,E-GEOD-44408,-1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',10.88081693815073
ENSG00000111530,4347.0,,,,8.3774712482411
ENSG00000148795,84.0,,,,4.442651256490317
ENSG00000137154,70345.0,,,,11.161181202361705
ENSG00000113905,9.0,E-GEOD-52194,6.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',2.302585092994046
ENSG00000204936,32.0,,,,3.4965075614664802
ENSG00000182749,435.0,,,,6.077642243349034
ENSG00000089289,2957.0,,,,7.992268643270745
ENSG00000071909,14.0,,,,2.70805020110221
ENSG00000174282,6452.0,E-GEOD-38959,-1.6,'breast cancer; breast' vs 'normal; breast',8.77230041793584
ENSG00000161547,7406.0,,,,8.91018077801329
ENSG00000127884,4656.0,,,,8.446126742982377
ENSG00000179934,0.0,E-GEOD-52194,4.9,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',0.0
ENSG00000179934,0.0,E-GEOD-52194,5.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000179934,0.0,E-GEOD-68086,-5.1,'breast carcinoma' vs 'normal',0.0
ENSG00000182253,6529.0,E-GEOD-54002,-5.0,'breast cancer' vs 'normal',8.784162222270476
ENSG00000182253,6529.0,E-GEOD-10780,-2.8,'breast carcinoma' vs 'normal',8.784162222270476
ENSG00000182253,6529.0,E-GEOD-38959,-2.1,'breast cancer; breast' vs 'normal; breast',8.784162222270476
ENSG00000073008,1076.0,,,,6.981934677156389
ENSG00000214160,1268.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',7.1459844677143876
ENSG00000134001,2635.0,,,,7.877017895622398
ENSG00000100985,117.0,E-GEOD-44408,1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.770684624465665
ENSG00000100985,117.0,E-GEOD-54002,1.9,'breast cancer' vs 'normal',4.770684624465665
ENSG00000100985,117.0,E-GEOD-10780,1.6,'breast carcinoma' vs 'normal',4.770684624465665
ENSG00000100985,117.0,E-MTAB-779,1.7,'breast carcinoma' vs 'normal',4.770684624465665
ENSG00000100985,117.0,E-GEOD-31138,4.6,'invasive ductal carcinoma' vs 'normal',4.770684624465665
ENSG00000077616,311.0,,,,5.7430031878094825
ENSG00000059378,1597.0,,,,7.37650812632622
ENSG00000163877,795.0,,,,6.679599185844383
ENSG00000137575,12307.0,,,,9.418004736441933
ENSG00000085117,1883.0,,,,7.5411524551363085
ENSG00000123131,2082.0,E-GEOD-38959,1.8,'breast cancer; breast' vs 'normal; breast',7.641564441260972
ENSG00000123131,2082.0,E-GEOD-31138,3.2,'invasive ductal carcinoma' vs 'normal',7.641564441260972
ENSG00000148926,8226.0,E-MTAB-779,-3.1,'breast carcinoma' vs 'normal',9.01517670716893
ENSG00000148926,8226.0,E-GEOD-52194,-5.2,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',9.01517670716893
ENSG00000162521,4570.0,,,,8.427487278331744
ENSG00000163531,1207.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',7.0967213784947605
ENSG00000163531,1207.0,E-GEOD-54002,-2.5,'breast cancer' vs 'normal',7.0967213784947605
ENSG00000168078,8.0,E-GEOD-54002,2.7,'breast cancer' vs 'normal',2.1972245773362196
ENSG00000168078,8.0,E-GEOD-10780,1.6,'breast carcinoma' vs 'normal',2.1972245773362196
ENSG00000168078,8.0,E-MTAB-779,1.8,'breast carcinoma' vs 'normal',2.1972245773362196
ENSG00000168078,8.0,E-GEOD-38959,1.6,'breast cancer; breast' vs 'normal; breast',2.1972245773362196
ENSG00000125388,224.0,,,,5.41610040220442
ENSG00000145819,2547.0,,,,7.843064016692054
ENSG00000156564,1.0,,,,0.6931471805599453
ENSG00000184507,3.0,,,,1.3862943611198906
ENSG00000166226,3768.0,,,,8.234564993267135
ENSG00000140262,3377.0,,,,8.125039097367745
ENSG00000115211,2456.0,,,,7.806696372521179
ENSG00000113161,896.0,,,,6.799055862058796
ENSG00000153094,1553.0,,,,7.348587530927593
ENSG00000278463,0.0,E-GEOD-38959,1.6,'breast cancer; breast' vs 'normal; breast',0.0
ENSG00000278463,0.0,E-GEOD-52194,8.7,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000278463,0.0,E-GEOD-52194,8.9,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',0.0
ENSG00000278463,0.0,E-GEOD-52194,7.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000145016,1470.0,,,,7.293697720601438
ENSG00000160563,607.0,,,,6.410174881966167
ENSG00000132670,4112.0,,,,8.321907968230423
ENSG00000165959,4833.0,,,,8.483429561263428
ENSG00000065057,334.0,,,,5.814130531825066
ENSG00000185507,1114.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',7.016609683894219
ENSG00000182782,281.0,,,,5.641907070938114
ENSG00000126264,55.0,,,,4.02535169073515
ENSG00000162522,2331.0,,,,7.754481547470383
ENSG00000087074,6188.0,E-GEOD-52194,-5.8,'triple-negative breast cancer; breast carcinoma' vs 'normal',8.73052880173936
ENSG00000087074,6188.0,E-GEOD-52194,-6.8,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',8.73052880173936
ENSG00000087074,6188.0,E-GEOD-52194,-6.3,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',8.73052880173936
ENSG00000010292,1617.0,,,,7.388946097618437
ENSG00000204389,1962.0,E-GEOD-31138,2.7,'invasive ductal carcinoma' vs 'normal',7.5822291942764615
ENSG00000204389,1962.0,E-GEOD-52194,-5.5,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',7.5822291942764615
ENSG00000204389,1962.0,E-GEOD-52194,-4.7,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',7.5822291942764615
ENSG00000204389,1962.0,E-GEOD-52194,-5.6,'triple-negative breast cancer; breast carcinoma' vs 'normal',7.5822291942764615
ENSG00000106682,14723.0,,,,9.597234094498912
ENSG00000165821,326.0,E-GEOD-7377,1.4,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',5.7899601708972535
ENSG00000165821,326.0,E-GEOD-38959,-1.5,'breast cancer; breast' vs 'normal; breast',5.7899601708972535
ENSG00000131471,12558.0,E-MTAB-779,-2.7,'breast carcinoma' vs 'normal',9.438192819018127
ENSG00000131471,12558.0,E-GEOD-10780,-2.0,'breast carcinoma' vs 'normal',9.438192819018127
ENSG00000182154,1929.0,,,,7.5652752818989315
ENSG00000143153,1488.0,,,,7.305860032684009
ENSG00000133703,1554.0,,,,7.349230824613334
ENSG00000081181,77.0,,,,4.356708826689592
ENSG00000102226,3050.0,,,,8.02322468471667
ENSG00000173120,7493.0,,,,8.921857979353632
ENSG00000137269,974.0,E-GEOD-44408,-1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.882437470997847
ENSG00000147465,23.0,,,,3.1780538303479458
ENSG00000146457,4840.0,,,,8.484876589939695
ENSG00000161057,2985.0,,,,8.001689978099135
ENSG00000119688,3065.0,,,,8.028129059431759
ENSG00000026559,23.0,,,,3.1780538303479458
ENSG00000138829,22.0,E-GEOD-54002,1.8,'breast cancer' vs 'normal',3.1354942159291497
ENSG00000182446,5716.0,,,,8.651199471263972
ENSG00000179921,327.0,,,,5.793013608384144
ENSG00000102119,3207.0,,,,8.073402968986406
ENSG00000170889,30240.0,,,,10.316953898529778
ENSG00000172113,591.0,,,,6.3835066348840055
ENSG00000091986,10899.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',9.296518068217235
ENSG00000142515,20.0,E-GEOD-68086,-5.3,'breast carcinoma' vs 'normal',3.044522437723423
ENSG00000076706,19065.0,E-GEOD-54002,-1.4,'breast cancer' vs 'normal',9.855661923053523
ENSG00000076706,19065.0,E-MTAB-779,-1.9,'breast carcinoma' vs 'normal',9.855661923053523
ENSG00000164405,2399.0,,,,7.783224016336037
ENSG00000172732,2230.0,,,,7.7102051944325325
ENSG00000101337,3394.0,,,,8.130059039992796
ENSG00000184381,2296.0,,,,7.739359202689098
ENSG00000186895,0.0,,,,0.0
ENSG00000219481,645.0,,,,6.470799503782602
ENSG00000197461,1179.0,E-GEOD-54002,-2.4,'breast cancer' vs 'normal',7.07326971745971
ENSG00000197461,1179.0,E-GEOD-20086,1.1,'breast cancer' vs 'normal',7.07326971745971
ENSG00000197461,1179.0,E-GEOD-10780,-1.7,'breast carcinoma' vs 'normal',7.07326971745971
ENSG00000073111,430.0,E-GEOD-54002,1.4,'breast cancer' vs 'normal',6.066108090103747
ENSG00000073111,430.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',6.066108090103747
ENSG00000073111,430.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',6.066108090103747
ENSG00000135913,333.0,,,,5.811140992976701
ENSG00000143595,1.0,,,,0.6931471805599453
ENSG00000159228,864.0,,,,6.762729506931879
ENSG00000185792,4.0,E-GEOD-68086,-5.0,'breast carcinoma' vs 'normal',1.6094379124341003
ENSG00000175315,13.0,,,,2.6390573296152584
ENSG00000099953,106.0,E-GEOD-38959,1.8,'breast cancer; breast' vs 'normal; breast',4.672828834461906
ENSG00000099953,106.0,E-GEOD-52194,4.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',4.672828834461906
ENSG00000099953,106.0,E-GEOD-44408,-2.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.672828834461906
ENSG00000099953,106.0,E-GEOD-54002,2.8,'breast cancer' vs 'normal',4.672828834461906
ENSG00000099953,106.0,E-MTAB-779,2.7,'breast carcinoma' vs 'normal',4.672828834461906
ENSG00000099953,106.0,E-GEOD-10780,2.5,'breast carcinoma' vs 'normal',4.672828834461906
ENSG00000148296,1787.0,,,,7.488852955733459
ENSG00000100030,4734.0,,,,8.462737005620179
ENSG00000277075,14.0,E-GEOD-31138,2.7,'invasive ductal carcinoma' vs 'normal',2.70805020110221
ENSG00000277075,14.0,E-GEOD-38959,1.8,'breast cancer; breast' vs 'normal; breast',2.70805020110221
ENSG00000277075,14.0,E-GEOD-52194,5.2,'triple-negative breast cancer; breast carcinoma' vs 'normal',2.70805020110221
ENSG00000277075,14.0,E-GEOD-52194,5.1,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',2.70805020110221
ENSG00000130208,365.0,E-MTAB-779,1.9,'breast carcinoma' vs 'normal',5.902633333401366
ENSG00000117650,18.0,E-GEOD-44408,-1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',2.9444389791664403
ENSG00000117650,18.0,E-GEOD-38959,1.7,'breast cancer; breast' vs 'normal; breast',2.9444389791664403
ENSG00000117650,18.0,E-GEOD-54002,3.7,'breast cancer' vs 'normal',2.9444389791664403
ENSG00000117650,18.0,E-GEOD-10780,2.5,'breast carcinoma' vs 'normal',2.9444389791664403
ENSG00000163515,0.0,,,,0.0
ENSG00000196730,1023.0,,,,6.931471805599453
ENSG00000094916,3260.0,,,,8.089789175789319
ENSG00000145545,385.0,,,,5.955837369464831
ENSG00000142867,631.0,,,,6.448889394146858
ENSG00000171346,5974.0,E-GEOD-52194,-4.8,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',8.695339376799712
ENSG00000171346,5974.0,E-GEOD-54002,-5.0,'breast cancer' vs 'normal',8.695339376799712
ENSG00000171346,5974.0,E-GEOD-10780,-2.6,'breast carcinoma' vs 'normal',8.695339376799712
ENSG00000171346,5974.0,E-GEOD-38959,-2.4,'breast cancer; breast' vs 'normal; breast',8.695339376799712
ENSG00000171346,5974.0,E-GEOD-52194,-6.3,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',8.695339376799712
ENSG00000103319,4139.0,,,,8.32845106681936
ENSG00000006453,836.0,,,,6.729824070489475
ENSG00000072110,18527.0,,,,9.827038380372722
ENSG00000172404,11.0,,,,2.4849066497880004
ENSG00000105552,1295.0,,,,7.16703787691222
ENSG00000163600,11.0,E-GEOD-44408,1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',2.4849066497880004
ENSG00000163600,11.0,E-GEOD-68086,-5.4,'breast carcinoma' vs 'normal',2.4849066497880004
ENSG00000080839,354.0,,,,5.872117789475416
ENSG00000114904,663.0,E-GEOD-7377,1.6,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.498282149476434
ENSG00000105707,222.0,,,,5.407171771460119
ENSG00000125977,3357.0,,,,8.119100837637486
ENSG00000169429,54.0,E-GEOD-52194,-6.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',4.007333185232471
ENSG00000164176,491.0,E-GEOD-31138,2.8,'invasive ductal carcinoma' vs 'normal',6.198478716492308
ENSG00000122376,1143.0,,,,7.042286171939743
ENSG00000186153,451.0,,,,6.113682179832232
ENSG00000196233,998.0,,,,6.906754778648554
ENSG00000131023,1863.0,,,,7.530479995245536
ENSG00000133110,4270.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',8.359603270841466
ENSG00000133110,4270.0,E-GEOD-10780,1.4,'breast carcinoma' vs 'normal',8.359603270841466
ENSG00000133110,4270.0,E-GEOD-44408,-3.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.359603270841466
ENSG00000008128,804.0,,,,6.690842277418564
ENSG00000064787,98.0,,,,4.59511985013459
ENSG00000123144,5402.0,,,,8.594709633844065
ENSG00000104783,409.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.016157159698354
ENSG00000104783,409.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',6.016157159698354
ENSG00000143933,15963.0,,,,9.678091466168624
ENSG00000132563,138.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',4.9344739331306915
ENSG00000198517,3374.0,,,,8.12415060330663
ENSG00000166478,873.0,,,,6.773080375655535
ENSG00000187837,1022.0,E-GEOD-54002,1.6,'breast cancer' vs 'normal',6.930494765951626
ENSG00000187837,1022.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',6.930494765951626
ENSG00000187837,1022.0,E-GEOD-44408,-1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.930494765951626
ENSG00000187837,1022.0,E-GEOD-10780,1.5,'breast carcinoma' vs 'normal',6.930494765951626
ENSG00000168036,13268.0,,,,9.493185766536437
ENSG00000158987,576.0,,,,6.3578422665081
ENSG00000265972,150980.0,E-GEOD-38959,-1.4,'breast cancer; breast' vs 'normal; breast',11.924909280065508
ENSG00000198765,11.0,,,,2.4849066497880004
ENSG00000099783,9329.0,,,,9.140990293841389
ENSG00000140451,71.0,,,,4.276666119016055
ENSG00000267855,76.0,,,,4.343805421853684
ENSG00000186818,176.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.176149732573829
ENSG00000205339,4845.0,,,,8.48590890137647
ENSG00000141338,4145.0,E-MTAB-779,-1.9,'breast carcinoma' vs 'normal',8.329899292995725
ENSG00000141338,4145.0,E-GEOD-10780,-3.0,'breast carcinoma' vs 'normal',8.329899292995725
ENSG00000131482,2.0,,,,1.0986122886681098
ENSG00000114270,1838.0,,,,7.516977224604321
ENSG00000137261,5.0,,,,1.791759469228055
ENSG00000169375,3729.0,,,,8.224163512637862
ENSG00000140854,938.0,,,,6.844815479208263
ENSG00000168958,2576.0,,,,7.854381210652365
ENSG00000163283,3.0,,,,1.3862943611198906
ENSG00000188130,1006.0,,,,6.914730892718563
ENSG00000162444,3025.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',8.014996894348302
ENSG00000162444,3025.0,E-GEOD-10780,-1.6,'breast carcinoma' vs 'normal',8.014996894348302
ENSG00000162444,3025.0,E-GEOD-31138,-3.2,'invasive ductal carcinoma' vs 'normal',8.014996894348302
ENSG00000020129,989.0,,,,6.897704943128636
ENSG00000131876,2021.0,,,,7.611842399580417
ENSG00000090659,389.0,E-GEOD-44408,3.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.966146739123692
ENSG00000138709,954.0,,,,6.86171134048073
ENSG00000044574,14511.0,E-GEOD-31138,3.5,'invasive ductal carcinoma' vs 'normal',9.582731172354919
ENSG00000138722,1455.0,E-GEOD-44408,1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.283448228756631
ENSG00000138722,1455.0,E-GEOD-10780,-1.6,'breast carcinoma' vs 'normal',7.283448228756631
ENSG00000149089,957.0,,,,6.86484777797086
ENSG00000138131,789.0,E-MTAB-779,-1.2,'breast carcinoma' vs 'normal',6.672032945461067
ENSG00000138131,789.0,E-GEOD-54002,-2.0,'breast cancer' vs 'normal',6.672032945461067
ENSG00000138131,789.0,E-GEOD-7377,-2.6,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.672032945461067
ENSG00000163743,982.0,,,,6.890609120147166
ENSG00000171791,2338.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',7.757478766584179
ENSG00000171791,2338.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',7.757478766584179
ENSG00000171791,2338.0,E-GEOD-31138,2.5,'invasive ductal carcinoma' vs 'normal',7.757478766584179
ENSG00000102265,5702.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.648747631156539
ENSG00000140416,22342.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',10.014268351879487
ENSG00000140416,22342.0,E-GEOD-38959,-1.3,'breast cancer; breast' vs 'normal; breast',10.014268351879487
ENSG00000140416,22342.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',10.014268351879487
ENSG00000124588,1956.0,,,,7.579167967396076
ENSG00000101413,1771.0,,,,7.4798641311650265
ENSG00000167772,6887.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',8.837536046107568
ENSG00000167772,6887.0,E-GEOD-52194,-5.0,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',8.837536046107568
ENSG00000167772,6887.0,E-GEOD-52194,-4.7,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',8.837536046107568
ENSG00000167772,6887.0,E-MTAB-779,-2.4,'breast carcinoma' vs 'normal',8.837536046107568
ENSG00000129084,1751.0,,,,7.468513271496337
ENSG00000108094,1419.0,,,,7.258412150595307
ENSG00000064687,1331.0,,,,7.194436851100335
ENSG00000109321,847.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',6.742880635791903
ENSG00000109321,847.0,E-GEOD-54002,-1.9,'breast cancer' vs 'normal',6.742880635791903
ENSG00000109321,847.0,E-GEOD-52194,-8.3,'triple-negative breast cancer; breast carcinoma' vs 'normal',6.742880635791903
ENSG00000109321,847.0,E-GEOD-52194,-6.1,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',6.742880635791903
ENSG00000109321,847.0,E-GEOD-52194,-5.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',6.742880635791903
ENSG00000109321,847.0,E-GEOD-7377,4.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.742880635791903
ENSG00000066322,3576.0,,,,8.182279739259018
ENSG00000111786,2363.0,,,,7.768110378525988
ENSG00000110436,103.0,,,,4.6443908991413725
ENSG00000143198,4877.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',8.492490578775866
ENSG00000134160,4.0,E-GEOD-52194,6.2,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.6094379124341003
ENSG00000134160,4.0,E-GEOD-52194,5.2,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',1.6094379124341003
ENSG00000168952,281.0,,,,5.641907070938114
ENSG00000140995,2733.0,,,,7.913521017283895
ENSG00000243156,1337.0,,,,7.198931240688173
ENSG00000152256,1162.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',7.0587581525186645
ENSG00000128951,2600.0,,,,7.8636512654486515
ENSG00000166710,83659.0,,,,11.33451624499619
ENSG00000077522,86.0,,,,4.465908118654584
ENSG00000146247,3901.0,,,,8.269244521183056
ENSG00000275302,86.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.465908118654584
ENSG00000156222,11.0,,,,2.4849066497880004
ENSG00000107742,464.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',6.142037405587356
ENSG00000107742,464.0,E-GEOD-44408,2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.142037405587356
ENSG00000198336,35.0,,,,3.58351893845611
ENSG00000146411,44.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',3.8066624897703196
ENSG00000166441,22380.0,,,,10.01596766362013
ENSG00000074276,7.0,,,,2.0794415416798357
ENSG00000115386,83.0,,,,4.430816798843313
ENSG00000165124,8468.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',9.0441677169216
ENSG00000165124,8468.0,E-GEOD-20086,-1.8,'breast cancer' vs 'normal',9.0441677169216
ENSG00000165124,8468.0,E-MTAB-779,-2.0,'breast carcinoma' vs 'normal',9.0441677169216
ENSG00000163918,400.0,E-GEOD-31138,2.3,'invasive ductal carcinoma' vs 'normal',5.993961427306569
ENSG00000163918,400.0,E-GEOD-38959,1.6,'breast cancer; breast' vs 'normal; breast',5.993961427306569
ENSG00000134258,952.0,E-GEOD-54002,-2.5,'breast cancer' vs 'normal',6.859614903654202
ENSG00000134258,952.0,E-GEOD-68086,-4.8,'breast carcinoma' vs 'normal',6.859614903654202
ENSG00000142208,5744.0,,,,8.656085190282855
ENSG00000166135,2474.0,,,,7.813995675002791
ENSG00000004487,3317.0,,,,8.10711747075039
ENSG00000170430,1139.0,,,,7.038783541388542
ENSG00000134186,4136.0,,,,8.327726166461412
ENSG00000204592,47346.0,E-GEOD-44408,1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',10.76525873863448
ENSG00000157005,1.0,,,,0.6931471805599453
ENSG00000104368,2082.0,E-GEOD-54002,-2.2,'breast cancer' vs 'normal',7.641564441260972
ENSG00000104368,2082.0,E-GEOD-10780,-1.5,'breast carcinoma' vs 'normal',7.641564441260972
ENSG00000104368,2082.0,E-GEOD-38959,-2.4,'breast cancer; breast' vs 'normal; breast',7.641564441260972
ENSG00000104368,2082.0,E-GEOD-7377,1.8,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.641564441260972
ENSG00000180921,642.0,E-MTAB-779,1.2,'breast carcinoma' vs 'normal',6.466144724237619
ENSG00000128683,15.0,,,,2.772588722239781
ENSG00000081760,1914.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.557472901614746
ENSG00000128309,2547.0,,,,7.843064016692054
ENSG00000185825,8910.0,,,,9.09504174761272
ENSG00000158941,3508.0,,,,8.163086375583216
ENSG00000161267,653.0,,,,6.483107351457199
ENSG00000163938,4050.0,,,,8.30671904320269
ENSG00000113088,19.0,E-GEOD-44408,2.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',2.995732273553991
ENSG00000254656,3.0,,,,1.3862943611198906
ENSG00000126777,9440.0,,,,9.152817185732516
ENSG00000108576,35.0,,,,3.58351893845611
ENSG00000147400,1256.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.136483208590247
ENSG00000147400,1256.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.136483208590247
ENSG00000147400,1256.0,E-GEOD-31138,3.4,'invasive ductal carcinoma' vs 'normal',7.136483208590247
ENSG00000154727,1857.0,,,,7.527255919373784
ENSG00000112984,25.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.258096538021482
ENSG00000112984,25.0,E-GEOD-10780,1.6,'breast carcinoma' vs 'normal',3.258096538021482
ENSG00000112984,25.0,E-GEOD-31138,2.8,'invasive ductal carcinoma' vs 'normal',3.258096538021482
ENSG00000112984,25.0,E-GEOD-38959,1.5,'breast cancer; breast' vs 'normal; breast',3.258096538021482
ENSG00000112984,25.0,E-GEOD-54002,3.2,'breast cancer' vs 'normal',3.258096538021482
ENSG00000165929,3157.0,,,,8.057694194815587
ENSG00000014216,6612.0,,,,8.796792687674662
ENSG00000076003,1274.0,E-GEOD-31138,2.2,'invasive ductal carcinoma' vs 'normal',7.150701457592526
ENSG00000076003,1274.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',7.150701457592526
ENSG00000107745,2216.0,,,,7.7039102096163115
ENSG00000128340,583.0,E-GEOD-44408,1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.369900982828227
ENSG00000110852,1330.0,,,,7.193685818395112
ENSG00000163331,7.0,,,,2.0794415416798357
ENSG00000136450,6489.0,,,,8.778017809698136
ENSG00000196923,5081.0,,,,8.53346016388011
ENSG00000189060,9187.0,E-GEOD-44408,-1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.125653563808989
ENSG00000272391,2159.0,,,,7.67786350067821
ENSG00000064300,1600.0,E-GEOD-52194,-5.3,'triple-negative breast cancer; breast carcinoma' vs 'normal',7.3783837129967145
ENSG00000064300,1600.0,E-GEOD-52194,-4.9,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',7.3783837129967145
ENSG00000196305,4522.0,,,,8.416930769477844
ENSG00000112149,262.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.572154032177765
ENSG00000132109,760.0,,,,6.634633357861686
ENSG00000159692,4193.0,,,,8.341410211461865
ENSG00000092621,1140.0,,,,7.039660349862076
ENSG00000139218,6150.0,,,,8.724369949208368
ENSG00000188760,168.0,,,,5.1298987149230735
ENSG00000139180,983.0,,,,6.891625897052253
ENSG00000165029,5066.0,,,,8.53050420547591
ENSG00000149294,317.0,E-GEOD-54002,-1.9,'breast cancer' vs 'normal',5.762051382780177
ENSG00000171720,2265.0,,,,7.725771441587952
ENSG00000204371,2298.0,,,,7.740229524763182
ENSG00000135862,23269.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',10.054920256296338
ENSG00000159263,59.0,E-GEOD-52194,4.8,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',4.0943445622221
ENSG00000164930,1380.0,,,,7.2305631534092925
ENSG00000001497,2322.0,,,,7.750614732770409
ENSG00000154767,2465.0,,,,7.81035268372429
ENSG00000197299,78.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',4.3694478524670215
ENSG00000197299,78.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',4.3694478524670215
ENSG00000111319,1623.0,E-GEOD-44408,-3.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.392647520721623
ENSG00000101138,958.0,,,,6.8658910748834385
ENSG00000143390,1416.0,,,,7.256297239690681
ENSG00000161405,137.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.927253685157205
ENSG00000161405,137.0,E-GEOD-52194,5.1,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',4.927253685157205
ENSG00000141526,1149.0,E-GEOD-38959,1.6,'breast cancer; breast' vs 'normal; breast',7.047517221357296
ENSG00000178021,2.0,E-GEOD-52194,5.0,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000178021,2.0,E-GEOD-52194,4.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000178021,2.0,E-GEOD-52194,5.7,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000069956,1383.0,,,,7.232733136177615
ENSG00000115919,300.0,,,,5.707110264748875
ENSG00000121410,24.0,,,,3.2188758248682006
ENSG00000164695,249.0,,,,5.521460917862246
ENSG00000109107,1127.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',7.028201432058005
ENSG00000185345,234.0,,,,5.459585514144159
ENSG00000174469,3.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',1.3862943611198906
ENSG00000174469,3.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',1.3862943611198906
ENSG00000174469,3.0,E-GEOD-54002,2.0,'breast cancer' vs 'normal',1.3862943611198906
ENSG00000174469,3.0,E-GEOD-52194,6.4,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',1.3862943611198906
ENSG00000174469,3.0,E-GEOD-52194,5.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',1.3862943611198906
ENSG00000175063,24.0,E-GEOD-31138,2.0,'invasive ductal carcinoma' vs 'normal',3.2188758248682006
ENSG00000175063,24.0,E-GEOD-54002,2.8,'breast cancer' vs 'normal',3.2188758248682006
ENSG00000175063,24.0,E-MTAB-779,3.1,'breast carcinoma' vs 'normal',3.2188758248682006
ENSG00000175063,24.0,E-GEOD-10780,1.7,'breast carcinoma' vs 'normal',3.2188758248682006
ENSG00000175063,24.0,E-GEOD-38959,3.6,'breast cancer; breast' vs 'normal; breast',3.2188758248682006
ENSG00000118640,1459.0,,,,7.286191714702382
ENSG00000129226,15.0,,,,2.772588722239781
ENSG00000158477,1.0,,,,0.6931471805599453
ENSG00000166819,17296.0,E-GEOD-10780,-2.6,'breast carcinoma' vs 'normal',9.758288355043923
ENSG00000111653,1451.0,,,,7.280697195384741
ENSG00000066336,668.0,,,,6.505784060128229
ENSG00000152601,9802.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.190443740261726
ENSG00000164326,1.0,,,,0.6931471805599453
ENSG00000141404,511.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.238324625039508
ENSG00000141404,511.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',6.238324625039508
ENSG00000141404,511.0,E-GEOD-54002,-2.8,'breast cancer' vs 'normal',6.238324625039508
ENSG00000108443,1852.0,,,,7.52456122628536
ENSG00000100453,44.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',3.8066624897703196
ENSG00000100453,44.0,E-GEOD-44408,3.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.8066624897703196
ENSG00000104312,610.0,,,,6.415096959171596
ENSG00000100567,3054.0,,,,8.024534871605695
ENSG00000181061,1966.0,,,,7.584264818389059
ENSG00000128602,559.0,,,,6.327936783729195
ENSG00000099194,8895.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',9.093357016490364
ENSG00000099194,8895.0,E-GEOD-54002,2.1,'breast cancer' vs 'normal',9.093357016490364
ENSG00000099194,8895.0,E-GEOD-31138,4.6,'invasive ductal carcinoma' vs 'normal',9.093357016490364
ENSG00000039600,4.0,,,,1.6094379124341003
ENSG00000078403,2330.0,,,,7.754052639035757
ENSG00000122862,5154.0,,,,8.54772239645106
ENSG00000185189,6545.0,,,,8.786609455061125
ENSG00000137875,9.0,,,,2.302585092994046
ENSG00000162992,0.0,,,,0.0
ENSG00000077157,6654.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',8.803123730829212
ENSG00000077157,6654.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',8.803123730829212
ENSG00000077157,6654.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',8.803123730829212
ENSG00000077157,6654.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',8.803123730829212
ENSG00000175792,1209.0,,,,7.098375638590786
ENSG00000143119,819.0,E-GEOD-44408,1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.709304340258298
ENSG00000085788,2723.0,,,,7.909856667269403
ENSG00000127616,3889.0,,,,8.266164436612492
ENSG00000105173,40.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',3.713572066704308
ENSG00000105173,40.0,E-GEOD-68086,-5.0,'breast carcinoma' vs 'normal',3.713572066704308
ENSG00000136490,456.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.124683390894205
ENSG00000008988,30957.0,,,,10.340386726133822
ENSG00000156642,3865.0,,,,8.259975659768276
ENSG00000155463,6247.0,,,,8.740016691519521
ENSG00000103546,38.0,,,,3.6635616461296463
ENSG00000123552,748.0,,,,6.618738983517219
ENSG00000082397,2808.0,,,,7.940583827104244
ENSG00000196628,6778.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',8.821584877430965
ENSG00000165119,21815.0,,,,9.990398924525424
ENSG00000181856,1111.0,,,,7.013915474810528
ENSG00000112851,3171.0,,,,8.06211758275474
ENSG00000121297,1023.0,,,,6.931471805599453
ENSG00000105939,1777.0,,,,7.48324441607385
ENSG00000178057,1969.0,,,,7.585788821732034
ENSG00000124212,3612.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',8.19229373114764
ENSG00000124212,3612.0,E-GEOD-7377,1.7,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.19229373114764
ENSG00000164023,510.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',6.236369590203704
ENSG00000125703,407.0,,,,6.0112671744041615
ENSG00000140505,3.0,,,,1.3862943611198906
ENSG00000172482,26.0,,,,3.295836866004329
ENSG00000145740,1816.0,,,,7.504942068396171
ENSG00000166959,0.0,,,,0.0
ENSG00000135679,3598.0,,,,8.188411308079031
ENSG00000171608,879.0,E-GEOD-44408,2.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.779921907472252
ENSG00000136997,8414.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',9.037771106624906
ENSG00000120915,1278.0,,,,7.153833801578843
ENSG00000186575,1156.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',7.053585727193677
ENSG00000012822,13737.0,,,,9.527920994773828
ENSG00000066117,2971.0,,,,7.99699040583765
ENSG00000197579,1042.0,,,,6.949856455000773
ENSG00000133131,1202.0,,,,7.0925737159746784
ENSG00000149131,40734.0,E-GEOD-20086,-1.4,'breast cancer' vs 'normal',10.614842952744743
ENSG00000273079,19.0,E-GEOD-68086,-5.0,'breast carcinoma' vs 'normal',2.995732273553991
ENSG00000198668,13181.0,,,,9.486607541612665
ENSG00000106367,750.0,,,,6.621405651764134
ENSG00000089280,13657.0,,,,9.522080709521035
ENSG00000117090,58.0,E-GEOD-44408,2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.07753744390572
ENSG00000131437,485.0,,,,6.186208623900494
ENSG00000017483,160.0,,,,5.081404364984463
ENSG00000211890,924.0,E-GEOD-38959,-2.5,'breast cancer; breast' vs 'normal; breast',6.829793737512425
ENSG00000204390,73.0,,,,4.30406509320417
ENSG00000135018,6317.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',8.75115798136203
ENSG00000106565,2333.0,,,,7.755338812846501
ENSG00000103089,21.0,,,,3.091042453358316
ENSG00000171314,5700.0,,,,8.648396877031582
ENSG00000148154,2613.0,,,,7.868636894184167
ENSG00000168040,260.0,,,,5.564520407322694
ENSG00000138663,1482.0,,,,7.301822342137932
ENSG00000154330,1760.0,E-GEOD-10780,-1.6,'breast carcinoma' vs 'normal',7.473637108496206
ENSG00000011304,11500.0,,,,9.350189267092581
ENSG00000128536,177.0,,,,5.181783550292085
ENSG00000198774,235.0,,,,5.4638318050256105
ENSG00000154451,161.0,E-GEOD-52194,5.4,'triple-negative breast cancer; breast carcinoma' vs 'normal',5.087596335232384
ENSG00000154451,161.0,E-GEOD-52194,5.2,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',5.087596335232384
ENSG00000088827,1139.0,E-GEOD-44408,2.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.038783541388542
ENSG00000027697,8309.0,,,,9.025214887849494
ENSG00000169738,3432.0,,,,8.141189793457691
ENSG00000169045,26772.0,,,,10.195149195980738
ENSG00000101773,957.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.86484777797086
ENSG00000086288,7.0,,,,2.0794415416798357
ENSG00000102908,3565.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',8.179199798423086
ENSG00000102908,3565.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',8.179199798423086
ENSG00000129116,8484.0,,,,9.046055177668327
ENSG00000250722,4573.0,,,,8.428143374582726
ENSG00000172172,734.0,E-GEOD-10780,1.5,'breast carcinoma' vs 'normal',6.5998704992128365
ENSG00000172172,734.0,E-GEOD-38959,1.7,'breast cancer; breast' vs 'normal; breast',6.5998704992128365
ENSG00000165240,896.0,,,,6.799055862058796
ENSG00000187608,395.0,E-MTAB-779,1.2,'breast carcinoma' vs 'normal',5.981414211254481
ENSG00000187608,395.0,E-GEOD-54002,2.7,'breast cancer' vs 'normal',5.981414211254481
ENSG00000187608,395.0,E-GEOD-10780,2.2,'breast carcinoma' vs 'normal',5.981414211254481
ENSG00000107562,11830.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.378478484253662
ENSG00000107562,11830.0,E-MTAB-779,-1.9,'breast carcinoma' vs 'normal',9.378478484253662
ENSG00000107562,11830.0,E-GEOD-10780,-2.0,'breast carcinoma' vs 'normal',9.378478484253662
ENSG00000132718,767.0,E-GEOD-31138,2.4,'invasive ductal carcinoma' vs 'normal',6.643789733147672
ENSG00000136881,2.0,,,,1.0986122886681098
ENSG00000111801,1114.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.016609683894219
ENSG00000168393,604.0,,,,6.405228458030842
ENSG00000095015,2410.0,E-GEOD-44408,1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.787796878181171
ENSG00000101294,4176.0,,,,8.337348564497175
ENSG00000163737,3.0,,,,1.3862943611198906
ENSG00000277157,0.0,E-GEOD-52194,7.5,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000277157,0.0,E-GEOD-52194,8.3,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',0.0
ENSG00000277157,0.0,E-GEOD-52194,7.1,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000128829,2315.0,,,,7.7475968386928855
ENSG00000173992,1471.0,,,,7.294377299288821
ENSG00000127324,136.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',4.919980925828125
ENSG00000173153,1720.0,,,,7.450660796211539
ENSG00000158636,1362.0,,,,7.217443431696533
ENSG00000173786,2612.0,,,,7.868254265520613
ENSG00000065413,823.0,,,,6.714170529909472
ENSG00000155229,3969.0,,,,8.286521373681236
ENSG00000101811,366.0,,,,5.905361848054571
ENSG00000115085,255.0,E-GEOD-44408,1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.545177444479562
ENSG00000111275,8912.0,,,,9.095266164130717
ENSG00000113532,382.0,E-GEOD-44408,2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.948034989180646
ENSG00000078699,1603.0,,,,7.38025578842646
ENSG00000180233,484.0,,,,6.184148890937483
ENSG00000186951,1246.0,E-MTAB-779,-1.2,'breast carcinoma' vs 'normal',7.1284959456800365
ENSG00000111802,1473.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',7.295735072749282
ENSG00000065320,557.0,,,,6.324358962381311
ENSG00000100290,67.0,,,,4.219507705176107
ENSG00000275074,331.0,,,,5.805134968916488
ENSG00000141741,1013.0,E-GEOD-31138,2.1,'invasive ductal carcinoma' vs 'normal',6.921658184151129
ENSG00000141741,1013.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',6.921658184151129
ENSG00000103194,2439.0,,,,7.799753318287247
ENSG00000137337,2793.0,,,,7.935229539816907
ENSG00000121774,5654.0,,,,8.640295388550221
ENSG00000163564,83.0,,,,4.430816798843313
ENSG00000141458,2735.0,,,,7.914252278742441
ENSG00000198721,2547.0,E-GEOD-7377,1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.843064016692054
ENSG00000146410,30.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',3.4339872044851463
ENSG00000146410,30.0,E-GEOD-54002,2.2,'breast cancer' vs 'normal',3.4339872044851463
ENSG00000140943,6269.0,,,,8.743531633626967
ENSG00000151491,6895.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.83869681234353
ENSG00000185630,4658.0,E-GEOD-44408,-2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.446556111816797
ENSG00000143353,651.0,,,,6.480044561926653
ENSG00000102575,703.0,,,,6.556778356158042
ENSG00000142319,12.0,,,,2.5649493574615367
ENSG00000162881,105.0,,,,4.663439094112067
ENSG00000138756,451.0,E-GEOD-38959,-1.4,'breast cancer; breast' vs 'normal; breast',6.113682179832232
ENSG00000138756,451.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.113682179832232
ENSG00000114867,15349.0,,,,9.638870753015343
ENSG00000183605,752.0,,,,6.6240652277998935
ENSG00000157212,777.0,E-GEOD-7377,2.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.656726524178391
ENSG00000002726,4.0,,,,1.6094379124341003
ENSG00000160654,44.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.8066624897703196
ENSG00000160654,44.0,E-GEOD-52194,4.8,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',3.8066624897703196
ENSG00000160654,44.0,E-GEOD-52194,5.2,'triple-negative breast cancer; breast carcinoma' vs 'normal',3.8066624897703196
ENSG00000051108,5910.0,,,,8.684570300824369
ENSG00000119139,5135.0,,,,8.544029845369797
ENSG00000177119,6450.0,E-GEOD-7377,1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.771990436532242
ENSG00000166794,4324.0,,,,8.37216741936598
ENSG00000214510,4.0,,,,1.6094379124341003
ENSG00000136193,1996.0,,,,7.599401333415815
ENSG00000120289,0.0,,,,0.0
ENSG00000168724,1849.0,,,,7.52294091807237
ENSG00000116194,1541.0,E-GEOD-10780,-1.5,'breast carcinoma' vs 'normal',7.340835554123275
ENSG00000116194,1541.0,E-MTAB-779,-2.3,'breast carcinoma' vs 'normal',7.340835554123275
ENSG00000142273,154.0,,,,5.043425116919247
ENSG00000092098,1102.0,,,,7.005789019253503
ENSG00000164692,31052.0,E-GEOD-44408,-1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',10.343450701051859
ENSG00000164692,31052.0,E-GEOD-38959,1.5,'breast cancer; breast' vs 'normal; breast',10.343450701051859
ENSG00000164692,31052.0,E-GEOD-54002,5.0,'breast cancer' vs 'normal',10.343450701051859
ENSG00000159352,4410.0,,,,8.39185670010494
ENSG00000163687,297.0,E-MTAB-779,-1.8,'breast carcinoma' vs 'normal',5.697093486505405
ENSG00000163687,297.0,E-GEOD-44408,3.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.697093486505405
ENSG00000135446,1904.0,,,,7.552237287560802
ENSG00000170775,31.0,,,,3.4657359027997265
ENSG00000026950,1724.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.45298232946546
ENSG00000134809,607.0,,,,6.410174881966167
ENSG00000177606,22007.0,E-MTAB-779,-1.8,'breast carcinoma' vs 'normal',9.99916130260441
ENSG00000134668,81.0,E-MTAB-779,1.6,'breast carcinoma' vs 'normal',4.406719247264253
ENSG00000105877,23.0,,,,3.1780538303479458
ENSG00000136160,3118.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.045267716607803
ENSG00000136160,3118.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',8.045267716607803
ENSG00000136160,3118.0,E-GEOD-10780,-1.9,'breast carcinoma' vs 'normal',8.045267716607803
ENSG00000101096,832.0,E-GEOD-54002,-2.3,'breast cancer' vs 'normal',6.725033642166843
ENSG00000116161,1683.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',7.428927194802272
ENSG00000123908,3503.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',8.161660452056282
ENSG00000112715,12134.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',9.403849118160702
ENSG00000124795,5051.0,E-GEOD-31138,2.0,'invasive ductal carcinoma' vs 'normal',8.527539483470381
ENSG00000115415,4077.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',8.3133619511344
ENSG00000115415,4077.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',8.3133619511344
ENSG00000179918,2092.0,,,,7.646353722445999
ENSG00000169031,148.0,E-GEOD-68086,-4.8,'breast carcinoma' vs 'normal',5.003946305945459
ENSG00000184110,430.0,,,,6.066108090103747
ENSG00000101182,6510.0,E-GEOD-38959,1.5,'breast cancer; breast' vs 'normal; breast',8.781248333236862
ENSG00000117601,10.0,,,,2.3978952727983707
ENSG00000137760,430.0,,,,6.066108090103747
ENSG00000263528,259.0,,,,5.560681631015528
ENSG00000079112,9.0,,,,2.302585092994046
ENSG00000169474,4.0,,,,1.6094379124341003
ENSG00000168148,1.0,E-MTAB-779,1.8,'breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000170312,131.0,E-GEOD-44408,-1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.882801922586371
ENSG00000170312,131.0,E-MTAB-779,1.9,'breast carcinoma' vs 'normal',4.882801922586371
ENSG00000170312,131.0,E-GEOD-54002,3.2,'breast cancer' vs 'normal',4.882801922586371
ENSG00000170312,131.0,E-GEOD-10780,2.1,'breast carcinoma' vs 'normal',4.882801922586371
ENSG00000213639,9511.0,,,,9.160309438370618
ENSG00000139567,3625.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',8.195885391314796
ENSG00000144677,2242.0,,,,7.715569534520208
ENSG00000122512,380.0,,,,5.942799375126701
ENSG00000122756,1725.0,,,,7.453561871643373
ENSG00000146054,247.0,,,,5.5134287461649825
ENSG00000136868,1199.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.090076835776092
ENSG00000136868,1199.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.090076835776092
ENSG00000028137,5858.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.675734219544788
ENSG00000175354,1565.0,,,,7.356279876550748
ENSG00000106397,2877.0,,,,7.964850887447313
ENSG00000112294,507.0,,,,6.230481447578482
ENSG00000137285,88.0,E-GEOD-38959,-1.5,'breast cancer; breast' vs 'normal; breast',4.48863636973214
ENSG00000137285,88.0,E-GEOD-10780,-1.7,'breast carcinoma' vs 'normal',4.48863636973214
ENSG00000137285,88.0,E-GEOD-52194,-5.5,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',4.48863636973214
ENSG00000137285,88.0,E-GEOD-54002,-3.5,'breast cancer' vs 'normal',4.48863636973214
ENSG00000137285,88.0,E-GEOD-52194,-5.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',4.48863636973214
ENSG00000137801,21440.0,,,,9.973060255888088
ENSG00000128159,5413.0,,,,8.596743470174246
ENSG00000169575,0.0,,,,0.0
ENSG00000149311,2686.0,E-GEOD-44408,2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.8961806086154915
ENSG00000007264,59.0,,,,4.0943445622221
ENSG00000120738,9334.0,E-GEOD-54002,-2.7,'breast cancer' vs 'normal',9.141526055975824
ENSG00000120738,9334.0,E-GEOD-10780,-1.5,'breast carcinoma' vs 'normal',9.141526055975824
ENSG00000120738,9334.0,E-GEOD-31138,-2.6,'invasive ductal carcinoma' vs 'normal',9.141526055975824
ENSG00000120738,9334.0,E-GEOD-52194,-5.2,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',9.141526055975824
ENSG00000120738,9334.0,E-GEOD-52194,-6.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',9.141526055975824
ENSG00000120738,9334.0,E-GEOD-52194,-5.0,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',9.141526055975824
ENSG00000171227,680.0,E-MTAB-779,-1.9,'breast carcinoma' vs 'normal',6.523562306149512
ENSG00000117868,7120.0,,,,8.870803443982124
ENSG00000173207,1147.0,,,,7.045776576879511
ENSG00000106070,4037.0,,,,8.303504798872783
ENSG00000186377,655.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',6.486160788944089
ENSG00000165682,4.0,,,,1.6094379124341003
ENSG00000026751,102.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.634728988229636
ENSG00000026751,102.0,E-GEOD-31138,-3.0,'invasive ductal carcinoma' vs 'normal',4.634728988229636
ENSG00000163848,1878.0,,,,7.538494999413465
ENSG00000120889,3681.0,,,,8.211211361793023
ENSG00000181090,3487.0,,,,8.15708378502887
ENSG00000083093,519.0,,,,6.253828811575473
ENSG00000122194,28.0,E-GEOD-52194,4.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',3.367295829986474
ENSG00000122194,28.0,E-GEOD-52194,5.6,'triple-negative breast cancer; breast carcinoma' vs 'normal',3.367295829986474
ENSG00000182199,2300.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',7.741099090035366
ENSG00000189182,12.0,,,,2.5649493574615367
ENSG00000090266,1536.0,,,,7.337587743538596
ENSG00000143412,246.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',5.5093883366279774
ENSG00000143412,246.0,E-GEOD-44408,-3.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.5093883366279774
ENSG00000137077,1058.0,E-GEOD-10780,-1.5,'breast carcinoma' vs 'normal',6.9650803456014065
ENSG00000137077,1058.0,E-GEOD-52194,-4.7,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',6.9650803456014065
ENSG00000137077,1058.0,E-GEOD-44408,3.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.9650803456014065
ENSG00000138772,2393.0,E-MTAB-779,-1.2,'breast carcinoma' vs 'normal',7.780720886117918
ENSG00000138772,2393.0,E-GEOD-54002,-2.7,'breast cancer' vs 'normal',7.780720886117918
ENSG00000138772,2393.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',7.780720886117918
ENSG00000276023,592.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.385194398997726
ENSG00000082805,2426.0,,,,7.794411205726601
ENSG00000177455,12.0,E-GEOD-44408,3.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',2.5649493574615367
ENSG00000138018,1150.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',7.048386408721883
ENSG00000138018,1150.0,E-GEOD-7377,1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.048386408721883
ENSG00000168781,661.0,,,,6.495265555937008
ENSG00000171150,1694.0,,,,7.43543801981455
ENSG00000012223,4865.0,E-GEOD-54002,-2.9,'breast cancer' vs 'normal',8.490027523343468
ENSG00000012223,4865.0,E-GEOD-31138,-3.2,'invasive ductal carcinoma' vs 'normal',8.490027523343468
ENSG00000012223,4865.0,E-GEOD-38959,-2.0,'breast cancer; breast' vs 'normal; breast',8.490027523343468
ENSG00000012223,4865.0,E-GEOD-7377,-2.4,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.490027523343468
ENSG00000102554,655.0,E-GEOD-54002,-2.0,'breast cancer' vs 'normal',6.486160788944089
ENSG00000102554,655.0,E-GEOD-7377,-1.9,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.486160788944089
ENSG00000113328,3592.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',8.186742787113518
ENSG00000077279,9.0,E-GEOD-68086,-4.8,'breast carcinoma' vs 'normal',2.302585092994046
ENSG00000077279,9.0,E-GEOD-38959,-1.7,'breast cancer; breast' vs 'normal; breast',2.302585092994046
ENSG00000128609,2056.0,,,,7.6290038896529575
ENSG00000187391,473.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',6.161207321695077
ENSG00000171860,331.0,,,,5.805134968916488
ENSG00000173706,3932.0,,,,8.27715777243181
ENSG00000083520,2215.0,,,,7.703459047867175
ENSG00000204569,2746.0,,,,7.918264686095274
ENSG00000112531,8457.0,,,,9.042868018032435
ENSG00000181555,4511.0,,,,8.414495793177895
ENSG00000198369,2386.0,E-GEOD-44408,-1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.77779262633883
ENSG00000070831,8615.0,,,,9.061376218836225
ENSG00000112029,190.0,,,,5.25227342804663
ENSG00000156110,857.0,,,,6.754604099487962
ENSG00000173638,752.0,,,,6.6240652277998935
ENSG00000101150,6169.0,,,,8.727454116899434
ENSG00000183423,36.0,,,,3.6109179126442243
ENSG00000043462,934.0,E-GEOD-44408,2.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.840546529288687
ENSG00000104067,4499.0,,,,8.411832675758411
ENSG00000166260,1446.0,,,,7.277247726631484
ENSG00000062822,777.0,,,,6.656726524178391
ENSG00000103042,795.0,,,,6.679599185844383
ENSG00000177189,3450.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.146419323098003
ENSG00000177189,3450.0,E-GEOD-54002,-2.3,'breast cancer' vs 'normal',8.146419323098003
ENSG00000111405,74.0,,,,4.31748811353631
ENSG00000106018,149.0,,,,5.0106352940962555
ENSG00000105220,10308.0,,,,9.240772579096385
ENSG00000157992,265.0,,,,5.583496308781699
ENSG00000181885,685.0,E-GEOD-44408,-3.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.530877627725885
ENSG00000151500,1405.0,,,,7.2485040723706105
ENSG00000109511,3.0,,,,1.3862943611198906
ENSG00000125166,2229.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.709756864454165
ENSG00000167363,555.0,,,,6.320768294250582
ENSG00000138668,10258.0,,,,9.235910648087712
ENSG00000163806,48.0,,,,3.8918202981106265
ENSG00000187957,48.0,,,,3.8918202981106265
ENSG00000143320,976.0,E-GEOD-44408,-3.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.884486652042782
ENSG00000136535,0.0,,,,0.0
ENSG00000168310,1919.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.560080465021827
ENSG00000184584,3306.0,,,,8.103796712981794
ENSG00000133246,112.0,,,,4.727387818712341
ENSG00000068028,3042.0,,,,8.02059914989697
ENSG00000197858,4258.0,,,,8.356789669923213
ENSG00000183421,379.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.940171252720432
ENSG00000183421,379.0,E-GEOD-54002,-2.0,'breast cancer' vs 'normal',5.940171252720432
ENSG00000113368,230.0,E-GEOD-54002,1.7,'breast cancer' vs 'normal',5.442417710521793
ENSG00000113368,230.0,E-GEOD-10780,1.6,'breast carcinoma' vs 'normal',5.442417710521793
ENSG00000113368,230.0,E-GEOD-38959,2.2,'breast cancer; breast' vs 'normal; breast',5.442417710521793
ENSG00000166224,1852.0,,,,7.52456122628536
ENSG00000152818,7786.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.960210955576986
ENSG00000152818,7786.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',8.960210955576986
ENSG00000152818,7786.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',8.960210955576986
ENSG00000152818,7786.0,E-GEOD-38959,-1.5,'breast cancer; breast' vs 'normal; breast',8.960210955576986
ENSG00000112679,3090.0,,,,8.036249942132116
ENSG00000127588,0.0,,,,0.0
ENSG00000103375,7.0,,,,2.0794415416798357
ENSG00000121211,10.0,,,,2.3978952727983707
ENSG00000138379,34.0,,,,3.5553480614894135
ENSG00000176014,5043.0,E-MTAB-779,-1.2,'breast carcinoma' vs 'normal',8.52595469708481
ENSG00000176014,5043.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',8.52595469708481
ENSG00000102317,14167.0,,,,9.55874117946267
ENSG00000100201,54222.0,,,,10.900860451658483
ENSG00000105647,15.0,,,,2.772588722239781
ENSG00000153283,142.0,E-GEOD-44408,2.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.962844630259907
ENSG00000115902,689.0,E-GEOD-31138,3.7,'invasive ductal carcinoma' vs 'normal',6.536691597591305
ENSG00000067900,3993.0,,,,8.29254851397576
ENSG00000072518,2312.0,,,,7.746300662231439
ENSG00000076053,1157.0,,,,7.05444965813294
ENSG00000134851,3652.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',8.203304026795282
ENSG00000033627,3378.0,,,,8.12533508671429
ENSG00000143398,2441.0,,,,7.80057265467065
ENSG00000105855,738.0,E-GEOD-54002,-2.3,'breast cancer' vs 'normal',6.6052979209482015
ENSG00000134121,1091.0,E-GEOD-44408,1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.9957661563048505
ENSG00000134121,1091.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',6.9957661563048505
ENSG00000134121,1091.0,E-GEOD-54002,-4.2,'breast cancer' vs 'normal',6.9957661563048505
ENSG00000134121,1091.0,E-GEOD-10780,-2.0,'breast carcinoma' vs 'normal',6.9957661563048505
ENSG00000172466,3457.0,,,,8.148445666243235
ENSG00000158710,18016.0,,,,9.7990710356157
ENSG00000170832,1378.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.229113877793302
ENSG00000165966,161.0,,,,5.087596335232384
ENSG00000149021,1.0,,,,0.6931471805599453
ENSG00000145476,1363.0,,,,7.218176838403408
ENSG00000132470,4581.0,,,,8.42989086301344
ENSG00000131015,14.0,E-GEOD-20086,1.2,'breast cancer' vs 'normal',2.70805020110221
ENSG00000198826,113.0,,,,4.736198448394496
ENSG00000243927,1255.0,,,,7.135687347028144
ENSG00000100605,3510.0,E-GEOD-7377,1.7,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.163656176168432
ENSG00000160223,343.0,,,,5.840641657373398
ENSG00000074416,11065.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',9.311632623458054
ENSG00000074416,11065.0,E-MTAB-779,-2.0,'breast carcinoma' vs 'normal',9.311632623458054
ENSG00000078328,5.0,,,,1.791759469228055
ENSG00000170881,1503.0,,,,7.315883504509785
ENSG00000131473,5053.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.52793528794814
ENSG00000105202,4726.0,,,,8.461046030793236
ENSG00000117009,28.0,E-GEOD-54002,2.4,'breast cancer' vs 'normal',3.367295829986474
ENSG00000117009,28.0,E-GEOD-10780,2.1,'breast carcinoma' vs 'normal',3.367295829986474
ENSG00000135363,1264.0,E-GEOD-7377,-1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.142827401161621
ENSG00000132465,812.0,E-GEOD-54002,-3.9,'breast cancer' vs 'normal',6.70073110954781
ENSG00000132465,812.0,E-GEOD-10780,-2.0,'breast carcinoma' vs 'normal',6.70073110954781
ENSG00000132465,812.0,E-GEOD-31138,-5.6,'invasive ductal carcinoma' vs 'normal',6.70073110954781
ENSG00000132465,812.0,E-GEOD-38959,-3.3,'breast cancer; breast' vs 'normal; breast',6.70073110954781
ENSG00000132465,812.0,E-GEOD-7377,-3.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.70073110954781
ENSG00000173662,11.0,,,,2.4849066497880004
ENSG00000121797,274.0,,,,5.616771097666572
ENSG00000104687,1248.0,,,,7.130098510125578
ENSG00000147649,4317.0,E-GEOD-31138,2.0,'invasive ductal carcinoma' vs 'normal',8.370547611074752
ENSG00000189058,46157.0,E-GEOD-10780,-2.0,'breast carcinoma' vs 'normal',10.73982557268699
ENSG00000189058,46157.0,E-GEOD-38959,-2.8,'breast cancer; breast' vs 'normal; breast',10.73982557268699
ENSG00000113231,811.0,,,,6.699500340161678
ENSG00000138735,1781.0,E-GEOD-54002,-3.3,'breast cancer' vs 'normal',7.485491608030754
ENSG00000172757,18238.0,,,,9.811317437563998
ENSG00000196526,1988.0,,,,7.5953872788539725
ENSG00000108424,7547.0,,,,8.92903790648844
ENSG00000085721,2312.0,,,,7.746300662231439
ENSG00000182752,196.0,,,,5.2832037287379885
ENSG00000100644,4669.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',8.448914350662942
ENSG00000168280,197.0,E-GEOD-38959,-2.7,'breast cancer; breast' vs 'normal; breast',5.288267030694535
ENSG00000146416,1196.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.087573705557973
ENSG00000132819,1109.0,,,,7.01211529430638
ENSG00000006747,67.0,,,,4.219507705176107
ENSG00000132382,3754.0,,,,8.230843564198235
ENSG00000166833,2900.0,E-GEOD-54002,-2.6,'breast cancer' vs 'normal',7.972810784121404
ENSG00000166833,2900.0,E-GEOD-10780,-1.6,'breast carcinoma' vs 'normal',7.972810784121404
ENSG00000166833,2900.0,E-GEOD-38959,-1.6,'breast cancer; breast' vs 'normal; breast',7.972810784121404
ENSG00000139083,4187.0,E-GEOD-7377,-1.9,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.339978571990427
ENSG00000147697,17.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',2.8903717578961645
ENSG00000174720,2051.0,,,,7.62657020629066
ENSG00000178741,2300.0,,,,7.741099090035366
ENSG00000075785,11893.0,E-GEOD-36765,1.2,'breast carcinoma' vs 'normal' in 'peripheral blood',9.38378935026654
ENSG00000150967,311.0,,,,5.7430031878094825
ENSG00000162959,219.0,,,,5.393627546352362
ENSG00000075239,3191.0,,,,8.068402958569699
ENSG00000083168,4134.0,,,,8.327242607457793
ENSG00000113361,329.0,,,,5.799092654460526
ENSG00000054983,1450.0,,,,7.280008252884188
ENSG00000107863,4719.0,,,,8.459564078579602
ENSG00000127084,497.0,,,,6.210600077024653
ENSG00000111605,4481.0,,,,8.407824654360873
ENSG00000092439,2529.0,,,,7.835974581721566
ENSG00000102974,2435.0,,,,7.798112628829788
ENSG00000205726,3884.0,,,,8.264878262801748
ENSG00000126821,761.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.635946555686647
ENSG00000126821,761.0,E-GEOD-7377,1.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.635946555686647
ENSG00000184432,5197.0,,,,8.556029215201436
ENSG00000103740,20.0,,,,3.044522437723423
ENSG00000114670,282.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.645446897643238
ENSG00000114670,282.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',5.645446897643238
ENSG00000137486,1845.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',7.520776415062797
ENSG00000164488,20.0,,,,3.044522437723423
ENSG00000117115,610.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',6.415096959171596
ENSG00000117115,610.0,E-GEOD-7377,-2.6,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.415096959171596
ENSG00000048392,1197.0,,,,7.088408778675395
ENSG00000180875,186.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',5.231108616854587
ENSG00000180875,186.0,E-GEOD-20086,-1.3,'breast cancer' vs 'normal',5.231108616854587
ENSG00000064547,404.0,,,,6.003887067106539
ENSG00000163435,4671.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',8.449342524508063
ENSG00000179526,2220.0,,,,7.7057128238944275
ENSG00000108298,43737.0,,,,10.685972568448268
ENSG00000141837,129.0,,,,4.867534450455582
ENSG00000107201,915.0,,,,6.82001636467413
ENSG00000110906,5393.0,,,,8.593042503699674
ENSG00000136122,106.0,,,,4.672828834461906
ENSG00000100462,1706.0,,,,7.442492722794441
ENSG00000109472,4375.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',8.383890344101816
ENSG00000109472,4375.0,E-GEOD-38959,-2.0,'breast cancer; breast' vs 'normal; breast',8.383890344101816
ENSG00000072778,29641.0,,,,10.29694755351686
ENSG00000162769,470.0,,,,6.154858094016418
ENSG00000145375,434.0,,,,6.075346031088684
ENSG00000142185,235.0,,,,5.4638318050256105
ENSG00000070018,2292.0,,,,7.737616282857904
ENSG00000135723,3214.0,,,,8.07558263667172
ENSG00000100142,41.0,,,,3.7376696182833684
ENSG00000185640,23.0,,,,3.1780538303479458
ENSG00000149451,6474.0,,,,8.775703886567738
ENSG00000277791,2192.0,,,,7.693025748417888
ENSG00000166016,339.0,,,,5.8289456176102075
ENSG00000139269,11.0,,,,2.4849066497880004
ENSG00000132780,5532.0,,,,8.618485442898109
ENSG00000105835,8872.0,,,,9.090768236835338
ENSG00000104537,20.0,,,,3.044522437723423
ENSG00000197249,935.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',6.841615476477592
ENSG00000125743,3645.0,,,,8.201385955238608
ENSG00000118689,7643.0,,,,8.941676305360163
ENSG00000133119,462.0,,,,6.137727054086234
ENSG00000074181,11110.0,,,,9.315690887584008
ENSG00000154358,2084.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',7.642524134232902
ENSG00000165731,90.0,E-GEOD-54002,2.7,'breast cancer' vs 'normal',4.51085950651685
ENSG00000213923,7847.0,,,,8.9680140012452
ENSG00000179902,4.0,,,,1.6094379124341003
ENSG00000131398,233.0,,,,5.455321115357702
ENSG00000100147,76.0,,,,4.343805421853684
ENSG00000112343,2598.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.8628820346414905
ENSG00000174640,1663.0,,,,7.416979621381154
ENSG00000004455,4944.0,,,,8.506132244056813
ENSG00000017797,3937.0,,,,8.278428259199071
ENSG00000163673,16.0,,,,2.833213344056216
ENSG00000144028,11643.0,,,,9.362546304865514
ENSG00000118596,1106.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',7.009408932708637
ENSG00000118596,1106.0,E-GEOD-10780,-1.9,'breast carcinoma' vs 'normal',7.009408932708637
ENSG00000108344,4810.0,E-MTAB-779,2.0,'breast carcinoma' vs 'normal',8.478660241699453
ENSG00000112769,7825.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',8.965206802770357
ENSG00000112769,7825.0,E-MTAB-779,-1.8,'breast carcinoma' vs 'normal',8.965206802770357
ENSG00000147050,1769.0,,,,7.478734825567875
ENSG00000169902,922.0,,,,6.827629234502852
ENSG00000058335,17.0,,,,2.8903717578961645
ENSG00000134910,3938.0,,,,8.278682162970906
ENSG00000122873,478.0,E-GEOD-31138,3.1,'invasive ductal carcinoma' vs 'normal',6.171700597410915
ENSG00000155096,4571.0,,,,8.427706024914702
ENSG00000143543,4446.0,,,,8.399984990510696
ENSG00000177239,3648.0,,,,8.202208436436448
ENSG00000105281,5764.0,,,,8.65956043270316
ENSG00000180891,2006.0,,,,7.604396348796338
ENSG00000213719,9590.0,,,,9.16858043772795
ENSG00000136485,3036.0,E-GEOD-31138,2.5,'invasive ductal carcinoma' vs 'normal',8.01862546504575
ENSG00000160294,4663.0,,,,8.447628728030327
ENSG00000146072,1234.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.118826249062078
ENSG00000146072,1234.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',7.118826249062078
ENSG00000146072,1234.0,E-GEOD-7377,-1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.118826249062078
ENSG00000121769,245.0,,,,5.5053315359323625
ENSG00000187094,1.0,,,,0.6931471805599453
ENSG00000109047,13.0,,,,2.6390573296152584
ENSG00000132677,16.0,,,,2.833213344056216
ENSG00000181924,1126.0,,,,7.027314514039777
ENSG00000196188,1.0,,,,0.6931471805599453
ENSG00000177045,706.0,,,,6.561030665896573
ENSG00000109861,3074.0,E-GEOD-44408,1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.031060180240619
ENSG00000109861,3074.0,E-GEOD-38959,1.6,'breast cancer; breast' vs 'normal; breast',8.031060180240619
ENSG00000146376,1089.0,,,,6.993932975223189
ENSG00000183087,8139.0,,,,9.004545458996587
ENSG00000179913,56.0,,,,4.04305126783455
ENSG00000157601,1627.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',7.395107546562485
ENSG00000157601,1627.0,E-GEOD-38959,1.7,'breast cancer; breast' vs 'normal; breast',7.395107546562485
ENSG00000147548,4368.0,,,,8.382289428951436
ENSG00000198900,3521.0,,,,8.166784289056151
ENSG00000108799,6813.0,E-GEOD-31138,-2.6,'invasive ductal carcinoma' vs 'normal',8.826734598220911
ENSG00000176890,173.0,E-GEOD-54002,2.1,'breast cancer' vs 'normal',5.159055299214529
ENSG00000176890,173.0,E-GEOD-10780,1.5,'breast carcinoma' vs 'normal',5.159055299214529
ENSG00000176890,173.0,E-MTAB-779,1.9,'breast carcinoma' vs 'normal',5.159055299214529
ENSG00000176890,173.0,E-GEOD-38959,2.4,'breast cancer; breast' vs 'normal; breast',5.159055299214529
ENSG00000111341,51976.0,E-GEOD-54002,-2.2,'breast cancer' vs 'normal',10.858556592024357
ENSG00000136807,3638.0,,,,8.19946419761216
ENSG00000184012,512.0,,,,6.240275845170769
ENSG00000171206,5501.0,,,,8.61286694148452
ENSG00000101400,1620.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',7.390798521735676
ENSG00000105723,2107.0,,,,7.653494909661253
ENSG00000133069,146.0,,,,4.990432586778736
ENSG00000103490,395.0,,,,5.981414211254481
ENSG00000020922,1663.0,,,,7.416979621381154
ENSG00000277586,5.0,,,,1.791759469228055
ENSG00000160593,338.0,,,,5.82600010738045
ENSG00000166913,11355.0,,,,9.337501517592862
ENSG00000068024,1379.0,,,,7.22983877815125
ENSG00000068903,3297.0,,,,8.101071503119543
ENSG00000183431,3022.0,,,,8.014004994779459
ENSG00000050748,1669.0,,,,7.4205789054108005
ENSG00000244734,3128.0,E-GEOD-10780,-2.1,'breast carcinoma' vs 'normal',8.048468743668883
ENSG00000151067,744.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',6.61338421837956
ENSG00000113758,3396.0,,,,8.130647968160584
ENSG00000171848,47.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',3.871201010907891
ENSG00000171848,47.0,E-GEOD-52194,4.9,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',3.871201010907891
ENSG00000171848,47.0,E-GEOD-54002,3.1,'breast cancer' vs 'normal',3.871201010907891
ENSG00000171848,47.0,E-GEOD-10780,3.0,'breast carcinoma' vs 'normal',3.871201010907891
ENSG00000171848,47.0,E-GEOD-31138,4.9,'invasive ductal carcinoma' vs 'normal',3.871201010907891
ENSG00000134755,947.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',6.854354502255021
ENSG00000138182,238.0,,,,5.476463551931511
ENSG00000131914,5.0,E-GEOD-52194,5.2,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',1.791759469228055
ENSG00000131914,5.0,E-GEOD-68086,-5.0,'breast carcinoma' vs 'normal',1.791759469228055
ENSG00000198682,2527.0,,,,7.8351837552667485
ENSG00000037637,1743.0,,,,7.463936604468925
ENSG00000213782,377.0,,,,5.934894195619588
ENSG00000196352,3465.0,,,,8.150756470275551
ENSG00000121022,2433.0,,,,7.797291273547472
ENSG00000041880,1478.0,,,,7.2991214627108
ENSG00000137573,1452.0,E-MTAB-779,1.2,'breast carcinoma' vs 'normal',7.2813856635702825
ENSG00000137573,1452.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',7.2813856635702825
ENSG00000137573,1452.0,E-GEOD-54002,1.9,'breast cancer' vs 'normal',7.2813856635702825
ENSG00000137573,1452.0,E-GEOD-10780,1.6,'breast carcinoma' vs 'normal',7.2813856635702825
ENSG00000137573,1452.0,E-GEOD-44408,-2.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.2813856635702825
ENSG00000137573,1452.0,E-GEOD-31138,3.5,'invasive ductal carcinoma' vs 'normal',7.2813856635702825
ENSG00000063854,1345.0,,,,7.204892510204673
ENSG00000155111,1123.0,,,,7.024649030453636
ENSG00000172551,305.0,E-GEOD-54002,-2.7,'breast cancer' vs 'normal',5.723585101952381
ENSG00000172551,305.0,E-GEOD-10780,-1.8,'breast carcinoma' vs 'normal',5.723585101952381
ENSG00000172551,305.0,E-GEOD-38959,-3.6,'breast cancer; breast' vs 'normal; breast',5.723585101952381
ENSG00000107262,2973.0,,,,7.9976631270201
ENSG00000074319,2611.0,,,,7.867871490396322
ENSG00000127946,3316.0,,,,8.106816038947052
ENSG00000117122,654.0,,,,6.484635235635252
ENSG00000163064,143.0,E-GEOD-38959,1.6,'breast cancer; breast' vs 'normal; breast',4.969813299576001
ENSG00000074071,1358.0,,,,7.214504414151143
ENSG00000136156,24572.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',10.109403558183711
ENSG00000138738,517.0,,,,6.249975242259483
ENSG00000120262,227.0,,,,5.429345628954441
ENSG00000153208,1367.0,E-GEOD-54002,-1.4,'breast cancer' vs 'normal',7.221105098182496
ENSG00000152234,15461.0,,,,9.64614067988042
ENSG00000110400,835.0,,,,6.728628613084702
ENSG00000115310,19396.0,,,,9.872873693918292
ENSG00000070214,3741.0,E-GEOD-7377,1.6,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.227375506834035
ENSG00000100568,2717.0,,,,7.907651594711089
ENSG00000123810,148.0,,,,5.003946305945459
ENSG00000153814,1115.0,,,,7.017506142941256
ENSG00000095627,20.0,E-GEOD-52194,5.1,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',3.044522437723423
ENSG00000180900,3687.0,,,,8.212839584676484
ENSG00000168924,2183.0,,,,7.688913336864796
ENSG00000137713,2185.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',7.689828668736484
ENSG00000273706,0.0,,,,0.0
ENSG00000146701,5978.0,E-GEOD-31138,2.6,'invasive ductal carcinoma' vs 'normal',8.696008608880904
ENSG00000114062,3276.0,,,,8.094683648698815
ENSG00000141376,1164.0,,,,7.060476365999801
ENSG00000143217,866.0,,,,6.7650389767805414
ENSG00000197901,0.0,,,,0.0
ENSG00000115267,664.0,E-GEOD-7377,-1.4,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.499787040655854
ENSG00000149257,6334.0,,,,8.75384509275524
ENSG00000023330,2040.0,,,,7.621195162809845
ENSG00000165527,3951.0,,,,8.281977058867758
ENSG00000138311,20.0,,,,3.044522437723423
ENSG00000131771,1217.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',7.1049654482698426
ENSG00000126247,14219.0,,,,9.562404703357231
ENSG00000092010,5268.0,,,,8.569595870209286
ENSG00000123338,810.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.698268054115413
ENSG00000112699,664.0,,,,6.499787040655854
ENSG00000138764,3775.0,E-GEOD-38959,-1.3,'breast cancer; breast' vs 'normal; breast',8.236420527265391
ENSG00000138764,3775.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.236420527265391
ENSG00000151353,1378.0,,,,7.229113877793302
ENSG00000132849,1821.0,,,,7.507690077819904
ENSG00000136247,1138.0,,,,7.037905963447182
ENSG00000229314,26.0,,,,3.295836866004329
ENSG00000177000,1835.0,,,,7.515344571180436
ENSG00000118971,2783.0,E-GEOD-54002,-1.4,'breast cancer' vs 'normal',7.931644021454311
ENSG00000118971,2783.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',7.931644021454311
ENSG00000118971,2783.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',7.931644021454311
ENSG00000118971,2783.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.931644021454311
ENSG00000118971,2783.0,E-GEOD-38959,-1.6,'breast cancer; breast' vs 'normal; breast',7.931644021454311
ENSG00000184661,14.0,,,,2.70805020110221
ENSG00000128322,1.0,,,,0.6931471805599453
ENSG00000133101,27.0,,,,3.332204510175204
ENSG00000060138,21352.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',9.968947524007914
ENSG00000060138,21352.0,E-GEOD-52194,-4.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',9.968947524007914
ENSG00000145604,477.0,,,,6.169610732491456
ENSG00000163785,3283.0,,,,8.096817470572319
ENSG00000104205,461.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',6.135564891081739
ENSG00000156738,33.0,E-GEOD-31138,-2.6,'invasive ductal carcinoma' vs 'normal',3.5263605246161616
ENSG00000156738,33.0,E-GEOD-52194,5.4,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',3.5263605246161616
ENSG00000156738,33.0,E-GEOD-44408,3.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.5263605246161616
ENSG00000151365,1262.0,E-MTAB-779,-2.5,'breast carcinoma' vs 'normal',7.141245122350491
ENSG00000151365,1262.0,E-GEOD-10780,-1.9,'breast carcinoma' vs 'normal',7.141245122350491
ENSG00000183044,635.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',6.455198563340122
ENSG00000183044,635.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',6.455198563340122
ENSG00000172380,4825.0,,,,8.481773246184977
ENSG00000140287,172.0,,,,5.153291594497779
ENSG00000100601,582.0,E-GEOD-31138,1.7,'invasive ductal carcinoma' vs 'normal',6.368187186350492
ENSG00000169057,4406.0,,,,8.390949464841986
ENSG00000180447,2777.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',7.9294865233142895
ENSG00000180447,2777.0,E-MTAB-779,-1.7,'breast carcinoma' vs 'normal',7.9294865233142895
ENSG00000180447,2777.0,E-GEOD-10780,-1.5,'breast carcinoma' vs 'normal',7.9294865233142895
ENSG00000180447,2777.0,E-GEOD-54002,-2.8,'breast cancer' vs 'normal',7.9294865233142895
ENSG00000130649,164.0,E-GEOD-31138,-1.6,'invasive ductal carcinoma' vs 'normal',5.10594547390058
ENSG00000084754,10993.0,,,,9.305104948420606
ENSG00000173692,3727.0,,,,8.223627175805483
ENSG00000171522,797.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.682108597449809
ENSG00000171522,797.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',6.682108597449809
ENSG00000259956,2391.0,,,,7.779885115070522
ENSG00000168497,4565.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.42639282708974
ENSG00000168497,4565.0,E-GEOD-31138,-3.0,'invasive ductal carcinoma' vs 'normal',8.42639282708974
ENSG00000168497,4565.0,E-GEOD-52194,-5.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',8.42639282708974
ENSG00000168497,4565.0,E-GEOD-10780,-2.6,'breast carcinoma' vs 'normal',8.42639282708974
ENSG00000177272,12.0,,,,2.5649493574615367
ENSG00000114013,119.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.787491742782046
ENSG00000143870,3491.0,,,,8.158229916959494
ENSG00000167107,2393.0,,,,7.780720886117918
ENSG00000101557,3091.0,,,,8.036573409707312
ENSG00000110848,234.0,E-GEOD-44408,3.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.459585514144159
ENSG00000239900,1826.0,,,,7.510430556378006
ENSG00000117385,1867.0,,,,7.532623618788788
ENSG00000164104,3740.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',8.227108234348146
ENSG00000151882,1053.0,E-GEOD-52194,-4.7,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',6.960347729101308
ENSG00000151882,1053.0,E-GEOD-54002,-4.2,'breast cancer' vs 'normal',6.960347729101308
ENSG00000151882,1053.0,E-GEOD-10780,-1.8,'breast carcinoma' vs 'normal',6.960347729101308
ENSG00000151882,1053.0,E-GEOD-38959,-2.6,'breast cancer; breast' vs 'normal; breast',6.960347729101308
ENSG00000151882,1053.0,E-GEOD-7377,-2.8,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.960347729101308
ENSG00000162613,5280.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',8.571870752706934
ENSG00000115091,6013.0,,,,8.701845363548474
ENSG00000062716,11225.0,,,,9.325987795502144
ENSG00000172922,1721.0,,,,7.451241684987676
ENSG00000119950,3263.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',8.090708716083997
ENSG00000120708,7591.0,,,,8.934850340289763
ENSG00000151247,1798.0,,,,7.4949862339505335
ENSG00000057935,1562.0,,,,7.354362330421477
ENSG00000083457,651.0,,,,6.480044561926653
ENSG00000155666,179.0,,,,5.19295685089021
ENSG00000139644,23940.0,,,,10.08334774933398
ENSG00000184347,7408.0,E-MTAB-779,-1.8,'breast carcinoma' vs 'normal',8.910450756416656
ENSG00000117640,2545.0,,,,7.842278779117352
ENSG00000133027,1957.0,,,,7.579678823090456
ENSG00000198915,157.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',5.062595033026967
ENSG00000033867,2511.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',7.828834527588089
ENSG00000033867,2511.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',7.828834527588089
ENSG00000049239,7951.0,,,,8.98117874833641
ENSG00000127241,158.0,E-GEOD-20086,-1.4,'breast cancer' vs 'normal',5.0689042022202315
ENSG00000150457,2643.0,,,,7.880048200971577
ENSG00000019582,38056.0,E-GEOD-20086,1.3,'breast cancer' vs 'normal',10.54684031483226
ENSG00000166902,1307.0,,,,7.176254532017144
ENSG00000105404,3883.0,,,,8.264620829411216
ENSG00000076382,191.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',5.2574953720277815
ENSG00000076382,191.0,E-GEOD-31138,2.5,'invasive ductal carcinoma' vs 'normal',5.2574953720277815
ENSG00000076382,191.0,E-GEOD-54002,2.2,'breast cancer' vs 'normal',5.2574953720277815
ENSG00000089248,3281.0,,,,8.096208271650037
ENSG00000079999,2485.0,,,,7.818430272070656
ENSG00000113648,6004.0,,,,8.700347734514084
ENSG00000147604,30667.0,,,,10.330975044678786
ENSG00000203859,9.0,,,,2.302585092994046
ENSG00000169696,1589.0,,,,7.371489295214277
ENSG00000169385,26.0,,,,3.295836866004329
ENSG00000135100,8.0,,,,2.1972245773362196
ENSG00000162896,732.0,E-GEOD-54002,-5.8,'breast cancer' vs 'normal',6.597145701886651
ENSG00000162896,732.0,E-GEOD-10780,-2.4,'breast carcinoma' vs 'normal',6.597145701886651
ENSG00000162896,732.0,E-GEOD-31138,-4.9,'invasive ductal carcinoma' vs 'normal',6.597145701886651
ENSG00000162896,732.0,E-GEOD-52194,-5.7,'triple-negative breast cancer; breast carcinoma' vs 'normal',6.597145701886651
ENSG00000162896,732.0,E-GEOD-52194,-7.0,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',6.597145701886651
ENSG00000162896,732.0,E-GEOD-38959,-5.0,'breast cancer; breast' vs 'normal; breast',6.597145701886651
ENSG00000172590,1022.0,,,,6.930494765951626
ENSG00000091592,4234.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.351138607086154
ENSG00000122035,886.0,,,,6.787844982309579
ENSG00000135655,3794.0,,,,8.24143968982973
ENSG00000163507,126.0,,,,4.844187086458591
ENSG00000137497,13865.0,,,,9.537195079502435
ENSG00000135503,2018.0,,,,7.610357618312838
ENSG00000245848,2076.0,E-MTAB-779,-2.0,'breast carcinoma' vs 'normal',7.638679823876112
ENSG00000166483,1861.0,E-GEOD-54002,-1.4,'breast cancer' vs 'normal',7.529406457837013
ENSG00000139428,1059.0,,,,6.966024187106113
ENSG00000114209,1286.0,,,,7.160069207596127
ENSG00000291237,0.0,,,,0.0
ENSG00000148671,0.0,E-GEOD-10780,-1.5,'breast carcinoma' vs 'normal',0.0
ENSG00000181552,0.0,,,,0.0
ENSG00000251297,0.0,,,,0.0
ENSG00000184735,0.0,E-GEOD-52194,5.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000262117,0.0,,,,0.0
ENSG00000181965,0.0,,,,0.0
ENSG00000148602,0.0,,,,0.0
ENSG00000226344,0.0,,,,0.0
ENSG00000274252,0.0,,,,0.0
ENSG00000186795,0.0,,,,0.0
ENSG00000237197,0.0,,,,0.0
ENSG00000132631,0.0,,,,0.0
ENSG00000163098,0.0,,,,0.0
ENSG00000258597,0.0,,,,0.0
ENSG00000237136,0.0,,,,0.0
ENSG00000227418,0.0,,,,0.0
ENSG00000204671,0.0,,,,0.0
ENSG00000170777,0.0,,,,0.0
ENSG00000214319,0.0,,,,0.0
ENSG00000267308,0.0,,,,0.0
ENSG00000242599,0.0,,,,0.0
ENSG00000100058,620.0,,,,6.431331081933479
ENSG00000138675,16.0,,,,2.833213344056216
ENSG00000138166,1552.0,,,,7.347943823148687
ENSG00000243766,0.0,,,,0.0
ENSG00000113763,40.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',3.713572066704308
ENSG00000101280,599.0,,,,6.396929655216146
ENSG00000125508,15.0,,,,2.772588722239781
ENSG00000066056,4218.0,E-GEOD-31138,-2.0,'invasive ductal carcinoma' vs 'normal',8.347353412124338
ENSG00000070444,1555.0,,,,7.349873704738337
ENSG00000183161,314.0,,,,5.752572638825633
ENSG00000274180,1594.0,,,,7.374629015218945
ENSG00000232677,503.0,,,,6.222576268071369
ENSG00000283787,0.0,,,,0.0
ENSG00000010030,39.0,,,,3.6888794541139363
ENSG00000131873,3045.0,,,,8.021584533455107
ENSG00000125084,2.0,,,,1.0986122886681098
ENSG00000174013,462.0,,,,6.137727054086234
ENSG00000278811,36.0,,,,3.6109179126442243
ENSG00000115665,5.0,,,,1.791759469228055
ENSG00000115457,2601.0,E-GEOD-44408,-2.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.86403565907245
ENSG00000115457,2601.0,E-GEOD-20086,2.6,'breast cancer' vs 'normal',7.86403565907245
ENSG00000115232,275.0,E-GEOD-44408,2.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.62040086571715
ENSG00000242516,95.0,,,,4.564348191467836
ENSG00000102287,5026.0,E-GEOD-20086,-1.1,'breast cancer' vs 'normal',8.522578663692576
ENSG00000102287,5026.0,E-MTAB-779,-2.7,'breast carcinoma' vs 'normal',8.522578663692576
ENSG00000237765,985.0,,,,6.893656354602635
ENSG00000163817,63.0,,,,4.1588830833596715
ENSG00000169604,4465.0,E-GEOD-31138,2.9,'invasive ductal carcinoma' vs 'normal',8.404248432400102
ENSG00000171873,46.0,,,,3.8501476017100584
ENSG00000113430,203.0,E-GEOD-52194,-5.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',5.318119993844216
ENSG00000198768,80.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',4.394449154672439
ENSG00000168243,41.0,E-GEOD-38959,1.5,'breast cancer; breast' vs 'normal; breast',3.7376696182833684
ENSG00000268257,1.0,,,,0.6931471805599453
ENSG00000124225,1975.0,E-GEOD-44408,-1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.588829878307813
ENSG00000124225,1975.0,E-GEOD-38959,1.8,'breast cancer; breast' vs 'normal; breast',7.588829878307813
ENSG00000167941,1.0,,,,0.6931471805599453
ENSG00000134531,17001.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',9.741086263177305
ENSG00000134531,17001.0,E-GEOD-54002,-2.1,'breast cancer' vs 'normal',9.741086263177305
ENSG00000061273,10390.0,,,,9.248695325852646
ENSG00000128710,113.0,,,,4.736198448394496
ENSG00000140379,54.0,E-GEOD-44408,2.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.007333185232471
ENSG00000148634,2454.0,,,,7.805882040228621
ENSG00000177294,27.0,,,,3.332204510175204
ENSG00000245694,960.0,,,,6.8679744089702925
ENSG00000261824,298.0,,,,5.700443573390687
ENSG00000117400,17.0,,,,2.8903717578961645
ENSG00000204344,1112.0,,,,7.014814351275545
ENSG00000153266,0.0,,,,0.0
ENSG00000127564,27.0,E-GEOD-38959,1.7,'breast cancer; breast' vs 'normal; breast',3.332204510175204
ENSG00000127564,27.0,E-MTAB-779,2.2,'breast carcinoma' vs 'normal',3.332204510175204
ENSG00000164330,3289.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',8.098642843759418
ENSG00000164330,3289.0,E-GEOD-10780,-2.5,'breast carcinoma' vs 'normal',8.098642843759418
ENSG00000164330,3289.0,E-GEOD-7377,-2.7,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.098642843759418
ENSG00000163539,2286.0,,,,7.734996194022781
ENSG00000169245,16.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',2.833213344056216
ENSG00000169245,16.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',2.833213344056216
ENSG00000169245,16.0,E-GEOD-54002,2.8,'breast cancer' vs 'normal',2.833213344056216
ENSG00000169245,16.0,E-GEOD-10780,2.3,'breast carcinoma' vs 'normal',2.833213344056216
ENSG00000138336,138.0,,,,4.9344739331306915
ENSG00000128512,1519.0,,,,7.326465613840322
ENSG00000253414,14.0,,,,2.70805020110221
ENSG00000182487,19.0,,,,2.995732273553991
ENSG00000172575,101.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.624972813284271
ENSG00000253898,3.0,,,,1.3862943611198906
ENSG00000084453,19.0,,,,2.995732273553991
ENSG00000232093,48.0,,,,3.8918202981106265
ENSG00000197181,181.0,,,,5.204006687076795
ENSG00000211829,52.0,E-GEOD-44408,2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.970291913552122
ENSG00000204301,6278.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',8.744966011114109
ENSG00000122691,1284.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',7.158513997329321
ENSG00000122691,1284.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',7.158513997329321
ENSG00000111732,11.0,,,,2.4849066497880004
ENSG00000164825,119.0,E-GEOD-54002,-2.3,'breast cancer' vs 'normal',4.787491742782046
ENSG00000164825,119.0,E-GEOD-52194,-5.9,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',4.787491742782046
ENSG00000230923,0.0,,,,0.0
ENSG00000102935,747.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',6.617402977974478
ENSG00000180549,5.0,,,,1.791759469228055
ENSG00000174365,609.0,,,,6.413458957167357
ENSG00000164128,851.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',6.747586526829315
ENSG00000164128,851.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',6.747586526829315
ENSG00000166206,55.0,,,,4.02535169073515
ENSG00000101188,2.0,,,,1.0986122886681098
ENSG00000143365,585.0,E-GEOD-38959,-2.0,'breast cancer; breast' vs 'normal; breast',6.373319789577012
ENSG00000152086,2.0,,,,1.0986122886681098
ENSG00000100625,158.0,,,,5.0689042022202315
ENSG00000156076,156.0,E-GEOD-52194,-4.9,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',5.056245805348308
ENSG00000156076,156.0,E-GEOD-54002,-5.2,'breast cancer' vs 'normal',5.056245805348308
ENSG00000156076,156.0,E-GEOD-10780,-3.5,'breast carcinoma' vs 'normal',5.056245805348308
ENSG00000156076,156.0,E-GEOD-38959,-3.8,'breast cancer; breast' vs 'normal; breast',5.056245805348308
ENSG00000156076,156.0,E-GEOD-52194,-7.3,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',5.056245805348308
ENSG00000162009,0.0,,,,0.0
ENSG00000132671,0.0,,,,0.0
ENSG00000204622,263.0,,,,5.575949103146316
ENSG00000172201,2104.0,E-GEOD-7377,-1.4,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.652070746116482
ENSG00000172201,2104.0,E-GEOD-54002,-4.8,'breast cancer' vs 'normal',7.652070746116482
ENSG00000172201,2104.0,E-MTAB-779,-2.1,'breast carcinoma' vs 'normal',7.652070746116482
ENSG00000172201,2104.0,E-GEOD-10780,-3.0,'breast carcinoma' vs 'normal',7.652070746116482
ENSG00000108379,101.0,E-GEOD-68086,-4.9,'breast carcinoma' vs 'normal',4.624972813284271
ENSG00000099622,20388.0,,,,9.922750818716974
ENSG00000123415,950.0,,,,6.85751406254539
ENSG00000233515,0.0,,,,0.0
ENSG00000006468,256.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',5.54907608489522
ENSG00000006468,256.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',5.54907608489522
ENSG00000160767,1231.0,,,,7.116394144093465
ENSG00000269821,996.0,,,,6.904750769961838
ENSG00000120279,1393.0,,,,7.2399325913204695
ENSG00000168267,0.0,,,,0.0
ENSG00000129214,14.0,,,,2.70805020110221
ENSG00000174498,10.0,E-GEOD-68086,-5.8,'breast carcinoma' vs 'normal',2.3978952727983707
ENSG00000124664,671.0,E-MTAB-779,1.6,'breast carcinoma' vs 'normal',6.51025834052315
ENSG00000124664,671.0,E-GEOD-44408,-2.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.51025834052315
ENSG00000072736,890.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.792344427470809
ENSG00000183579,5.0,,,,1.791759469228055
ENSG00000151923,4755.0,,,,8.467162257810672
ENSG00000233532,0.0,,,,0.0
ENSG00000114378,569.0,E-GEOD-68086,-4.9,'breast carcinoma' vs 'normal',6.345636360828596
ENSG00000260105,281.0,,,,5.641907070938114
ENSG00000114999,1479.0,E-GEOD-31138,1.8,'invasive ductal carcinoma' vs 'normal',7.299797366758161
ENSG00000114999,1479.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.299797366758161
ENSG00000138136,0.0,,,,0.0
ENSG00000172602,85.0,E-GEOD-44408,-1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.454347296253507
ENSG00000172602,85.0,E-GEOD-52194,-5.3,'triple-negative breast cancer; breast carcinoma' vs 'normal',4.454347296253507
ENSG00000172602,85.0,E-GEOD-52194,-5.9,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',4.454347296253507
ENSG00000203711,2.0,,,,1.0986122886681098
ENSG00000223922,7.0,,,,2.0794415416798357
ENSG00000178814,1379.0,,,,7.22983877815125
ENSG00000147570,13.0,E-GEOD-52194,4.8,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',2.6390573296152584
ENSG00000156873,1165.0,,,,7.061334366910438
ENSG00000236830,153.0,,,,5.0369526024136295
ENSG00000227674,6.0,,,,1.9459101490553132
ENSG00000266265,41.0,,,,3.7376696182833684
ENSG00000103241,72.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.290459441148391
ENSG00000179094,21854.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',9.992185007297415
ENSG00000179094,21854.0,E-GEOD-31138,-2.4,'invasive ductal carcinoma' vs 'normal',9.992185007297415
ENSG00000179094,21854.0,E-GEOD-52194,-5.2,'triple-negative breast cancer; breast carcinoma' vs 'normal',9.992185007297415
ENSG00000179094,21854.0,E-GEOD-52194,-4.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',9.992185007297415
ENSG00000208036,1.0,,,,0.6931471805599453
ENSG00000164619,233.0,,,,5.455321115357702
ENSG00000087237,123.0,E-GEOD-44408,4.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.820281565605037
ENSG00000279685,2.0,,,,1.0986122886681098
ENSG00000185352,40.0,E-GEOD-52194,4.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',3.713572066704308
ENSG00000241233,3.0,,,,1.3862943611198906
ENSG00000125910,132.0,E-GEOD-44408,1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.890349128221754
ENSG00000155846,435.0,,,,6.077642243349034
ENSG00000131153,70.0,E-MTAB-779,1.2,'breast carcinoma' vs 'normal',4.2626798770413155
ENSG00000131153,70.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',4.2626798770413155
ENSG00000151876,562.0,,,,6.333279628139691
ENSG00000261664,7.0,,,,2.0794415416798357
ENSG00000082482,348.0,,,,5.855071922202427
ENSG00000247556,3780.0,,,,8.237743803890933
ENSG00000162892,62.0,,,,4.143134726391533
ENSG00000165810,17195.0,E-GEOD-38959,-1.3,'breast cancer; breast' vs 'normal; breast',9.752432077616172
ENSG00000165810,17195.0,E-MTAB-779,-1.9,'breast carcinoma' vs 'normal',9.752432077616172
ENSG00000165810,17195.0,E-GEOD-52194,-5.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',9.752432077616172
ENSG00000165810,17195.0,E-GEOD-31138,-3.7,'invasive ductal carcinoma' vs 'normal',9.752432077616172
ENSG00000232956,1132.0,,,,7.0326242610280065
ENSG00000183935,236.0,,,,5.4680601411351315
ENSG00000138613,1119.0,,,,7.02108396428914
ENSG00000177169,5211.0,,,,8.558718938244736
ENSG00000089094,1218.0,,,,7.105786129481271
ENSG00000087495,14.0,,,,2.70805020110221
ENSG00000149600,2021.0,,,,7.611842399580417
ENSG00000204516,229.0,E-GEOD-38959,1.6,'breast cancer; breast' vs 'normal; breast',5.438079308923196
ENSG00000225830,547.0,,,,6.306275286948016
ENSG00000146674,15734.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',9.663642809498507
ENSG00000146674,15734.0,E-GEOD-44408,1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.663642809498507
ENSG00000169836,0.0,,,,0.0
ENSG00000148735,594.0,E-GEOD-54002,-2.0,'breast cancer' vs 'normal',6.38856140554563
ENSG00000188379,0.0,,,,0.0
ENSG00000173376,210.0,,,,5.351858133476067
ENSG00000223731,2.0,,,,1.0986122886681098
ENSG00000109881,220.0,,,,5.3981627015177525
ENSG00000057593,14.0,,,,2.70805020110221
ENSG00000118985,4629.0,E-GEOD-54002,-2.4,'breast cancer' vs 'normal',8.440312147080279
ENSG00000118985,4629.0,E-GEOD-31138,3.1,'invasive ductal carcinoma' vs 'normal',8.440312147080279
ENSG00000069764,4.0,,,,1.6094379124341003
ENSG00000111665,138.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',4.9344739331306915
ENSG00000111665,138.0,E-GEOD-54002,2.6,'breast cancer' vs 'normal',4.9344739331306915
ENSG00000225733,6475.0,,,,8.775858314797526
ENSG00000251655,0.0,,,,0.0
ENSG00000163501,2.0,,,,1.0986122886681098
ENSG00000154328,794.0,,,,6.678342114654332
ENSG00000136840,951.0,,,,6.858565034791365
ENSG00000164690,1.0,E-GEOD-68086,-5.8,'breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000161509,68.0,,,,4.23410650459726
ENSG00000108342,30.0,E-GEOD-52194,-8.5,'triple-negative breast cancer; breast carcinoma' vs 'normal',3.4339872044851463
ENSG00000108342,30.0,E-GEOD-52194,-10.1,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',3.4339872044851463
ENSG00000108342,30.0,E-GEOD-52194,-9.3,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',3.4339872044851463
ENSG00000184990,2609.0,,,,7.867105500316739
ENSG00000204657,2.0,,,,1.0986122886681098
ENSG00000174990,57.0,E-GEOD-52194,6.4,'triple-negative breast cancer; breast carcinoma' vs 'normal',4.060443010546419
ENSG00000174990,57.0,E-GEOD-52194,5.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',4.060443010546419
ENSG00000179978,27.0,,,,3.332204510175204
ENSG00000180053,0.0,,,,0.0
ENSG00000100335,1710.0,,,,7.444833273892193
ENSG00000104825,988.0,,,,6.8966943316227125
ENSG00000144119,4.0,E-GEOD-52194,-4.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',1.6094379124341003
ENSG00000154556,2190.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',7.692113339595466
ENSG00000154556,2190.0,E-GEOD-54002,-2.5,'breast cancer' vs 'normal',7.692113339595466
ENSG00000172752,0.0,E-GEOD-52194,4.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000172752,0.0,E-GEOD-52194,6.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000135697,4.0,,,,1.6094379124341003
ENSG00000167208,74.0,E-GEOD-52194,5.0,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',4.31748811353631
ENSG00000119684,1347.0,,,,7.206377291472252
ENSG00000086717,6.0,,,,1.9459101490553132
ENSG00000122223,21.0,,,,3.091042453358316
ENSG00000174808,80.0,E-GEOD-54002,-1.4,'breast cancer' vs 'normal',4.394449154672439
ENSG00000005513,135.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',4.912654885736052
ENSG00000005513,135.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',4.912654885736052
ENSG00000005513,135.0,E-GEOD-52194,-5.3,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',4.912654885736052
ENSG00000005513,135.0,E-GEOD-7377,-2.4,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',4.912654885736052
ENSG00000075388,0.0,,,,0.0
ENSG00000179057,57.0,,,,4.060443010546419
ENSG00000179284,17.0,,,,2.8903717578961645
ENSG00000197757,878.0,,,,6.778784897685177
ENSG00000127663,3603.0,E-GEOD-7377,2.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.189799618728228
ENSG00000112425,452.0,,,,6.115892125483034
ENSG00000134443,1.0,E-GEOD-7377,3.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',0.6931471805599453
ENSG00000130997,216.0,,,,5.37989735354046
ENSG00000215808,27.0,,,,3.332204510175204
ENSG00000129152,0.0,,,,0.0
ENSG00000077152,50.0,E-GEOD-54002,2.8,'breast cancer' vs 'normal',3.9318256327243257
ENSG00000077152,50.0,E-MTAB-779,2.1,'breast carcinoma' vs 'normal',3.9318256327243257
ENSG00000077152,50.0,E-GEOD-10780,2.4,'breast carcinoma' vs 'normal',3.9318256327243257
ENSG00000077152,50.0,E-GEOD-38959,3.0,'breast cancer; breast' vs 'normal; breast',3.9318256327243257
ENSG00000154582,1411.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',7.252762418053187
ENSG00000115286,1579.0,,,,7.365180126021013
ENSG00000123219,51.0,E-GEOD-54002,1.7,'breast cancer' vs 'normal',3.9512437185814275
ENSG00000123219,51.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',3.9512437185814275
ENSG00000171621,2163.0,,,,7.679713639966372
ENSG00000172059,2611.0,,,,7.867871490396322
ENSG00000108700,39.0,,,,3.6888794541139363
ENSG00000102781,1084.0,,,,6.98933526597456
ENSG00000196912,410.0,,,,6.018593214496234
ENSG00000124532,1194.0,,,,7.085901464365611
ENSG00000138316,24.0,,,,3.2188758248682006
ENSG00000080986,39.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',3.6888794541139363
ENSG00000080986,39.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',3.6888794541139363
ENSG00000080986,39.0,E-GEOD-31138,2.8,'invasive ductal carcinoma' vs 'normal',3.6888794541139363
ENSG00000080986,39.0,E-GEOD-54002,3.2,'breast cancer' vs 'normal',3.6888794541139363
ENSG00000080986,39.0,E-GEOD-38959,2.1,'breast cancer; breast' vs 'normal; breast',3.6888794541139363
ENSG00000127129,28.0,E-GEOD-38959,2.1,'breast cancer; breast' vs 'normal; breast',3.367295829986474
ENSG00000140961,406.0,,,,6.008813185442595
ENSG00000165819,3207.0,,,,8.073402968986406
ENSG00000158050,216.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.37989735354046
ENSG00000158050,216.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',5.37989735354046
ENSG00000131094,16.0,,,,2.833213344056216
ENSG00000163637,1394.0,,,,7.240649694255466
ENSG00000099985,34.0,,,,3.5553480614894135
ENSG00000205274,0.0,,,,0.0
ENSG00000120875,3408.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',8.134174272137903
ENSG00000267123,1.0,,,,0.6931471805599453
ENSG00000103888,117.0,E-GEOD-54002,1.9,'breast cancer' vs 'normal',4.770684624465665
ENSG00000103888,117.0,E-GEOD-44408,2.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.770684624465665
ENSG00000119899,1140.0,,,,7.039660349862076
ENSG00000206195,164.0,,,,5.10594547390058
ENSG00000054598,919.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',6.824373670043086
ENSG00000054598,919.0,E-GEOD-54002,-2.2,'breast cancer' vs 'normal',6.824373670043086
ENSG00000054598,919.0,E-MTAB-779,-2.0,'breast carcinoma' vs 'normal',6.824373670043086
ENSG00000054598,919.0,E-GEOD-7377,-3.4,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.824373670043086
ENSG00000152128,71.0,,,,4.276666119016055
ENSG00000149090,624.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',6.437751649736401
ENSG00000149090,624.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',6.437751649736401
ENSG00000149090,624.0,E-GEOD-54002,-3.1,'breast cancer' vs 'normal',6.437751649736401
ENSG00000281560,25.0,,,,3.258096538021482
ENSG00000144285,1.0,E-GEOD-52194,7.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000144285,1.0,E-GEOD-52194,6.1,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000260455,6.0,,,,1.9459101490553132
ENSG00000169551,1.0,E-GEOD-52194,4.9,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000213160,397.0,,,,5.986452005284438
ENSG00000213213,59.0,,,,4.0943445622221
ENSG00000145242,4.0,,,,1.6094379124341003
ENSG00000102466,54.0,,,,4.007333185232471
ENSG00000174951,283.0,,,,5.648974238161206
ENSG00000166822,712.0,,,,6.569481420414296
ENSG00000104517,7218.0,,,,8.88447171813916
ENSG00000149658,2362.0,,,,7.767687277186908
ENSG00000112242,678.0,E-GEOD-38959,1.8,'breast cancer; breast' vs 'normal; breast',6.520621127558696
ENSG00000157985,1434.0,E-GEOD-44408,-2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.268920128193722
ENSG00000099849,500.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',6.2166061010848646
ENSG00000125144,133.0,,,,4.897839799950911
ENSG00000113369,5921.0,E-GEOD-54002,-2.9,'breast cancer' vs 'normal',8.686429508661536
ENSG00000149968,447.0,,,,6.104793232414985
ENSG00000175283,500.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',6.2166061010848646
ENSG00000100422,2319.0,E-GEOD-7377,-1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.749322464660356
ENSG00000154133,3316.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',8.106816038947052
ENSG00000005810,5970.0,,,,8.694669696546992
ENSG00000184719,281.0,,,,5.641907070938114
ENSG00000198380,3562.0,E-GEOD-44408,-1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.178358165605836
ENSG00000198380,3562.0,E-GEOD-31138,3.1,'invasive ductal carcinoma' vs 'normal',8.178358165605836
ENSG00000158481,22.0,E-GEOD-44408,2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.1354942159291497
ENSG00000188629,2.0,,,,1.0986122886681098
ENSG00000141696,455.0,E-GEOD-44408,-1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.1224928095143865
ENSG00000077721,2625.0,E-GEOD-31138,2.8,'invasive ductal carcinoma' vs 'normal',7.873217054862741
ENSG00000184371,5280.0,,,,8.571870752706934
ENSG00000178980,6062.0,,,,8.70996000607173
ENSG00000187554,380.0,,,,5.942799375126701
ENSG00000226979,11.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',2.4849066497880004
ENSG00000128645,21.0,,,,3.091042453358316
ENSG00000215474,0.0,,,,0.0
ENSG00000112164,7.0,,,,2.0794415416798357
ENSG00000276160,0.0,,,,0.0
ENSG00000175445,15957.0,E-GEOD-54002,-1.4,'breast cancer' vs 'normal',9.677715549868227
ENSG00000175445,15957.0,E-GEOD-7377,-1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',9.677715549868227
ENSG00000175445,15957.0,E-MTAB-779,-2.3,'breast carcinoma' vs 'normal',9.677715549868227
ENSG00000175445,15957.0,E-GEOD-10780,-2.8,'breast carcinoma' vs 'normal',9.677715549868227
ENSG00000163568,24.0,E-GEOD-44408,2.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.2188758248682006
ENSG00000138083,3.0,,,,1.3862943611198906
ENSG00000100234,1180.0,,,,7.074116816197362
ENSG00000147804,324.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',5.783825182329737
ENSG00000256453,0.0,,,,0.0
ENSG00000165621,38.0,,,,3.6635616461296463
ENSG00000053438,434.0,,,,6.075346031088684
ENSG00000139144,170.0,E-GEOD-54002,-3.7,'breast cancer' vs 'normal',5.14166355650266
ENSG00000139144,170.0,E-GEOD-38959,-2.0,'breast cancer; breast' vs 'normal; breast',5.14166355650266
ENSG00000170364,1158.0,,,,7.055312843339752
ENSG00000125850,104.0,E-GEOD-44408,-2.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.653960350157523
ENSG00000131849,196.0,,,,5.2832037287379885
ENSG00000232560,0.0,,,,0.0
ENSG00000272333,4879.0,,,,8.492900498847193
ENSG00000117069,64.0,E-GEOD-54002,-2.1,'breast cancer' vs 'normal',4.174387269895637
ENSG00000117069,64.0,E-GEOD-20086,2.4,'breast cancer' vs 'normal',4.174387269895637
ENSG00000157150,4282.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',8.36240897761537
ENSG00000157150,4282.0,E-MTAB-779,-2.1,'breast carcinoma' vs 'normal',8.36240897761537
ENSG00000171320,20.0,,,,3.044522437723423
ENSG00000177706,3522.0,,,,8.167068178341237
ENSG00000198822,6.0,,,,1.9459101490553132
ENSG00000224078,1832.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',7.513709247839705
ENSG00000224078,1832.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',7.513709247839705
ENSG00000211725,0.0,,,,0.0
ENSG00000164935,3.0,,,,1.3862943611198906
ENSG00000160781,153.0,,,,5.0369526024136295
ENSG00000269893,2492.0,,,,7.821242083523558
ENSG00000048462,6.0,E-GEOD-52194,4.9,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.9459101490553132
ENSG00000048462,6.0,E-GEOD-52194,5.0,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',1.9459101490553132
ENSG00000160712,1528.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.332369205929062
ENSG00000176194,1497.0,E-MTAB-779,-2.2,'breast carcinoma' vs 'normal',7.311886164077165
ENSG00000139610,0.0,,,,0.0
ENSG00000127337,441.0,,,,6.091309882077698
ENSG00000203497,70.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.2626798770413155
ENSG00000134323,12.0,,,,2.5649493574615367
ENSG00000096996,59.0,,,,4.0943445622221
ENSG00000125787,7.0,,,,2.0794415416798357
ENSG00000233077,5.0,,,,1.791759469228055
ENSG00000074590,2354.0,,,,7.764296006450518
ENSG00000119714,154.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',5.043425116919247
ENSG00000230989,2571.0,,,,7.85243908535751
ENSG00000002016,687.0,,,,6.5337888379333435
ENSG00000241370,164.0,,,,5.10594547390058
ENSG00000121236,221.0,E-GEOD-31138,2.4,'invasive ductal carcinoma' vs 'normal',5.402677381872279
ENSG00000151657,726.0,,,,6.588926477533519
ENSG00000184226,287.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',5.662960480135946
ENSG00000184226,287.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',5.662960480135946
ENSG00000126603,908.0,,,,6.812345094177479
ENSG00000243479,0.0,,,,0.0
ENSG00000109819,288.0,,,,5.666426688112432
ENSG00000211623,0.0,,,,0.0
ENSG00000183873,74.0,,,,4.31748811353631
ENSG00000168843,0.0,,,,0.0
ENSG00000242294,815.0,,,,6.704414354964107
ENSG00000132681,33.0,E-GEOD-68086,-5.0,'breast carcinoma' vs 'normal',3.5263605246161616
ENSG00000186188,68.0,,,,4.23410650459726
ENSG00000238113,129.0,E-GEOD-31138,2.5,'invasive ductal carcinoma' vs 'normal',4.867534450455582
ENSG00000115548,4961.0,,,,8.509564164251746
ENSG00000214049,9.0,,,,2.302585092994046
ENSG00000156574,28.0,,,,3.367295829986474
ENSG00000179520,0.0,,,,0.0
ENSG00000119715,16.0,,,,2.833213344056216
ENSG00000136045,2106.0,,,,7.653020413804189
ENSG00000198216,7.0,E-GEOD-52194,4.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',2.0794415416798357
ENSG00000198216,7.0,E-GEOD-52194,5.5,'triple-negative breast cancer; breast carcinoma' vs 'normal',2.0794415416798357
ENSG00000147571,0.0,,,,0.0
ENSG00000178343,88.0,,,,4.48863636973214
ENSG00000143171,51.0,,,,3.9512437185814275
ENSG00000173917,1196.0,E-GEOD-7377,2.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.087573705557973
ENSG00000116990,48.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.8918202981106265
ENSG00000111339,58.0,,,,4.07753744390572
ENSG00000115020,2392.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.780303087908373
ENSG00000185053,4.0,,,,1.6094379124341003
ENSG00000105339,5174.0,,,,8.55159461813357
ENSG00000092969,210.0,E-GEOD-20086,1.7,'breast cancer' vs 'normal',5.351858133476067
ENSG00000092969,210.0,E-GEOD-31138,3.1,'invasive ductal carcinoma' vs 'normal',5.351858133476067
ENSG00000152213,60.0,,,,4.110873864173311
ENSG00000174125,246.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.5093883366279774
ENSG00000138769,12.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',2.5649493574615367
ENSG00000258867,3.0,,,,1.3862943611198906
ENSG00000133640,20.0,,,,3.044522437723423
ENSG00000070047,2915.0,,,,7.977968093128549
ENSG00000164946,336.0,,,,5.820082930352362
ENSG00000198633,7.0,,,,2.0794415416798357
ENSG00000279192,96.0,,,,4.574710978503383
ENSG00000118972,0.0,E-GEOD-52194,5.3,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000179242,38.0,,,,3.6635616461296463
ENSG00000066735,752.0,,,,6.6240652277998935
ENSG00000123689,7010.0,E-GEOD-10780,-2.3,'breast carcinoma' vs 'normal',8.855235623206967
ENSG00000123689,7010.0,E-MTAB-779,-2.7,'breast carcinoma' vs 'normal',8.855235623206967
ENSG00000109471,1.0,,,,0.6931471805599453
ENSG00000259974,1.0,,,,0.6931471805599453
ENSG00000107854,3778.0,,,,8.237214703349489
ENSG00000124479,23.0,E-GEOD-7377,1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',3.1780538303479458
ENSG00000145996,689.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',6.536691597591305
ENSG00000103429,2560.0,,,,7.848153086199526
ENSG00000163734,50.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.9318256327243257
ENSG00000163734,50.0,E-GEOD-52194,-7.4,'triple-negative breast cancer; breast carcinoma' vs 'normal',3.9318256327243257
ENSG00000163734,50.0,E-GEOD-52194,-7.3,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',3.9318256327243257
ENSG00000163734,50.0,E-GEOD-52194,-8.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',3.9318256327243257
ENSG00000163734,50.0,E-GEOD-7377,-1.9,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',3.9318256327243257
ENSG00000163513,24693.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',10.11431557812769
ENSG00000163513,24693.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',10.11431557812769
ENSG00000163513,24693.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',10.11431557812769
ENSG00000163513,24693.0,E-GEOD-38959,-1.3,'breast cancer; breast' vs 'normal; breast',10.11431557812769
ENSG00000163513,24693.0,E-GEOD-54002,-2.4,'breast cancer' vs 'normal',10.11431557812769
ENSG00000131759,3149.0,,,,8.055157731819678
ENSG00000170425,57.0,,,,4.060443010546419
ENSG00000183671,17.0,,,,2.8903717578961645
ENSG00000185112,1156.0,,,,7.053585727193677
ENSG00000263934,1.0,,,,0.6931471805599453
ENSG00000189238,2.0,,,,1.0986122886681098
ENSG00000152785,50.0,,,,3.9318256327243257
ENSG00000184261,6.0,,,,1.9459101490553132
ENSG00000116251,17518.0,,,,9.771041285235823
ENSG00000214851,25.0,,,,3.258096538021482
ENSG00000255874,191.0,,,,5.2574953720277815
ENSG00000163606,40.0,,,,3.713572066704308
ENSG00000250786,301.0,,,,5.71042701737487
ENSG00000259104,14.0,,,,2.70805020110221
ENSG00000137834,853.0,,,,6.74993119378857
ENSG00000152784,453.0,,,,6.118097198041348
ENSG00000177335,57.0,,,,4.060443010546419
ENSG00000108469,1317.0,,,,7.183870715062453
ENSG00000106258,416.0,,,,6.0330862217988015
ENSG00000086991,292.0,E-GEOD-54002,1.8,'breast cancer' vs 'normal',5.680172609017068
ENSG00000086991,292.0,E-GEOD-44408,-2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.680172609017068
ENSG00000161682,35.0,,,,3.58351893845611
ENSG00000237489,77.0,,,,4.356708826689592
ENSG00000116741,2221.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',7.706162970199576
ENSG00000116741,2221.0,E-MTAB-779,-1.7,'breast carcinoma' vs 'normal',7.706162970199576
ENSG00000116741,2221.0,E-GEOD-54002,-5.0,'breast cancer' vs 'normal',7.706162970199576
ENSG00000106100,1512.0,,,,7.321849713788356
ENSG00000251493,14.0,,,,2.70805020110221
ENSG00000183856,45.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',3.828641396489095
ENSG00000183856,45.0,E-GEOD-54002,2.9,'breast cancer' vs 'normal',3.828641396489095
ENSG00000167565,1223.0,,,,7.1098794630722715
ENSG00000182674,2.0,,,,1.0986122886681098
ENSG00000152377,2109.0,E-GEOD-44408,-2.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.6544432264701125
ENSG00000152377,2109.0,E-GEOD-54002,2.3,'breast cancer' vs 'normal',7.6544432264701125
ENSG00000075218,34.0,,,,3.5553480614894135
ENSG00000225937,1.0,E-GEOD-52194,5.8,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000225937,1.0,E-GEOD-52194,5.0,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000228078,3.0,,,,1.3862943611198906
ENSG00000203883,1474.0,,,,7.29641326877392
ENSG00000185433,2.0,,,,1.0986122886681098
ENSG00000213398,1459.0,,,,7.286191714702382
ENSG00000106123,778.0,,,,6.658011045870748
ENSG00000134245,469.0,,,,6.152732694704104
ENSG00000169016,805.0,,,,6.692083742506628
ENSG00000015171,4424.0,,,,8.39502555744203
ENSG00000144619,175.0,E-GEOD-54002,-2.1,'breast cancer' vs 'normal',5.170483995038151
ENSG00000187689,0.0,,,,0.0
ENSG00000148513,424.0,E-GEOD-38959,-3.9,'breast cancer; breast' vs 'normal; breast',6.052089168924417
ENSG00000240405,8.0,,,,2.1972245773362196
ENSG00000070886,0.0,,,,0.0
ENSG00000272143,150.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',5.017279836814924
ENSG00000147689,7.0,,,,2.0794415416798357
ENSG00000151388,959.0,E-GEOD-54002,1.9,'breast cancer' vs 'normal',6.866933284461882
ENSG00000125657,27.0,,,,3.332204510175204
ENSG00000224559,11.0,E-GEOD-52194,4.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',2.4849066497880004
ENSG00000166923,381.0,E-GEOD-54002,2.6,'breast cancer' vs 'normal',5.945420608606575
ENSG00000166923,381.0,E-GEOD-31138,3.4,'invasive ductal carcinoma' vs 'normal',5.945420608606575
ENSG00000206503,20431.0,,,,9.92485757827232
ENSG00000169252,1471.0,E-GEOD-44408,1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.294377299288821
ENSG00000169252,1471.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',7.294377299288821
ENSG00000169252,1471.0,E-MTAB-779,-1.8,'breast carcinoma' vs 'normal',7.294377299288821
ENSG00000104998,699.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.551080335043404
ENSG00000104998,699.0,E-GEOD-20086,1.6,'breast cancer' vs 'normal',6.551080335043404
ENSG00000214102,11.0,,,,2.4849066497880004
ENSG00000140320,1417.0,,,,7.257002707092073
ENSG00000149435,0.0,,,,0.0
ENSG00000243910,1.0,,,,0.6931471805599453
ENSG00000171462,97.0,,,,4.584967478670572
ENSG00000263753,2061.0,,,,7.631431664576906
ENSG00000160339,76.0,,,,4.343805421853684
ENSG00000268751,40.0,,,,3.713572066704308
ENSG00000102384,43.0,E-GEOD-54002,1.4,'breast cancer' vs 'normal',3.784189633918261
ENSG00000102384,43.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',3.784189633918261
ENSG00000101945,312.0,,,,5.746203190540153
ENSG00000139540,18.0,,,,2.9444389791664403
ENSG00000188175,31.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',3.4657359027997265
ENSG00000188175,31.0,E-GEOD-52194,-5.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',3.4657359027997265
ENSG00000167771,29.0,,,,3.4011973816621555
ENSG00000127314,6948.0,,,,8.846353043314327
ENSG00000266904,159.0,,,,5.075173815233827
ENSG00000196756,1239.0,,,,7.122866658599083
ENSG00000204866,3.0,,,,1.3862943611198906
ENSG00000160113,1072.0,E-GEOD-44408,-1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.9782137426306985
ENSG00000163739,72.0,E-GEOD-52194,-6.9,'triple-negative breast cancer; breast carcinoma' vs 'normal',4.290459441148391
ENSG00000163739,72.0,E-GEOD-52194,-8.1,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',4.290459441148391
ENSG00000144645,995.0,,,,6.903747257584598
ENSG00000074966,64.0,E-GEOD-44408,2.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.174387269895637
ENSG00000116260,5052.0,,,,8.527737405291909
ENSG00000175324,590.0,,,,6.3818160174060985
ENSG00000155090,4256.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',8.356319965828153
ENSG00000171819,162.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',5.093750200806762
ENSG00000171819,162.0,E-GEOD-68086,-5.9,'breast carcinoma' vs 'normal',5.093750200806762
ENSG00000124159,8.0,,,,2.1972245773362196
ENSG00000181418,11.0,,,,2.4849066497880004
ENSG00000186416,376.0,,,,5.932245187448011
ENSG00000222041,380.0,,,,5.942799375126701
ENSG00000113594,8424.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.038958755220563
ENSG00000113594,8424.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',9.038958755220563
ENSG00000113594,8424.0,E-MTAB-779,-2.0,'breast carcinoma' vs 'normal',9.038958755220563
ENSG00000113594,8424.0,E-GEOD-10780,-2.5,'breast carcinoma' vs 'normal',9.038958755220563
ENSG00000113594,8424.0,E-GEOD-31138,-4.7,'invasive ductal carcinoma' vs 'normal',9.038958755220563
ENSG00000113594,8424.0,E-GEOD-38959,-2.0,'breast cancer; breast' vs 'normal; breast',9.038958755220563
ENSG00000142611,217.0,,,,5.384495062789089
ENSG00000151005,1.0,,,,0.6931471805599453
ENSG00000143493,550.0,,,,6.311734809152915
ENSG00000154589,255.0,E-GEOD-44408,1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.545177444479562
ENSG00000226479,750.0,,,,6.621405651764134
ENSG00000251381,14.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',2.70805020110221
ENSG00000121742,3.0,,,,1.3862943611198906
ENSG00000152578,49.0,E-GEOD-38959,-1.4,'breast cancer; breast' vs 'normal; breast',3.912023005428146
ENSG00000213906,219.0,,,,5.393627546352362
ENSG00000231806,7.0,,,,2.0794415416798357
ENSG00000147669,1263.0,,,,7.142036574706803
ENSG00000140506,1.0,,,,0.6931471805599453
ENSG00000237412,0.0,,,,0.0
ENSG00000133321,885.0,,,,6.786716950605081
ENSG00000108405,151.0,,,,5.0238805208462765
ENSG00000066382,175.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',5.170483995038151
ENSG00000066382,175.0,E-GEOD-54002,-4.1,'breast cancer' vs 'normal',5.170483995038151
ENSG00000069696,43.0,,,,3.784189633918261
ENSG00000130675,2.0,,,,1.0986122886681098
ENSG00000132321,79.0,E-GEOD-38959,-1.9,'breast cancer; breast' vs 'normal; breast',4.382026634673881
ENSG00000085741,896.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',6.799055862058796
ENSG00000185669,31.0,,,,3.4657359027997265
ENSG00000164114,362.0,E-GEOD-31138,2.8,'invasive ductal carcinoma' vs 'normal',5.8944028342648505
ENSG00000088881,948.0,E-GEOD-7377,1.9,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.855408798609928
ENSG00000261040,7.0,,,,2.0794415416798357
ENSG00000006377,4.0,,,,1.6094379124341003
ENSG00000115850,2.0,,,,1.0986122886681098
ENSG00000170961,109.0,E-GEOD-120774,1.3,'coronary artery disease' vs 'normal' in 'subcutaneous adipose tissue',4.700480365792417
ENSG00000111886,46.0,,,,3.8501476017100584
ENSG00000187193,5059.0,E-GEOD-52194,-4.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',8.52912176228151
ENSG00000178104,3799.0,E-GEOD-54002,1.7,'breast cancer' vs 'normal',8.242756345714477
ENSG00000178104,3799.0,E-GEOD-31138,2.8,'invasive ductal carcinoma' vs 'normal',8.242756345714477
ENSG00000174136,430.0,,,,6.066108090103747
ENSG00000184985,173.0,,,,5.159055299214529
ENSG00000198496,244.0,,,,5.501258210544727
ENSG00000105372,24589.0,,,,10.110095135210239
ENSG00000116717,3345.0,E-GEOD-52194,-5.9,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',8.11552088154677
ENSG00000116717,3345.0,E-GEOD-52194,-5.2,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',8.11552088154677
ENSG00000166211,0.0,,,,0.0
ENSG00000176953,2819.0,,,,7.944492163932159
ENSG00000136848,4682.0,,,,8.451694209183541
ENSG00000163655,2047.0,,,,7.6246189861593985
ENSG00000167633,4.0,E-GEOD-52194,5.2,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.6094379124341003
ENSG00000204054,2761.0,,,,7.923710333969238
ENSG00000276557,0.0,,,,0.0
ENSG00000117000,1830.0,,,,7.5126175446745105
ENSG00000237984,60.0,,,,4.110873864173311
ENSG00000261189,19.0,,,,2.995732273553991
ENSG00000228486,398.0,,,,5.988961416889864
ENSG00000183303,0.0,,,,0.0
ENSG00000227868,1.0,,,,0.6931471805599453
ENSG00000085365,1598.0,,,,7.377133712833954
ENSG00000111241,0.0,E-GEOD-52194,5.4,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000174130,157.0,,,,5.062595033026967
ENSG00000117707,230.0,,,,5.442417710521793
ENSG00000166451,108.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',4.6913478822291435
ENSG00000130827,2616.0,,,,7.869783902530146
ENSG00000148488,62.0,E-GEOD-38959,-1.5,'breast cancer; breast' vs 'normal; breast',4.143134726391533
ENSG00000165178,26.0,,,,3.295836866004329
ENSG00000160932,5927.0,E-GEOD-36765,1.2,'breast carcinoma' vs 'normal' in 'peripheral blood',8.687442166975924
ENSG00000161653,138.0,,,,4.9344739331306915
ENSG00000155542,249.0,,,,5.521460917862246
ENSG00000180867,194.0,,,,5.272999558563747
ENSG00000137747,226.0,,,,5.424950017481403
ENSG00000231074,1228.0,,,,7.113956109566034
ENSG00000188290,466.0,,,,6.1463292576688975
ENSG00000258659,23.0,,,,3.1780538303479458
ENSG00000177669,6.0,,,,1.9459101490553132
ENSG00000172061,40.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',3.713572066704308
ENSG00000172061,40.0,E-GEOD-31138,2.7,'invasive ductal carcinoma' vs 'normal',3.713572066704308
ENSG00000172061,40.0,E-GEOD-54002,3.1,'breast cancer' vs 'normal',3.713572066704308
ENSG00000172061,40.0,E-GEOD-10780,1.7,'breast carcinoma' vs 'normal',3.713572066704308
ENSG00000172061,40.0,E-GEOD-44408,-2.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.713572066704308
ENSG00000167117,9.0,,,,2.302585092994046
ENSG00000092847,1607.0,E-GEOD-7377,1.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.382746449738912
ENSG00000221957,3.0,,,,1.3862943611198906
ENSG00000268089,0.0,,,,0.0
ENSG00000179915,54.0,,,,4.007333185232471
ENSG00000215190,269.0,,,,5.598421958998375
ENSG00000150630,802.0,,,,6.688354713946762
ENSG00000143494,149.0,,,,5.0106352940962555
ENSG00000204525,27575.0,,,,10.224701108196701
ENSG00000156920,14.0,E-GEOD-52194,6.6,'triple-negative breast cancer; breast carcinoma' vs 'normal',2.70805020110221
ENSG00000156920,14.0,E-GEOD-52194,5.0,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',2.70805020110221
ENSG00000160791,36.0,,,,3.6109179126442243
ENSG00000172927,328.0,,,,5.796057750765372
ENSG00000169418,6701.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',8.810161268297255
ENSG00000169418,6701.0,E-MTAB-779,-1.8,'breast carcinoma' vs 'normal',8.810161268297255
ENSG00000275385,34.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',3.5553480614894135
ENSG00000275385,34.0,E-GEOD-52194,5.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',3.5553480614894135
ENSG00000275385,34.0,E-GEOD-52194,5.9,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',3.5553480614894135
ENSG00000147100,807.0,,,,6.694562058521095
ENSG00000138696,38.0,E-MTAB-779,3.0,'breast carcinoma' vs 'normal',3.6635616461296463
ENSG00000138696,38.0,E-GEOD-10780,2.3,'breast carcinoma' vs 'normal',3.6635616461296463
ENSG00000138696,38.0,E-GEOD-52194,6.3,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',3.6635616461296463
ENSG00000182636,1581.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',7.366445148327599
ENSG00000182636,1581.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',7.366445148327599
ENSG00000182636,1581.0,E-GEOD-38959,-2.4,'breast cancer; breast' vs 'normal; breast',7.366445148327599
ENSG00000185133,331.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',5.805134968916488
ENSG00000110148,1.0,E-GEOD-52194,6.4,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000129195,12.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',2.5649493574615367
ENSG00000138135,135.0,E-GEOD-52194,-4.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',4.912654885736052
ENSG00000138135,135.0,E-GEOD-52194,-5.7,'triple-negative breast cancer; breast carcinoma' vs 'normal',4.912654885736052
ENSG00000163082,60.0,,,,4.110873864173311
ENSG00000164742,346.0,,,,5.849324779946859
ENSG00000178971,2906.0,,,,7.9748769005588755
ENSG00000226950,1134.0,,,,7.034387929915503
ENSG00000144057,32.0,,,,3.4965075614664802
ENSG00000263761,0.0,,,,0.0
ENSG00000120337,2.0,,,,1.0986122886681098
ENSG00000256463,0.0,,,,0.0
ENSG00000099617,0.0,,,,0.0
ENSG00000175318,231.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',5.44673737166631
ENSG00000197110,0.0,,,,0.0
ENSG00000140534,162.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',5.093750200806762
ENSG00000245146,132.0,,,,4.890349128221754
ENSG00000106404,1226.0,,,,7.112327444710911
ENSG00000107949,1572.0,,,,7.360739903058278
ENSG00000180772,0.0,,,,0.0
ENSG00000184923,14.0,,,,2.70805020110221
ENSG00000196935,1163.0,,,,7.059617628291383
ENSG00000131080,282.0,,,,5.645446897643238
ENSG00000213694,940.0,E-GEOD-31138,1.5,'invasive ductal carcinoma' vs 'normal',6.846943139585379
ENSG00000213694,940.0,E-GEOD-20086,-1.3,'breast cancer' vs 'normal',6.846943139585379
ENSG00000253716,210.0,,,,5.351858133476067
ENSG00000171492,576.0,,,,6.3578422665081
ENSG00000125484,1146.0,,,,7.044905117129371
ENSG00000110243,1.0,,,,0.6931471805599453
ENSG00000128510,63.0,,,,4.1588830833596715
ENSG00000276234,814.0,,,,6.703188113240863
ENSG00000187151,30.0,,,,3.4339872044851463
ENSG00000044012,0.0,,,,0.0
ENSG00000259527,0.0,E-GEOD-68086,-5.1,'breast carcinoma' vs 'normal',0.0
ENSG00000171777,204.0,,,,5.3230099791384085
ENSG00000249628,5.0,,,,1.791759469228055
ENSG00000229807,37.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',3.6375861597263857
ENSG00000229807,37.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',3.6375861597263857
ENSG00000122180,1.0,,,,0.6931471805599453
ENSG00000090554,108.0,,,,4.6913478822291435
ENSG00000207744,8.0,,,,2.1972245773362196
ENSG00000106086,709.0,,,,6.565264970035361
ENSG00000175745,1143.0,E-MTAB-779,-1.7,'breast carcinoma' vs 'normal',7.042286171939743
ENSG00000175745,1143.0,E-GEOD-10780,-1.7,'breast carcinoma' vs 'normal',7.042286171939743
ENSG00000101447,43.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',3.784189633918261
ENSG00000101447,43.0,E-GEOD-54002,3.2,'breast cancer' vs 'normal',3.784189633918261
ENSG00000101447,43.0,E-GEOD-10780,1.8,'breast carcinoma' vs 'normal',3.784189633918261
ENSG00000175329,0.0,E-GEOD-52194,4.9,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000175329,0.0,E-GEOD-52194,4.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000123329,488.0,,,,6.192362489474872
ENSG00000178403,1.0,,,,0.6931471805599453
ENSG00000172215,47.0,,,,3.871201010907891
ENSG00000277117,13.0,,,,2.6390573296152584
ENSG00000006606,15.0,,,,2.772588722239781
ENSG00000132031,165.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',5.111987788356544
ENSG00000168477,6830.0,,,,8.82922635473185
ENSG00000122912,1172.0,,,,7.067319848653476
ENSG00000198763,356841.0,,,,12.785048385764844
ENSG00000238057,26.0,,,,3.295836866004329
ENSG00000120256,1025.0,,,,6.933423025730715
ENSG00000124171,131.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',4.882801922586371
ENSG00000124171,131.0,E-GEOD-7377,1.6,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',4.882801922586371
ENSG00000124171,131.0,E-MTAB-779,2.1,'breast carcinoma' vs 'normal',4.882801922586371
ENSG00000183674,0.0,,,,0.0
ENSG00000123388,5.0,,,,1.791759469228055
ENSG00000078804,1441.0,,,,7.273786317844895
ENSG00000128714,1.0,,,,0.6931471805599453
ENSG00000171243,60.0,E-GEOD-68086,-4.9,'breast carcinoma' vs 'normal',4.110873864173311
ENSG00000171243,60.0,E-GEOD-54002,-4.7,'breast cancer' vs 'normal',4.110873864173311
ENSG00000171243,60.0,E-GEOD-10780,-2.0,'breast carcinoma' vs 'normal',4.110873864173311
ENSG00000163046,1.0,,,,0.6931471805599453
ENSG00000119630,610.0,,,,6.415096959171596
ENSG00000146197,65.0,E-GEOD-52194,5.4,'triple-negative breast cancer; breast carcinoma' vs 'normal',4.189654742026425
ENSG00000108384,468.0,,,,6.150602768446279
ENSG00000207088,0.0,,,,0.0
ENSG00000203760,124.0,E-GEOD-38959,2.4,'breast cancer; breast' vs 'normal; breast',4.8283137373023015
ENSG00000228223,581.0,,,,6.366470447731438
ENSG00000213244,2.0,,,,1.0986122886681098
ENSG00000125498,3.0,,,,1.3862943611198906
ENSG00000101204,1.0,E-GEOD-52194,6.3,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000101204,1.0,E-GEOD-52194,5.2,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000171316,1364.0,,,,7.21890970761906
ENSG00000169174,8.0,,,,2.1972245773362196
ENSG00000009709,0.0,E-GEOD-52194,6.2,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000009709,0.0,E-GEOD-52194,4.9,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000111424,837.0,E-GEOD-44408,-2.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.731018100482083
ENSG00000198856,1929.0,,,,7.5652752818989315
ENSG00000260259,13.0,,,,2.6390573296152584
ENSG00000267496,6.0,,,,1.9459101490553132
ENSG00000129204,368.0,,,,5.910796644040527
ENSG00000055609,5277.0,,,,8.57130251706327
ENSG00000241186,8.0,,,,2.1972245773362196
ENSG00000138081,1739.0,,,,7.461640392208575
ENSG00000163485,186.0,,,,5.231108616854587
ENSG00000102962,39.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.6888794541139363
ENSG00000171004,26.0,E-GEOD-7377,2.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',3.295836866004329
ENSG00000125826,4026.0,,,,8.300776960851454
ENSG00000136802,3514.0,,,,8.164794804244766
ENSG00000140455,1689.0,E-GEOD-7377,1.4,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.432483807917119
ENSG00000116985,145.0,,,,4.983606621708336
ENSG00000235072,27.0,,,,3.332204510175204
ENSG00000135916,1642.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.404279118037268
ENSG00000174326,129.0,E-GEOD-52194,-5.4,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',4.867534450455582
ENSG00000172476,36.0,,,,3.6109179126442243
ENSG00000160216,2759.0,,,,7.9229859587111955
ENSG00000108878,7.0,,,,2.0794415416798357
ENSG00000168779,952.0,,,,6.859614903654202
ENSG00000095596,4.0,,,,1.6094379124341003
ENSG00000138395,87.0,,,,4.477336814478207
ENSG00000189409,65.0,,,,4.189654742026425
ENSG00000228274,118.0,,,,4.77912349311153
ENSG00000137449,1697.0,,,,7.437206366871292
ENSG00000143207,1706.0,,,,7.442492722794441
ENSG00000186160,145.0,E-GEOD-10780,1.5,'breast carcinoma' vs 'normal',4.983606621708336
ENSG00000133962,97.0,,,,4.584967478670572
ENSG00000156150,2.0,,,,1.0986122886681098
ENSG00000242950,84.0,,,,4.442651256490317
ENSG00000123728,1788.0,,,,7.489412083508719
ENSG00000225194,49.0,,,,3.912023005428146
ENSG00000112293,76.0,,,,4.343805421853684
ENSG00000091010,2.0,,,,1.0986122886681098
ENSG00000132341,5572.0,,,,8.625688787569537
ENSG00000113742,2615.0,E-GEOD-31138,2.2,'invasive ductal carcinoma' vs 'normal',7.86940171257709
ENSG00000116151,300.0,,,,5.707110264748875
ENSG00000152939,151.0,,,,5.0238805208462765
ENSG00000150787,630.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.447305862541213
ENSG00000152990,1210.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.099201743553092
ENSG00000083307,492.0,E-GEOD-44408,-2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.20050917404269
ENSG00000099942,3090.0,,,,8.036249942132116
ENSG00000115112,1474.0,E-GEOD-54002,-2.1,'breast cancer' vs 'normal',7.29641326877392
ENSG00000147457,1743.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.463936604468925
ENSG00000162804,3480.0,E-GEOD-20086,-1.5,'breast cancer' vs 'normal',8.15507488781144
ENSG00000073350,1117.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.0192966537150445
ENSG00000089123,593.0,,,,6.386879319362645
ENSG00000145416,554.0,E-GEOD-52194,5.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',6.318968113746434
ENSG00000145416,554.0,E-GEOD-52194,4.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',6.318968113746434
ENSG00000145416,554.0,E-GEOD-44408,2.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.318968113746434
ENSG00000145416,554.0,E-GEOD-52194,5.7,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',6.318968113746434
ENSG00000003137,1035.0,,,,6.943122422819428
ENSG00000152683,1201.0,,,,7.091742115095153
ENSG00000196712,3257.0,E-GEOD-38959,-1.3,'breast cancer; breast' vs 'normal; breast',8.08886878916199
ENSG00000139211,1552.0,E-GEOD-54002,-2.7,'breast cancer' vs 'normal',7.347943823148687
ENSG00000139211,1552.0,E-GEOD-20086,1.8,'breast cancer' vs 'normal',7.347943823148687
ENSG00000139211,1552.0,E-GEOD-10780,-1.9,'breast carcinoma' vs 'normal',7.347943823148687
ENSG00000139211,1552.0,E-GEOD-38959,-2.5,'breast cancer; breast' vs 'normal; breast',7.347943823148687
ENSG00000101004,642.0,,,,6.466144724237619
ENSG00000110911,2923.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.980707820869669
ENSG00000104885,1968.0,,,,7.585281078639126
ENSG00000066135,1616.0,,,,7.388327859577107
ENSG00000188778,4.0,,,,1.6094379124341003
ENSG00000205476,882.0,,,,6.78332520060396
ENSG00000100916,458.0,,,,6.129050210060545
ENSG00000008256,3881.0,,,,8.264105763728956
ENSG00000169851,230.0,E-GEOD-54002,-2.4,'breast cancer' vs 'normal',5.442417710521793
ENSG00000169851,230.0,E-GEOD-68086,-5.4,'breast carcinoma' vs 'normal',5.442417710521793
ENSG00000272636,1534.0,,,,7.336285660021297
ENSG00000073712,6528.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',8.784009071186633
ENSG00000073712,6528.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',8.784009071186633
ENSG00000157168,177.0,E-GEOD-38959,-2.5,'breast cancer; breast' vs 'normal; breast',5.181783550292085
ENSG00000140941,5997.0,,,,8.699181359308954
ENSG00000172716,2470.0,,,,7.81237820598861
ENSG00000155962,1205.0,E-GEOD-44408,2.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.095064377287131
ENSG00000213676,4363.0,,,,8.381144346952961
ENSG00000213949,4805.0,,,,8.477620416296414
ENSG00000148702,4.0,,,,1.6094379124341003
ENSG00000169908,7347.0,E-GEOD-54002,-2.0,'breast cancer' vs 'normal',8.902183446335016
ENSG00000169908,7347.0,E-GEOD-20086,1.7,'breast cancer' vs 'normal',8.902183446335016
ENSG00000182463,1774.0,E-GEOD-54002,-4.4,'breast cancer' vs 'normal',7.4815557019095165
ENSG00000182463,1774.0,E-GEOD-10780,-1.9,'breast carcinoma' vs 'normal',7.4815557019095165
ENSG00000182463,1774.0,E-GEOD-68086,-5.0,'breast carcinoma' vs 'normal',7.4815557019095165
ENSG00000165588,0.0,,,,0.0
ENSG00000165752,351.0,,,,5.863631175598097
ENSG00000067225,19671.0,E-GEOD-36765,1.1,'breast carcinoma' vs 'normal' in 'peripheral blood',9.886951583896028
ENSG00000136574,2.0,E-GEOD-52194,5.6,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000136574,2.0,E-GEOD-52194,6.3,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000134030,3632.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',8.197814032221203
ENSG00000196208,1016.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',6.92461239604856
ENSG00000196208,1016.0,E-GEOD-7377,1.9,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.92461239604856
ENSG00000196208,1016.0,E-GEOD-44408,-3.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.92461239604856
ENSG00000107317,1465.0,,,,7.290292882446597
ENSG00000134020,44.0,,,,3.8066624897703196
ENSG00000170634,493.0,,,,6.202535517187923
ENSG00000071794,1058.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',6.9650803456014065
ENSG00000108239,889.0,,,,6.7912214627261855
ENSG00000115290,106.0,,,,4.672828834461906
ENSG00000113712,3917.0,,,,8.273336598504486
ENSG00000147536,64.0,,,,4.174387269895637
ENSG00000138658,351.0,,,,5.863631175598097
ENSG00000123485,25.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',3.258096538021482
ENSG00000123485,25.0,E-GEOD-54002,2.1,'breast cancer' vs 'normal',3.258096538021482
ENSG00000123485,25.0,E-GEOD-52194,5.2,'triple-negative breast cancer; breast carcinoma' vs 'normal',3.258096538021482
ENSG00000018610,900.0,,,,6.803505257608338
ENSG00000196620,2.0,,,,1.0986122886681098
ENSG00000183741,2608.0,,,,7.866722285136729
ENSG00000064655,702.0,E-MTAB-779,-1.2,'breast carcinoma' vs 'normal',6.555356891810665
ENSG00000064655,702.0,E-GEOD-54002,-1.9,'breast cancer' vs 'normal',6.555356891810665
ENSG00000064655,702.0,E-GEOD-7377,-1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.555356891810665
ENSG00000185897,23.0,,,,3.1780538303479458
ENSG00000034053,96.0,,,,4.574710978503383
ENSG00000183479,43.0,,,,3.784189633918261
ENSG00000163710,2134.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.666221925662725
ENSG00000163710,2134.0,E-GEOD-10780,-2.4,'breast carcinoma' vs 'normal',7.666221925662725
ENSG00000163710,2134.0,E-MTAB-779,-2.7,'breast carcinoma' vs 'normal',7.666221925662725
ENSG00000184564,37.0,E-GEOD-52194,5.9,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',3.6375861597263857
ENSG00000180318,6.0,,,,1.9459101490553132
ENSG00000254470,1290.0,,,,7.1631723908466425
ENSG00000188641,2305.0,E-GEOD-54002,-2.1,'breast cancer' vs 'normal',7.743269700829004
ENSG00000106785,735.0,,,,6.601230118728877
ENSG00000188158,699.0,,,,6.551080335043404
ENSG00000164647,581.0,,,,6.366470447731438
ENSG00000157303,138.0,E-MTAB-779,1.8,'breast carcinoma' vs 'normal',4.9344739331306915
ENSG00000211592,1732.0,E-GEOD-7377,-3.6,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.457609289715606
ENSG00000153233,10.0,,,,2.3978952727983707
ENSG00000139910,2382.0,E-GEOD-54002,-2.1,'breast cancer' vs 'normal',7.776115477098742
ENSG00000139910,2382.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',7.776115477098742
ENSG00000139910,2382.0,E-GEOD-31138,-2.4,'invasive ductal carcinoma' vs 'normal',7.776115477098742
ENSG00000160310,4223.0,,,,8.348537825386098
ENSG00000275700,2094.0,,,,7.647308832356238
ENSG00000185652,78.0,E-GEOD-52194,-5.4,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',4.3694478524670215
ENSG00000185652,78.0,E-GEOD-20086,1.4,'breast cancer' vs 'normal',4.3694478524670215
ENSG00000197070,2299.0,,,,7.7406644019172415
ENSG00000198918,19878.0,,,,9.897419177134521
ENSG00000122417,2296.0,,,,7.739359202689098
ENSG00000141873,585.0,,,,6.373319789577012
ENSG00000147905,820.0,,,,6.710523109452428
ENSG00000090776,3300.0,,,,8.101980731853192
ENSG00000135845,1056.0,,,,6.963189985870238
ENSG00000139192,961.0,,,,6.8690144506657065
ENSG00000109971,18046.0,,,,9.800734744961298
ENSG00000151914,19010.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',9.852773037991627
ENSG00000151914,19010.0,E-GEOD-38959,-1.7,'breast cancer; breast' vs 'normal; breast',9.852773037991627
ENSG00000151914,19010.0,E-GEOD-10780,-3.6,'breast carcinoma' vs 'normal',9.852773037991627
ENSG00000168612,444.0,,,,6.09807428216624
ENSG00000162739,63.0,,,,4.1588830833596715
ENSG00000184304,736.0,E-GEOD-54002,-2.0,'breast cancer' vs 'normal',6.602587892189336
ENSG00000175274,6188.0,,,,8.73052880173936
ENSG00000169047,2653.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',7.8838232148921525
ENSG00000169047,2653.0,E-GEOD-54002,-2.2,'breast cancer' vs 'normal',7.8838232148921525
ENSG00000169047,2653.0,E-GEOD-38959,-2.2,'breast cancer; breast' vs 'normal; breast',7.8838232148921525
ENSG00000189129,1336.0,E-MTAB-779,-1.9,'breast carcinoma' vs 'normal',7.198183577101943
ENSG00000189129,1336.0,E-GEOD-10780,-1.8,'breast carcinoma' vs 'normal',7.198183577101943
ENSG00000106615,3936.0,,,,8.278174290943738
ENSG00000060982,550.0,E-GEOD-54002,1.6,'breast cancer' vs 'normal',6.311734809152915
ENSG00000179409,1575.0,,,,7.362645270417825
ENSG00000204469,11162.0,,,,9.320360017014732
ENSG00000144063,739.0,,,,6.606650186198215
ENSG00000135776,880.0,,,,6.78105762593618
ENSG00000203872,58.0,,,,4.07753744390572
ENSG00000169136,1553.0,,,,7.348587530927593
ENSG00000164626,400.0,,,,5.993961427306569
ENSG00000164347,838.0,,,,6.732210706467206
ENSG00000196411,4315.0,,,,8.370084326378025
ENSG00000145284,407.0,E-GEOD-54002,-2.4,'breast cancer' vs 'normal',6.0112671744041615
ENSG00000167333,609.0,,,,6.413458957167357
ENSG00000014641,5093.0,E-GEOD-31138,2.4,'invasive ductal carcinoma' vs 'normal',8.535818655539403
ENSG00000153976,17.0,,,,2.8903717578961645
ENSG00000146476,911.0,E-GEOD-31138,3.9,'invasive ductal carcinoma' vs 'normal',6.815639990074331
ENSG00000146476,911.0,E-GEOD-7377,1.8,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.815639990074331
ENSG00000104518,3877.0,,,,8.263074835802596
ENSG00000145782,2349.0,,,,7.762170607138205
ENSG00000100532,568.0,,,,6.343880434126331
ENSG00000105366,24.0,,,,3.2188758248682006
ENSG00000145779,1074.0,E-GEOD-44408,2.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.980075940561763
ENSG00000188312,233.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',5.455321115357702
ENSG00000148229,1846.0,,,,7.52131798019924
ENSG00000165474,30.0,E-GEOD-31138,2.3,'invasive ductal carcinoma' vs 'normal',3.4339872044851463
ENSG00000165474,30.0,E-GEOD-54002,2.6,'breast cancer' vs 'normal',3.4339872044851463
ENSG00000165474,30.0,E-GEOD-10780,2.5,'breast carcinoma' vs 'normal',3.4339872044851463
ENSG00000165474,30.0,E-GEOD-38959,2.1,'breast cancer; breast' vs 'normal; breast',3.4339872044851463
ENSG00000119147,604.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',6.405228458030842
ENSG00000119147,604.0,E-GEOD-52194,-5.4,'triple-negative breast cancer; breast carcinoma' vs 'normal',6.405228458030842
ENSG00000119147,604.0,E-GEOD-52194,-5.5,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',6.405228458030842
ENSG00000119147,604.0,E-GEOD-54002,-4.8,'breast cancer' vs 'normal',6.405228458030842
ENSG00000119147,604.0,E-GEOD-10780,-3.5,'breast carcinoma' vs 'normal',6.405228458030842
ENSG00000119147,604.0,E-GEOD-52194,-6.3,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',6.405228458030842
ENSG00000176435,2617.0,,,,7.870165946469845
ENSG00000088836,257.0,,,,5.552959584921617
ENSG00000105221,7681.0,,,,8.94663520890585
ENSG00000143761,15938.0,E-MTAB-779,2.3,'breast carcinoma' vs 'normal',9.676524215119054
ENSG00000189057,16.0,E-GEOD-54002,2.0,'breast cancer' vs 'normal',2.833213344056216
ENSG00000189057,16.0,E-GEOD-38959,1.9,'breast cancer; breast' vs 'normal; breast',2.833213344056216
ENSG00000140403,1492.0,,,,7.30854279753919
ENSG00000011405,4088.0,,,,8.316055720364643
ENSG00000174576,13.0,,,,2.6390573296152584
ENSG00000164951,887.0,,,,6.78897174299217
ENSG00000147655,1.0,E-GEOD-52194,5.6,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000154263,2274.0,,,,7.729735331385051
ENSG00000111087,124.0,,,,4.8283137373023015
ENSG00000163964,671.0,,,,6.51025834052315
ENSG00000228716,811.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',6.699500340161678
ENSG00000228716,811.0,E-GEOD-31138,3.0,'invasive ductal carcinoma' vs 'normal',6.699500340161678
ENSG00000169515,605.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',6.406879986069314
ENSG00000169515,605.0,E-GEOD-54002,-2.6,'breast cancer' vs 'normal',6.406879986069314
ENSG00000144857,3318.0,E-GEOD-7377,-1.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.107418811719974
ENSG00000144857,3318.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',8.107418811719974
ENSG00000144857,3318.0,E-GEOD-10780,-2.0,'breast carcinoma' vs 'normal',8.107418811719974
ENSG00000104341,2060.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',7.630946580890459
ENSG00000165097,711.0,,,,6.568077911411976
ENSG00000135424,11716.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',9.368796057668156
ENSG00000135424,11716.0,E-MTAB-779,-2.0,'breast carcinoma' vs 'normal',9.368796057668156
ENSG00000186532,1206.0,,,,7.095893221097532
ENSG00000143379,1976.0,,,,7.589335823170617
ENSG00000106080,686.0,,,,6.532334292222349
ENSG00000130755,1288.0,E-GEOD-44408,2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.161622002939187
ENSG00000175221,3138.0,,,,8.051659556841953
ENSG00000198963,54.0,,,,4.007333185232471
ENSG00000006042,1217.0,,,,7.1049654482698426
ENSG00000102996,574.0,,,,6.354370040797351
ENSG00000166012,4708.0,,,,8.457230850243555
ENSG00000145526,7.0,E-GEOD-52194,5.4,'triple-negative breast cancer; breast carcinoma' vs 'normal',2.0794415416798357
ENSG00000145526,7.0,E-GEOD-52194,5.0,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',2.0794415416798357
ENSG00000183735,1441.0,,,,7.273786317844895
ENSG00000142544,164.0,,,,5.10594547390058
ENSG00000170153,728.0,E-GEOD-54002,-2.0,'breast cancer' vs 'normal',6.591673732008658
ENSG00000170153,728.0,E-GEOD-20086,1.1,'breast cancer' vs 'normal',6.591673732008658
ENSG00000143224,1062.0,,,,6.968850378341948
ENSG00000163884,1595.0,,,,7.3752557780097545
ENSG00000151892,3024.0,E-MTAB-779,1.9,'breast carcinoma' vs 'normal',8.014666370464942
ENSG00000108679,9050.0,E-GEOD-44408,-1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.11063052782717
ENSG00000160447,1444.0,,,,7.275864600546533
ENSG00000176624,1405.0,,,,7.2485040723706105
ENSG00000124160,1985.0,,,,7.593877844605118
ENSG00000101307,56.0,E-GEOD-52194,4.8,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',4.04305126783455
ENSG00000101307,56.0,E-GEOD-52194,4.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',4.04305126783455
ENSG00000204710,0.0,,,,0.0
ENSG00000151025,5.0,,,,1.791759469228055
ENSG00000118579,2813.0,,,,7.942362237674335
ENSG00000100479,97.0,E-GEOD-31138,3.1,'invasive ductal carcinoma' vs 'normal',4.584967478670572
ENSG00000141934,691.0,E-GEOD-44408,-2.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.539585955617669
ENSG00000129559,1733.0,,,,7.458186157340487
ENSG00000204628,43807.0,,,,10.687571728088175
ENSG00000180616,344.0,,,,5.84354441703136
ENSG00000117222,833.0,,,,6.726233402358747
ENSG00000108551,4770.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',8.470311205516108
ENSG00000108551,4770.0,E-GEOD-52194,-5.3,'triple-negative breast cancer; breast carcinoma' vs 'normal',8.470311205516108
ENSG00000108551,4770.0,E-GEOD-52194,-5.9,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',8.470311205516108
ENSG00000187601,708.0,,,,6.5638555265321274
ENSG00000071054,7025.0,,,,8.857372832825773
ENSG00000111669,10588.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',9.267571005430455
ENSG00000141068,1863.0,,,,7.530479995245536
ENSG00000008130,5831.0,,,,8.671115273688494
ENSG00000137807,130.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',4.875197323201151
ENSG00000137807,130.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',4.875197323201151
ENSG00000137807,130.0,E-GEOD-54002,2.4,'breast cancer' vs 'normal',4.875197323201151
ENSG00000137807,130.0,E-GEOD-38959,1.8,'breast cancer; breast' vs 'normal; breast',4.875197323201151
ENSG00000122507,729.0,,,,6.593044534142437
ENSG00000135423,11.0,,,,2.4849066497880004
ENSG00000147676,457.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',6.126869184114185
ENSG00000147676,457.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',6.126869184114185
ENSG00000147676,457.0,E-GEOD-10780,1.7,'breast carcinoma' vs 'normal',6.126869184114185
ENSG00000152894,2549.0,,,,7.843848638152472
ENSG00000100150,801.0,,,,6.687108607866515
ENSG00000106034,1189.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',7.081708586105575
ENSG00000197905,545.0,,,,6.302618975744905
ENSG00000240505,6.0,,,,1.9459101490553132
ENSG00000185900,39.0,,,,3.6888794541139363
ENSG00000101670,90.0,,,,4.51085950651685
ENSG00000145390,5084.0,,,,8.53405030848266
ENSG00000116688,5554.0,,,,8.62245370207373
ENSG00000140598,769.0,,,,6.646390514847729
ENSG00000153975,402.0,E-GEOD-31138,2.1,'invasive ductal carcinoma' vs 'normal',5.998936561946683
ENSG00000176396,406.0,,,,6.008813185442595
ENSG00000188559,4178.0,,,,8.337827262447915
ENSG00000137809,640.0,,,,6.46302945692067
ENSG00000136237,1590.0,,,,7.372118028337787
ENSG00000126088,2678.0,,,,7.893198869544609
ENSG00000188042,1726.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.454141078146678
ENSG00000188042,1726.0,E-GEOD-54002,-3.3,'breast cancer' vs 'normal',7.454141078146678
ENSG00000111331,978.0,E-GEOD-54002,1.8,'breast cancer' vs 'normal',6.88653164253051
ENSG00000111331,978.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',6.88653164253051
ENSG00000132824,9904.0,,,,9.20079495913265
ENSG00000079462,224.0,E-GEOD-44408,-1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.41610040220442
ENSG00000079462,224.0,E-GEOD-54002,1.6,'breast cancer' vs 'normal',5.41610040220442
ENSG00000079462,224.0,E-GEOD-10780,1.5,'breast carcinoma' vs 'normal',5.41610040220442
ENSG00000079462,224.0,E-MTAB-779,1.7,'breast carcinoma' vs 'normal',5.41610040220442
ENSG00000176083,6.0,,,,1.9459101490553132
ENSG00000157837,2489.0,,,,7.820037989458753
ENSG00000019505,7.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',2.0794415416798357
ENSG00000019505,7.0,E-GEOD-54002,2.2,'breast cancer' vs 'normal',2.0794415416798357
ENSG00000198879,1185.0,,,,7.078341579557671
ENSG00000164117,923.0,,,,6.828712071641684
ENSG00000099821,2339.0,,,,7.757906208351747
ENSG00000129595,655.0,,,,6.486160788944089
ENSG00000172260,1049.0,,,,6.956545443151569
ENSG00000072310,6649.0,,,,8.8023721336499
ENSG00000134107,19446.0,,,,9.875448095504883
ENSG00000156006,2.0,,,,1.0986122886681098
ENSG00000121005,250.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',5.5254529391317835
ENSG00000121005,250.0,E-GEOD-54002,-4.0,'breast cancer' vs 'normal',5.5254529391317835
ENSG00000121005,250.0,E-GEOD-31138,3.5,'invasive ductal carcinoma' vs 'normal',5.5254529391317835
ENSG00000169621,210.0,,,,5.351858133476067
ENSG00000135378,331.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.805134968916488
ENSG00000141682,80.0,,,,4.394449154672439
ENSG00000176566,0.0,E-GEOD-68086,-5.2,'breast carcinoma' vs 'normal',0.0
ENSG00000114698,3117.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',8.044947049617722
ENSG00000114698,3117.0,E-GEOD-54002,-2.3,'breast cancer' vs 'normal',8.044947049617722
ENSG00000114698,3117.0,E-GEOD-38959,-1.6,'breast cancer; breast' vs 'normal; breast',8.044947049617722
ENSG00000114698,3117.0,E-GEOD-10780,-1.7,'breast carcinoma' vs 'normal',8.044947049617722
ENSG00000171357,68.0,,,,4.23410650459726
ENSG00000172273,1116.0,,,,7.018401799069201
ENSG00000235568,198.0,,,,5.293304824724492
ENSG00000078399,518.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',6.251903883165888
ENSG00000078399,518.0,E-GEOD-54002,-2.5,'breast cancer' vs 'normal',6.251903883165888
ENSG00000078399,518.0,E-GEOD-10780,-1.5,'breast carcinoma' vs 'normal',6.251903883165888
ENSG00000078399,518.0,E-GEOD-38959,-1.9,'breast cancer; breast' vs 'normal; breast',6.251903883165888
ENSG00000119778,1163.0,,,,7.059617628291383
ENSG00000164543,975.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.883462586413092
ENSG00000174562,0.0,,,,0.0
ENSG00000174460,7.0,,,,2.0794415416798357
ENSG00000228696,56.0,,,,4.04305126783455
ENSG00000111859,8546.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',9.053335623166017
ENSG00000111859,8546.0,E-GEOD-54002,-2.2,'breast cancer' vs 'normal',9.053335623166017
ENSG00000076248,1319.0,,,,7.1853870155804165
ENSG00000103335,10694.0,,,,9.277531621516506
ENSG00000196642,3769.0,,,,8.234830280442056
ENSG00000132323,1647.0,,,,7.4073177104694174
ENSG00000185201,11498.0,,,,9.350015354048665
ENSG00000016602,24.0,E-GEOD-54002,-2.7,'breast cancer' vs 'normal',3.2188758248682006
ENSG00000016602,24.0,E-GEOD-68086,-4.9,'breast carcinoma' vs 'normal',3.2188758248682006
ENSG00000169607,10.0,,,,2.3978952727983707
ENSG00000204397,157.0,,,,5.062595033026967
ENSG00000103494,273.0,E-GEOD-31138,2.2,'invasive ductal carcinoma' vs 'normal',5.6131281063880705
ENSG00000144724,3194.0,,,,8.069342366811636
ENSG00000167508,1103.0,,,,7.00669522683704
ENSG00000078098,572.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',6.35088571671474
ENSG00000078098,572.0,E-GEOD-54002,2.1,'breast cancer' vs 'normal',6.35088571671474
ENSG00000078098,572.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',6.35088571671474
ENSG00000078098,572.0,E-GEOD-31138,3.0,'invasive ductal carcinoma' vs 'normal',6.35088571671474
ENSG00000078098,572.0,E-GEOD-68086,-5.1,'breast carcinoma' vs 'normal',6.35088571671474
ENSG00000078098,572.0,E-GEOD-44408,-3.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.35088571671474
ENSG00000050628,1998.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.6004023345004
ENSG00000125378,579.0,,,,6.363028103540465
ENSG00000162924,467.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.148468295917647
ENSG00000158042,884.0,,,,6.785587645007929
ENSG00000173213,3.0,,,,1.3862943611198906
ENSG00000133895,1551.0,,,,7.347299700743164
ENSG00000112237,1678.0,,,,7.425953657077541
ENSG00000100138,3242.0,,,,8.084254106307318
ENSG00000110011,1500.0,,,,7.313886831633462
ENSG00000185324,3480.0,,,,8.15507488781144
ENSG00000145824,6716.0,E-GEOD-7377,-1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.812396905266864
ENSG00000145824,6716.0,E-GEOD-54002,-2.7,'breast cancer' vs 'normal',8.812396905266864
ENSG00000145824,6716.0,E-GEOD-31138,2.8,'invasive ductal carcinoma' vs 'normal',8.812396905266864
ENSG00000145824,6716.0,E-GEOD-10780,-1.9,'breast carcinoma' vs 'normal',8.812396905266864
ENSG00000168758,3196.0,,,,8.069968149059841
ENSG00000162063,220.0,,,,5.3981627015177525
ENSG00000134690,65.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',4.189654742026425
ENSG00000134690,65.0,E-GEOD-54002,1.9,'breast cancer' vs 'normal',4.189654742026425
ENSG00000134690,65.0,E-GEOD-38959,1.7,'breast cancer; breast' vs 'normal; breast',4.189654742026425
ENSG00000064651,1615.0,E-GEOD-38959,-1.3,'breast cancer; breast' vs 'normal; breast',7.38770923908104
ENSG00000064651,1615.0,E-GEOD-31138,2.5,'invasive ductal carcinoma' vs 'normal',7.38770923908104
ENSG00000072415,1133.0,,,,7.033506484287697
ENSG00000122224,87.0,E-GEOD-44408,2.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.477336814478207
ENSG00000196371,372.0,,,,5.921578419643816
ENSG00000070614,5906.0,,,,8.683893367307235
ENSG00000105246,55.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.02535169073515
ENSG00000138413,2777.0,,,,7.9294865233142895
ENSG00000150394,16.0,,,,2.833213344056216
ENSG00000154764,0.0,,,,0.0
ENSG00000111602,727.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',6.590301048196686
ENSG00000111602,727.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',6.590301048196686
ENSG00000111602,727.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',6.590301048196686
ENSG00000124782,3675.0,,,,8.209580483475577
ENSG00000073734,32.0,E-GEOD-52194,5.3,'triple-negative breast cancer; breast carcinoma' vs 'normal',3.4965075614664802
ENSG00000117713,4997.0,,,,8.516793111394898
ENSG00000113657,4987.0,,,,8.514790306799927
ENSG00000126231,6.0,,,,1.9459101490553132
ENSG00000153879,2028.0,,,,7.615298339825815
ENSG00000143815,2571.0,E-GEOD-44408,1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.85243908535751
ENSG00000143815,2571.0,E-GEOD-38959,1.6,'breast cancer; breast' vs 'normal; breast',7.85243908535751
ENSG00000169550,67.0,E-GEOD-54002,-5.3,'breast cancer' vs 'normal',4.219507705176107
ENSG00000002933,1638.0,,,,7.40184157874383
ENSG00000092964,7002.0,E-GEOD-54002,-2.3,'breast cancer' vs 'normal',8.854093907655518
ENSG00000092964,7002.0,E-GEOD-10780,-1.6,'breast carcinoma' vs 'normal',8.854093907655518
ENSG00000117394,1521.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',7.3277805384216315
ENSG00000117394,1521.0,E-GEOD-31138,2.7,'invasive ductal carcinoma' vs 'normal',7.3277805384216315
ENSG00000117394,1521.0,E-GEOD-38959,2.2,'breast cancer; breast' vs 'normal; breast',7.3277805384216315
ENSG00000131203,28.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.367295829986474
ENSG00000120217,180.0,,,,5.198497031265826
ENSG00000010671,217.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.384495062789089
ENSG00000161533,3276.0,,,,8.094683648698815
ENSG00000037474,3064.0,,,,8.027802848370312
ENSG00000126216,1489.0,,,,7.306531398939505
ENSG00000100065,1347.0,,,,7.206377291472252
ENSG00000142192,26496.0,,,,10.184786798018687
ENSG00000169410,1898.0,,,,7.549082710812286
ENSG00000117724,95.0,E-GEOD-44408,-1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.564348191467836
ENSG00000117724,95.0,E-GEOD-10780,1.4,'breast carcinoma' vs 'normal',4.564348191467836
ENSG00000117724,95.0,E-GEOD-52194,5.3,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',4.564348191467836
ENSG00000117724,95.0,E-GEOD-54002,3.2,'breast cancer' vs 'normal',4.564348191467836
ENSG00000117724,95.0,E-MTAB-779,2.6,'breast carcinoma' vs 'normal',4.564348191467836
ENSG00000117724,95.0,E-GEOD-38959,3.3,'breast cancer; breast' vs 'normal; breast',4.564348191467836
ENSG00000067992,332.0,,,,5.808142489980444
ENSG00000139289,2426.0,,,,7.794411205726601
ENSG00000100429,498.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',6.212606095751519
ENSG00000198840,97243.0,,,,11.484978562919277
ENSG00000184557,3918.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',8.273591798199632
ENSG00000182985,476.0,E-GEOD-31138,2.9,'invasive ductal carcinoma' vs 'normal',6.1675164908883415
ENSG00000182985,476.0,E-GEOD-20086,2.5,'breast cancer' vs 'normal',6.1675164908883415
ENSG00000142166,2926.0,,,,7.9817332866918855
ENSG00000162551,1720.0,,,,7.450660796211539
ENSG00000198804,470037.0,,,,13.0605688214818
ENSG00000104892,121.0,,,,4.804021044733257
ENSG00000160808,136.0,,,,4.919980925828125
ENSG00000149534,80.0,,,,4.394449154672439
ENSG00000151164,38.0,,,,3.6635616461296463
ENSG00000171428,130.0,E-MTAB-779,2.7,'breast carcinoma' vs 'normal',4.875197323201151
ENSG00000171428,130.0,E-GEOD-10780,1.9,'breast carcinoma' vs 'normal',4.875197323201151
ENSG00000171428,130.0,E-GEOD-7377,3.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',4.875197323201151
ENSG00000182220,4565.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',8.42639282708974
ENSG00000182220,4565.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.42639282708974
ENSG00000141258,5120.0,,,,8.54110501146255
ENSG00000179348,1147.0,E-GEOD-54002,1.6,'breast cancer' vs 'normal',7.045776576879511
ENSG00000069011,22.0,E-GEOD-54002,1.8,'breast cancer' vs 'normal',3.1354942159291497
ENSG00000170873,2135.0,,,,7.666690200080086
ENSG00000165006,3569.0,,,,8.180320874773685
ENSG00000150907,5410.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.596189197642735
ENSG00000150907,5410.0,E-GEOD-54002,-2.0,'breast cancer' vs 'normal',8.596189197642735
ENSG00000150907,5410.0,E-MTAB-779,-1.7,'breast carcinoma' vs 'normal',8.596189197642735
ENSG00000120885,19801.0,,,,9.89353822168246
ENSG00000125656,1541.0,,,,7.340835554123275
ENSG00000165471,0.0,,,,0.0
ENSG00000107798,3599.0,E-MTAB-779,1.2,'breast carcinoma' vs 'normal',8.1886891244442
ENSG00000107798,3599.0,E-GEOD-31138,2.9,'invasive ductal carcinoma' vs 'normal',8.1886891244442
ENSG00000196975,3061.0,E-GEOD-31138,3.1,'invasive ductal carcinoma' vs 'normal',8.026823576217629
ENSG00000134812,2.0,E-GEOD-52194,4.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000227234,0.0,,,,0.0
ENSG00000066933,2429.0,,,,7.795646536334594
ENSG00000276045,855.0,,,,6.752270376141742
ENSG00000114316,3223.0,,,,8.07837810362652
ENSG00000197969,2531.0,,,,7.836764783264067
ENSG00000197892,1976.0,E-GEOD-38959,-1.3,'breast cancer; breast' vs 'normal; breast',7.589335823170617
ENSG00000112062,3890.0,,,,8.266421472984554
ENSG00000154734,14024.0,E-GEOD-54002,-2.4,'breast cancer' vs 'normal',9.548596730390898
ENSG00000154734,14024.0,E-GEOD-10780,-1.5,'breast carcinoma' vs 'normal',9.548596730390898
ENSG00000166689,1591.0,,,,7.3727463664043285
ENSG00000023287,2896.0,,,,7.9714309977693505
ENSG00000173327,4509.0,,,,8.414052432496725
ENSG00000109171,2642.0,,,,7.879669914604289
ENSG00000171302,1831.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.513163545234075
ENSG00000149480,3982.0,,,,8.289790583181643
ENSG00000166167,1014.0,,,,6.922643891475888
ENSG00000106399,418.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',6.037870919922137
ENSG00000075651,1084.0,,,,6.98933526597456
ENSG00000205927,0.0,,,,0.0
ENSG00000198964,1163.0,,,,7.059617628291383
ENSG00000184602,2589.0,,,,7.859413154693583
ENSG00000204287,11639.0,E-GEOD-20086,1.6,'breast cancer' vs 'normal',9.36220272128543
ENSG00000204287,11639.0,E-MTAB-779,2.0,'breast carcinoma' vs 'normal',9.36220272128543
ENSG00000123999,54.0,,,,4.007333185232471
ENSG00000084207,8615.0,,,,9.061376218836225
ENSG00000162496,5840.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',8.67265729404031
ENSG00000166825,8048.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',8.993303139093733
ENSG00000166825,8048.0,E-GEOD-54002,-4.0,'breast cancer' vs 'normal',8.993303139093733
ENSG00000196503,8.0,,,,2.1972245773362196
ENSG00000163171,4537.0,E-GEOD-44408,1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.420241665339788
ENSG00000163171,4537.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',8.420241665339788
ENSG00000163171,4537.0,E-GEOD-54002,-2.0,'breast cancer' vs 'normal',8.420241665339788
ENSG00000121897,427.0,,,,6.059123195581797
ENSG00000188257,3631.0,E-GEOD-120774,1.2,'coronary artery disease' vs 'normal' in 'subcutaneous adipose tissue',8.197538739721184
ENSG00000163527,4763.0,,,,8.46884293047519
ENSG00000179715,386.0,,,,5.958424693029782
ENSG00000100351,110.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.709530201312334
ENSG00000161011,11007.0,,,,9.306377560173125
ENSG00000158691,417.0,,,,6.035481432524756
ENSG00000125798,0.0,,,,0.0
ENSG00000104941,0.0,,,,0.0
ENSG00000111057,2115.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',7.65728279297819
ENSG00000111057,2115.0,E-MTAB-779,1.8,'breast carcinoma' vs 'normal',7.65728279297819
ENSG00000111057,2115.0,E-GEOD-44408,-3.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.65728279297819
ENSG00000141905,8795.0,,,,9.082052351674651
ENSG00000167281,26.0,,,,3.295836866004329
ENSG00000068971,1382.0,,,,7.232010331664759
ENSG00000079931,123.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',4.820281565605037
ENSG00000119912,1471.0,,,,7.294377299288821
ENSG00000163558,1229.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.114769448366463
ENSG00000113916,22062.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',10.001657276308372
ENSG00000113916,22062.0,E-GEOD-52194,-5.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',10.001657276308372
ENSG00000113916,22062.0,E-GEOD-52194,-5.2,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',10.001657276308372
ENSG00000149177,756.0,,,,6.6293632534374485
ENSG00000130176,2838.0,E-GEOD-52194,-4.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',7.951207156472972
ENSG00000130176,2838.0,E-GEOD-54002,-4.1,'breast cancer' vs 'normal',7.951207156472972
ENSG00000130176,2838.0,E-GEOD-10780,-2.5,'breast carcinoma' vs 'normal',7.951207156472972
ENSG00000166402,1196.0,,,,7.087573705557973
ENSG00000178691,1524.0,E-GEOD-31138,2.4,'invasive ductal carcinoma' vs 'normal',7.329749689041512
ENSG00000106443,1292.0,,,,7.164720378771857
ENSG00000069667,2184.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',7.68937110752969
ENSG00000069667,2184.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',7.68937110752969
ENSG00000134242,134.0,E-GEOD-44408,2.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.90527477843843
ENSG00000204217,4181.0,,,,8.338544879988579
ENSG00000119383,3348.0,,,,8.116417072794205
ENSG00000137857,272.0,,,,5.60947179518496
ENSG00000105953,4966.0,,,,8.51057131510735
ENSG00000106692,1083.0,,,,6.988413181999592
ENSG00000122188,37.0,E-GEOD-44408,2.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.6375861597263857
ENSG00000089220,9266.0,,,,9.134214981586691
ENSG00000168092,2898.0,,,,7.972121128921655
ENSG00000118137,13.0,,,,2.6390573296152584
ENSG00000015133,1356.0,E-MTAB-779,1.2,'breast carcinoma' vs 'normal',7.213031659834869
ENSG00000172425,73.0,,,,4.30406509320417
ENSG00000177432,288.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',5.666426688112432
ENSG00000177432,288.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',5.666426688112432
ENSG00000126778,158.0,E-GEOD-54002,2.6,'breast cancer' vs 'normal',5.0689042022202315
ENSG00000126778,158.0,E-GEOD-68086,-4.9,'breast carcinoma' vs 'normal',5.0689042022202315
ENSG00000126778,158.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',5.0689042022202315
ENSG00000126778,158.0,E-GEOD-38959,1.7,'breast cancer; breast' vs 'normal; breast',5.0689042022202315
ENSG00000154127,208.0,,,,5.342334251964811
ENSG00000051523,2430.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.796057974316123
ENSG00000122026,25302.0,,,,10.138678244761005
ENSG00000160679,4118.0,,,,8.323365694436081
ENSG00000205923,0.0,,,,0.0
ENSG00000162105,421.0,E-GEOD-44408,-2.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.045005314036012
ENSG00000162105,421.0,E-GEOD-7377,-2.9,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.045005314036012
ENSG00000103024,1790.0,,,,7.490529402060711
ENSG00000251546,0.0,,,,0.0
ENSG00000104267,254.0,E-GEOD-54002,-2.1,'breast cancer' vs 'normal',5.541263545158426
ENSG00000134533,1409.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',7.251344983372214
ENSG00000134533,1409.0,E-GEOD-38959,-2.1,'breast cancer; breast' vs 'normal; breast',7.251344983372214
ENSG00000164111,19596.0,E-GEOD-36765,1.4,'breast carcinoma' vs 'normal' in 'peripheral blood',9.883131772279054
ENSG00000047597,30.0,,,,3.4339872044851463
ENSG00000161800,324.0,E-GEOD-54002,2.0,'breast cancer' vs 'normal',5.783825182329737
ENSG00000161800,324.0,E-MTAB-779,1.6,'breast carcinoma' vs 'normal',5.783825182329737
ENSG00000161800,324.0,E-GEOD-38959,1.8,'breast cancer; breast' vs 'normal; breast',5.783825182329737
ENSG00000161800,324.0,E-GEOD-10780,1.7,'breast carcinoma' vs 'normal',5.783825182329737
ENSG00000161800,324.0,E-GEOD-31138,4.7,'invasive ductal carcinoma' vs 'normal',5.783825182329737
ENSG00000140950,639.0,,,,6.461468176353717
ENSG00000101460,1422.0,,,,7.260522598089852
ENSG00000182117,1602.0,,,,7.3796321526095525
ENSG00000115263,1.0,,,,0.6931471805599453
ENSG00000102743,130.0,,,,4.875197323201151
ENSG00000101323,0.0,,,,0.0
ENSG00000183691,16.0,E-GEOD-68086,-5.4,'breast carcinoma' vs 'normal',2.833213344056216
ENSG00000169925,1458.0,,,,7.285506548522785
ENSG00000001167,1332.0,,,,7.195187320178709
ENSG00000102290,15.0,,,,2.772588722239781
ENSG00000152804,522.0,E-GEOD-44408,2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.259581464064923
ENSG00000138592,2592.0,,,,7.860570785538664
ENSG00000005844,364.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.8998973535824915
ENSG00000126878,2762.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',7.924072324923417
ENSG00000126878,2762.0,E-GEOD-7377,-2.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.924072324923417
ENSG00000137094,604.0,,,,6.405228458030842
ENSG00000148680,25.0,,,,3.258096538021482
ENSG00000127995,1404.0,E-GEOD-31138,4.5,'invasive ductal carcinoma' vs 'normal',7.247792581767846
ENSG00000156298,1847.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',7.521859252201629
ENSG00000156298,1847.0,E-GEOD-44408,2.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.521859252201629
ENSG00000090376,3573.0,,,,8.181440695719374
ENSG00000092067,3.0,,,,1.3862943611198906
ENSG00000115486,1772.0,,,,7.480428306074208
ENSG00000131711,5184.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',8.553525120663627
ENSG00000131711,5184.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',8.553525120663627
ENSG00000131711,5184.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',8.553525120663627
ENSG00000100347,2239.0,,,,7.7142311448490855
ENSG00000168309,3284.0,E-GEOD-31138,-2.3,'invasive ductal carcinoma' vs 'normal',8.09712193091871
ENSG00000168309,3284.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',8.09712193091871
ENSG00000168309,3284.0,E-MTAB-779,-1.8,'breast carcinoma' vs 'normal',8.09712193091871
ENSG00000168309,3284.0,E-GEOD-52194,-4.7,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',8.09712193091871
ENSG00000091831,1171.0,E-GEOD-38959,-1.8,'breast cancer; breast' vs 'normal; breast',7.066466970136958
ENSG00000091831,1171.0,E-MTAB-779,2.0,'breast carcinoma' vs 'normal',7.066466970136958
ENSG00000091831,1171.0,E-GEOD-7377,1.8,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.066466970136958
ENSG00000091831,1171.0,E-GEOD-44408,-4.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.066466970136958
ENSG00000105968,3821.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',8.248529124800218
ENSG00000113520,3.0,,,,1.3862943611198906
ENSG00000270276,2.0,,,,1.0986122886681098
ENSG00000044090,2298.0,,,,7.740229524763182
ENSG00000112183,205.0,,,,5.327876168789581
ENSG00000100714,2728.0,,,,7.911690520708339
ENSG00000143578,966.0,,,,6.874198495453294
ENSG00000003436,4258.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.356789669923213
ENSG00000003436,4258.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',8.356789669923213
ENSG00000003436,4258.0,E-GEOD-10780,-2.0,'breast carcinoma' vs 'normal',8.356789669923213
ENSG00000081138,9.0,,,,2.302585092994046
ENSG00000104408,12395.0,,,,9.42512911890764
ENSG00000173267,1645.0,,,,7.406103381237015
ENSG00000101132,497.0,,,,6.210600077024653
ENSG00000143554,3097.0,,,,8.038512020976814
ENSG00000178607,1643.0,,,,7.404887575616125
ENSG00000168539,21.0,,,,3.091042453358316
ENSG00000178537,1298.0,,,,7.1693500166706
ENSG00000198888,337561.0,,,,12.729504476126966
ENSG00000215021,7710.0,,,,8.95040315983296
ENSG00000104823,4695.0,,,,8.454466361507933
ENSG00000131620,2569.0,E-GEOD-44408,-2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.851661177889265
ENSG00000131620,2569.0,E-GEOD-54002,-2.4,'breast cancer' vs 'normal',7.851661177889265
ENSG00000131620,2569.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',7.851661177889265
ENSG00000131620,2569.0,E-GEOD-38959,-3.0,'breast cancer; breast' vs 'normal; breast',7.851661177889265
ENSG00000087269,2215.0,,,,7.703459047867175
ENSG00000087258,113.0,,,,4.736198448394496
ENSG00000144040,476.0,,,,6.1675164908883415
ENSG00000074527,3126.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',8.047829357457841
ENSG00000074527,3126.0,E-GEOD-54002,-2.4,'breast cancer' vs 'normal',8.047829357457841
ENSG00000074527,3126.0,E-GEOD-38959,-3.0,'breast cancer; breast' vs 'normal; breast',8.047829357457841
ENSG00000116539,4836.0,,,,8.484049972822984
ENSG00000177548,897.0,,,,6.8001700683022
ENSG00000130725,1675.0,,,,7.424165281042028
ENSG00000092445,730.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',6.594413459749778
ENSG00000165584,0.0,,,,0.0
ENSG00000100823,4868.0,E-GEOD-31138,2.0,'invasive ductal carcinoma' vs 'normal',8.4906438561827
ENSG00000083720,1657.0,,,,7.4133673356952405
ENSG00000139292,99.0,,,,4.605170185988092
ENSG00000110245,5.0,,,,1.791759469228055
ENSG00000248144,899.0,E-MTAB-779,-2.5,'breast carcinoma' vs 'normal',6.802394763324311
ENSG00000166347,4861.0,E-GEOD-44408,-1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.48920515487607
ENSG00000166347,4861.0,E-GEOD-7377,1.7,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.48920515487607
ENSG00000030110,607.0,,,,6.410174881966167
ENSG00000136521,1863.0,,,,7.530479995245536
ENSG00000019549,1345.0,E-GEOD-31138,2.6,'invasive ductal carcinoma' vs 'normal',7.204892510204673
ENSG00000019549,1345.0,E-GEOD-38959,-1.3,'breast cancer; breast' vs 'normal; breast',7.204892510204673
ENSG00000019549,1345.0,E-GEOD-54002,-2.2,'breast cancer' vs 'normal',7.204892510204673
ENSG00000137203,1251.0,E-GEOD-20086,1.7,'breast cancer' vs 'normal',7.132497551660044
ENSG00000137203,1251.0,E-GEOD-31138,3.5,'invasive ductal carcinoma' vs 'normal',7.132497551660044
ENSG00000137203,1251.0,E-GEOD-44408,-4.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.132497551660044
ENSG00000130303,3580.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',8.183397369998433
ENSG00000129455,39.0,,,,3.6888794541139363
ENSG00000110799,24231.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',10.095429352707074
ENSG00000137825,8.0,,,,2.1972245773362196
ENSG00000198681,0.0,E-GEOD-52194,4.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000056736,417.0,,,,6.035481432524756
ENSG00000165490,57.0,,,,4.060443010546419
ENSG00000188229,3970.0,E-MTAB-779,1.2,'breast carcinoma' vs 'normal',8.286773231131251
ENSG00000132535,1002.0,,,,6.910750787961936
ENSG00000104419,15853.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',9.671177113397102
ENSG00000104419,15853.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',9.671177113397102
ENSG00000160194,1562.0,,,,7.354362330421477
ENSG00000129484,1251.0,,,,7.132497551660044
ENSG00000137714,747.0,,,,6.617402977974478
ENSG00000164815,689.0,,,,6.536691597591305
ENSG00000163956,4178.0,,,,8.337827262447915
ENSG00000168883,2201.0,,,,7.697121317282625
ENSG00000123159,2516.0,,,,7.830822995135316
ENSG00000175198,1281.0,,,,7.156176637480615
ENSG00000112130,687.0,,,,6.5337888379333435
ENSG00000198625,3969.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.286521373681236
ENSG00000076641,829.0,,,,6.721425700790643
ENSG00000143748,795.0,,,,6.679599185844383
ENSG00000165916,3732.0,,,,8.224967478914584
ENSG00000114861,3102.0,E-GEOD-38959,-1.5,'breast cancer; breast' vs 'normal; breast',8.04012466444838
ENSG00000140650,565.0,,,,6.338594078203183
ENSG00000170345,9893.0,E-GEOD-54002,-2.6,'breast cancer' vs 'normal',9.199683791787654
ENSG00000170345,9893.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',9.199683791787654
ENSG00000170345,9893.0,E-MTAB-779,-2.1,'breast carcinoma' vs 'normal',9.199683791787654
ENSG00000170876,7380.0,,,,8.906664409770052
ENSG00000039139,109.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',4.700480365792417
ENSG00000106976,1795.0,,,,7.493317248862145
ENSG00000129993,850.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.7464121285733745
ENSG00000160117,63.0,,,,4.1588830833596715
ENSG00000145692,23.0,,,,3.1780538303479458
ENSG00000198959,4419.0,,,,8.393894975071744
ENSG00000197872,1322.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.187657164114956
ENSG00000130948,58.0,,,,4.07753744390572
ENSG00000151929,3207.0,E-GEOD-44408,-1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.073402968986406
ENSG00000151929,3207.0,E-GEOD-52194,-6.8,'triple-negative breast cancer; breast carcinoma' vs 'normal',8.073402968986406
ENSG00000151929,3207.0,E-GEOD-52194,-6.2,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',8.073402968986406
ENSG00000151929,3207.0,E-GEOD-52194,-6.2,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',8.073402968986406
ENSG00000179091,3292.0,,,,8.099554282376364
ENSG00000132604,1335.0,,,,7.197435354096591
ENSG00000168522,2779.0,,,,7.930206206684683
ENSG00000141052,208.0,E-GEOD-68086,-4.9,'breast carcinoma' vs 'normal',5.342334251964811
ENSG00000014824,2309.0,,,,7.745002803515839
ENSG00000064999,3141.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.052614818815567
ENSG00000243678,1664.0,,,,7.417580402414544
ENSG00000100450,19.0,,,,2.995732273553991
ENSG00000145649,45.0,E-GEOD-44408,2.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.828641396489095
ENSG00000160868,16.0,,,,2.833213344056216
ENSG00000123561,0.0,,,,0.0
ENSG00000144935,647.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',6.473890696352274
ENSG00000144935,647.0,E-GEOD-54002,-2.4,'breast cancer' vs 'normal',6.473890696352274
ENSG00000106683,1038.0,,,,6.946013991099227
ENSG00000089041,253.0,,,,5.537334267018537
ENSG00000166741,13407.0,,,,9.503606822721864
ENSG00000198821,137.0,E-GEOD-44408,2.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.927253685157205
ENSG00000261236,1411.0,,,,7.252762418053187
ENSG00000087088,1242.0,,,,7.1252830915107115
ENSG00000173473,3654.0,,,,8.203851372183879
ENSG00000070010,2611.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',7.867871490396322
ENSG00000135940,3448.0,,,,8.145839612936841
ENSG00000142657,4751.0,,,,8.466320861042481
ENSG00000082175,633.0,E-GEOD-54002,-2.0,'breast cancer' vs 'normal',6.452048954437226
ENSG00000082175,633.0,E-GEOD-38959,-1.3,'breast cancer; breast' vs 'normal; breast',6.452048954437226
ENSG00000082175,633.0,E-GEOD-7377,2.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.452048954437226
ENSG00000137942,2844.0,E-GEOD-44408,-2.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.953318346560431
ENSG00000138080,3756.0,,,,8.231376045573969
ENSG00000118298,39.0,,,,3.6888794541139363
ENSG00000185000,3176.0,,,,8.063692634269517
ENSG00000005001,200.0,,,,5.303304908059076
ENSG00000107736,953.0,,,,6.860663671448287
ENSG00000143190,1757.0,,,,7.471932078245122
ENSG00000110880,5731.0,,,,8.653819788948063
ENSG00000163950,1536.0,,,,7.337587743538596
ENSG00000132274,4390.0,E-GEOD-44408,1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.387312270561717
ENSG00000132274,4390.0,E-GEOD-7377,-1.6,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.387312270561717
ENSG00000185885,6114.0,E-GEOD-54002,1.6,'breast cancer' vs 'normal',8.718500048121273
ENSG00000274286,260.0,,,,5.564520407322694
ENSG00000130822,23.0,,,,3.1780538303479458
ENSG00000275023,11582.0,,,,9.357293784932345
ENSG00000135924,3926.0,,,,8.27563105457801
ENSG00000129911,390.0,,,,5.968707559985366
ENSG00000134240,105.0,E-GEOD-54002,-2.2,'breast cancer' vs 'normal',4.663439094112067
ENSG00000134240,105.0,E-GEOD-38959,-2.7,'breast cancer; breast' vs 'normal; breast',4.663439094112067
ENSG00000167613,896.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.799055862058796
ENSG00000183091,345.0,,,,5.846438775057725
ENSG00000177469,34223.0,,,,10.440682431322188
ENSG00000189001,25.0,,,,3.258096538021482
ENSG00000188313,3382.0,,,,8.12651816878071
ENSG00000172534,3282.0,,,,8.096512917501594
ENSG00000174358,0.0,,,,0.0
ENSG00000138792,871.0,,,,6.77078942390898
ENSG00000004468,220.0,,,,5.3981627015177525
ENSG00000112964,3301.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',8.102283624480073
ENSG00000112964,3301.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',8.102283624480073
ENSG00000112964,3301.0,E-GEOD-10780,-2.0,'breast carcinoma' vs 'normal',8.102283624480073
ENSG00000096968,1999.0,,,,7.600902459542082
ENSG00000104856,811.0,,,,6.699500340161678
ENSG00000117091,111.0,E-GEOD-44408,2.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.718498871295094
ENSG00000136531,46.0,,,,3.8501476017100584
ENSG00000175595,375.0,,,,5.929589143389895
ENSG00000138162,2187.0,E-GEOD-44408,-2.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.690743163541872
ENSG00000129514,529.0,E-MTAB-779,2.7,'breast carcinoma' vs 'normal',6.272877006546167
ENSG00000129514,529.0,E-GEOD-38959,-2.7,'breast cancer; breast' vs 'normal; breast',6.272877006546167
ENSG00000129514,529.0,E-GEOD-7377,2.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.272877006546167
ENSG00000152822,2.0,,,,1.0986122886681098
ENSG00000266094,825.0,,,,6.716594773520978
ENSG00000151702,2316.0,E-GEOD-44408,2.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.748028524432376
ENSG00000118785,650.0,E-GEOD-54002,1.7,'breast cancer' vs 'normal',6.478509642208569
ENSG00000118785,650.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',6.478509642208569
ENSG00000118785,650.0,E-GEOD-10780,2.6,'breast carcinoma' vs 'normal',6.478509642208569
ENSG00000118785,650.0,E-MTAB-779,2.3,'breast carcinoma' vs 'normal',6.478509642208569
ENSG00000118785,650.0,E-GEOD-25407,-4.4,'breast cancer' vs 'normal',6.478509642208569
ENSG00000102081,2328.0,,,,7.753194269884341
ENSG00000172724,293.0,,,,5.683579767338681
ENSG00000100994,7022.0,,,,8.856945756159021
ENSG00000125895,148.0,,,,5.003946305945459
ENSG00000158769,2232.0,,,,7.711101251840158
ENSG00000117595,1248.0,E-GEOD-44408,-2.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.130098510125578
ENSG00000178498,1853.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',7.5251007461258
ENSG00000159842,5082.0,,,,8.533656917446903
ENSG00000163017,3479.0,E-GEOD-20086,2.6,'breast cancer' vs 'normal',8.15478757276852
ENSG00000163017,3479.0,E-GEOD-54002,-4.3,'breast cancer' vs 'normal',8.15478757276852
ENSG00000163017,3479.0,E-MTAB-779,-2.1,'breast carcinoma' vs 'normal',8.15478757276852
ENSG00000163017,3479.0,E-GEOD-10780,-2.3,'breast carcinoma' vs 'normal',8.15478757276852
ENSG00000163017,3479.0,E-GEOD-52194,-5.9,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',8.15478757276852
ENSG00000123643,871.0,,,,6.77078942390898
ENSG00000164120,384.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.953243334287785
ENSG00000280987,38.0,,,,3.6635616461296463
ENSG00000183454,21.0,,,,3.091042453358316
ENSG00000124523,885.0,,,,6.786716950605081
ENSG00000283632,0.0,,,,0.0
ENSG00000136158,4212.0,E-GEOD-54002,-2.8,'breast cancer' vs 'normal',8.345930261979017
ENSG00000136158,4212.0,E-GEOD-10780,-2.1,'breast carcinoma' vs 'normal',8.345930261979017
ENSG00000136158,4212.0,E-MTAB-779,-2.1,'breast carcinoma' vs 'normal',8.345930261979017
ENSG00000101210,113.0,E-GEOD-10780,1.7,'breast carcinoma' vs 'normal',4.736198448394496
ENSG00000102245,20.0,,,,3.044522437723423
ENSG00000115159,1676.0,,,,7.424761761823209
ENSG00000130826,2151.0,,,,7.674152921281675
ENSG00000175334,2848.0,,,,7.954723334497908
ENSG00000165140,643.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',6.467698726104354
ENSG00000165140,643.0,E-GEOD-44408,-2.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.467698726104354
ENSG00000165140,643.0,E-MTAB-779,2.1,'breast carcinoma' vs 'normal',6.467698726104354
ENSG00000137509,4409.0,,,,8.391629968440892
ENSG00000151366,992.0,,,,6.900730664045173
ENSG00000137745,1.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',0.6931471805599453
ENSG00000137745,1.0,E-GEOD-68086,-4.9,'breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000135624,6838.0,,,,8.830396801098097
ENSG00000157617,3442.0,,,,8.144098463338524
ENSG00000197448,6693.0,,,,8.808966881771273
ENSG00000071242,4434.0,,,,8.39728289474368
ENSG00000135318,1298.0,E-GEOD-44408,1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.1693500166706
ENSG00000135318,1298.0,E-GEOD-31138,2.5,'invasive ductal carcinoma' vs 'normal',7.1693500166706
ENSG00000079134,1862.0,,,,7.529943370601589
ENSG00000119686,250.0,,,,5.5254529391317835
ENSG00000164761,100.0,,,,4.61512051684126
ENSG00000126947,1378.0,,,,7.229113877793302
ENSG00000174917,1435.0,,,,7.269616749608169
ENSG00000203879,7715.0,,,,8.951051374025619
ENSG00000100811,4574.0,,,,8.428361977709622
ENSG00000091583,3.0,,,,1.3862943611198906
ENSG00000117448,2760.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',7.923348211930154
ENSG00000167434,1699.0,E-MTAB-779,-2.0,'breast carcinoma' vs 'normal',7.438383530044307
ENSG00000167434,1699.0,E-GEOD-52194,-6.6,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',7.438383530044307
ENSG00000240849,1239.0,,,,7.122866658599083
ENSG00000177807,9.0,,,,2.302585092994046
ENSG00000120063,2780.0,,,,7.930565854233965
ENSG00000182871,11115.0,,,,9.316140790862395
ENSG00000084733,4476.0,,,,8.406708458240965
ENSG00000071539,93.0,E-GEOD-54002,1.9,'breast cancer' vs 'normal',4.543294782270004
ENSG00000071539,93.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',4.543294782270004
ENSG00000264522,1636.0,,,,7.400620577371135
ENSG00000114026,1243.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',7.126087273299125
ENSG00000278195,1.0,E-GEOD-52194,5.6,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000145863,0.0,E-GEOD-68086,-5.3,'breast carcinoma' vs 'normal',0.0
ENSG00000255398,50.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',3.9318256327243257
ENSG00000138794,440.0,,,,6.089044875446846
ENSG00000143776,2807.0,,,,7.940227765145702
ENSG00000143546,618.0,E-GEOD-10780,1.6,'breast carcinoma' vs 'normal',6.428105272684596
ENSG00000143546,618.0,E-GEOD-52194,5.6,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',6.428105272684596
ENSG00000143546,618.0,E-GEOD-38959,1.9,'breast cancer; breast' vs 'normal; breast',6.428105272684596
ENSG00000115760,4335.0,,,,8.374707543119483
ENSG00000174989,802.0,,,,6.688354713946762
ENSG00000188643,3717.0,,,,8.220941168281389
ENSG00000183723,975.0,,,,6.883462586413092
ENSG00000113621,2108.0,,,,7.653969180478774
ENSG00000213809,25.0,,,,3.258096538021482
ENSG00000186517,789.0,,,,6.672032945461067
ENSG00000275722,0.0,,,,0.0
ENSG00000257923,3031.0,,,,8.016977746762262
ENSG00000133561,2023.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',7.6128310304073565
ENSG00000133561,2023.0,E-GEOD-44408,1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.6128310304073565
ENSG00000169919,3293.0,,,,8.099857910737585
ENSG00000170340,1155.0,E-GEOD-31138,2.9,'invasive ductal carcinoma' vs 'normal',7.052721049232323
ENSG00000149428,3026.0,,,,8.01532730902172
ENSG00000096063,1469.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',7.293017679772782
ENSG00000151952,0.0,E-GEOD-52194,6.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000151952,0.0,E-GEOD-52194,5.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000106853,1539.0,,,,7.3395376954076745
ENSG00000198798,0.0,,,,0.0
ENSG00000134588,0.0,,,,0.0
ENSG00000144554,360.0,,,,5.8888779583328805
ENSG00000135597,1648.0,,,,7.407924322559599
ENSG00000153574,1054.0,,,,6.961296045910167
ENSG00000121716,628.0,,,,6.444131256700441
ENSG00000186815,5895.0,,,,8.682029433869172
ENSG00000111981,25.0,,,,3.258096538021482
ENSG00000126261,5914.0,,,,8.685246776412487
ENSG00000101916,48.0,,,,3.8918202981106265
ENSG00000117399,63.0,E-GEOD-54002,2.6,'breast cancer' vs 'normal',4.1588830833596715
ENSG00000117399,63.0,E-GEOD-10780,1.8,'breast carcinoma' vs 'normal',4.1588830833596715
ENSG00000204983,99.0,,,,4.605170185988092
ENSG00000189043,4944.0,E-GEOD-31138,2.1,'invasive ductal carcinoma' vs 'normal',8.506132244056813
ENSG00000176136,0.0,,,,0.0
ENSG00000166173,1298.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',7.1693500166706
ENSG00000166173,1298.0,E-MTAB-779,-2.0,'breast carcinoma' vs 'normal',7.1693500166706
ENSG00000124209,1788.0,E-GEOD-31138,3.3,'invasive ductal carcinoma' vs 'normal',7.489412083508719
ENSG00000116678,2289.0,E-GEOD-54002,-1.4,'breast cancer' vs 'normal',7.736307096548285
ENSG00000116678,2289.0,E-GEOD-31138,-2.4,'invasive ductal carcinoma' vs 'normal',7.736307096548285
ENSG00000116678,2289.0,E-GEOD-10780,-2.5,'breast carcinoma' vs 'normal',7.736307096548285
ENSG00000244274,190.0,,,,5.25227342804663
ENSG00000062194,3734.0,,,,8.225503097566918
ENSG00000198021,0.0,,,,0.0
ENSG00000059573,1339.0,,,,7.200424892944957
ENSG00000125398,740.0,E-GEOD-7377,-1.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.608000625296087
ENSG00000125398,740.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',6.608000625296087
ENSG00000125398,740.0,E-GEOD-20086,1.6,'breast cancer' vs 'normal',6.608000625296087
ENSG00000125398,740.0,E-GEOD-44408,-3.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.608000625296087
ENSG00000125637,1253.0,,,,7.134093721192866
ENSG00000213366,4783.0,,,,8.473032295630468
ENSG00000182621,624.0,E-GEOD-54002,-2.4,'breast cancer' vs 'normal',6.437751649736401
ENSG00000167004,9768.0,,,,9.186969385652942
ENSG00000104722,7.0,E-GEOD-52194,-5.6,'triple-negative breast cancer; breast carcinoma' vs 'normal',2.0794415416798357
ENSG00000104722,7.0,E-GEOD-52194,-8.9,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',2.0794415416798357
ENSG00000104722,7.0,E-GEOD-52194,-5.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',2.0794415416798357
ENSG00000167173,2071.0,,,,7.6362696033793735
ENSG00000180263,484.0,,,,6.184148890937483
ENSG00000132698,355.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',5.87493073085203
ENSG00000132698,355.0,E-GEOD-44408,-3.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.87493073085203
ENSG00000109390,1143.0,,,,7.042286171939743
ENSG00000112559,538.0,,,,6.289715570908998
ENSG00000173846,1204.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',7.094234845924755
ENSG00000083896,5030.0,,,,8.523374050491318
ENSG00000163220,2084.0,E-GEOD-10780,1.5,'breast carcinoma' vs 'normal',7.642524134232902
ENSG00000186642,5899.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',8.68270762989381
ENSG00000186642,5899.0,E-MTAB-779,-2.3,'breast carcinoma' vs 'normal',8.68270762989381
ENSG00000091137,52.0,,,,3.970291913552122
ENSG00000157764,2125.0,,,,7.661997558901893
ENSG00000108479,766.0,,,,6.642486801367256
ENSG00000168878,71.0,,,,4.276666119016055
ENSG00000151726,24194.0,,,,10.093901279227419
ENSG00000177885,4954.0,,,,8.508152446764088
ENSG00000231389,5807.0,,,,8.666991556504632
ENSG00000175567,2639.0,,,,7.878534196140362
ENSG00000100281,1209.0,,,,7.098375638590786
ENSG00000152430,7.0,,,,2.0794415416798357
ENSG00000149124,106.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',4.672828834461906
ENSG00000117362,5486.0,,,,8.610136937058975
ENSG00000170653,3245.0,,,,8.085178748074537
ENSG00000080824,25167.0,,,,10.13332862529806
ENSG00000167880,290.0,,,,5.673323267171493
ENSG00000077150,2645.0,E-GEOD-44408,1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.880804344674901
ENSG00000138378,279.0,E-GEOD-31138,-1.7,'invasive ductal carcinoma' vs 'normal',5.634789603169249
ENSG00000138378,279.0,E-GEOD-44408,2.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.634789603169249
ENSG00000083857,3235.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',8.082093278178382
ENSG00000083857,3235.0,E-GEOD-31138,2.3,'invasive ductal carcinoma' vs 'normal',8.082093278178382
ENSG00000083857,3235.0,E-GEOD-54002,-2.0,'breast cancer' vs 'normal',8.082093278178382
ENSG00000187091,1304.0,,,,7.173958319756794
ENSG00000087494,88.0,E-GEOD-54002,-2.9,'breast cancer' vs 'normal',4.48863636973214
ENSG00000087494,88.0,E-GEOD-38959,-2.1,'breast cancer; breast' vs 'normal; breast',4.48863636973214
ENSG00000087494,88.0,E-GEOD-52194,-6.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',4.48863636973214
ENSG00000087494,88.0,E-GEOD-52194,-5.2,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',4.48863636973214
ENSG00000087494,88.0,E-GEOD-7377,3.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',4.48863636973214
ENSG00000211625,2.0,,,,1.0986122886681098
ENSG00000198049,0.0,,,,0.0
ENSG00000108947,149.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',5.0106352940962555
ENSG00000108947,149.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',5.0106352940962555
ENSG00000101868,745.0,,,,6.61472560020376
ENSG00000117983,86.0,E-GEOD-10780,1.4,'breast carcinoma' vs 'normal',4.465908118654584
ENSG00000134516,717.0,E-GEOD-44408,2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.576469569048224
ENSG00000095713,102.0,,,,4.634728988229636
ENSG00000119547,4.0,E-GEOD-52194,7.0,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',1.6094379124341003
ENSG00000071564,2531.0,,,,7.836764783264067
ENSG00000153989,1842.0,,,,7.519149957669823
ENSG00000136546,525.0,E-GEOD-31138,-3.4,'invasive ductal carcinoma' vs 'normal',6.26530121273771
ENSG00000133794,1713.0,,,,7.446585099157725
ENSG00000093009,38.0,E-GEOD-54002,1.6,'breast cancer' vs 'normal',3.6635616461296463
ENSG00000093009,38.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',3.6635616461296463
ENSG00000093009,38.0,E-GEOD-38959,2.5,'breast cancer; breast' vs 'normal; breast',3.6635616461296463
ENSG00000136874,827.0,,,,6.71901315438526
ENSG00000278535,501.0,,,,6.218600119691729
ENSG00000066230,95.0,,,,4.564348191467836
ENSG00000076555,19602.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',9.883437894730424
ENSG00000076555,19602.0,E-GEOD-31138,-2.9,'invasive ductal carcinoma' vs 'normal',9.883437894730424
ENSG00000107485,3012.0,E-MTAB-779,1.8,'breast carcinoma' vs 'normal',8.0106915391303
ENSG00000107485,3012.0,E-GEOD-20086,1.9,'breast cancer' vs 'normal',8.0106915391303
ENSG00000107485,3012.0,E-GEOD-38959,-2.1,'breast cancer; breast' vs 'normal; breast',8.0106915391303
ENSG00000107485,3012.0,E-GEOD-44408,-2.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.0106915391303
ENSG00000116748,15.0,E-GEOD-31138,-3.8,'invasive ductal carcinoma' vs 'normal',2.772588722239781
ENSG00000079385,853.0,,,,6.74993119378857
ENSG00000101162,14.0,,,,2.70805020110221
ENSG00000187239,2716.0,E-GEOD-44408,1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.907283609426348
ENSG00000135625,0.0,,,,0.0
ENSG00000154096,1077.0,E-GEOD-31138,2.2,'invasive ductal carcinoma' vs 'normal',6.982862751468942
ENSG00000143756,1559.0,,,,7.352441100243583
ENSG00000175414,660.0,,,,6.493753839851686
ENSG00000123975,110.0,E-GEOD-54002,2.5,'breast cancer' vs 'normal',4.709530201312334
ENSG00000123975,110.0,E-MTAB-779,1.8,'breast carcinoma' vs 'normal',4.709530201312334
ENSG00000123975,110.0,E-GEOD-10780,2.7,'breast carcinoma' vs 'normal',4.709530201312334
ENSG00000123975,110.0,E-GEOD-38959,2.5,'breast cancer; breast' vs 'normal; breast',4.709530201312334
ENSG00000148848,771.0,,,,6.648984550024776
ENSG00000124253,1906.0,E-GEOD-10780,-1.7,'breast carcinoma' vs 'normal',7.553286605600419
ENSG00000124253,1906.0,E-MTAB-779,-1.8,'breast carcinoma' vs 'normal',7.553286605600419
ENSG00000102158,2638.0,E-MTAB-779,1.8,'breast carcinoma' vs 'normal',7.878155336503324
ENSG00000102158,2638.0,E-GEOD-31138,2.9,'invasive ductal carcinoma' vs 'normal',7.878155336503324
ENSG00000108561,2225.0,,,,7.70796153183549
ENSG00000104814,185.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.225746673713202
ENSG00000126107,3737.0,,,,8.226305988015508
ENSG00000176884,44.0,,,,3.8066624897703196
ENSG00000100433,0.0,E-GEOD-52194,6.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000100433,0.0,E-GEOD-52194,5.1,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000130300,10016.0,,,,9.212038928611765
ENSG00000181617,51.0,E-GEOD-54002,-4.5,'breast cancer' vs 'normal',3.9512437185814275
ENSG00000181617,51.0,E-GEOD-52194,-5.7,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',3.9512437185814275
ENSG00000130635,4507.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',8.413608875159667
ENSG00000130635,4507.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',8.413608875159667
ENSG00000130635,4507.0,E-GEOD-54002,2.5,'breast cancer' vs 'normal',8.413608875159667
ENSG00000130635,4507.0,E-GEOD-44408,-2.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.413608875159667
ENSG00000186635,4568.0,,,,8.427049641563272
ENSG00000169896,532.0,,,,6.278521424165844
ENSG00000157766,21.0,,,,3.091042453358316
ENSG00000102921,2855.0,,,,7.957177323459475
ENSG00000129596,1080.0,E-GEOD-54002,-1.9,'breast cancer' vs 'normal',6.985641817639208
ENSG00000129596,1080.0,E-GEOD-38959,-1.7,'breast cancer; breast' vs 'normal; breast',6.985641817639208
ENSG00000129596,1080.0,E-MTAB-779,-2.1,'breast carcinoma' vs 'normal',6.985641817639208
ENSG00000129596,1080.0,E-GEOD-10780,-1.9,'breast carcinoma' vs 'normal',6.985641817639208
ENSG00000065882,2753.0,,,,7.9208096792886
ENSG00000119614,2.0,,,,1.0986122886681098
ENSG00000099381,2260.0,,,,7.72356247227797
ENSG00000115593,65.0,,,,4.189654742026425
ENSG00000149503,444.0,,,,6.09807428216624
ENSG00000204970,4.0,,,,1.6094379124341003
ENSG00000110330,2349.0,,,,7.762170607138205
ENSG00000091622,189.0,,,,5.247024072160486
ENSG00000104879,190.0,,,,5.25227342804663
ENSG00000102882,4518.0,,,,8.41604600941128
ENSG00000154277,339.0,E-GEOD-38959,1.8,'breast cancer; breast' vs 'normal; breast',5.8289456176102075
ENSG00000156136,635.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.455198563340122
ENSG00000156136,635.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',6.455198563340122
ENSG00000175785,283.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',5.648974238161206
ENSG00000159713,511.0,,,,6.238324625039508
ENSG00000205155,611.0,,,,6.416732282512326
ENSG00000118518,3034.0,,,,8.017966703493599
ENSG00000116809,1702.0,,,,7.440146680662688
ENSG00000088726,18.0,,,,2.9444389791664403
ENSG00000109956,42.0,,,,3.7612001156935624
ENSG00000167553,921.0,E-GEOD-38959,1.5,'breast cancer; breast' vs 'normal; breast',6.826545223556594
ENSG00000172137,698.0,,,,6.54965074223381
ENSG00000185338,200.0,,,,5.303304908059076
ENSG00000119888,366.0,E-MTAB-779,2.0,'breast carcinoma' vs 'normal',5.905361848054571
ENSG00000119888,366.0,E-GEOD-31138,3.3,'invasive ductal carcinoma' vs 'normal',5.905361848054571
ENSG00000119888,366.0,E-GEOD-44408,-4.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.905361848054571
ENSG00000170558,26.0,,,,3.295836866004329
ENSG00000197444,5.0,,,,1.791759469228055
ENSG00000075618,1709.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.444248649496705
ENSG00000183010,298.0,E-MTAB-779,1.7,'breast carcinoma' vs 'normal',5.700443573390687
ENSG00000183010,298.0,E-GEOD-38959,1.7,'breast cancer; breast' vs 'normal; breast',5.700443573390687
ENSG00000100941,7515.0,,,,8.924789360533357
ENSG00000187244,8195.0,,,,9.011401509358791
ENSG00000168291,2216.0,,,,7.7039102096163115
ENSG00000153002,169.0,E-GEOD-68086,-5.9,'breast carcinoma' vs 'normal',5.135798437050262
ENSG00000198732,347.0,,,,5.8522024797744745
ENSG00000164327,3028.0,,,,8.015987811027237
ENSG00000126804,2033.0,,,,7.617759576608505
ENSG00000103932,1460.0,,,,7.2868764117507
ENSG00000185862,305.0,E-GEOD-44408,2.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.723585101952381
ENSG00000144218,912.0,,,,6.816735880594968
ENSG00000144118,3010.0,,,,8.010027528481734
ENSG00000108175,7421.0,,,,8.912203841620542
ENSG00000069702,10832.0,E-MTAB-779,-1.8,'breast carcinoma' vs 'normal',9.290352309945568
ENSG00000069702,10832.0,E-GEOD-54002,-2.8,'breast cancer' vs 'normal',9.290352309945568
ENSG00000069702,10832.0,E-GEOD-20086,-1.5,'breast cancer' vs 'normal',9.290352309945568
ENSG00000069702,10832.0,E-GEOD-10780,-2.3,'breast carcinoma' vs 'normal',9.290352309945568
ENSG00000007908,265.0,E-GEOD-52194,-8.2,'triple-negative breast cancer; breast carcinoma' vs 'normal',5.583496308781699
ENSG00000007908,265.0,E-GEOD-52194,-6.4,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',5.583496308781699
ENSG00000007908,265.0,E-GEOD-52194,-6.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',5.583496308781699
ENSG00000136238,10678.0,,,,9.276034475171546
ENSG00000126456,3134.0,,,,8.050384453067021
ENSG00000111142,3068.0,E-GEOD-31138,2.3,'invasive ductal carcinoma' vs 'normal',8.029107054619736
ENSG00000099817,5485.0,,,,8.60995467149755
ENSG00000174946,33.0,E-GEOD-44408,2.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.5263605246161616
ENSG00000129538,5535.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',8.619027497297505
ENSG00000129538,5535.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',8.619027497297505
ENSG00000198176,2247.0,,,,7.717796211013582
ENSG00000124496,609.0,,,,6.413458957167357
ENSG00000173599,2353.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',7.763871287820222
ENSG00000135144,946.0,E-MTAB-779,-1.2,'breast carcinoma' vs 'normal',6.853299093186078
ENSG00000067606,150.0,,,,5.017279836814924
ENSG00000103266,1551.0,,,,7.347299700743164
ENSG00000148965,36.0,,,,3.6109179126442243
ENSG00000126934,4435.0,,,,8.397508348470257
ENSG00000021355,2947.0,,,,7.988882253309227
ENSG00000121594,8.0,,,,2.1972245773362196
ENSG00000178363,14.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',2.70805020110221
ENSG00000105325,2161.0,,,,7.6787889981991535
ENSG00000141456,2480.0,,,,7.816416983691801
ENSG00000061337,397.0,E-GEOD-31138,2.3,'invasive ductal carcinoma' vs 'normal',5.986452005284438
ENSG00000142655,1049.0,,,,6.956545443151569
ENSG00000157315,18.0,,,,2.9444389791664403
ENSG00000111728,189.0,E-GEOD-44408,1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.247024072160486
ENSG00000111728,189.0,E-GEOD-54002,-2.3,'breast cancer' vs 'normal',5.247024072160486
ENSG00000166411,881.0,,,,6.782192056006791
ENSG00000138443,2158.0,,,,7.677400430514807
ENSG00000183648,1357.0,,,,7.213768308118642
ENSG00000125347,1802.0,,,,7.497207223203318
ENSG00000110484,1544.0,E-GEOD-10780,-1.6,'breast carcinoma' vs 'normal',7.3427791893318455
ENSG00000110484,1544.0,E-GEOD-54002,-3.7,'breast cancer' vs 'normal',7.3427791893318455
ENSG00000110484,1544.0,E-GEOD-38959,-3.9,'breast cancer; breast' vs 'normal; breast',7.3427791893318455
ENSG00000168621,18.0,E-GEOD-68086,-5.7,'breast carcinoma' vs 'normal',2.9444389791664403
ENSG00000072609,1753.0,E-GEOD-7377,1.4,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.469654172932128
ENSG00000139352,1.0,,,,0.6931471805599453
ENSG00000237649,85.0,,,,4.454347296253507
ENSG00000111679,1041.0,E-GEOD-44408,2.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.948897222313312
ENSG00000164442,6585.0,,,,8.792701462936309
ENSG00000108846,1897.0,,,,7.5485559791698735
ENSG00000106483,2054.0,E-GEOD-44408,-2.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.628031126930335
ENSG00000151320,268.0,,,,5.594711379601839
ENSG00000204220,807.0,,,,6.694562058521095
ENSG00000128487,1265.0,,,,7.143617602704121
ENSG00000002549,4157.0,,,,8.332789468417959
ENSG00000166501,152.0,E-GEOD-44408,2.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.030437921392435
ENSG00000146926,1.0,,,,0.6931471805599453
ENSG00000133019,64.0,,,,4.174387269895637
ENSG00000108528,1910.0,,,,7.555381944240273
ENSG00000115459,2700.0,,,,7.901377353792616
ENSG00000092054,186.0,E-GEOD-52194,6.8,'triple-negative breast cancer; breast carcinoma' vs 'normal',5.231108616854587
ENSG00000092054,186.0,E-GEOD-52194,5.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',5.231108616854587
ENSG00000057663,1338.0,,,,7.199678345691172
ENSG00000174099,3880.0,E-MTAB-779,-1.2,'breast carcinoma' vs 'normal',8.263848131368906
ENSG00000174099,3880.0,E-GEOD-54002,-2.4,'breast cancer' vs 'normal',8.263848131368906
ENSG00000084234,20525.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',9.92944765420566
ENSG00000137962,6431.0,,,,8.769040810858803
ENSG00000151490,54.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.007333185232471
ENSG00000070961,1663.0,,,,7.416979621381154
ENSG00000120053,932.0,,,,6.838405200847344
ENSG00000143520,34.0,E-GEOD-68086,-5.4,'breast carcinoma' vs 'normal',3.5553480614894135
ENSG00000104522,1824.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',7.509335266016592
ENSG00000104522,1824.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',7.509335266016592
ENSG00000138796,4335.0,,,,8.374707543119483
ENSG00000091317,2425.0,E-GEOD-31138,2.1,'invasive ductal carcinoma' vs 'normal',7.793999089503996
ENSG00000143384,20588.0,,,,9.932512231576744
ENSG00000156239,560.0,,,,6.329720905522696
ENSG00000164509,2.0,,,,1.0986122886681098
ENSG00000158402,5.0,E-GEOD-54002,1.8,'breast cancer' vs 'normal',1.791759469228055
ENSG00000171587,3.0,,,,1.3862943611198906
ENSG00000131981,12838.0,,,,9.460242692591084
ENSG00000205426,26.0,E-GEOD-52194,-4.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',3.295836866004329
ENSG00000078902,2484.0,,,,7.818027938530729
ENSG00000163453,21044.0,E-GEOD-54002,2.1,'breast cancer' vs 'normal',9.95441828120467
ENSG00000148677,43.0,,,,3.784189633918261
ENSG00000145012,11665.0,,,,9.364433907313582
ENSG00000198586,2109.0,E-GEOD-31138,1.9,'invasive ductal carcinoma' vs 'normal',7.6544432264701125
ENSG00000114115,312.0,E-GEOD-7377,2.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',5.746203190540153
ENSG00000171431,2.0,,,,1.0986122886681098
ENSG00000103449,26.0,,,,3.295836866004329
ENSG00000146285,28.0,,,,3.367295829986474
ENSG00000131979,471.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',6.156978985585555
ENSG00000065911,2640.0,E-GEOD-10780,1.4,'breast carcinoma' vs 'normal',7.878912912297133
ENSG00000065911,2640.0,E-GEOD-38959,1.6,'breast cancer; breast' vs 'normal; breast',7.878912912297133
ENSG00000178951,2333.0,,,,7.755338812846501
ENSG00000244038,5815.0,,,,8.668368019213355
ENSG00000198707,997.0,,,,6.905753276311464
ENSG00000167110,4652.0,,,,8.445267451844648
ENSG00000009765,21.0,,,,3.091042453358316
ENSG00000197956,22654.0,,,,10.028135857101239
ENSG00000124193,8871.0,,,,9.090655529030203
ENSG00000163191,8569.0,E-GEOD-44408,-1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.056023011591826
ENSG00000163191,8569.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',9.056023011591826
ENSG00000089163,37.0,,,,3.6375861597263857
ENSG00000112038,0.0,E-GEOD-52194,4.9,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000112038,0.0,E-GEOD-52194,5.8,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000103479,5098.0,,,,8.536799721055155
ENSG00000169583,47.0,,,,3.871201010907891
ENSG00000165272,517.0,,,,6.249975242259483
ENSG00000182473,3199.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',8.070906088787819
ENSG00000116138,974.0,,,,6.882437470997847
ENSG00000124145,5484.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',8.609772372709331
ENSG00000124145,5484.0,E-GEOD-44408,-2.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.609772372709331
ENSG00000092199,14267.0,,,,9.565774546478782
ENSG00000140545,19532.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',9.879860621904971
ENSG00000197063,1768.0,,,,7.478169694159785
ENSG00000196415,6.0,,,,1.9459101490553132
ENSG00000053918,280.0,,,,5.638354669333745
ENSG00000185950,5846.0,E-GEOD-54002,-2.0,'breast cancer' vs 'normal',8.67368398817567
ENSG00000185950,5846.0,E-GEOD-10780,-1.5,'breast carcinoma' vs 'normal',8.67368398817567
ENSG00000026025,100881.0,,,,11.521706795977567
ENSG00000116984,3661.0,,,,8.205764725234456
ENSG00000108187,384.0,E-GEOD-7377,1.8,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',5.953243334287785
ENSG00000073756,144.0,E-GEOD-44408,2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.976733742420574
ENSG00000073756,144.0,E-GEOD-10780,-1.6,'breast carcinoma' vs 'normal',4.976733742420574
ENSG00000073756,144.0,E-GEOD-54002,-3.0,'breast cancer' vs 'normal',4.976733742420574
ENSG00000073756,144.0,E-GEOD-52194,-5.0,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',4.976733742420574
ENSG00000163104,1602.0,,,,7.3796321526095525
ENSG00000163399,17961.0,,,,9.796013694230895
ENSG00000149084,2795.0,,,,7.935945103353701
ENSG00000138646,513.0,E-GEOD-7377,-1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.2422232654551655
ENSG00000137960,316.0,E-GEOD-54002,-2.5,'breast cancer' vs 'normal',5.75890177387728
ENSG00000107165,2.0,,,,1.0986122886681098
ENSG00000159131,2500.0,,,,7.824445930877619
ENSG00000185686,7.0,E-GEOD-52194,5.0,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',2.0794415416798357
ENSG00000185686,7.0,E-GEOD-38959,2.3,'breast cancer; breast' vs 'normal; breast',2.0794415416798357
ENSG00000016402,334.0,E-GEOD-54002,-2.2,'breast cancer' vs 'normal',5.814130531825066
ENSG00000016402,334.0,E-GEOD-38959,-2.4,'breast cancer; breast' vs 'normal; breast',5.814130531825066
ENSG00000249992,65.0,,,,4.189654742026425
ENSG00000130943,27.0,,,,3.332204510175204
ENSG00000183779,2983.0,,,,8.001019961323651
ENSG00000148773,84.0,E-GEOD-54002,1.9,'breast cancer' vs 'normal',4.442651256490317
ENSG00000148773,84.0,E-GEOD-31138,3.6,'invasive ductal carcinoma' vs 'normal',4.442651256490317
ENSG00000078142,2100.0,,,,7.650168700845001
ENSG00000038427,4758.0,E-GEOD-31138,2.5,'invasive ductal carcinoma' vs 'normal',8.46779284112111
ENSG00000038427,4758.0,E-GEOD-54002,3.2,'breast cancer' vs 'normal',8.46779284112111
ENSG00000038427,4758.0,E-GEOD-44408,-3.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.46779284112111
ENSG00000188536,486.0,E-MTAB-779,-2.1,'breast carcinoma' vs 'normal',6.18826412308259
ENSG00000204463,9567.0,,,,9.166179476190413
ENSG00000178538,303.0,E-GEOD-38959,-1.7,'breast cancer; breast' vs 'normal; breast',5.717027701406222
ENSG00000153498,0.0,,,,0.0
ENSG00000134398,5.0,,,,1.791759469228055
ENSG00000108100,3418.0,,,,8.137103389639302
ENSG00000100842,1577.0,,,,7.363913501405819
ENSG00000185499,2199.0,E-GEOD-10780,1.4,'breast carcinoma' vs 'normal',7.696212639346407
ENSG00000185499,2199.0,E-MTAB-779,2.1,'breast carcinoma' vs 'normal',7.696212639346407
ENSG00000185499,2199.0,E-GEOD-44408,-2.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.696212639346407
ENSG00000122735,17.0,,,,2.8903717578961645
ENSG00000198947,2412.0,E-MTAB-779,-1.9,'breast carcinoma' vs 'normal',7.7886260656250315
ENSG00000198947,2412.0,E-GEOD-54002,-4.7,'breast cancer' vs 'normal',7.7886260656250315
ENSG00000198947,2412.0,E-GEOD-10780,-2.6,'breast carcinoma' vs 'normal',7.7886260656250315
ENSG00000198947,2412.0,E-GEOD-38959,-3.2,'breast cancer; breast' vs 'normal; breast',7.7886260656250315
ENSG00000005893,5735.0,,,,8.654517382279456
ENSG00000126752,0.0,,,,0.0
ENSG00000096006,9.0,,,,2.302585092994046
ENSG00000204580,5285.0,E-GEOD-44408,-2.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.572817095164234
ENSG00000071127,12694.0,,,,9.448963494138779
ENSG00000136244,266.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.58724865840025
ENSG00000136244,266.0,E-GEOD-52194,-10.3,'triple-negative breast cancer; breast carcinoma' vs 'normal',5.58724865840025
ENSG00000136244,266.0,E-GEOD-52194,-9.6,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',5.58724865840025
ENSG00000136244,266.0,E-GEOD-52194,-9.7,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',5.58724865840025
ENSG00000159216,6105.0,,,,8.717027173294824
ENSG00000076242,1495.0,,,,7.310550158534422
ENSG00000150764,1950.0,,,,7.576097340623111
ENSG00000073910,2691.0,,,,7.898039690764619
ENSG00000254647,1.0,,,,0.6931471805599453
ENSG00000112996,1141.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',7.040536390215956
ENSG00000082212,1236.0,,,,7.1204443723924875
ENSG00000125652,1353.0,,,,7.21081845347222
ENSG00000169884,30.0,,,,3.4339872044851463
ENSG00000182022,1983.0,E-GEOD-7377,1.4,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.592870287844818
ENSG00000187764,847.0,E-GEOD-44408,1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.742880635791903
ENSG00000276644,446.0,,,,6.102558594613569
ENSG00000170231,1.0,,,,0.6931471805599453
ENSG00000180370,4582.0,E-GEOD-31138,2.0,'invasive ductal carcinoma' vs 'normal',8.430109084509125
ENSG00000113303,16.0,,,,2.833213344056216
ENSG00000156475,41.0,,,,3.7376696182833684
ENSG00000130402,19341.0,,,,9.870034176276908
ENSG00000167861,2051.0,,,,7.62657020629066
ENSG00000101441,0.0,E-GEOD-52194,4.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000120992,1843.0,,,,7.519692404116539
ENSG00000100285,47.0,,,,3.871201010907891
ENSG00000121380,22.0,,,,3.1354942159291497
ENSG00000111644,74.0,,,,4.31748811353631
ENSG00000105879,1170.0,,,,7.065613363597717
ENSG00000105699,1290.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.1631723908466425
ENSG00000072849,1641.0,,,,7.403670290012373
ENSG00000114650,4018.0,,,,8.2987883944492
ENSG00000128016,22421.0,E-GEOD-52194,-7.6,'triple-negative breast cancer; breast carcinoma' vs 'normal',10.017797898713539
ENSG00000128016,22421.0,E-GEOD-52194,-6.6,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',10.017797898713539
ENSG00000128016,22421.0,E-GEOD-52194,-6.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',10.017797898713539
ENSG00000161798,34.0,E-MTAB-779,-1.8,'breast carcinoma' vs 'normal',3.5553480614894135
ENSG00000140564,6370.0,,,,8.759511722116487
ENSG00000186265,13.0,,,,2.6390573296152584
ENSG00000124422,6615.0,,,,8.797246236703527
ENSG00000074201,2066.0,,,,7.633853559681768
ENSG00000141579,179.0,E-GEOD-54002,-1.9,'breast cancer' vs 'normal',5.19295685089021
ENSG00000118922,789.0,,,,6.672032945461067
ENSG00000073282,668.0,E-GEOD-54002,-4.5,'breast cancer' vs 'normal',6.505784060128229
ENSG00000073282,668.0,E-MTAB-779,-2.1,'breast carcinoma' vs 'normal',6.505784060128229
ENSG00000073282,668.0,E-GEOD-10780,-2.3,'breast carcinoma' vs 'normal',6.505784060128229
ENSG00000073282,668.0,E-GEOD-38959,-3.1,'breast cancer; breast' vs 'normal; breast',6.505784060128229
ENSG00000095787,7856.0,,,,8.969160133175821
ENSG00000169403,308.0,,,,5.733341276897746
ENSG00000175899,37139.0,,,,10.522449834906697
ENSG00000110660,329.0,E-GEOD-31138,2.1,'invasive ductal carcinoma' vs 'normal',5.799092654460526
ENSG00000128422,8666.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',9.067277989134345
ENSG00000128422,8666.0,E-GEOD-54002,-4.1,'breast cancer' vs 'normal',9.067277989134345
ENSG00000128422,8666.0,E-GEOD-10780,-2.2,'breast carcinoma' vs 'normal',9.067277989134345
ENSG00000128422,8666.0,E-GEOD-52194,-5.7,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',9.067277989134345
ENSG00000128422,8666.0,E-GEOD-52194,-7.0,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',9.067277989134345
ENSG00000173898,394.0,,,,5.978885764901122
ENSG00000186522,3399.0,,,,8.131530710604252
ENSG00000106541,199.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',5.298317366548036
ENSG00000106541,199.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',5.298317366548036
ENSG00000106541,199.0,E-MTAB-779,2.8,'breast carcinoma' vs 'normal',5.298317366548036
ENSG00000106541,199.0,E-GEOD-7377,2.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',5.298317366548036
ENSG00000106541,199.0,E-GEOD-44408,-5.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.298317366548036
ENSG00000139278,945.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.852242569051878
ENSG00000139278,945.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',6.852242569051878
ENSG00000221829,520.0,,,,6.255750041753367
ENSG00000126749,569.0,,,,6.345636360828596
ENSG00000019485,756.0,E-GEOD-31138,-3.3,'invasive ductal carcinoma' vs 'normal',6.6293632534374485
ENSG00000160948,5037.0,,,,8.524764456912555
ENSG00000104332,7091.0,E-GEOD-38959,-1.8,'breast cancer; breast' vs 'normal; breast',8.866722667194098
ENSG00000104332,7091.0,E-GEOD-54002,-5.9,'breast cancer' vs 'normal',8.866722667194098
ENSG00000104332,7091.0,E-GEOD-10780,-3.0,'breast carcinoma' vs 'normal',8.866722667194098
ENSG00000104332,7091.0,E-MTAB-779,-3.0,'breast carcinoma' vs 'normal',8.866722667194098
ENSG00000197386,4159.0,,,,8.333270353255308
ENSG00000104388,6081.0,,,,8.71308886823731
ENSG00000175893,1429.0,,,,7.265429723253953
ENSG00000112081,13079.0,,,,9.47883962501119
ENSG00000021645,101.0,E-GEOD-20086,1.4,'breast cancer' vs 'normal',4.624972813284271
ENSG00000100324,1475.0,,,,7.297091005160418
ENSG00000135372,2537.0,,,,7.839131648274333
ENSG00000135486,29612.0,,,,10.295968733085997
ENSG00000088305,144.0,,,,4.976733742420574
ENSG00000127824,1204.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',7.094234845924755
ENSG00000157106,7274.0,,,,8.892199092039693
ENSG00000143199,16.0,,,,2.833213344056216
ENSG00000183258,2687.0,,,,7.89655270164304
ENSG00000167105,12.0,,,,2.5649493574615367
ENSG00000100079,24.0,E-GEOD-44408,2.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.2188758248682006
ENSG00000169436,10.0,,,,2.3978952727983707
ENSG00000124164,2526.0,,,,7.834788107388194
ENSG00000145287,82.0,E-GEOD-44408,3.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.418840607796598
ENSG00000166557,1645.0,,,,7.406103381237015
ENSG00000119318,7006.0,,,,8.854664928370534
ENSG00000134644,5014.0,,,,8.520188700396035
ENSG00000221978,16184.0,,,,9.691840166360345
ENSG00000113810,756.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',6.6293632534374485
ENSG00000113810,756.0,E-GEOD-38959,2.0,'breast cancer; breast' vs 'normal; breast',6.6293632534374485
ENSG00000047457,412.0,E-GEOD-31138,2.1,'invasive ductal carcinoma' vs 'normal',6.023447592961033
ENSG00000047457,412.0,E-GEOD-38959,2.1,'breast cancer; breast' vs 'normal; breast',6.023447592961033
ENSG00000184916,2248.0,,,,7.718240951959316
ENSG00000116014,2.0,,,,1.0986122886681098
ENSG00000134256,38.0,,,,3.6635616461296463
ENSG00000180176,2.0,,,,1.0986122886681098
ENSG00000140905,736.0,,,,6.602587892189336
ENSG00000160789,19057.0,,,,9.855242239908133
ENSG00000112249,1560.0,,,,7.353081920515432
ENSG00000278705,1.0,E-GEOD-52194,9.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000278705,1.0,E-GEOD-52194,8.7,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000278705,1.0,E-GEOD-52194,8.0,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000137101,193.0,E-GEOD-44408,2.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.267858159063328
ENSG00000243649,282.0,,,,5.645446897643238
ENSG00000184640,9525.0,,,,9.161780181360806
ENSG00000244405,812.0,E-GEOD-54002,-1.9,'breast cancer' vs 'normal',6.70073110954781
ENSG00000147123,1915.0,,,,7.557994958530806
ENSG00000118245,3.0,,,,1.3862943611198906
ENSG00000095321,2872.0,,,,7.96311205897929
ENSG00000167588,13608.0,E-MTAB-779,-2.8,'breast carcinoma' vs 'normal',9.518486617560317
ENSG00000167588,13608.0,E-GEOD-10780,-1.8,'breast carcinoma' vs 'normal',9.518486617560317
ENSG00000130592,2857.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.957877358489813
ENSG00000146670,57.0,E-GEOD-54002,1.6,'breast cancer' vs 'normal',4.060443010546419
ENSG00000146670,57.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',4.060443010546419
ENSG00000146670,57.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',4.060443010546419
ENSG00000146670,57.0,E-GEOD-38959,1.6,'breast cancer; breast' vs 'normal; breast',4.060443010546419
ENSG00000134882,2397.0,,,,7.7823903355874595
ENSG00000110375,4.0,,,,1.6094379124341003
ENSG00000173467,47.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',3.871201010907891
ENSG00000173467,47.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',3.871201010907891
ENSG00000173467,47.0,E-MTAB-779,2.0,'breast carcinoma' vs 'normal',3.871201010907891
ENSG00000163131,1657.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.4133673356952405
ENSG00000118523,11187.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',9.32259705432185
ENSG00000148346,170.0,,,,5.14166355650266
ENSG00000172071,1132.0,,,,7.0326242610280065
ENSG00000062725,2089.0,,,,7.644919344958857
ENSG00000197451,3602.0,,,,8.189522110748094
ENSG00000138650,16.0,,,,2.833213344056216
ENSG00000063046,19695.0,,,,9.888170848424235
ENSG00000127955,1930.0,E-GEOD-54002,-2.6,'breast cancer' vs 'normal',7.565793282428515
ENSG00000127955,1930.0,E-GEOD-10780,-1.7,'breast carcinoma' vs 'normal',7.565793282428515
ENSG00000100060,1017.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.925595197110468
ENSG00000164466,905.0,,,,6.80903930604298
ENSG00000105229,1052.0,,,,6.959398512133975
ENSG00000131016,8796.0,E-GEOD-10780,-1.8,'breast carcinoma' vs 'normal',9.082166033252674
ENSG00000131016,8796.0,E-MTAB-779,-2.3,'breast carcinoma' vs 'normal',9.082166033252674
ENSG00000181019,1947.0,E-GEOD-7377,2.7,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.5745584842024805
ENSG00000181019,1947.0,E-GEOD-44408,-3.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.5745584842024805
ENSG00000180871,30.0,E-GEOD-44408,1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.4339872044851463
ENSG00000078808,6085.0,,,,8.713746330456916
ENSG00000111674,1460.0,,,,7.2868764117507
ENSG00000172020,10.0,,,,2.3978952727983707
ENSG00000155093,348.0,,,,5.855071922202427
ENSG00000104951,30.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',3.4339872044851463
ENSG00000104951,30.0,E-GEOD-38959,1.6,'breast cancer; breast' vs 'normal; breast',3.4339872044851463
ENSG00000133636,3.0,,,,1.3862943611198906
ENSG00000100298,17.0,,,,2.8903717578961645
ENSG00000118194,105.0,,,,4.663439094112067
ENSG00000159399,2826.0,,,,7.946971357693591
ENSG00000079263,69.0,E-GEOD-44408,2.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.248495242049359
ENSG00000005339,6657.0,,,,8.80357441813497
ENSG00000172349,1884.0,E-GEOD-44408,2.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.541683099882111
ENSG00000151239,2338.0,E-GEOD-44408,-1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.757478766584179
ENSG00000151239,2338.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.757478766584179
ENSG00000164430,204.0,E-GEOD-38959,1.6,'breast cancer; breast' vs 'normal; breast',5.3230099791384085
ENSG00000170906,1118.0,,,,7.020190708311925
ENSG00000164867,1156.0,,,,7.053585727193677
ENSG00000204388,1313.0,E-GEOD-44408,-1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.1808311990445555
ENSG00000204388,1313.0,E-GEOD-52194,-5.5,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',7.1808311990445555
ENSG00000204388,1313.0,E-GEOD-31138,3.6,'invasive ductal carcinoma' vs 'normal',7.1808311990445555
ENSG00000204388,1313.0,E-GEOD-52194,-5.5,'triple-negative breast cancer; breast carcinoma' vs 'normal',7.1808311990445555
ENSG00000204388,1313.0,E-GEOD-52194,-5.2,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',7.1808311990445555
ENSG00000174482,2.0,,,,1.0986122886681098
ENSG00000065427,4939.0,,,,8.505120610181969
ENSG00000100292,884.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',6.785587645007929
ENSG00000049323,2227.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',7.708859601047175
ENSG00000165060,333.0,,,,5.811140992976701
ENSG00000178209,19571.0,,,,9.881855252409014
ENSG00000001617,2575.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.853993087224244
ENSG00000001617,2575.0,E-GEOD-44408,-1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.853993087224244
ENSG00000130287,1.0,,,,0.6931471805599453
ENSG00000124181,6715.0,,,,8.812248018197431
ENSG00000107159,7.0,,,,2.0794415416798357
ENSG00000096696,3951.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',8.281977058867758
ENSG00000096696,3951.0,E-GEOD-44408,-2.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.281977058867758
ENSG00000078140,2914.0,,,,7.977625098784593
ENSG00000185585,1931.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',7.566311014772463
ENSG00000185585,1931.0,E-GEOD-31138,2.8,'invasive ductal carcinoma' vs 'normal',7.566311014772463
ENSG00000148120,1188.0,,,,7.080867896690782
ENSG00000120251,32.0,,,,3.4965075614664802
ENSG00000088826,337.0,,,,5.823045895483019
ENSG00000101856,4739.0,,,,8.463792414689122
ENSG00000147647,15.0,,,,2.772588722239781
ENSG00000146469,62.0,E-GEOD-31138,-2.6,'invasive ductal carcinoma' vs 'normal',4.143134726391533
ENSG00000085465,276.0,,,,5.6240175061873385
ENSG00000101109,1674.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.423568444259167
ENSG00000001626,42.0,,,,3.7612001156935624
ENSG00000241058,591.0,,,,6.3835066348840055
ENSG00000151623,747.0,E-GEOD-54002,-3.5,'breast cancer' vs 'normal',6.617402977974478
ENSG00000151623,747.0,E-GEOD-10780,-1.8,'breast carcinoma' vs 'normal',6.617402977974478
ENSG00000197405,598.0,,,,6.395261598115449
ENSG00000115657,357.0,,,,5.8805329864007
ENSG00000169612,538.0,,,,6.289715570908998
ENSG00000196549,4933.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',8.503905297089302
ENSG00000196549,4933.0,E-MTAB-779,-1.8,'breast carcinoma' vs 'normal',8.503905297089302
ENSG00000196549,4933.0,E-GEOD-54002,-3.6,'breast cancer' vs 'normal',8.503905297089302
ENSG00000196549,4933.0,E-GEOD-10780,-1.8,'breast carcinoma' vs 'normal',8.503905297089302
ENSG00000095303,473.0,,,,6.161207321695077
ENSG00000168679,337.0,E-GEOD-54002,-1.9,'breast cancer' vs 'normal',5.823045895483019
ENSG00000123080,1358.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',7.214504414151143
ENSG00000123080,1358.0,E-MTAB-779,-1.7,'breast carcinoma' vs 'normal',7.214504414151143
ENSG00000123080,1358.0,E-GEOD-38959,1.7,'breast cancer; breast' vs 'normal; breast',7.214504414151143
ENSG00000123080,1358.0,E-GEOD-7377,-1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.214504414151143
ENSG00000164362,0.0,,,,0.0
ENSG00000086159,21.0,,,,3.091042453358316
ENSG00000163520,11101.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',9.314880551250107
ENSG00000028277,176.0,,,,5.176149732573829
ENSG00000099917,5647.0,,,,8.639056779173078
ENSG00000176788,829.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',6.721425700790643
ENSG00000166405,638.0,E-GEOD-38959,-2.4,'breast cancer; breast' vs 'normal; breast',6.459904454377535
ENSG00000163629,1606.0,,,,7.382124365737512
ENSG00000143184,7.0,,,,2.0794415416798357
ENSG00000123454,10.0,,,,2.3978952727983707
ENSG00000141101,1391.0,,,,7.238496840894365
ENSG00000139572,14.0,,,,2.70805020110221
ENSG00000138119,9883.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',9.1986725671085
ENSG00000138119,9883.0,E-GEOD-44408,-2.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.1986725671085
ENSG00000128655,110.0,,,,4.709530201312334
ENSG00000140678,590.0,,,,6.3818160174060985
ENSG00000108984,245.0,,,,5.5053315359323625
ENSG00000077009,8.0,,,,2.1972245773362196
ENSG00000197111,12438.0,,,,9.428591977209965
ENSG00000133422,1922.0,,,,7.56164174558878
ENSG00000187109,18216.0,,,,9.81011050303083
ENSG00000198053,4989.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',8.515191188745565
ENSG00000198053,4989.0,E-GEOD-7377,-1.6,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.515191188745565
ENSG00000143367,680.0,E-GEOD-44408,-3.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.523562306149512
ENSG00000161217,3766.0,,,,8.23403420769204
ENSG00000106348,3647.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.201934351194222
ENSG00000007350,14.0,,,,2.70805020110221
ENSG00000132356,5248.0,,,,8.5657928612523
ENSG00000184113,10180.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.228278517107196
ENSG00000184113,10180.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',9.228278517107196
ENSG00000184113,10180.0,E-MTAB-779,-2.7,'breast carcinoma' vs 'normal',9.228278517107196
ENSG00000100348,2663.0,,,,7.88758403166028
ENSG00000128965,37.0,,,,3.6375861597263857
ENSG00000122359,12543.0,,,,9.436997742590188
ENSG00000197702,5038.0,E-GEOD-44408,-1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.524962928680598
ENSG00000211445,103947.0,E-GEOD-10780,-1.6,'breast carcinoma' vs 'normal',11.551646053081827
ENSG00000211445,103947.0,E-MTAB-779,-1.9,'breast carcinoma' vs 'normal',11.551646053081827
ENSG00000078900,56.0,,,,4.04305126783455
ENSG00000140511,1413.0,,,,7.254177846456518
ENSG00000100325,3230.0,,,,8.080546965824498
ENSG00000128567,5272.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',8.57035473953047
ENSG00000137941,489.0,,,,6.194405391104672
ENSG00000156711,1685.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.430114138561801
ENSG00000101190,568.0,,,,6.343880434126331
ENSG00000116329,19.0,E-GEOD-52194,5.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',2.995732273553991
ENSG00000116329,19.0,E-GEOD-52194,5.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',2.995732273553991
ENSG00000172403,10667.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',9.275003885301905
ENSG00000172403,10667.0,E-GEOD-54002,-3.0,'breast cancer' vs 'normal',9.275003885301905
ENSG00000172403,10667.0,E-GEOD-10780,-2.0,'breast carcinoma' vs 'normal',9.275003885301905
ENSG00000171368,342.0,E-GEOD-54002,-2.2,'breast cancer' vs 'normal',5.8377304471659395
ENSG00000112419,1495.0,E-GEOD-7377,-1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.310550158534422
ENSG00000162231,7640.0,,,,8.941283763647567
ENSG00000175535,63.0,,,,4.1588830833596715
ENSG00000169564,6741.0,,,,8.816111895794005
ENSG00000160801,705.0,,,,6.559615237493242
ENSG00000165660,870.0,,,,6.769641976852503
ENSG00000105289,315.0,E-GEOD-44408,-1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.755742213586912
ENSG00000169967,3189.0,,,,8.06777619577889
ENSG00000146648,5853.0,E-GEOD-10780,-2.2,'breast carcinoma' vs 'normal',8.674880467251832
ENSG00000146648,5853.0,E-GEOD-36765,-1.7,'breast carcinoma' vs 'normal' in 'peripheral blood',8.674880467251832
ENSG00000159307,204.0,,,,5.3230099791384085
ENSG00000167757,42.0,,,,3.7612001156935624
ENSG00000182583,0.0,,,,0.0
ENSG00000111666,3825.0,,,,8.249575150000199
ENSG00000079308,33472.0,E-GEOD-10780,-1.9,'breast carcinoma' vs 'normal',10.41849442269534
ENSG00000168569,468.0,,,,6.150602768446279
ENSG00000184207,604.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',6.405228458030842
ENSG00000139687,2028.0,,,,7.615298339825815
ENSG00000084674,131.0,,,,4.882801922586371
ENSG00000174744,1440.0,,,,7.273092595999522
ENSG00000049541,767.0,,,,6.643789733147672
ENSG00000143556,3.0,,,,1.3862943611198906
ENSG00000181433,0.0,,,,0.0
ENSG00000113851,2376.0,,,,7.773594467360194
ENSG00000173372,1596.0,,,,7.3758821482150125
ENSG00000100983,1500.0,,,,7.313886831633462
ENSG00000100652,4.0,,,,1.6094379124341003
ENSG00000196136,169.0,E-GEOD-52194,-4.8,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',5.135798437050262
ENSG00000196136,169.0,E-GEOD-52194,-5.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',5.135798437050262
ENSG00000196136,169.0,E-GEOD-52194,-5.3,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',5.135798437050262
ENSG00000028528,7612.0,,,,8.937612591306213
ENSG00000131236,11770.0,,,,9.37339415841248
ENSG00000101439,19223.0,,,,9.863914777416305
ENSG00000107611,332.0,,,,5.808142489980444
ENSG00000152700,2641.0,E-GEOD-31138,1.8,'invasive ductal carcinoma' vs 'normal',7.879291485082271
ENSG00000175634,1849.0,,,,7.52294091807237
ENSG00000167037,156.0,,,,5.056245805348308
ENSG00000105197,1810.0,,,,7.501634457883413
ENSG00000108771,845.0,,,,6.740519359606223
ENSG00000198400,42.0,,,,3.7612001156935624
ENSG00000047365,441.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.091309882077698
ENSG00000163631,108.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',4.6913478822291435
ENSG00000163631,108.0,E-GEOD-54002,-3.2,'breast cancer' vs 'normal',4.6913478822291435
ENSG00000115392,541.0,,,,6.295266001439646
ENSG00000111726,1257.0,,,,7.1372784372603855
ENSG00000183765,283.0,,,,5.648974238161206
ENSG00000168496,358.0,E-GEOD-31138,2.3,'invasive ductal carcinoma' vs 'normal',5.883322388488279
ENSG00000111596,3179.0,,,,8.064636475774222
ENSG00000164924,18637.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',9.8329577863456
ENSG00000127951,2305.0,E-GEOD-44408,1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.743269700829004
ENSG00000121989,936.0,,,,6.842683282238422
ENSG00000105379,1799.0,,,,7.495541943884256
ENSG00000164588,7.0,,,,2.0794415416798357
ENSG00000108819,2821.0,,,,7.945201132412759
ENSG00000169169,214.0,,,,5.3706380281276624
ENSG00000173369,2282.0,,,,7.733245646529795
ENSG00000019991,636.0,E-GEOD-31138,-2.2,'invasive ductal carcinoma' vs 'normal',6.456769655572163
ENSG00000144468,1132.0,,,,7.0326242610280065
ENSG00000216490,57.0,,,,4.060443010546419
ENSG00000107581,11782.0,,,,9.37441309371334
ENSG00000166263,480.0,,,,6.175867270105761
ENSG00000173110,185.0,,,,5.225746673713202
ENSG00000177283,433.0,,,,6.073044534100405
ENSG00000155760,1401.0,E-GEOD-54002,-2.7,'breast cancer' vs 'normal',7.2456550675945355
ENSG00000155760,1401.0,E-GEOD-10780,-1.5,'breast carcinoma' vs 'normal',7.2456550675945355
ENSG00000049192,127.0,,,,4.852030263919617
ENSG00000113790,314.0,,,,5.752572638825633
ENSG00000168398,521.0,,,,6.257667587882639
ENSG00000108312,4623.0,,,,8.439015410352214
ENSG00000127603,12995.0,,,,9.472396896788991
ENSG00000124126,3488.0,E-GEOD-7377,1.6,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.157370441186774
ENSG00000164107,323.0,,,,5.780743515792329
ENSG00000135476,78.0,E-GEOD-54002,1.9,'breast cancer' vs 'normal',4.3694478524670215
ENSG00000179909,304.0,E-GEOD-38959,-2.0,'breast cancer; breast' vs 'normal; breast',5.720311776607412
ENSG00000125952,3124.0,,,,8.047189562170502
ENSG00000159339,22.0,,,,3.1354942159291497
ENSG00000189159,638.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',6.459904454377535
ENSG00000189159,638.0,E-GEOD-54002,2.3,'breast cancer' vs 'normal',6.459904454377535
ENSG00000189159,638.0,E-GEOD-10780,1.8,'breast carcinoma' vs 'normal',6.459904454377535
ENSG00000189159,638.0,E-GEOD-38959,2.2,'breast cancer; breast' vs 'normal; breast',6.459904454377535
ENSG00000025434,3238.0,,,,8.08301991917133
ENSG00000175806,801.0,,,,6.687108607866515
ENSG00000156026,990.0,,,,6.898714534329988
ENSG00000120798,1678.0,,,,7.425953657077541
ENSG00000078725,33.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',3.5263605246161616
ENSG00000078725,33.0,E-GEOD-20086,-1.1,'breast cancer' vs 'normal',3.5263605246161616
ENSG00000078725,33.0,E-GEOD-52194,-5.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',3.5263605246161616
ENSG00000189067,6960.0,,,,8.848078421168667
ENSG00000025156,792.0,,,,6.675823221634848
ENSG00000171551,62.0,E-GEOD-52194,-5.1,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',4.143134726391533
ENSG00000105393,1278.0,,,,7.153833801578843
ENSG00000104290,369.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',5.91350300563827
ENSG00000136960,6237.0,E-MTAB-779,-1.9,'breast carcinoma' vs 'normal',8.738414897167749
ENSG00000136960,6237.0,E-GEOD-44408,2.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.738414897167749
ENSG00000136960,6237.0,E-GEOD-10780,-1.9,'breast carcinoma' vs 'normal',8.738414897167749
ENSG00000136960,6237.0,E-GEOD-7377,-1.7,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.738414897167749
ENSG00000129083,5203.0,,,,8.557182839632397
ENSG00000167642,2341.0,E-GEOD-44408,-1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.758760544157663
ENSG00000167642,2341.0,E-MTAB-779,1.7,'breast carcinoma' vs 'normal',7.758760544157663
ENSG00000167642,2341.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.758760544157663
ENSG00000141424,3289.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',8.098642843759418
ENSG00000141424,3289.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',8.098642843759418
ENSG00000141424,3289.0,E-GEOD-44408,-1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.098642843759418
ENSG00000141424,3289.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.098642843759418
ENSG00000141424,3289.0,E-GEOD-31138,2.9,'invasive ductal carcinoma' vs 'normal',8.098642843759418
ENSG00000156515,5673.0,,,,8.643649615368796
ENSG00000180644,222.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.407171771460119
ENSG00000102001,78.0,,,,4.3694478524670215
ENSG00000163132,515.0,,,,6.246106765481563
ENSG00000196937,2139.0,E-GEOD-31138,1.9,'invasive ductal carcinoma' vs 'normal',7.668561108015897
ENSG00000139318,2895.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',7.971085753505607
ENSG00000139318,2895.0,E-GEOD-54002,-2.0,'breast cancer' vs 'normal',7.971085753505607
ENSG00000139318,2895.0,E-GEOD-10780,-1.5,'breast carcinoma' vs 'normal',7.971085753505607
ENSG00000107263,5393.0,,,,8.593042503699674
ENSG00000131018,5626.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.635331719433278
ENSG00000110422,9829.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.193194213141211
ENSG00000115252,316.0,E-GEOD-20086,-2.3,'breast cancer' vs 'normal',5.75890177387728
ENSG00000164032,3199.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',8.070906088787819
ENSG00000164032,3199.0,E-GEOD-38959,1.7,'breast cancer; breast' vs 'normal; breast',8.070906088787819
ENSG00000164032,3199.0,E-GEOD-31138,4.8,'invasive ductal carcinoma' vs 'normal',8.070906088787819
ENSG00000102572,3062.0,,,,8.027150106832774
ENSG00000107731,384.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',5.953243334287785
ENSG00000106819,371.0,E-GEOD-31138,2.5,'invasive ductal carcinoma' vs 'normal',5.918893854273146
ENSG00000106819,371.0,E-GEOD-10780,1.4,'breast carcinoma' vs 'normal',5.918893854273146
ENSG00000106819,371.0,E-GEOD-44408,-2.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.918893854273146
ENSG00000106819,371.0,E-GEOD-54002,4.4,'breast cancer' vs 'normal',5.918893854273146
ENSG00000107771,2208.0,,,,7.700295203420117
ENSG00000166147,7107.0,E-GEOD-54002,2.1,'breast cancer' vs 'normal',8.868976189274543
ENSG00000070404,3478.0,,,,8.154500175151941
ENSG00000145632,2617.0,E-GEOD-31138,2.9,'invasive ductal carcinoma' vs 'normal',7.870165946469845
ENSG00000145632,2617.0,E-GEOD-38959,-1.9,'breast cancer; breast' vs 'normal; breast',7.870165946469845
ENSG00000085978,1762.0,,,,7.47477218239787
ENSG00000095970,67.0,E-GEOD-44408,-1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.219507705176107
ENSG00000100033,308.0,,,,5.733341276897746
ENSG00000115414,14927.0,E-GEOD-44408,-2.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.610993923087126
ENSG00000115414,14927.0,E-GEOD-54002,5.0,'breast cancer' vs 'normal',9.610993923087126
ENSG00000115414,14927.0,E-GEOD-10780,1.9,'breast carcinoma' vs 'normal',9.610993923087126
ENSG00000115414,14927.0,E-MTAB-779,2.3,'breast carcinoma' vs 'normal',9.610993923087126
ENSG00000115414,14927.0,E-GEOD-31138,4.9,'invasive ductal carcinoma' vs 'normal',9.610993923087126
ENSG00000115414,14927.0,E-GEOD-38959,3.8,'breast cancer; breast' vs 'normal; breast',9.610993923087126
ENSG00000167085,2733.0,,,,7.913521017283895
ENSG00000129991,9.0,,,,2.302585092994046
ENSG00000160877,1195.0,,,,7.086737934510577
ENSG00000144713,33470.0,,,,10.41843467126129
ENSG00000004975,1876.0,,,,7.537430036586509
ENSG00000150990,1409.0,,,,7.251344983372214
ENSG00000163993,36.0,E-MTAB-779,1.8,'breast carcinoma' vs 'normal',3.6109179126442243
ENSG00000163993,36.0,E-GEOD-54002,3.8,'breast cancer' vs 'normal',3.6109179126442243
ENSG00000163993,36.0,E-GEOD-10780,3.1,'breast carcinoma' vs 'normal',3.6109179126442243
ENSG00000163993,36.0,E-GEOD-38959,3.3,'breast cancer; breast' vs 'normal; breast',3.6109179126442243
ENSG00000109654,1219.0,E-MTAB-779,-1.7,'breast carcinoma' vs 'normal',7.106606137727303
ENSG00000109654,1219.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',7.106606137727303
ENSG00000109654,1219.0,E-GEOD-54002,-2.8,'breast cancer' vs 'normal',7.106606137727303
ENSG00000109654,1219.0,E-GEOD-7377,-1.8,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.106606137727303
ENSG00000132305,3375.0,,,,8.124446855715847
ENSG00000170004,7299.0,,,,8.895629627136483
ENSG00000145386,123.0,E-GEOD-54002,1.7,'breast cancer' vs 'normal',4.820281565605037
ENSG00000145386,123.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',4.820281565605037
ENSG00000145386,123.0,E-GEOD-38959,2.1,'breast cancer; breast' vs 'normal; breast',4.820281565605037
ENSG00000129219,2314.0,,,,7.747164966520335
ENSG00000118263,3350.0,,,,8.11701408773731
ENSG00000124469,10.0,,,,2.3978952727983707
ENSG00000149489,236.0,,,,5.4680601411351315
ENSG00000141522,9154.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',9.122055457108612
ENSG00000088538,73.0,,,,4.30406509320417
ENSG00000109685,2292.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',7.737616282857904
ENSG00000115524,24951.0,,,,10.12470925828764
ENSG00000126353,182.0,E-GEOD-44408,2.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.209486152841421
ENSG00000188846,22925.0,,,,10.040026916674956
ENSG00000165629,4217.0,E-GEOD-31138,2.5,'invasive ductal carcinoma' vs 'normal',8.34711636103872
ENSG00000139193,40.0,E-GEOD-44408,2.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.713572066704308
ENSG00000088053,21.0,,,,3.091042453358316
ENSG00000112414,349.0,,,,5.857933154483459
ENSG00000048162,630.0,,,,6.447305862541213
ENSG00000120093,2310.0,E-GEOD-38959,-1.3,'breast cancer; breast' vs 'normal; breast',7.745435610274381
ENSG00000120093,2310.0,E-GEOD-7377,1.8,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.745435610274381
ENSG00000088756,382.0,,,,5.948034989180646
ENSG00000099326,2081.0,,,,7.641084249174914
ENSG00000144381,7826.0,,,,8.965334573804839
ENSG00000043514,879.0,,,,6.779921907472252
ENSG00000158062,1823.0,,,,7.508787170634276
ENSG00000168264,6257.0,,,,8.741615924228828
ENSG00000112697,6157.0,,,,8.725507328484445
ENSG00000048649,2329.0,,,,7.753623546559746
ENSG00000143627,2.0,,,,1.0986122886681098
ENSG00000160182,5.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',1.791759469228055
ENSG00000160182,5.0,E-MTAB-779,3.2,'breast carcinoma' vs 'normal',1.791759469228055
ENSG00000160182,5.0,E-GEOD-38959,-2.0,'breast cancer; breast' vs 'normal; breast',1.791759469228055
ENSG00000160182,5.0,E-GEOD-52194,-6.8,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.791759469228055
ENSG00000160182,5.0,E-GEOD-7377,2.0,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',1.791759469228055
ENSG00000160182,5.0,E-GEOD-44408,-5.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',1.791759469228055
ENSG00000023516,2925.0,,,,7.98139158158007
ENSG00000136986,3046.0,,,,8.021912778985708
ENSG00000181322,50.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',3.9318256327243257
ENSG00000115561,3659.0,E-GEOD-31138,2.7,'invasive ductal carcinoma' vs 'normal',8.205218426395412
ENSG00000184470,1250.0,,,,7.1316985104669115
ENSG00000205277,7.0,,,,2.0794415416798357
ENSG00000111348,6137.0,E-GEOD-20086,1.1,'breast cancer' vs 'normal',8.722254235179681
ENSG00000107105,7.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',2.0794415416798357
ENSG00000164022,2079.0,E-GEOD-38959,-1.4,'breast cancer; breast' vs 'normal; breast',7.640123172695364
ENSG00000167419,11.0,,,,2.4849066497880004
ENSG00000138035,1207.0,,,,7.0967213784947605
ENSG00000078081,23.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',3.1780538303479458
ENSG00000078081,23.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',3.1780538303479458
ENSG00000078081,23.0,E-GEOD-44408,2.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.1780538303479458
ENSG00000087502,1194.0,E-GEOD-31138,2.1,'invasive ductal carcinoma' vs 'normal',7.085901464365611
ENSG00000114054,877.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.777646593635117
ENSG00000214253,3794.0,,,,8.24143968982973
ENSG00000189221,7153.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',8.875426919818963
ENSG00000189221,7153.0,E-GEOD-54002,-2.2,'breast cancer' vs 'normal',8.875426919818963
ENSG00000189221,7153.0,E-MTAB-779,-2.2,'breast carcinoma' vs 'normal',8.875426919818963
ENSG00000189221,7153.0,E-GEOD-10780,-1.8,'breast carcinoma' vs 'normal',8.875426919818963
ENSG00000167306,341.0,,,,5.834810737062605
ENSG00000174021,2655.0,E-GEOD-52194,-4.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',7.884576510596324
ENSG00000117614,3047.0,,,,8.022240916806537
ENSG00000204472,460.0,,,,6.133398042996649
ENSG00000049283,109.0,,,,4.700480365792417
ENSG00000133392,10907.0,E-MTAB-779,-1.9,'breast carcinoma' vs 'normal',9.297251743965479
ENSG00000133392,10907.0,E-GEOD-54002,-3.7,'breast cancer' vs 'normal',9.297251743965479
ENSG00000133392,10907.0,E-GEOD-20086,2.1,'breast cancer' vs 'normal',9.297251743965479
ENSG00000133392,10907.0,E-GEOD-10780,-2.1,'breast carcinoma' vs 'normal',9.297251743965479
ENSG00000133392,10907.0,E-GEOD-38959,-2.6,'breast cancer; breast' vs 'normal; breast',9.297251743965479
ENSG00000171345,5971.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',8.69483715865908
ENSG00000171345,5971.0,E-GEOD-44408,-6.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.69483715865908
ENSG00000181163,17487.0,,,,9.76927021041632
ENSG00000153922,2936.0,,,,7.98514393119862
ENSG00000105928,614.0,,,,6.421622267806518
ENSG00000158092,1929.0,,,,7.5652752818989315
ENSG00000107404,3364.0,,,,8.121183242078828
ENSG00000116675,151.0,,,,5.0238805208462765
ENSG00000132388,2370.0,E-GEOD-7377,1.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.771067086065406
ENSG00000213585,4719.0,E-GEOD-31138,3.4,'invasive ductal carcinoma' vs 'normal',8.459564078579602
ENSG00000090861,5173.0,,,,8.551401362745974
ENSG00000104689,489.0,,,,6.194405391104672
ENSG00000163704,165.0,,,,5.111987788356544
ENSG00000101425,22.0,,,,3.1354942159291497
ENSG00000015413,18.0,,,,2.9444389791664403
ENSG00000167815,4076.0,,,,8.313116702819253
ENSG00000127528,4956.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.508555998020574
ENSG00000205189,1423.0,,,,7.261225091971921
ENSG00000059758,2431.0,,,,7.796469243086058
ENSG00000011454,3508.0,,,,8.163086375583216
ENSG00000008086,850.0,,,,6.7464121285733745
ENSG00000124571,1776.0,,,,7.482681828154651
ENSG00000169756,3114.0,,,,8.043984431221553
ENSG00000198125,314.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',5.752572638825633
ENSG00000198125,314.0,E-GEOD-44408,-2.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.752572638825633
ENSG00000198910,197.0,,,,5.288267030694535
ENSG00000121579,4583.0,,,,8.430327258394575
ENSG00000113649,4180.0,,,,8.338305731356565
ENSG00000198938,375731.0,,,,12.836631402276161
ENSG00000182566,61.0,,,,4.127134385045092
ENSG00000139405,503.0,,,,6.222576268071369
ENSG00000155097,2684.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',7.895436006942965
ENSG00000006210,5449.0,E-MTAB-779,-1.9,'breast carcinoma' vs 'normal',8.60337088765729
ENSG00000006210,5449.0,E-GEOD-54002,-3.6,'breast cancer' vs 'normal',8.60337088765729
ENSG00000006210,5449.0,E-GEOD-10780,-2.2,'breast carcinoma' vs 'normal',8.60337088765729
ENSG00000006210,5449.0,E-GEOD-38959,-2.1,'breast cancer; breast' vs 'normal; breast',8.60337088765729
ENSG00000006210,5449.0,E-GEOD-52194,-6.1,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',8.60337088765729
ENSG00000103485,190.0,,,,5.25227342804663
ENSG00000128641,3981.0,,,,8.289539484624141
ENSG00000063978,3064.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',8.027802848370312
ENSG00000172543,81.0,,,,4.406719247264253
ENSG00000179776,5523.0,,,,8.616857514529183
ENSG00000197153,0.0,E-GEOD-52194,5.9,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000197153,0.0,E-GEOD-52194,7.6,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',0.0
ENSG00000197153,0.0,E-GEOD-52194,6.0,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000147065,19340.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.86998247397873
ENSG00000147065,19340.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',9.86998247397873
ENSG00000131686,4.0,E-GEOD-52194,-5.0,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',1.6094379124341003
ENSG00000131686,4.0,E-GEOD-7377,-1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',1.6094379124341003
ENSG00000163395,118.0,,,,4.77912349311153
ENSG00000108854,1545.0,,,,7.343426229147367
ENSG00000094804,58.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',4.07753744390572
ENSG00000164916,2027.0,,,,7.614805364711073
ENSG00000113100,0.0,,,,0.0
ENSG00000259494,471.0,,,,6.156978985585555
ENSG00000171236,292.0,E-MTAB-779,1.7,'breast carcinoma' vs 'normal',5.680172609017068
ENSG00000132510,2988.0,E-GEOD-52194,-5.8,'triple-negative breast cancer; breast carcinoma' vs 'normal',8.002694162283937
ENSG00000132510,2988.0,E-GEOD-52194,-5.0,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',8.002694162283937
ENSG00000165671,3046.0,,,,8.021912778985708
ENSG00000196976,313.0,E-GEOD-54002,1.4,'breast cancer' vs 'normal',5.749392985908253
ENSG00000196976,313.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',5.749392985908253
ENSG00000196976,313.0,E-GEOD-38959,1.6,'breast cancer; breast' vs 'normal; breast',5.749392985908253
ENSG00000115053,18874.0,,,,9.845593574117226
ENSG00000131069,4666.0,,,,8.448271745949816
ENSG00000139921,1553.0,E-GEOD-7377,1.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.348587530927593
ENSG00000139921,1553.0,E-GEOD-31138,3.6,'invasive ductal carcinoma' vs 'normal',7.348587530927593
ENSG00000112210,257.0,,,,5.552959584921617
ENSG00000171155,780.0,E-GEOD-31138,2.2,'invasive ductal carcinoma' vs 'normal',6.660575149839686
ENSG00000129474,615.0,,,,6.423246963533519
ENSG00000125730,33002.0,,,,10.404353745407546
ENSG00000156011,474.0,E-GEOD-31138,1.9,'invasive ductal carcinoma' vs 'normal',6.163314804034641
ENSG00000165795,12322.0,E-GEOD-38959,-1.5,'breast cancer; breast' vs 'normal; breast',9.419222713938122
ENSG00000165795,12322.0,E-GEOD-54002,-3.4,'breast cancer' vs 'normal',9.419222713938122
ENSG00000165795,12322.0,E-GEOD-10780,-1.8,'breast carcinoma' vs 'normal',9.419222713938122
ENSG00000165795,12322.0,E-MTAB-779,-2.1,'breast carcinoma' vs 'normal',9.419222713938122
ENSG00000165795,12322.0,E-GEOD-7377,-1.9,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',9.419222713938122
ENSG00000141642,254.0,,,,5.541263545158426
ENSG00000171604,1618.0,,,,7.389563953677635
ENSG00000101444,3262.0,,,,8.09040229659332
ENSG00000167635,2840.0,,,,7.951911381854188
ENSG00000101349,20.0,,,,3.044522437723423
ENSG00000120899,1764.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.475905969367397
ENSG00000075856,2696.0,,,,7.89989532313973
ENSG00000109118,3212.0,,,,8.074960359115858
ENSG00000091436,5540.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',8.61993026886735
ENSG00000091436,5540.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',8.61993026886735
ENSG00000124939,35.0,E-GEOD-54002,-2.7,'breast cancer' vs 'normal',3.58351893845611
ENSG00000124939,35.0,E-GEOD-68086,-4.8,'breast carcinoma' vs 'normal',3.58351893845611
ENSG00000077097,5983.0,,,,8.696844519654313
ENSG00000128617,88.0,,,,4.48863636973214
ENSG00000102003,120.0,,,,4.795790545596741
ENSG00000102024,2904.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',7.974188669286011
ENSG00000122254,119.0,,,,4.787491742782046
ENSG00000115828,194.0,E-GEOD-38959,1.8,'breast cancer; breast' vs 'normal; breast',5.272999558563747
ENSG00000181852,2017.0,,,,7.609862200913554
ENSG00000122122,371.0,,,,5.918893854273146
ENSG00000124731,45.0,,,,3.828641396489095
ENSG00000163421,11.0,,,,2.4849066497880004
ENSG00000147872,24914.0,,,,10.123225310715505
ENSG00000123505,2739.0,,,,7.9157131993821155
ENSG00000152977,9.0,E-GEOD-38959,2.3,'breast cancer; breast' vs 'normal; breast',2.302585092994046
ENSG00000168763,1272.0,,,,7.149131598557407
ENSG00000197238,6.0,,,,1.9459101490553132
ENSG00000120215,31.0,,,,3.4657359027997265
ENSG00000166426,34.0,,,,3.5553480614894135
ENSG00000188976,3076.0,,,,8.031710375322042
ENSG00000138160,90.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',4.51085950651685
ENSG00000138160,90.0,E-GEOD-54002,2.2,'breast cancer' vs 'normal',4.51085950651685
ENSG00000138160,90.0,E-GEOD-10780,1.7,'breast carcinoma' vs 'normal',4.51085950651685
ENSG00000006831,5582.0,,,,8.62748154531036
ENSG00000115350,1412.0,,,,7.253470382684528
ENSG00000135821,66542.0,,,,11.105603634218898
ENSG00000144357,2995.0,,,,8.005033344637111
ENSG00000158516,37.0,,,,3.6375861597263857
ENSG00000145391,5264.0,,,,8.568836424568076
ENSG00000171109,2230.0,,,,7.7102051944325325
ENSG00000088888,6085.0,,,,8.713746330456916
ENSG00000168090,3257.0,,,,8.08886878916199
ENSG00000188486,388.0,E-GEOD-54002,1.7,'breast cancer' vs 'normal',5.963579343618446
ENSG00000188486,388.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',5.963579343618446
ENSG00000188486,388.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',5.963579343618446
ENSG00000188486,388.0,E-MTAB-779,2.1,'breast carcinoma' vs 'normal',5.963579343618446
ENSG00000147862,6624.0,E-GEOD-54002,-2.6,'breast cancer' vs 'normal',8.798605650854423
ENSG00000147862,6624.0,E-GEOD-10780,-1.6,'breast carcinoma' vs 'normal',8.798605650854423
ENSG00000130770,1573.0,,,,7.3613754289773485
ENSG00000182185,238.0,E-GEOD-7377,1.7,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',5.476463551931511
ENSG00000204310,2154.0,,,,7.675546002537848
ENSG00000204227,2302.0,,,,7.741967899820685
ENSG00000080493,126.0,,,,4.844187086458591
ENSG00000154188,550.0,E-MTAB-779,-1.9,'breast carcinoma' vs 'normal',6.311734809152915
ENSG00000154188,550.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',6.311734809152915
ENSG00000133216,170.0,,,,5.14166355650266
ENSG00000175832,84.0,,,,4.442651256490317
ENSG00000153201,4848.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',8.486527777105353
ENSG00000087253,1545.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',7.343426229147367
ENSG00000087253,1545.0,E-GEOD-54002,-2.5,'breast cancer' vs 'normal',7.343426229147367
ENSG00000087253,1545.0,E-GEOD-20086,1.1,'breast cancer' vs 'normal',7.343426229147367
ENSG00000087253,1545.0,E-GEOD-38959,-1.5,'breast cancer; breast' vs 'normal; breast',7.343426229147367
ENSG00000127870,1325.0,E-GEOD-31138,3.2,'invasive ductal carcinoma' vs 'normal',7.189922170745808
ENSG00000134108,3914.0,,,,8.272570608424903
ENSG00000145113,76.0,E-GEOD-52194,-5.1,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',4.343805421853684
ENSG00000145113,76.0,E-GEOD-68086,-5.0,'breast carcinoma' vs 'normal',4.343805421853684
ENSG00000114638,8.0,E-GEOD-52194,4.8,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',2.1972245773362196
ENSG00000005961,92.0,,,,4.532599493153256
ENSG00000125817,3705.0,,,,8.217708406845306
ENSG00000136634,39.0,,,,3.6888794541139363
ENSG00000158445,569.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',6.345636360828596
ENSG00000060339,3823.0,,,,8.249052274171293
ENSG00000101846,1319.0,,,,7.1853870155804165
ENSG00000178922,954.0,,,,6.86171134048073
ENSG00000198830,11161.0,,,,9.320270431348378
ENSG00000152127,1471.0,,,,7.294377299288821
ENSG00000159259,286.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',5.659482215759621
ENSG00000105639,933.0,,,,6.839476438228843
ENSG00000001084,1696.0,E-GEOD-7377,1.4,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.436617265234227
ENSG00000100003,574.0,,,,6.354370040797351
ENSG00000170955,1751.0,,,,7.468513271496337
ENSG00000188611,65.0,E-GEOD-68086,-5.8,'breast carcinoma' vs 'normal',4.189654742026425
ENSG00000080007,80.0,,,,4.394449154672439
ENSG00000164919,3029.0,E-GEOD-44408,-1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.016317898503415
ENSG00000164919,3029.0,E-GEOD-54002,1.6,'breast cancer' vs 'normal',8.016317898503415
ENSG00000164919,3029.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',8.016317898503415
ENSG00000164919,3029.0,E-MTAB-779,1.9,'breast carcinoma' vs 'normal',8.016317898503415
ENSG00000164919,3029.0,E-GEOD-31138,3.2,'invasive ductal carcinoma' vs 'normal',8.016317898503415
ENSG00000120733,4795.0,,,,8.475537516147405
ENSG00000176697,23.0,,,,3.1780538303479458
ENSG00000148344,1023.0,,,,6.931471805599453
ENSG00000102189,2127.0,,,,7.662937850461535
ENSG00000172179,25.0,,,,3.258096538021482
ENSG00000100307,3537.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',8.17131687471973
ENSG00000100307,3537.0,E-GEOD-31138,-2.0,'invasive ductal carcinoma' vs 'normal',8.17131687471973
ENSG00000100307,3537.0,E-GEOD-44408,1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.17131687471973
ENSG00000100307,3537.0,E-GEOD-54002,-1.9,'breast cancer' vs 'normal',8.17131687471973
ENSG00000100307,3537.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',8.17131687471973
ENSG00000100307,3537.0,E-GEOD-38959,-1.9,'breast cancer; breast' vs 'normal; breast',8.17131687471973
ENSG00000067177,807.0,,,,6.694562058521095
ENSG00000116062,1858.0,,,,7.527793987721444
ENSG00000085662,2937.0,,,,7.9854843567338225
ENSG00000182541,3775.0,,,,8.236420527265391
ENSG00000159459,2087.0,,,,7.643961949002529
ENSG00000156831,679.0,,,,6.522092798170152
ENSG00000124216,512.0,E-GEOD-52194,-5.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',6.240275845170769
ENSG00000198563,14031.0,,,,9.549095714611964
ENSG00000000971,5479.0,E-MTAB-779,-1.9,'breast carcinoma' vs 'normal',8.608860379942062
ENSG00000000971,5479.0,E-GEOD-10780,-1.5,'breast carcinoma' vs 'normal',8.608860379942062
ENSG00000067560,26144.0,,,,10.171413246622231
ENSG00000205323,96.0,,,,4.574710978503383
ENSG00000100299,2640.0,,,,7.878912912297133
ENSG00000197122,1469.0,,,,7.293017679772782
ENSG00000143632,338.0,,,,5.82600010738045
ENSG00000101445,1170.0,E-GEOD-44408,2.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.065613363597717
ENSG00000166326,4971.0,,,,8.511577452630602
ENSG00000188404,173.0,E-GEOD-44408,2.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.159055299214529
ENSG00000073060,5488.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',8.610501368549889
ENSG00000160469,134.0,,,,4.90527477843843
ENSG00000182916,183.0,E-GEOD-54002,-3.6,'breast cancer' vs 'normal',5.214935757608986
ENSG00000182916,183.0,E-GEOD-10780,-1.8,'breast carcinoma' vs 'normal',5.214935757608986
ENSG00000167965,1297.0,,,,7.168579897264035
ENSG00000126953,190.0,,,,5.25227342804663
ENSG00000089057,2090.0,,,,7.645397699428633
ENSG00000067704,4553.0,E-GEOD-31138,3.0,'invasive ductal carcinoma' vs 'normal',8.423761246623686
ENSG00000056972,1926.0,,,,7.563719668414366
ENSG00000143727,2481.0,,,,7.8168199657645525
ENSG00000175582,4832.0,,,,8.483222671845084
ENSG00000105675,7.0,,,,2.0794415416798357
ENSG00000164318,1692.0,E-MTAB-779,-1.8,'breast carcinoma' vs 'normal',7.4342573821331355
ENSG00000164342,295.0,,,,5.69035945432406
ENSG00000139629,706.0,E-GEOD-44408,-1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.561030665896573
ENSG00000139629,706.0,E-GEOD-10780,1.6,'breast carcinoma' vs 'normal',6.561030665896573
ENSG00000153044,152.0,,,,5.030437921392435
ENSG00000091651,129.0,E-GEOD-54002,1.6,'breast cancer' vs 'normal',4.867534450455582
ENSG00000091651,129.0,E-GEOD-31138,2.4,'invasive ductal carcinoma' vs 'normal',4.867534450455582
ENSG00000126233,4.0,,,,1.6094379124341003
ENSG00000087510,812.0,E-GEOD-20086,1.5,'breast cancer' vs 'normal',6.70073110954781
ENSG00000087510,812.0,E-GEOD-44408,-3.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.70073110954781
ENSG00000187678,1657.0,,,,7.4133673356952405
ENSG00000162104,1572.0,E-GEOD-44408,-1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.360739903058278
ENSG00000114812,1425.0,,,,7.262628600974241
ENSG00000160213,4105.0,E-GEOD-38959,2.1,'breast cancer; breast' vs 'normal; breast',8.32020459757888
ENSG00000103202,2683.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.895063498091573
ENSG00000188508,16.0,,,,2.833213344056216
ENSG00000163644,923.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',6.828712071641684
ENSG00000042980,236.0,E-GEOD-44408,2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.4680601411351315
ENSG00000134873,12.0,,,,2.5649493574615367
ENSG00000182718,28461.0,E-GEOD-7377,1.4,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',10.256325143243606
ENSG00000151414,3599.0,,,,8.1886891244442
ENSG00000133574,2049.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.6255950721324535
ENSG00000173744,4887.0,,,,8.494538500851432
ENSG00000153802,3.0,E-GEOD-52194,5.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.3862943611198906
ENSG00000153802,3.0,E-GEOD-52194,6.7,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',1.3862943611198906
ENSG00000153802,3.0,E-GEOD-52194,5.9,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',1.3862943611198906
ENSG00000198793,3154.0,,,,8.056743774975313
ENSG00000102755,5106.0,,,,8.538367426647644
ENSG00000135828,674.0,,,,6.51471269087253
ENSG00000114353,15863.0,,,,9.671807670199632
ENSG00000119866,82.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',4.418840607796598
ENSG00000119866,82.0,E-GEOD-44408,2.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.418840607796598
ENSG00000163735,10.0,E-GEOD-52194,-6.1,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',2.3978952727983707
ENSG00000163735,10.0,E-GEOD-7377,-2.4,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',2.3978952727983707
ENSG00000163735,10.0,E-GEOD-44408,4.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',2.3978952727983707
ENSG00000146232,342.0,,,,5.8377304471659395
ENSG00000196591,2932.0,,,,7.983781068977451
ENSG00000121807,39.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.6888794541139363
ENSG00000121807,39.0,E-GEOD-52194,5.6,'triple-negative breast cancer; breast carcinoma' vs 'normal',3.6888794541139363
ENSG00000121807,39.0,E-GEOD-52194,5.8,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',3.6888794541139363
ENSG00000186350,6683.0,E-GEOD-7377,1.9,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.807471889715284
ENSG00000116017,551.0,,,,6.313548046277095
ENSG00000177575,5302.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',8.57602797713713
ENSG00000117472,144.0,E-GEOD-54002,1.4,'breast cancer' vs 'normal',4.976733742420574
ENSG00000117472,144.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',4.976733742420574
ENSG00000117472,144.0,E-GEOD-44408,-2.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.976733742420574
ENSG00000109572,1951.0,,,,7.5766097669730375
ENSG00000164082,48.0,,,,3.8918202981106265
ENSG00000125458,820.0,,,,6.710523109452428
ENSG00000187730,19.0,,,,2.995732273553991
ENSG00000159267,862.0,,,,6.760414691083428
ENSG00000182704,4866.0,,,,8.490233009833455
ENSG00000151694,1209.0,,,,7.098375638590786
ENSG00000166508,3568.0,,,,8.18004072349016
ENSG00000155903,1621.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.3914152346753585
ENSG00000103363,3265.0,,,,8.09132127353041
ENSG00000162511,4101.0,E-GEOD-44408,1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.319229938632326
ENSG00000162511,4101.0,E-GEOD-20086,1.6,'breast cancer' vs 'normal',8.319229938632326
ENSG00000169813,7490.0,,,,8.921457578947884
ENSG00000128595,5936.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',8.688959234270676
ENSG00000128595,5936.0,E-GEOD-31138,2.5,'invasive ductal carcinoma' vs 'normal',8.688959234270676
ENSG00000160678,475.0,,,,6.16541785423142
ENSG00000104447,4865.0,E-GEOD-31138,2.3,'invasive ductal carcinoma' vs 'normal',8.490027523343468
ENSG00000104447,4865.0,E-MTAB-779,1.8,'breast carcinoma' vs 'normal',8.490027523343468
ENSG00000104447,4865.0,E-GEOD-44408,-3.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.490027523343468
ENSG00000160710,10643.0,,,,9.27275163209758
ENSG00000167658,99664.0,,,,11.509569841156866
ENSG00000131508,3176.0,,,,8.063692634269517
ENSG00000105011,44.0,,,,3.8066624897703196
ENSG00000076351,272.0,,,,5.60947179518496
ENSG00000134077,1058.0,,,,6.9650803456014065
ENSG00000126838,57.0,E-GEOD-52194,5.1,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',4.060443010546419
ENSG00000196843,5660.0,E-GEOD-54002,-1.9,'breast cancer' vs 'normal',8.64135583403666
ENSG00000170855,725.0,E-GEOD-31138,2.8,'invasive ductal carcinoma' vs 'normal',6.587550014824796
ENSG00000196498,10019.0,,,,9.212338374638856
ENSG00000165059,0.0,,,,0.0
ENSG00000154229,663.0,E-GEOD-44408,1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.498282149476434
ENSG00000154229,663.0,E-GEOD-54002,-2.0,'breast cancer' vs 'normal',6.498282149476434
ENSG00000077514,900.0,,,,6.803505257608338
ENSG00000100031,187.0,,,,5.236441962829949
ENSG00000075213,242.0,E-GEOD-68086,-5.0,'breast carcinoma' vs 'normal',5.493061443340548
ENSG00000154380,3754.0,E-GEOD-44408,-2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.230843564198235
ENSG00000027075,2155.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.6760099320288875
ENSG00000184357,0.0,E-GEOD-52194,9.6,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000184357,0.0,E-GEOD-52194,9.9,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',0.0
ENSG00000184357,0.0,E-GEOD-52194,8.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000165025,614.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.421622267806518
ENSG00000165025,614.0,E-GEOD-7377,1.6,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.421622267806518
ENSG00000144668,1164.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',7.060476365999801
ENSG00000196812,180.0,,,,5.198497031265826
ENSG00000057149,2.0,,,,1.0986122886681098
ENSG00000118898,7384.0,E-GEOD-54002,-1.4,'breast cancer' vs 'normal',8.90720619496548
ENSG00000118898,7384.0,E-GEOD-44408,-1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.90720619496548
ENSG00000118898,7384.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',8.90720619496548
ENSG00000118898,7384.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',8.90720619496548
ENSG00000147437,256.0,,,,5.54907608489522
ENSG00000131196,1566.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.356918242356021
ENSG00000100297,1460.0,,,,7.2868764117507
ENSG00000092421,1862.0,E-GEOD-54002,-2.3,'breast cancer' vs 'normal',7.529943370601589
ENSG00000092421,1862.0,E-GEOD-10780,-1.9,'breast carcinoma' vs 'normal',7.529943370601589
ENSG00000196072,1000.0,,,,6.90875477931522
ENSG00000106028,2039.0,E-MTAB-779,1.2,'breast carcinoma' vs 'normal',7.620705086838262
ENSG00000163251,431.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',6.068425588244111
ENSG00000118520,55.0,,,,4.02535169073515
ENSG00000187323,8.0,,,,2.1972245773362196
ENSG00000160957,281.0,E-GEOD-54002,1.6,'breast cancer' vs 'normal',5.641907070938114
ENSG00000160957,281.0,E-MTAB-779,1.6,'breast carcinoma' vs 'normal',5.641907070938114
ENSG00000008196,540.0,E-GEOD-54002,-2.2,'breast cancer' vs 'normal',6.293419278846481
ENSG00000008196,540.0,E-GEOD-38959,-2.3,'breast cancer; breast' vs 'normal; breast',6.293419278846481
ENSG00000008196,540.0,E-GEOD-7377,2.4,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.293419278846481
ENSG00000183395,0.0,,,,0.0
ENSG00000171564,14.0,,,,2.70805020110221
ENSG00000143061,449.0,E-GEOD-44408,-2.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.1092475827643655
ENSG00000116127,1082.0,,,,6.9874902470009905
ENSG00000092929,1206.0,,,,7.095893221097532
ENSG00000104853,4713.0,,,,8.458292083496076
ENSG00000129654,1.0,,,,0.6931471805599453
ENSG00000173535,83.0,,,,4.430816798843313
ENSG00000105810,1049.0,E-GEOD-54002,-2.1,'breast cancer' vs 'normal',6.956545443151569
ENSG00000088356,671.0,,,,6.51025834052315
ENSG00000110931,3305.0,,,,8.10349427838097
ENSG00000165264,1094.0,,,,6.9985096422506015
ENSG00000165672,5096.0,,,,8.536407410340042
ENSG00000151632,2890.0,,,,7.969357742016346
ENSG00000106153,6259.0,,,,8.741935464094144
ENSG00000134709,272.0,,,,5.60947179518496
ENSG00000177731,11825.0,,,,9.378055776380775
ENSG00000057657,594.0,,,,6.38856140554563
ENSG00000134982,1333.0,,,,7.195937226475569
ENSG00000179271,1258.0,,,,7.138073034044347
ENSG00000185122,4994.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',8.516192691082654
ENSG00000148737,3304.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',8.103191752285786
ENSG00000148737,3304.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',8.103191752285786
ENSG00000161202,6544.0,,,,8.786456678344
ENSG00000125037,2514.0,E-GEOD-7377,1.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.83002808253384
ENSG00000170374,2.0,,,,1.0986122886681098
ENSG00000130347,170.0,,,,5.14166355650266
ENSG00000178726,2772.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.927685045615778
ENSG00000178726,2772.0,E-GEOD-20086,-1.2,'breast cancer' vs 'normal',7.927685045615778
ENSG00000100721,1.0,E-GEOD-52194,5.1,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000100721,1.0,E-GEOD-44408,3.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',0.6931471805599453
ENSG00000018408,4364.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',8.381373468273702
ENSG00000162344,0.0,,,,0.0
ENSG00000174059,8208.0,,,,9.012986392348266
ENSG00000197943,1945.0,E-GEOD-44408,2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.57353126274595
ENSG00000205420,70.0,,,,4.2626798770413155
ENSG00000107104,3996.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',8.293299358711323
ENSG00000107104,3996.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',8.293299358711323
ENSG00000198929,98.0,,,,4.59511985013459
ENSG00000078043,1335.0,,,,7.197435354096591
ENSG00000198399,3167.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.060855752934316
ENSG00000136448,5350.0,,,,8.585038738311304
ENSG00000143507,443.0,E-GEOD-7377,1.8,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.095824562432225
ENSG00000008952,5695.0,,,,8.647519453091812
ENSG00000177465,167.0,,,,5.123963979403259
ENSG00000158055,23.0,,,,3.1780538303479458
ENSG00000163808,33.0,E-GEOD-54002,2.7,'breast cancer' vs 'normal',3.5263605246161616
ENSG00000105369,43.0,E-GEOD-44408,2.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.784189633918261
ENSG00000162931,86.0,,,,4.465908118654584
ENSG00000163378,2185.0,E-GEOD-54002,-2.6,'breast cancer' vs 'normal',7.689828668736484
ENSG00000163378,2185.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',7.689828668736484
ENSG00000137309,1564.0,E-GEOD-52194,-4.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',7.355641102974253
ENSG00000112592,789.0,,,,6.672032945461067
ENSG00000187840,1757.0,,,,7.471932078245122
ENSG00000128050,2288.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',7.735870319952567
ENSG00000021762,2792.0,,,,7.934871565945177
ENSG00000157184,624.0,,,,6.437751649736401
ENSG00000152266,0.0,,,,0.0
ENSG00000042832,122.0,,,,4.812184355372417
ENSG00000124713,59.0,,,,4.0943445622221
ENSG00000221914,3311.0,,,,8.10530751550515
ENSG00000078401,1173.0,E-MTAB-779,-1.7,'breast carcinoma' vs 'normal',7.068172000388042
ENSG00000148935,54.0,,,,4.007333185232471
ENSG00000047648,1092.0,E-GEOD-20086,-1.4,'breast cancer' vs 'normal',6.996681488176539
ENSG00000141738,809.0,,,,6.697034247666484
ENSG00000102145,10.0,,,,2.3978952727983707
ENSG00000139329,7639.0,E-GEOD-54002,2.1,'breast cancer' vs 'normal',8.941152882160566
ENSG00000139329,7639.0,E-GEOD-68086,-5.0,'breast carcinoma' vs 'normal',8.941152882160566
ENSG00000128708,1737.0,,,,7.460490305825338
ENSG00000133961,4621.0,,,,8.438582790834326
ENSG00000070540,1967.0,E-GEOD-44408,-1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.584773077612199
ENSG00000070540,1967.0,E-GEOD-7377,2.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.584773077612199
ENSG00000179593,371.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',5.918893854273146
ENSG00000171634,3988.0,,,,8.291295851905407
ENSG00000122861,925.0,E-GEOD-31138,2.6,'invasive ductal carcinoma' vs 'normal',6.8308742346461795
ENSG00000144182,256.0,,,,5.54907608489522
ENSG00000259207,342.0,,,,5.8377304471659395
ENSG00000101412,114.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',4.74493212836325
ENSG00000136143,1875.0,,,,7.53689712956617
ENSG00000140835,5.0,,,,1.791759469228055
ENSG00000129351,12598.0,,,,9.44137272471063
ENSG00000214193,953.0,,,,6.860663671448287
ENSG00000162512,3130.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.049107721326406
ENSG00000167693,1725.0,,,,7.453561871643373
ENSG00000163814,376.0,,,,5.932245187448011
ENSG00000172943,2682.0,,,,7.894690850425624
ENSG00000164266,19.0,,,,2.995732273553991
ENSG00000174705,4234.0,,,,8.351138607086154
ENSG00000166869,6.0,,,,1.9459101490553132
ENSG00000182307,2301.0,,,,7.741533589281828
ENSG00000186104,635.0,,,,6.455198563340122
ENSG00000107816,5246.0,,,,8.565411763686711
ENSG00000089902,2091.0,,,,7.645875825184813
ENSG00000144895,4143.0,,,,8.329416783939319
ENSG00000168906,11266.0,,,,9.329633378164166
ENSG00000144908,1388.0,E-MTAB-779,-1.7,'breast carcinoma' vs 'normal',7.236339342754344
ENSG00000114573,1895.0,,,,7.547501682814967
ENSG00000007168,6973.0,,,,8.849944227235596
ENSG00000186687,718.0,,,,6.577861357721047
ENSG00000177238,60.0,,,,4.110873864173311
ENSG00000125356,1942.0,,,,7.57198844937744
ENSG00000085733,11214.0,E-GEOD-44408,-1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.32500744695431
ENSG00000016490,3.0,,,,1.3862943611198906
ENSG00000004939,17.0,,,,2.8903717578961645
ENSG00000162645,7541.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',8.928242677818302
ENSG00000103534,243.0,,,,5.497168225293202
ENSG00000120254,483.0,,,,6.182084906716632
ENSG00000086548,20.0,E-GEOD-54002,2.4,'breast cancer' vs 'normal',3.044522437723423
ENSG00000086548,20.0,E-GEOD-52194,5.4,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',3.044522437723423
ENSG00000086548,20.0,E-GEOD-10780,2.3,'breast carcinoma' vs 'normal',3.044522437723423
ENSG00000168899,2103.0,,,,7.651595573857601
ENSG00000188554,6937.0,,,,8.844768827529695
ENSG00000107295,5.0,,,,1.791759469228055
ENSG00000074800,25314.0,,,,10.13915238440401
ENSG00000167552,3474.0,,,,8.153349757998892
ENSG00000135838,400.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.993961427306569
ENSG00000141655,256.0,E-GEOD-54002,-2.4,'breast cancer' vs 'normal',5.54907608489522
ENSG00000087470,3109.0,,,,8.04237800517328
ENSG00000129038,558.0,E-GEOD-44408,-1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.326149473155099
ENSG00000129038,558.0,E-GEOD-54002,2.1,'breast cancer' vs 'normal',6.326149473155099
ENSG00000168385,16570.0,,,,9.715409458629793
ENSG00000083642,2014.0,,,,7.608374474380783
ENSG00000163602,2020.0,,,,7.611347717403621
ENSG00000185787,12971.0,,,,9.470548467427209
ENSG00000197694,12798.0,,,,9.457122321855792
ENSG00000093000,1803.0,,,,7.4977617006225685
ENSG00000165802,2718.0,,,,7.908019444632471
ENSG00000148334,1541.0,,,,7.340835554123275
ENSG00000143401,1606.0,E-GEOD-38959,1.6,'breast cancer; breast' vs 'normal; breast',7.382124365737512
ENSG00000069275,10095.0,,,,9.219894584780995
ENSG00000114349,0.0,,,,0.0
ENSG00000126858,1743.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',7.463936604468925
ENSG00000162385,829.0,,,,6.721425700790643
ENSG00000096088,56.0,,,,4.04305126783455
ENSG00000118432,1801.0,E-GEOD-31138,-2.5,'invasive ductal carcinoma' vs 'normal',7.496652438168283
ENSG00000168229,98.0,,,,4.59511985013459
ENSG00000159082,1022.0,,,,6.930494765951626
ENSG00000103121,623.0,E-GEOD-38959,1.6,'breast cancer; breast' vs 'normal; breast',6.436150368369428
ENSG00000096401,2176.0,,,,7.685703061234547
ENSG00000115233,1393.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.2399325913204695
ENSG00000115233,1393.0,E-GEOD-38959,1.7,'breast cancer; breast' vs 'normal; breast',7.2399325913204695
ENSG00000115233,1393.0,E-GEOD-31138,3.1,'invasive ductal carcinoma' vs 'normal',7.2399325913204695
ENSG00000101266,3092.0,,,,8.03689677268507
ENSG00000115041,297.0,,,,5.697093486505405
ENSG00000101040,2466.0,,,,7.810758116529357
ENSG00000215301,17189.0,,,,9.752083098376895
ENSG00000006704,769.0,E-GEOD-44408,-1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.646390514847729
ENSG00000104529,5893.0,,,,8.68169016329764
ENSG00000100353,9317.0,,,,9.139703292376742
ENSG00000066654,2210.0,,,,7.701200180857446
ENSG00000158473,173.0,E-GEOD-44408,2.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.159055299214529
ENSG00000177485,911.0,,,,6.815639990074331
ENSG00000068745,4054.0,E-GEOD-38959,-1.5,'breast cancer; breast' vs 'normal; breast',8.307705966549513
ENSG00000257335,47.0,,,,3.871201010907891
ENSG00000116833,515.0,,,,6.246106765481563
ENSG00000106077,928.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.834108738813838
ENSG00000086758,10804.0,,,,9.287764268940986
ENSG00000117899,1790.0,E-GEOD-7377,1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.490529402060711
ENSG00000110944,28.0,,,,3.367295829986474
ENSG00000135604,796.0,,,,6.680854678790215
ENSG00000143013,2257.0,E-GEOD-38959,1.5,'breast cancer; breast' vs 'normal; breast',7.722234744709607
ENSG00000071073,1400.0,,,,7.244941546337007
ENSG00000175426,77.0,E-GEOD-52194,4.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',4.356708826689592
ENSG00000100197,144.0,,,,4.976733742420574
ENSG00000135077,314.0,,,,5.752572638825633
ENSG00000132286,1179.0,,,,7.07326971745971
ENSG00000185010,2060.0,,,,7.630946580890459
ENSG00000112378,4917.0,E-GEOD-31138,2.3,'invasive ductal carcinoma' vs 'normal',8.500657222776137
ENSG00000112378,4917.0,E-GEOD-44408,-2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.500657222776137
ENSG00000115107,1931.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.566311014772463
ENSG00000277363,365.0,,,,5.902633333401366
ENSG00000171643,4.0,,,,1.6094379124341003
ENSG00000185813,1445.0,,,,7.27655640271871
ENSG00000172531,2988.0,,,,8.002694162283937
ENSG00000115942,1506.0,,,,7.317876198626496
ENSG00000135093,895.0,,,,6.79794041297493
ENSG00000009335,3543.0,,,,8.173011311724972
ENSG00000185721,1831.0,,,,7.513163545234075
ENSG00000196396,3327.0,,,,8.1101268019411
ENSG00000124788,1890.0,,,,7.544861068658458
ENSG00000029725,4102.0,,,,8.319473692442186
ENSG00000152455,191.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',5.2574953720277815
ENSG00000025293,2156.0,,,,7.676473646389156
ENSG00000184330,0.0,E-GEOD-52194,5.4,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000197157,6372.0,,,,8.759825595314295
ENSG00000172915,729.0,,,,6.593044534142437
ENSG00000181915,740.0,E-GEOD-31138,1.9,'invasive ductal carcinoma' vs 'normal',6.608000625296087
ENSG00000134684,2913.0,,,,7.97728198675515
ENSG00000179115,1598.0,,,,7.377133712833954
ENSG00000105290,69.0,,,,4.248495242049359
ENSG00000107968,1813.0,,,,7.503289630675082
ENSG00000084676,4159.0,,,,8.333270353255308
ENSG00000070081,1773.0,,,,7.480992162869525
ENSG00000185559,109.0,E-MTAB-779,-2.0,'breast carcinoma' vs 'normal',4.700480365792417
ENSG00000185559,109.0,E-GEOD-10780,-2.4,'breast carcinoma' vs 'normal',4.700480365792417
ENSG00000185559,109.0,E-GEOD-52194,-5.6,'triple-negative breast cancer; breast carcinoma' vs 'normal',4.700480365792417
ENSG00000185559,109.0,E-GEOD-52194,-7.9,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',4.700480365792417
ENSG00000132182,620.0,,,,6.431331081933479
ENSG00000150995,2842.0,E-GEOD-54002,-1.9,'breast cancer' vs 'normal',7.952615111651
ENSG00000150995,2842.0,E-GEOD-38959,-1.4,'breast cancer; breast' vs 'normal; breast',7.952615111651
ENSG00000107331,2861.0,,,,7.959275960116396
ENSG00000150593,6344.0,,,,8.755422380148488
ENSG00000123349,11310.0,,,,9.33353098253138
ENSG00000160191,581.0,,,,6.366470447731438
ENSG00000132326,1631.0,E-GEOD-54002,-1.9,'breast cancer' vs 'normal',7.397561535524052
ENSG00000132326,1631.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',7.397561535524052
ENSG00000132326,1631.0,E-GEOD-38959,-1.4,'breast cancer; breast' vs 'normal; breast',7.397561535524052
ENSG00000138376,368.0,,,,5.910796644040527
ENSG00000049130,1068.0,E-GEOD-31138,3.3,'invasive ductal carcinoma' vs 'normal',6.974478911025045
ENSG00000117020,3470.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',8.152198015861787
ENSG00000117020,3470.0,E-GEOD-38959,-1.7,'breast cancer; breast' vs 'normal; breast',8.152198015861787
ENSG00000149782,1704.0,,,,7.4413203897176174
ENSG00000169231,2118.0,,,,7.6586995582682995
ENSG00000138685,1488.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',7.305860032684009
ENSG00000081059,337.0,E-GEOD-44408,1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.823045895483019
ENSG00000173905,1765.0,,,,7.476472381163905
ENSG00000129535,50.0,,,,3.9318256327243257
ENSG00000250565,212.0,,,,5.3612921657094255
ENSG00000154655,384.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',5.953243334287785
ENSG00000180198,1005.0,,,,6.913737350659685
ENSG00000185479,235.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',5.4638318050256105
ENSG00000185479,235.0,E-GEOD-54002,-4.7,'breast cancer' vs 'normal',5.4638318050256105
ENSG00000185479,235.0,E-GEOD-52194,-6.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',5.4638318050256105
ENSG00000008441,7109.0,,,,8.869257522797287
ENSG00000135063,1524.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',7.329749689041512
ENSG00000135063,1524.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',7.329749689041512
ENSG00000135063,1524.0,E-GEOD-54002,-3.2,'breast cancer' vs 'normal',7.329749689041512
ENSG00000135063,1524.0,E-GEOD-38959,-2.4,'breast cancer; breast' vs 'normal; breast',7.329749689041512
ENSG00000127022,17442.0,,,,9.766693701018134
ENSG00000196405,4112.0,E-MTAB-779,1.2,'breast carcinoma' vs 'normal',8.321907968230423
ENSG00000196405,4112.0,E-GEOD-7377,1.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.321907968230423
ENSG00000171560,18.0,E-GEOD-68086,-5.0,'breast carcinoma' vs 'normal',2.9444389791664403
ENSG00000144810,802.0,E-GEOD-10780,1.6,'breast carcinoma' vs 'normal',6.688354713946762
ENSG00000144810,802.0,E-GEOD-31138,4.5,'invasive ductal carcinoma' vs 'normal',6.688354713946762
ENSG00000144810,802.0,E-GEOD-38959,2.0,'breast cancer; breast' vs 'normal; breast',6.688354713946762
ENSG00000146678,3.0,E-GEOD-52194,-5.6,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',1.3862943611198906
ENSG00000146678,3.0,E-GEOD-52194,-4.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',1.3862943611198906
ENSG00000153317,4126.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',8.325306029752582
ENSG00000196569,7216.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',8.884194633072273
ENSG00000196569,7216.0,E-GEOD-31138,-3.0,'invasive ductal carcinoma' vs 'normal',8.884194633072273
ENSG00000164687,3299.0,,,,8.101677747454572
ENSG00000197043,16738.0,,,,9.72549660510262
ENSG00000002822,866.0,,,,6.7650389767805414
ENSG00000065978,18067.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',9.801897696774494
ENSG00000005108,591.0,,,,6.3835066348840055
ENSG00000196914,6875.0,,,,8.83579236650274
ENSG00000147099,616.0,,,,6.424869023905388
ENSG00000105388,9.0,E-GEOD-54002,2.2,'breast cancer' vs 'normal',2.302585092994046
ENSG00000105388,9.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',2.302585092994046
ENSG00000116824,62.0,E-GEOD-44408,2.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.143134726391533
ENSG00000144283,4404.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.39049553837028
ENSG00000165934,1847.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.521859252201629
ENSG00000105287,3814.0,,,,8.246695943718557
ENSG00000008083,1313.0,,,,7.1808311990445555
ENSG00000117228,1828.0,E-GEOD-7377,-1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.511524648390866
ENSG00000139437,1049.0,,,,6.956545443151569
ENSG00000172936,2033.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',7.617759576608505
ENSG00000008405,1294.0,,,,7.166265974133638
ENSG00000178035,7049.0,,,,8.860782895806315
ENSG00000137265,598.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.395261598115449
ENSG00000161813,1947.0,,,,7.5745584842024805
ENSG00000046889,1264.0,,,,7.142827401161621
ENSG00000213088,7756.0,E-GEOD-44408,2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.956350940490871
ENSG00000213088,7756.0,E-GEOD-10780,-1.5,'breast carcinoma' vs 'normal',8.956350940490871
ENSG00000213088,7756.0,E-GEOD-31138,-2.8,'invasive ductal carcinoma' vs 'normal',8.956350940490871
ENSG00000213088,7756.0,E-GEOD-52194,-5.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',8.956350940490871
ENSG00000173726,7120.0,,,,8.870803443982124
ENSG00000110987,547.0,,,,6.306275286948016
ENSG00000253729,5465.0,,,,8.606302366488013
ENSG00000130762,411.0,,,,6.021023349349527
ENSG00000129355,350.0,E-GEOD-38959,1.8,'breast cancer; breast' vs 'normal; breast',5.860786223465865
ENSG00000157625,1520.0,,,,7.327123292259293
ENSG00000170145,5900.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',8.682877107057168
ENSG00000037280,2718.0,,,,7.908019444632471
ENSG00000168918,1740.0,E-GEOD-44408,2.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.462214939768189
ENSG00000130309,5934.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',8.688622307043769
ENSG00000147677,8648.0,,,,9.065198986306513
ENSG00000141867,5814.0,,,,8.668196064952765
ENSG00000137266,1145.0,,,,7.044032897274685
ENSG00000089692,81.0,,,,4.406719247264253
ENSG00000159461,3490.0,,,,8.157943507105037
ENSG00000076067,4025.0,,,,8.300528606199737
ENSG00000041353,238.0,E-GEOD-38959,-1.5,'breast cancer; breast' vs 'normal; breast',5.476463551931511
ENSG00000041353,238.0,E-GEOD-7377,2.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',5.476463551931511
ENSG00000121413,1926.0,,,,7.563719668414366
ENSG00000160181,3.0,,,,1.3862943611198906
ENSG00000185344,1271.0,,,,7.148345743900068
ENSG00000169313,40.0,,,,3.713572066704308
ENSG00000132196,463.0,,,,6.139884552226255
ENSG00000134884,10010.0,,,,9.211439767419483
ENSG00000163638,3206.0,E-GEOD-52194,-5.2,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',8.073091199693154
ENSG00000102007,4127.0,,,,8.325548307161398
ENSG00000186666,157.0,,,,5.062595033026967
ENSG00000130202,3523.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.16735198705607
ENSG00000136732,4735.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.462948176563842
ENSG00000033800,2264.0,,,,7.725330037917135
ENSG00000167325,1718.0,E-GEOD-31138,2.3,'invasive ductal carcinoma' vs 'normal',7.449498005382849
ENSG00000110619,2954.0,,,,7.991253929840199
ENSG00000111144,3425.0,,,,8.139148678884066
ENSG00000102699,2985.0,,,,8.001689978099135
ENSG00000137948,6.0,,,,1.9459101490553132
ENSG00000072682,963.0,E-GEOD-44408,-2.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.871091294610546
ENSG00000079435,11658.0,E-MTAB-779,-2.9,'breast carcinoma' vs 'normal',9.36383369293329
ENSG00000204941,4.0,E-GEOD-20086,-1.3,'breast cancer' vs 'normal',1.6094379124341003
ENSG00000185896,12477.0,,,,9.431722372670732
ENSG00000004961,677.0,,,,6.519147287940395
ENSG00000189403,13755.0,,,,9.529230371552156
ENSG00000077942,19657.0,E-GEOD-54002,1.4,'breast cancer' vs 'normal',9.886239659126575
ENSG00000077942,19657.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',9.886239659126575
ENSG00000077942,19657.0,E-GEOD-20086,-1.7,'breast cancer' vs 'normal',9.886239659126575
ENSG00000160180,337.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',5.823045895483019
ENSG00000160180,337.0,E-GEOD-38959,-1.8,'breast cancer; breast' vs 'normal; breast',5.823045895483019
ENSG00000145715,2262.0,,,,7.724446645633537
ENSG00000116711,362.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',5.8944028342648505
ENSG00000116711,362.0,E-GEOD-44408,2.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.8944028342648505
ENSG00000116711,362.0,E-GEOD-54002,-2.6,'breast cancer' vs 'normal',5.8944028342648505
ENSG00000069869,1360.0,,,,7.215975002651466
ENSG00000130254,3530.0,,,,8.169336395928386
ENSG00000165046,125.0,E-GEOD-38959,-1.7,'breast cancer; breast' vs 'normal; breast',4.836281906951478
ENSG00000106459,976.0,,,,6.884486652042782
ENSG00000171724,17.0,,,,2.8903717578961645
ENSG00000113262,29.0,,,,3.4011973816621555
ENSG00000165322,2066.0,,,,7.633853559681768
ENSG00000137817,4409.0,,,,8.391629968440892
ENSG00000076984,2600.0,,,,7.8636512654486515
ENSG00000140105,4432.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',8.396831834745054
ENSG00000159335,9096.0,,,,9.115699967822062
ENSG00000188352,1227.0,,,,7.113142108707088
ENSG00000006118,465.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',6.144185634125646
ENSG00000113296,1252.0,E-GEOD-7377,2.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.133295954896068
ENSG00000063245,5231.0,,,,8.562548893137034
ENSG00000100804,2569.0,,,,7.851661177889265
ENSG00000158417,5724.0,,,,8.65259782842244
ENSG00000084093,1407.0,,,,7.249925536717988
ENSG00000105329,2600.0,,,,7.8636512654486515
ENSG00000126561,6528.0,,,,8.784009071186633
ENSG00000166199,811.0,,,,6.699500340161678
ENSG00000113966,111.0,,,,4.718498871295094
ENSG00000144867,1394.0,,,,7.240649694255466
ENSG00000148719,2786.0,,,,7.932721027481948
ENSG00000004779,1487.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',7.305188215393037
ENSG00000271503,243.0,,,,5.497168225293202
ENSG00000107882,1056.0,,,,6.963189985870238
ENSG00000149346,377.0,,,,5.934894195619588
ENSG00000126709,1048.0,,,,6.955592608396297
ENSG00000106144,1844.0,,,,7.520234556474628
ENSG00000134899,1384.0,,,,7.233455418621439
ENSG00000106263,8317.0,,,,9.026177120302856
ENSG00000110079,612.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.418364935936212
ENSG00000116701,471.0,,,,6.156978985585555
ENSG00000174607,84.0,,,,4.442651256490317
ENSG00000164171,505.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',6.226536669287466
ENSG00000178568,231.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',5.44673737166631
ENSG00000178568,231.0,E-GEOD-7377,1.6,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',5.44673737166631
ENSG00000178568,231.0,E-GEOD-38959,-2.2,'breast cancer; breast' vs 'normal; breast',5.44673737166631
ENSG00000169715,2713.0,,,,7.906178840394815
ENSG00000087365,9831.0,,,,9.19339765124587
ENSG00000117477,26.0,,,,3.295836866004329
ENSG00000130522,9159.0,,,,9.122601457668177
ENSG00000203747,585.0,,,,6.373319789577012
ENSG00000161921,1093.0,,,,6.9975959829819265
ENSG00000095585,134.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.90527477843843
ENSG00000168672,1267.0,E-MTAB-779,1.6,'breast carcinoma' vs 'normal',7.145196134997171
ENSG00000130348,753.0,E-GEOD-44408,1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.625392368007956
ENSG00000090104,1183.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',7.076653815443951
ENSG00000090104,1183.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',7.076653815443951
ENSG00000090104,1183.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',7.076653815443951
ENSG00000148516,3868.0,E-GEOD-54002,1.6,'breast cancer' vs 'normal',8.260751354700513
ENSG00000014123,1771.0,,,,7.4798641311650265
ENSG00000154930,1929.0,,,,7.5652752818989315
ENSG00000163781,1665.0,,,,7.418180822726788
ENSG00000168209,8517.0,,,,9.049936850483158
ENSG00000090447,449.0,,,,6.1092475827643655
ENSG00000129173,9.0,E-GEOD-52194,5.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',2.302585092994046
ENSG00000129173,9.0,E-GEOD-52194,5.0,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',2.302585092994046
ENSG00000129173,9.0,E-GEOD-54002,2.9,'breast cancer' vs 'normal',2.302585092994046
ENSG00000100320,4788.0,,,,8.47407690034261
ENSG00000135917,1957.0,E-MTAB-779,-1.7,'breast carcinoma' vs 'normal',7.579678823090456
ENSG00000214107,0.0,,,,0.0
ENSG00000087842,600.0,E-GEOD-54002,1.9,'breast cancer' vs 'normal',6.398594934535208
ENSG00000087842,600.0,E-GEOD-38959,1.6,'breast cancer; breast' vs 'normal; breast',6.398594934535208
ENSG00000039560,1190.0,,,,7.0825485693553
ENSG00000134352,15610.0,,,,9.655731072956666
ENSG00000167996,29750.0,,,,10.300618023854234
ENSG00000206073,1.0,,,,0.6931471805599453
ENSG00000138688,5665.0,,,,8.642238680390461
ENSG00000185033,2857.0,,,,7.957877358489813
ENSG00000104325,2789.0,,,,7.933796874815411
ENSG00000105851,88.0,E-GEOD-44408,2.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.48863636973214
ENSG00000105851,88.0,E-GEOD-52194,5.1,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',4.48863636973214
ENSG00000085998,2640.0,,,,7.878912912297133
ENSG00000162664,2170.0,,,,7.682943169878292
ENSG00000197417,195.0,,,,5.278114659230517
ENSG00000109670,1796.0,,,,7.493873886783559
ENSG00000181788,1094.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',6.9985096422506015
ENSG00000163714,5458.0,,,,8.605020901781758
ENSG00000138185,2298.0,,,,7.740229524763182
ENSG00000120948,5533.0,,,,8.618666160346871
ENSG00000142512,118.0,,,,4.77912349311153
ENSG00000261371,22240.0,,,,10.009692711382444
ENSG00000104884,814.0,,,,6.703188113240863
ENSG00000163359,39369.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',10.580759383937783
ENSG00000163359,39369.0,E-GEOD-54002,3.1,'breast cancer' vs 'normal',10.580759383937783
ENSG00000111335,778.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',6.658011045870748
ENSG00000111335,778.0,E-GEOD-10780,1.7,'breast carcinoma' vs 'normal',6.658011045870748
ENSG00000159445,886.0,,,,6.787844982309579
ENSG00000182580,550.0,,,,6.311734809152915
ENSG00000174851,1855.0,,,,7.526178913346146
ENSG00000102312,533.0,,,,6.280395838960195
ENSG00000072364,6133.0,,,,8.721602344674197
ENSG00000277972,1008.0,,,,6.9167150203536085
ENSG00000164611,57.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',4.060443010546419
ENSG00000164611,57.0,E-GEOD-54002,2.2,'breast cancer' vs 'normal',4.060443010546419
ENSG00000164611,57.0,E-MTAB-779,2.4,'breast carcinoma' vs 'normal',4.060443010546419
ENSG00000164611,57.0,E-GEOD-38959,3.2,'breast cancer; breast' vs 'normal; breast',4.060443010546419
ENSG00000135404,22646.0,,,,10.027782671807735
ENSG00000185591,6091.0,,,,8.714731714015052
ENSG00000134371,1929.0,,,,7.5652752818989315
ENSG00000276043,50.0,E-MTAB-779,2.1,'breast carcinoma' vs 'normal',3.9318256327243257
ENSG00000276043,50.0,E-GEOD-38959,3.0,'breast cancer; breast' vs 'normal; breast',3.9318256327243257
ENSG00000143418,4421.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.394347361417392
ENSG00000143418,4421.0,E-GEOD-31138,2.0,'invasive ductal carcinoma' vs 'normal',8.394347361417392
ENSG00000143418,4421.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',8.394347361417392
ENSG00000143418,4421.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',8.394347361417392
ENSG00000143418,4421.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.394347361417392
ENSG00000124767,2925.0,E-GEOD-7377,1.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.98139158158007
ENSG00000172062,224.0,,,,5.41610040220442
ENSG00000124766,2067.0,E-GEOD-44408,-1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.63433723562832
ENSG00000127948,4373.0,,,,8.383433201236713
ENSG00000177191,125.0,,,,4.836281906951478
ENSG00000103769,4942.0,,,,8.505727713306959
ENSG00000108309,41.0,,,,3.7376696182833684
ENSG00000104960,4579.0,,,,8.429454277108231
ENSG00000139351,35.0,E-GEOD-38959,-1.5,'breast cancer; breast' vs 'normal; breast',3.58351893845611
ENSG00000166598,21703.0,,,,9.985251854338768
ENSG00000166949,4947.0,,,,8.506738733512378
ENSG00000120438,7460.0,,,,8.917444732471514
ENSG00000058668,8024.0,,,,8.990316947998217
ENSG00000150768,1455.0,,,,7.283448228756631
ENSG00000134574,1755.0,,,,7.470793774195062
ENSG00000167136,200.0,,,,5.303304908059076
ENSG00000091542,3495.0,,,,8.159374736775426
ENSG00000103066,853.0,,,,6.74993119378857
ENSG00000163577,343.0,,,,5.840641657373398
ENSG00000189091,6127.0,,,,8.720623711420426
ENSG00000170027,7703.0,,,,8.949494953477961
ENSG00000265241,3146.0,E-GEOD-31138,2.1,'invasive ductal carcinoma' vs 'normal',8.054204897064407
ENSG00000170946,447.0,,,,6.104793232414985
ENSG00000160753,1738.0,E-GEOD-44408,-1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.461065514354283
ENSG00000105971,5877.0,E-MTAB-779,-1.7,'breast carcinoma' vs 'normal',8.678971846978863
ENSG00000105971,5877.0,E-GEOD-54002,-3.7,'breast cancer' vs 'normal',8.678971846978863
ENSG00000105971,5877.0,E-GEOD-10780,-2.2,'breast carcinoma' vs 'normal',8.678971846978863
ENSG00000136492,59.0,E-GEOD-54002,1.8,'breast cancer' vs 'normal',4.0943445622221
ENSG00000136492,59.0,E-GEOD-31138,2.5,'invasive ductal carcinoma' vs 'normal',4.0943445622221
ENSG00000079102,1018.0,E-GEOD-31138,-2.0,'invasive ductal carcinoma' vs 'normal',6.926577033222725
ENSG00000079102,1018.0,E-MTAB-779,-1.8,'breast carcinoma' vs 'normal',6.926577033222725
ENSG00000079102,1018.0,E-GEOD-10780,-1.9,'breast carcinoma' vs 'normal',6.926577033222725
ENSG00000075711,2312.0,,,,7.746300662231439
ENSG00000186660,3452.0,,,,8.146998697389993
ENSG00000153944,2012.0,,,,7.607381425639791
ENSG00000138356,6121.0,,,,8.719644119505357
ENSG00000134453,5063.0,,,,8.529911963824013
ENSG00000115221,428.0,E-GEOD-54002,-1.9,'breast cancer' vs 'normal',6.061456918928017
ENSG00000099810,1429.0,,,,7.265429723253953
ENSG00000132906,671.0,,,,6.51025834052315
ENSG00000163069,2100.0,,,,7.650168700845001
ENSG00000171855,0.0,,,,0.0
ENSG00000183709,0.0,,,,0.0
ENSG00000197487,0.0,,,,0.0
ENSG00000258710,0.0,,,,0.0
ENSG00000108702,0.0,,,,0.0
ENSG00000211563,0.0,,,,0.0
ENSG00000211918,0.0,,,,0.0
ENSG00000166351,0.0,,,,0.0
ENSG00000220349,0.0,,,,0.0
ENSG00000125879,0.0,E-GEOD-52194,4.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000164256,0.0,,,,0.0
ENSG00000182652,0.0,,,,0.0
ENSG00000177047,0.0,,,,0.0
ENSG00000151615,0.0,,,,0.0
ENSG00000249065,0.0,,,,0.0
ENSG00000130385,0.0,,,,0.0
ENSG00000235123,0.0,E-GEOD-54002,2.6,'breast cancer' vs 'normal',0.0
ENSG00000235123,0.0,E-GEOD-52194,5.2,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',0.0
ENSG00000235123,0.0,E-GEOD-10780,1.9,'breast carcinoma' vs 'normal',0.0
ENSG00000235123,0.0,E-GEOD-52194,6.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000213820,0.0,,,,0.0
ENSG00000212722,0.0,,,,0.0
ENSG00000197919,0.0,,,,0.0
ENSG00000152591,0.0,,,,0.0
ENSG00000258724,0.0,,,,0.0
ENSG00000183955,1690.0,,,,7.43307534889858
ENSG00000235082,5.0,,,,1.791759469228055
ENSG00000174403,13.0,E-GEOD-52194,4.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',2.6390573296152584
ENSG00000112695,2487.0,,,,7.81923445385907
ENSG00000223485,9.0,,,,2.302585092994046
ENSG00000073614,2986.0,E-GEOD-31138,2.7,'invasive ductal carcinoma' vs 'normal',8.00202481821611
ENSG00000187079,4424.0,,,,8.39502555744203
ENSG00000211678,0.0,,,,0.0
ENSG00000203780,98.0,E-GEOD-38959,-1.7,'breast cancer; breast' vs 'normal; breast',4.59511985013459
ENSG00000112561,1205.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.095064377287131
ENSG00000179750,13.0,,,,2.6390573296152584
ENSG00000146425,2100.0,,,,7.650168700845001
ENSG00000124882,30.0,E-GEOD-52194,-6.7,'triple-negative breast cancer; breast carcinoma' vs 'normal',3.4339872044851463
ENSG00000124882,30.0,E-GEOD-52194,-7.2,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',3.4339872044851463
ENSG00000124882,30.0,E-GEOD-52194,-7.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',3.4339872044851463
ENSG00000185736,35.0,,,,3.58351893845611
ENSG00000280734,123.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',4.820281565605037
ENSG00000181092,13056.0,E-MTAB-779,-2.9,'breast carcinoma' vs 'normal',9.477079667408038
ENSG00000181092,13056.0,E-GEOD-10780,-2.9,'breast carcinoma' vs 'normal',9.477079667408038
ENSG00000182168,154.0,,,,5.043425116919247
ENSG00000170820,0.0,,,,0.0
ENSG00000081985,31.0,,,,3.4657359027997265
ENSG00000175087,349.0,,,,5.857933154483459
ENSG00000237512,2.0,,,,1.0986122886681098
ENSG00000224511,2.0,,,,1.0986122886681098
ENSG00000204060,59.0,E-GEOD-7377,1.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',4.0943445622221
ENSG00000235387,347.0,,,,5.8522024797744745
ENSG00000140853,2172.0,,,,7.6838639802564295
ENSG00000118702,0.0,,,,0.0
ENSG00000164535,1054.0,,,,6.961296045910167
ENSG00000240403,2.0,,,,1.0986122886681098
ENSG00000163491,136.0,E-GEOD-38959,-2.6,'breast cancer; breast' vs 'normal; breast',4.919980925828125
ENSG00000267107,766.0,,,,6.642486801367256
ENSG00000112685,1602.0,E-GEOD-7377,1.6,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.3796321526095525
ENSG00000102891,0.0,,,,0.0
ENSG00000070193,628.0,,,,6.444131256700441
ENSG00000102096,367.0,,,,5.908082938168931
ENSG00000175097,0.0,,,,0.0
ENSG00000067955,1929.0,,,,7.5652752818989315
ENSG00000021300,189.0,,,,5.247024072160486
ENSG00000245910,3140.0,,,,8.052296499538647
ENSG00000237290,0.0,,,,0.0
ENSG00000175054,1587.0,,,,7.370230641807081
ENSG00000165349,13.0,,,,2.6390573296152584
ENSG00000213453,4.0,,,,1.6094379124341003
ENSG00000166090,3.0,,,,1.3862943611198906
ENSG00000173511,5895.0,,,,8.682029433869172
ENSG00000197912,4857.0,,,,8.488382109562117
ENSG00000228288,74.0,,,,4.31748811353631
ENSG00000152931,39.0,,,,3.6888794541139363
ENSG00000108773,6003.0,,,,8.700181192753353
ENSG00000169306,1.0,,,,0.6931471805599453
ENSG00000197915,24.0,,,,3.2188758248682006
ENSG00000179761,28.0,,,,3.367295829986474
ENSG00000127990,1732.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',7.457609289715606
ENSG00000127990,1732.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',7.457609289715606
ENSG00000127990,1732.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',7.457609289715606
ENSG00000127990,1732.0,E-GEOD-31138,3.0,'invasive ductal carcinoma' vs 'normal',7.457609289715606
ENSG00000120158,831.0,,,,6.723832440821209
ENSG00000137818,47925.0,,,,10.777413433632514
ENSG00000261742,1.0,E-GEOD-52194,5.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000261742,1.0,E-GEOD-52194,5.0,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000121039,1099.0,E-GEOD-38959,1.6,'breast cancer; breast' vs 'normal; breast',7.003065458786462
ENSG00000143387,9264.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.13399913871946
ENSG00000143387,9264.0,E-GEOD-54002,1.7,'breast cancer' vs 'normal',9.13399913871946
ENSG00000273111,0.0,,,,0.0
ENSG00000055950,1718.0,,,,7.449498005382849
ENSG00000250337,10.0,E-GEOD-52194,5.2,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',2.3978952727983707
ENSG00000231298,5.0,,,,1.791759469228055
ENSG00000258169,7.0,,,,2.0794415416798357
ENSG00000162738,498.0,,,,6.212606095751519
ENSG00000169509,3.0,,,,1.3862943611198906
ENSG00000196367,2845.0,,,,7.953669778649798
ENSG00000234722,60.0,,,,4.110873864173311
ENSG00000226363,13.0,,,,2.6390573296152584
ENSG00000163463,563.0,,,,6.335054251498059
ENSG00000228639,77.0,,,,4.356708826689592
ENSG00000239571,0.0,,,,0.0
ENSG00000085552,221.0,E-MTAB-779,1.6,'breast carcinoma' vs 'normal',5.402677381872279
ENSG00000228315,90.0,,,,4.51085950651685
ENSG00000119699,1440.0,E-GEOD-38959,-1.3,'breast cancer; breast' vs 'normal; breast',7.273092595999522
ENSG00000166450,158.0,,,,5.0689042022202315
ENSG00000114315,3375.0,E-GEOD-44408,-1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.124446855715847
ENSG00000258609,6.0,,,,1.9459101490553132
ENSG00000106113,55.0,,,,4.02535169073515
ENSG00000173915,1611.0,,,,7.385230923066573
ENSG00000177614,47.0,,,,3.871201010907891
ENSG00000159346,4317.0,,,,8.370547611074752
ENSG00000120057,35.0,,,,3.58351893845611
ENSG00000124875,10.0,,,,2.3978952727983707
ENSG00000121966,1190.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.0825485693553
ENSG00000121966,1190.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',7.0825485693553
ENSG00000121966,1190.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',7.0825485693553
ENSG00000163517,652.0,,,,6.481577129276431
ENSG00000164344,35.0,,,,3.58351893845611
ENSG00000160471,71.0,,,,4.276666119016055
ENSG00000185522,183.0,,,,5.214935757608986
ENSG00000205250,3483.0,,,,8.155936337972394
ENSG00000112238,0.0,,,,0.0
ENSG00000166311,1562.0,,,,7.354362330421477
ENSG00000125510,98.0,,,,4.59511985013459
ENSG00000139626,68.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.23410650459726
ENSG00000167755,40.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',3.713572066704308
ENSG00000167755,40.0,E-GEOD-52194,-4.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',3.713572066704308
ENSG00000185379,604.0,,,,6.405228458030842
ENSG00000147601,1282.0,,,,7.1569563646156364
ENSG00000181544,30.0,,,,3.4339872044851463
ENSG00000243197,0.0,E-GEOD-68086,-5.8,'breast carcinoma' vs 'normal',0.0
ENSG00000165891,11.0,E-GEOD-54002,2.6,'breast cancer' vs 'normal',2.4849066497880004
ENSG00000187741,111.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',4.718498871295094
ENSG00000237523,42.0,,,,3.7612001156935624
ENSG00000167196,984.0,,,,6.892641641172089
ENSG00000101197,7.0,,,,2.0794415416798357
ENSG00000171234,3.0,E-GEOD-52194,5.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.3862943611198906
ENSG00000155816,39.0,,,,3.6888794541139363
ENSG00000110195,53.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',3.9889840465642745
ENSG00000110195,53.0,E-GEOD-7377,-1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',3.9889840465642745
ENSG00000110195,53.0,E-GEOD-52194,-4.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',3.9889840465642745
ENSG00000110195,53.0,E-GEOD-54002,-3.5,'breast cancer' vs 'normal',3.9889840465642745
ENSG00000148200,165.0,,,,5.111987788356544
ENSG00000138496,2174.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',7.684783943522785
ENSG00000138496,2174.0,E-GEOD-7377,1.6,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.684783943522785
ENSG00000220205,5016.0,,,,8.520587424484253
ENSG00000116815,709.0,,,,6.565264970035361
ENSG00000135740,224.0,,,,5.41610040220442
ENSG00000121207,22.0,,,,3.1354942159291497
ENSG00000230978,6.0,E-GEOD-52194,-5.0,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',1.9459101490553132
ENSG00000162373,224.0,E-GEOD-44408,1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.41610040220442
ENSG00000185946,2177.0,,,,7.686162303492906
ENSG00000197084,1.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000255248,1368.0,E-GEOD-10780,-1.7,'breast carcinoma' vs 'normal',7.221835825288449
ENSG00000255248,1368.0,E-GEOD-38959,-1.7,'breast cancer; breast' vs 'normal; breast',7.221835825288449
ENSG00000255248,1368.0,E-GEOD-54002,-2.9,'breast cancer' vs 'normal',7.221835825288449
ENSG00000122952,121.0,E-GEOD-44408,-1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.804021044733257
ENSG00000122952,121.0,E-GEOD-54002,2.2,'breast cancer' vs 'normal',4.804021044733257
ENSG00000122952,121.0,E-MTAB-779,1.7,'breast carcinoma' vs 'normal',4.804021044733257
ENSG00000122952,121.0,E-GEOD-10780,2.1,'breast carcinoma' vs 'normal',4.804021044733257
ENSG00000122952,121.0,E-GEOD-38959,2.7,'breast cancer; breast' vs 'normal; breast',4.804021044733257
ENSG00000107447,0.0,,,,0.0
ENSG00000134253,449.0,,,,6.1092475827643655
ENSG00000124134,8.0,,,,2.1972245773362196
ENSG00000224853,0.0,E-GEOD-52194,5.3,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000112335,7626.0,,,,8.939449862164238
ENSG00000103355,0.0,,,,0.0
ENSG00000095587,16.0,,,,2.833213344056216
ENSG00000095752,15.0,,,,2.772588722239781
ENSG00000169714,16379.0,,,,9.70381635740706
ENSG00000116857,1961.0,,,,7.581719640125308
ENSG00000121853,0.0,,,,0.0
ENSG00000272168,225.0,,,,5.420534999272286
ENSG00000234186,1.0,,,,0.6931471805599453
ENSG00000032742,598.0,,,,6.395261598115449
ENSG00000188729,5.0,,,,1.791759469228055
ENSG00000102349,2133.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',7.665753431861699
ENSG00000102349,2133.0,E-GEOD-7377,1.9,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.665753431861699
ENSG00000162994,189.0,,,,5.247024072160486
ENSG00000181649,106.0,E-MTAB-779,1.6,'breast carcinoma' vs 'normal',4.672828834461906
ENSG00000181649,106.0,E-GEOD-52194,-4.8,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',4.672828834461906
ENSG00000181649,106.0,E-GEOD-20086,1.1,'breast cancer' vs 'normal',4.672828834461906
ENSG00000181649,106.0,E-GEOD-44408,-2.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.672828834461906
ENSG00000181649,106.0,E-GEOD-52194,-5.5,'triple-negative breast cancer; breast carcinoma' vs 'normal',4.672828834461906
ENSG00000181649,106.0,E-GEOD-52194,-6.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',4.672828834461906
ENSG00000240160,4.0,,,,1.6094379124341003
ENSG00000143570,4536.0,,,,8.420021279663963
ENSG00000134539,241.0,,,,5.488937726156687
ENSG00000138606,273.0,,,,5.6131281063880705
ENSG00000204025,0.0,,,,0.0
ENSG00000157045,1371.0,,,,7.22402480828583
ENSG00000196584,62.0,,,,4.143134726391533
ENSG00000243902,0.0,,,,0.0
ENSG00000149554,172.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',5.153291594497779
ENSG00000224259,27.0,,,,3.332204510175204
ENSG00000212127,95.0,E-GEOD-31138,3.2,'invasive ductal carcinoma' vs 'normal',4.564348191467836
ENSG00000126759,159.0,,,,5.075173815233827
ENSG00000166225,1398.0,,,,7.243512974665482
ENSG00000140406,1109.0,,,,7.01211529430638
ENSG00000212993,46.0,,,,3.8501476017100584
ENSG00000180432,27.0,,,,3.332204510175204
ENSG00000264589,2.0,,,,1.0986122886681098
ENSG00000106829,1109.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.01211529430638
ENSG00000183762,0.0,,,,0.0
ENSG00000113360,2086.0,,,,7.643482907077201
ENSG00000180914,786.0,E-GEOD-31138,-2.7,'invasive ductal carcinoma' vs 'normal',6.668228248417403
ENSG00000180914,786.0,E-GEOD-54002,-4.9,'breast cancer' vs 'normal',6.668228248417403
ENSG00000180914,786.0,E-MTAB-779,-2.2,'breast carcinoma' vs 'normal',6.668228248417403
ENSG00000180914,786.0,E-GEOD-10780,-3.5,'breast carcinoma' vs 'normal',6.668228248417403
ENSG00000180914,786.0,E-GEOD-38959,-3.6,'breast cancer; breast' vs 'normal; breast',6.668228248417403
ENSG00000180914,786.0,E-GEOD-52194,-5.3,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',6.668228248417403
ENSG00000257084,20.0,,,,3.044522437723423
ENSG00000241563,9.0,,,,2.302585092994046
ENSG00000249375,5.0,,,,1.791759469228055
ENSG00000063176,707.0,,,,6.56244409369372
ENSG00000168356,69.0,,,,4.248495242049359
ENSG00000185247,0.0,E-GEOD-52194,5.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000185247,0.0,E-GEOD-52194,4.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000106004,757.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',6.630683385642372
ENSG00000106004,757.0,E-GEOD-54002,-3.6,'breast cancer' vs 'normal',6.630683385642372
ENSG00000106004,757.0,E-GEOD-10780,-2.0,'breast carcinoma' vs 'normal',6.630683385642372
ENSG00000078596,3232.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.081165777725433
ENSG00000078596,3232.0,E-GEOD-38959,-1.3,'breast cancer; breast' vs 'normal; breast',8.081165777725433
ENSG00000078596,3232.0,E-GEOD-54002,-2.2,'breast cancer' vs 'normal',8.081165777725433
ENSG00000078596,3232.0,E-MTAB-779,-1.7,'breast carcinoma' vs 'normal',8.081165777725433
ENSG00000078596,3232.0,E-GEOD-10780,-1.7,'breast carcinoma' vs 'normal',8.081165777725433
ENSG00000113494,952.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',6.859614903654202
ENSG00000113494,952.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',6.859614903654202
ENSG00000113494,952.0,E-GEOD-7377,1.8,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.859614903654202
ENSG00000149716,1093.0,E-MTAB-779,1.7,'breast carcinoma' vs 'normal',6.9975959829819265
ENSG00000214456,1591.0,,,,7.3727463664043285
ENSG00000170185,1131.0,,,,7.0317412587631285
ENSG00000188153,1035.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',6.943122422819428
ENSG00000130294,21.0,,,,3.091042453358316
ENSG00000172123,347.0,,,,5.8522024797744745
ENSG00000142677,43.0,,,,3.784189633918261
ENSG00000282608,0.0,,,,0.0
ENSG00000052850,220.0,,,,5.3981627015177525
ENSG00000249550,8.0,,,,2.1972245773362196
ENSG00000104899,41.0,,,,3.7376696182833684
ENSG00000248663,1.0,,,,0.6931471805599453
ENSG00000155849,1627.0,E-GEOD-44408,2.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.395107546562485
ENSG00000224557,3.0,,,,1.3862943611198906
ENSG00000170381,183.0,E-GEOD-38959,-1.4,'breast cancer; breast' vs 'normal; breast',5.214935757608986
ENSG00000182931,1.0,,,,0.6931471805599453
ENSG00000171450,0.0,,,,0.0
ENSG00000136014,95.0,,,,4.564348191467836
ENSG00000184697,1.0,,,,0.6931471805599453
ENSG00000105697,10.0,,,,2.3978952727983707
ENSG00000165863,28.0,,,,3.367295829986474
ENSG00000117407,53.0,,,,3.9889840465642745
ENSG00000170214,74.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',4.31748811353631
ENSG00000135374,426.0,E-GEOD-10780,-1.6,'breast carcinoma' vs 'normal',6.056784013228625
ENSG00000135374,426.0,E-GEOD-54002,-3.9,'breast cancer' vs 'normal',6.056784013228625
ENSG00000135374,426.0,E-GEOD-52194,-6.0,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',6.056784013228625
ENSG00000135374,426.0,E-GEOD-7377,-4.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.056784013228625
ENSG00000146676,2651.0,,,,7.883069351305753
ENSG00000131910,0.0,,,,0.0
ENSG00000215458,42.0,,,,3.7612001156935624
ENSG00000177640,51.0,,,,3.9512437185814275
ENSG00000238266,4.0,,,,1.6094379124341003
ENSG00000100075,3633.0,,,,8.198089248956116
ENSG00000124343,493.0,E-GEOD-38959,1.8,'breast cancer; breast' vs 'normal; breast',6.202535517187923
ENSG00000164379,9.0,,,,2.302585092994046
ENSG00000187790,307.0,,,,5.730099782973574
ENSG00000174748,31952.0,,,,10.372021352111275
ENSG00000275718,1.0,,,,0.6931471805599453
ENSG00000145506,212.0,,,,5.3612921657094255
ENSG00000204475,8.0,E-GEOD-44408,1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',2.1972245773362196
ENSG00000177954,27532.0,,,,10.223140564230144
ENSG00000125726,7.0,,,,2.0794415416798357
ENSG00000105698,5893.0,,,,8.68169016329764
ENSG00000152767,2648.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.88193748927207
ENSG00000081041,595.0,E-GEOD-54002,-5.1,'breast cancer' vs 'normal',6.39024066706535
ENSG00000081041,595.0,E-GEOD-10780,-2.6,'breast carcinoma' vs 'normal',6.39024066706535
ENSG00000081041,595.0,E-MTAB-779,-2.3,'breast carcinoma' vs 'normal',6.39024066706535
ENSG00000081041,595.0,E-GEOD-31138,-3.1,'invasive ductal carcinoma' vs 'normal',6.39024066706535
ENSG00000081041,595.0,E-GEOD-38959,-2.0,'breast cancer; breast' vs 'normal; breast',6.39024066706535
ENSG00000081041,595.0,E-GEOD-52194,-8.4,'triple-negative breast cancer; breast carcinoma' vs 'normal',6.39024066706535
ENSG00000081041,595.0,E-GEOD-52194,-8.3,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',6.39024066706535
ENSG00000081041,595.0,E-GEOD-52194,-9.0,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',6.39024066706535
ENSG00000081041,595.0,E-GEOD-44408,4.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.39024066706535
ENSG00000184792,195.0,,,,5.278114659230517
ENSG00000162998,560.0,E-GEOD-10780,-1.5,'breast carcinoma' vs 'normal',6.329720905522696
ENSG00000151503,893.0,,,,6.795705775173514
ENSG00000114268,194.0,,,,5.272999558563747
ENSG00000176749,62.0,,,,4.143134726391533
ENSG00000120669,3.0,,,,1.3862943611198906
ENSG00000100219,0.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',0.0
ENSG00000100219,0.0,E-GEOD-38959,-1.7,'breast cancer; breast' vs 'normal; breast',0.0
ENSG00000136048,1361.0,,,,7.216709486709457
ENSG00000197989,1439.0,,,,7.272398392570047
ENSG00000105371,0.0,,,,0.0
ENSG00000115944,2732.0,,,,7.913155185928068
ENSG00000137757,5.0,,,,1.791759469228055
ENSG00000234199,2.0,,,,1.0986122886681098
ENSG00000064933,913.0,,,,6.81783057145415
ENSG00000248672,0.0,,,,0.0
ENSG00000112175,120.0,,,,4.795790545596741
ENSG00000182521,27.0,,,,3.332204510175204
ENSG00000196242,0.0,,,,0.0
ENSG00000188092,162.0,,,,5.093750200806762
ENSG00000235408,16.0,,,,2.833213344056216
ENSG00000215788,762.0,,,,6.637258031284457
ENSG00000248323,17.0,,,,2.8903717578961645
ENSG00000150667,26.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',3.295836866004329
ENSG00000150667,26.0,E-GEOD-10780,1.4,'breast carcinoma' vs 'normal',3.295836866004329
ENSG00000189013,5.0,E-GEOD-52194,5.3,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.791759469228055
ENSG00000166670,1.0,,,,0.6931471805599453
ENSG00000177156,5165.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',8.549853973655786
ENSG00000225231,0.0,,,,0.0
ENSG00000135925,10.0,,,,2.3978952727983707
ENSG00000068489,87.0,,,,4.477336814478207
ENSG00000155868,499.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.214608098422191
ENSG00000008735,134.0,,,,4.90527477843843
ENSG00000170296,1351.0,,,,7.20934025660291
ENSG00000262772,18.0,,,,2.9444389791664403
ENSG00000196363,1840.0,,,,7.518064181233078
ENSG00000173175,1243.0,,,,7.126087273299125
ENSG00000242125,1200.0,,,,7.0909098220799835
ENSG00000163239,403.0,,,,6.0014148779611505
ENSG00000069122,5653.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',8.640118538253535
ENSG00000170779,284.0,,,,5.652489180268651
ENSG00000184489,2394.0,,,,7.781138509845015
ENSG00000088882,1771.0,,,,7.4798641311650265
ENSG00000187871,3.0,,,,1.3862943611198906
ENSG00000143228,23.0,E-MTAB-779,1.7,'breast carcinoma' vs 'normal',3.1780538303479458
ENSG00000143228,23.0,E-GEOD-10780,1.4,'breast carcinoma' vs 'normal',3.1780538303479458
ENSG00000143228,23.0,E-GEOD-38959,1.5,'breast cancer; breast' vs 'normal; breast',3.1780538303479458
ENSG00000143228,23.0,E-GEOD-54002,3.6,'breast cancer' vs 'normal',3.1780538303479458
ENSG00000143228,23.0,E-GEOD-31138,3.1,'invasive ductal carcinoma' vs 'normal',3.1780538303479458
ENSG00000129465,700.0,,,,6.55250788703459
ENSG00000138092,341.0,,,,5.834810737062605
ENSG00000199038,2.0,,,,1.0986122886681098
ENSG00000006634,247.0,,,,5.5134287461649825
ENSG00000253352,7691.0,,,,8.94793610670867
ENSG00000101463,15.0,E-GEOD-52194,5.2,'triple-negative breast cancer; breast carcinoma' vs 'normal',2.772588722239781
ENSG00000101463,15.0,E-GEOD-52194,4.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',2.772588722239781
ENSG00000148826,2.0,,,,1.0986122886681098
ENSG00000012504,0.0,,,,0.0
ENSG00000281189,9.0,,,,2.302585092994046
ENSG00000233237,221.0,E-GEOD-54002,-2.1,'breast cancer' vs 'normal',5.402677381872279
ENSG00000143179,1256.0,,,,7.136483208590247
ENSG00000248329,2.0,,,,1.0986122886681098
ENSG00000105997,631.0,E-GEOD-54002,-4.2,'breast cancer' vs 'normal',6.448889394146858
ENSG00000105997,631.0,E-GEOD-10780,-1.8,'breast carcinoma' vs 'normal',6.448889394146858
ENSG00000105997,631.0,E-GEOD-68086,-5.1,'breast carcinoma' vs 'normal',6.448889394146858
ENSG00000160888,3633.0,,,,8.198089248956116
ENSG00000170846,609.0,,,,6.413458957167357
ENSG00000133195,875.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',6.775366090936392
ENSG00000133195,875.0,E-MTAB-779,1.6,'breast carcinoma' vs 'normal',6.775366090936392
ENSG00000224189,247.0,,,,5.5134287461649825
ENSG00000277399,13.0,,,,2.6390573296152584
ENSG00000186564,41.0,,,,3.7376696182833684
ENSG00000253161,14.0,,,,2.70805020110221
ENSG00000130304,2707.0,,,,7.903965634032166
ENSG00000166803,41.0,E-GEOD-54002,2.7,'breast cancer' vs 'normal',3.7376696182833684
ENSG00000166803,41.0,E-GEOD-10780,2.6,'breast carcinoma' vs 'normal',3.7376696182833684
ENSG00000166803,41.0,E-MTAB-779,2.6,'breast carcinoma' vs 'normal',3.7376696182833684
ENSG00000166803,41.0,E-GEOD-38959,3.3,'breast cancer; breast' vs 'normal; breast',3.7376696182833684
ENSG00000185883,476.0,E-GEOD-52194,-5.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',6.1675164908883415
ENSG00000227268,63.0,,,,4.1588830833596715
ENSG00000237298,463.0,,,,6.139884552226255
ENSG00000262406,7.0,,,,2.0794415416798357
ENSG00000165323,47.0,,,,3.871201010907891
ENSG00000213937,11.0,,,,2.4849066497880004
ENSG00000158470,3386.0,E-GEOD-31138,3.1,'invasive ductal carcinoma' vs 'normal',8.127699852817772
ENSG00000154262,3597.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',8.188133414510478
ENSG00000154262,3597.0,E-MTAB-779,-1.8,'breast carcinoma' vs 'normal',8.188133414510478
ENSG00000154262,3597.0,E-GEOD-31138,-3.1,'invasive ductal carcinoma' vs 'normal',8.188133414510478
ENSG00000166509,1.0,,,,0.6931471805599453
ENSG00000137507,7289.0,,,,8.894258825002703
ENSG00000100154,1881.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',7.540090320145325
ENSG00000100154,1881.0,E-GEOD-54002,-1.9,'breast cancer' vs 'normal',7.540090320145325
ENSG00000215912,91.0,,,,4.5217885770490405
ENSG00000277632,44.0,,,,3.8066624897703196
ENSG00000160951,10.0,,,,2.3978952727983707
ENSG00000256155,0.0,,,,0.0
ENSG00000171456,7563.0,,,,8.931155429778348
ENSG00000156671,2634.0,,,,7.876638460975463
ENSG00000184160,305.0,,,,5.723585101952381
ENSG00000182004,1505.0,,,,7.317212408359839
ENSG00000122877,334.0,E-GEOD-7377,-1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',5.814130531825066
ENSG00000138684,0.0,E-GEOD-52194,5.2,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',0.0
ENSG00000162552,76.0,,,,4.343805421853684
ENSG00000121270,36.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',3.6109179126442243
ENSG00000213023,5.0,,,,1.791759469228055
ENSG00000134532,341.0,,,,5.834810737062605
ENSG00000109625,35.0,,,,3.58351893845611
ENSG00000257150,23.0,,,,3.1780538303479458
ENSG00000183337,1526.0,,,,7.3310603052186325
ENSG00000256128,4.0,,,,1.6094379124341003
ENSG00000163597,1691.0,E-GEOD-31138,3.2,'invasive ductal carcinoma' vs 'normal',7.433666540166168
ENSG00000175164,460.0,,,,6.133398042996649
ENSG00000166035,19.0,,,,2.995732273553991
ENSG00000185149,64.0,E-GEOD-38959,-2.1,'breast cancer; breast' vs 'normal; breast',4.174387269895637
ENSG00000176222,135.0,,,,4.912654885736052
ENSG00000203585,2.0,,,,1.0986122886681098
ENSG00000276070,11.0,,,,2.4849066497880004
ENSG00000055118,16.0,,,,2.833213344056216
ENSG00000165186,174.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',5.1647859739235145
ENSG00000165186,174.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',5.1647859739235145
ENSG00000165186,174.0,E-GEOD-7377,-1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',5.1647859739235145
ENSG00000165186,174.0,E-GEOD-54002,-4.0,'breast cancer' vs 'normal',5.1647859739235145
ENSG00000084628,7.0,E-MTAB-779,2.3,'breast carcinoma' vs 'normal',2.0794415416798357
ENSG00000084628,7.0,E-GEOD-52194,5.3,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',2.0794415416798357
ENSG00000100526,37.0,E-MTAB-779,1.6,'breast carcinoma' vs 'normal',3.6375861597263857
ENSG00000100526,37.0,E-GEOD-54002,2.5,'breast cancer' vs 'normal',3.6375861597263857
ENSG00000100526,37.0,E-GEOD-10780,1.5,'breast carcinoma' vs 'normal',3.6375861597263857
ENSG00000100526,37.0,E-GEOD-38959,1.6,'breast cancer; breast' vs 'normal; breast',3.6375861597263857
ENSG00000179603,1.0,,,,0.6931471805599453
ENSG00000207730,1.0,,,,0.6931471805599453
ENSG00000147596,0.0,,,,0.0
ENSG00000127533,964.0,,,,6.872128101338986
ENSG00000169297,5.0,,,,1.791759469228055
ENSG00000111432,60.0,E-GEOD-31138,2.9,'invasive ductal carcinoma' vs 'normal',4.110873864173311
ENSG00000278570,15.0,,,,2.772588722239781
ENSG00000255717,3481.0,,,,8.155362120328135
ENSG00000258884,0.0,,,,0.0
ENSG00000215386,273.0,E-MTAB-779,-1.7,'breast carcinoma' vs 'normal',5.6131281063880705
ENSG00000215386,273.0,E-GEOD-38959,-1.7,'breast cancer; breast' vs 'normal; breast',5.6131281063880705
ENSG00000166881,1050.0,,,,6.957497370876951
ENSG00000115008,1.0,,,,0.6931471805599453
ENSG00000104918,8.0,,,,2.1972245773362196
ENSG00000123095,1298.0,E-GEOD-10780,-1.5,'breast carcinoma' vs 'normal',7.1693500166706
ENSG00000123095,1298.0,E-GEOD-38959,-1.7,'breast cancer; breast' vs 'normal; breast',7.1693500166706
ENSG00000123095,1298.0,E-GEOD-54002,-3.0,'breast cancer' vs 'normal',7.1693500166706
ENSG00000173432,13533.0,E-GEOD-120774,-1.5,'coronary artery disease' vs 'normal' in 'subcutaneous adipose tissue',9.51296031679217
ENSG00000225746,29.0,,,,3.4011973816621555
ENSG00000236213,6.0,,,,1.9459101490553132
ENSG00000185728,2829.0,,,,7.948031990637284
ENSG00000170579,53.0,,,,3.9889840465642745
ENSG00000108417,0.0,,,,0.0
ENSG00000262152,11.0,,,,2.4849066497880004
ENSG00000154678,314.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',5.752572638825633
ENSG00000269416,1.0,E-GEOD-52194,5.2,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000269416,1.0,E-GEOD-52194,4.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000134590,4647.0,,,,8.444192298531748
ENSG00000182870,10.0,,,,2.3978952727983707
ENSG00000137571,27.0,,,,3.332204510175204
ENSG00000196550,18.0,,,,2.9444389791664403
ENSG00000221869,10566.0,,,,9.265491216441031
ENSG00000281664,0.0,,,,0.0
ENSG00000227751,0.0,,,,0.0
ENSG00000111249,11.0,,,,2.4849066497880004
ENSG00000176720,2339.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',7.757906208351747
ENSG00000245750,12.0,,,,2.5649493574615367
ENSG00000185313,0.0,E-GEOD-52194,4.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000185313,0.0,E-GEOD-68086,-5.2,'breast carcinoma' vs 'normal',0.0
ENSG00000185313,0.0,E-GEOD-52194,5.6,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000153993,201.0,,,,5.308267697401205
ENSG00000170571,580.0,,,,6.364750756851911
ENSG00000144481,3.0,E-GEOD-52194,5.4,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.3862943611198906
ENSG00000114491,859.0,E-GEOD-31138,2.1,'invasive ductal carcinoma' vs 'normal',6.756932389247553
ENSG00000263429,5.0,,,,1.791759469228055
ENSG00000087085,113.0,,,,4.736198448394496
ENSG00000122299,3871.0,,,,8.261526448396468
ENSG00000137462,1193.0,E-GEOD-7377,-1.9,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.085064293952548
ENSG00000269190,989.0,,,,6.897704943128636
ENSG00000254550,0.0,,,,0.0
ENSG00000221818,1271.0,,,,7.148345743900068
ENSG00000107077,862.0,,,,6.760414691083428
ENSG00000151468,2411.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',7.788211557847076
ENSG00000151468,2411.0,E-MTAB-779,-2.3,'breast carcinoma' vs 'normal',7.788211557847076
ENSG00000144852,6.0,,,,1.9459101490553132
ENSG00000278662,74.0,,,,4.31748811353631
ENSG00000181222,11205.0,,,,9.32420462812523
ENSG00000130821,1838.0,E-GEOD-44408,-1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.516977224604321
ENSG00000197588,1.0,,,,0.6931471805599453
ENSG00000278970,1947.0,E-GEOD-38959,-1.8,'breast cancer; breast' vs 'normal; breast',7.5745584842024805
ENSG00000108622,1063.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',6.96979066990159
ENSG00000108622,1063.0,E-GEOD-44408,2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.96979066990159
ENSG00000146143,315.0,,,,5.755742213586912
ENSG00000173083,96.0,,,,4.574710978503383
ENSG00000107984,66.0,,,,4.204692619390966
ENSG00000198930,0.0,,,,0.0
ENSG00000121858,3731.0,,,,8.224699561967235
ENSG00000187621,13.0,E-GEOD-52194,4.7,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',2.6390573296152584
ENSG00000187621,13.0,E-GEOD-52194,6.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',2.6390573296152584
ENSG00000126215,1024.0,,,,6.932447891572509
ENSG00000134504,483.0,,,,6.182084906716632
ENSG00000182968,0.0,,,,0.0
ENSG00000136267,23.0,,,,3.1780538303479458
ENSG00000114251,310.0,E-GEOD-7377,1.8,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',5.739792912179234
ENSG00000115844,2.0,,,,1.0986122886681098
ENSG00000167634,1.0,E-GEOD-52194,5.0,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000129048,131.0,,,,4.882801922586371
ENSG00000172969,1.0,,,,0.6931471805599453
ENSG00000127743,32.0,,,,3.4965075614664802
ENSG00000119314,3417.0,,,,8.136810863675537
ENSG00000112195,8.0,E-GEOD-52194,5.7,'triple-negative breast cancer; breast carcinoma' vs 'normal',2.1972245773362196
ENSG00000225383,19.0,,,,2.995732273553991
ENSG00000185347,299.0,,,,5.703782474656201
ENSG00000205269,656.0,,,,6.48768401848461
ENSG00000240498,33.0,,,,3.5263605246161616
ENSG00000026103,1192.0,E-GEOD-44408,1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.084226422097916
ENSG00000026103,1192.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',7.084226422097916
ENSG00000173812,31193.0,,,,10.347981047611771
ENSG00000119725,106.0,,,,4.672828834461906
ENSG00000158161,1105.0,,,,7.00850518208228
ENSG00000164400,0.0,,,,0.0
ENSG00000147588,14.0,,,,2.70805020110221
ENSG00000197446,4.0,,,,1.6094379124341003
ENSG00000157368,305.0,,,,5.723585101952381
ENSG00000101282,31.0,,,,3.4657359027997265
ENSG00000169188,887.0,,,,6.78897174299217
ENSG00000256667,274.0,,,,5.616771097666572
ENSG00000222014,19.0,,,,2.995732273553991
ENSG00000161133,1.0,,,,0.6931471805599453
ENSG00000174332,82.0,,,,4.418840607796598
ENSG00000186480,2811.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',7.941651252930556
ENSG00000214274,663.0,,,,6.498282149476434
ENSG00000205667,3.0,,,,1.3862943611198906
ENSG00000076108,8652.0,,,,9.06566136060674
ENSG00000081026,730.0,,,,6.594413459749778
ENSG00000184344,3.0,,,,1.3862943611198906
ENSG00000214575,137.0,,,,4.927253685157205
ENSG00000197046,23.0,E-GEOD-31138,2.5,'invasive ductal carcinoma' vs 'normal',3.1780538303479458
ENSG00000207870,12.0,,,,2.5649493574615367
ENSG00000203875,5680.0,,,,8.644882552557126
ENSG00000096264,0.0,E-GEOD-52194,4.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000096264,0.0,E-GEOD-52194,5.9,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000183287,327.0,E-MTAB-779,-1.2,'breast carcinoma' vs 'normal',5.793013608384144
ENSG00000140367,1984.0,,,,7.59337419312129
ENSG00000188338,41.0,,,,3.7376696182833684
ENSG00000171388,135.0,,,,4.912654885736052
ENSG00000140932,11.0,,,,2.4849066497880004
ENSG00000272701,26.0,,,,3.295836866004329
ENSG00000134028,11.0,E-GEOD-52194,5.0,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',2.4849066497880004
ENSG00000134028,11.0,E-GEOD-10780,1.7,'breast carcinoma' vs 'normal',2.4849066497880004
ENSG00000134028,11.0,E-GEOD-38959,2.3,'breast cancer; breast' vs 'normal; breast',2.4849066497880004
ENSG00000109424,3.0,,,,1.3862943611198906
ENSG00000125533,0.0,,,,0.0
ENSG00000111684,1029.0,,,,6.937314081223682
ENSG00000120129,33804.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',10.428363999524779
ENSG00000140400,7828.0,,,,8.965590066907914
ENSG00000139734,17.0,E-GEOD-38959,2.0,'breast cancer; breast' vs 'normal; breast',2.8903717578961645
ENSG00000231721,1197.0,,,,7.088408778675395
ENSG00000142700,0.0,,,,0.0
ENSG00000202354,0.0,E-GEOD-52194,5.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000202354,0.0,E-GEOD-52194,4.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000197019,656.0,E-GEOD-52194,-4.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',6.48768401848461
ENSG00000107738,6218.0,,,,8.735364401103888
ENSG00000279296,9.0,,,,2.302585092994046
ENSG00000008277,296.0,,,,5.6937321388027
ENSG00000231160,297.0,E-GEOD-54002,-2.0,'breast cancer' vs 'normal',5.697093486505405
ENSG00000185155,3.0,,,,1.3862943611198906
ENSG00000235947,17.0,,,,2.8903717578961645
ENSG00000065675,59.0,E-GEOD-44408,2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.0943445622221
ENSG00000100505,170.0,,,,5.14166355650266
ENSG00000134716,72.0,E-GEOD-7377,1.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',4.290459441148391
ENSG00000196542,22.0,,,,3.1354942159291497
ENSG00000177084,2381.0,,,,7.775695749915245
ENSG00000180178,32.0,,,,3.4965075614664802
ENSG00000197766,30372.0,E-GEOD-20086,-2.4,'breast cancer' vs 'normal',10.321309334853664
ENSG00000197766,30372.0,E-GEOD-10780,-2.9,'breast carcinoma' vs 'normal',10.321309334853664
ENSG00000197766,30372.0,E-MTAB-779,-2.1,'breast carcinoma' vs 'normal',10.321309334853664
ENSG00000150551,6.0,,,,1.9459101490553132
ENSG00000143248,6491.0,,,,8.778325928634482
ENSG00000105664,392.0,E-GEOD-54002,2.7,'breast cancer' vs 'normal',5.973809611869261
ENSG00000105664,392.0,E-GEOD-10780,2.6,'breast carcinoma' vs 'normal',5.973809611869261
ENSG00000105664,392.0,E-MTAB-779,2.3,'breast carcinoma' vs 'normal',5.973809611869261
ENSG00000105664,392.0,E-GEOD-44408,-3.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.973809611869261
ENSG00000126010,17.0,E-GEOD-38959,-1.7,'breast cancer; breast' vs 'normal; breast',2.8903717578961645
ENSG00000260032,13045.0,,,,9.476236852356042
ENSG00000189377,16.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',2.833213344056216
ENSG00000119919,0.0,,,,0.0
ENSG00000187260,581.0,E-GEOD-7377,-1.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.366470447731438
ENSG00000187260,581.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',6.366470447731438
ENSG00000187260,581.0,E-GEOD-31138,-3.5,'invasive ductal carcinoma' vs 'normal',6.366470447731438
ENSG00000180592,46.0,,,,3.8501476017100584
ENSG00000114383,977.0,,,,6.885509670034818
ENSG00000198060,2288.0,,,,7.735870319952567
ENSG00000131724,5165.0,,,,8.549853973655786
ENSG00000149781,865.0,,,,6.763884908562435
ENSG00000198054,0.0,,,,0.0
ENSG00000185085,958.0,,,,6.8658910748834385
ENSG00000109255,1.0,E-GEOD-38959,1.7,'breast cancer; breast' vs 'normal; breast',0.6931471805599453
ENSG00000233429,670.0,,,,6.508769136971682
ENSG00000171617,707.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.56244409369372
ENSG00000142227,1424.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.261927092702751
ENSG00000177337,200.0,,,,5.303304908059076
ENSG00000242252,48.0,,,,3.8918202981106265
ENSG00000106331,0.0,E-GEOD-52194,4.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000106331,0.0,E-GEOD-52194,5.5,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000104964,12784.0,,,,9.456027887725288
ENSG00000242808,7.0,,,,2.0794415416798357
ENSG00000130487,18.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',2.9444389791664403
ENSG00000128513,932.0,,,,6.838405200847344
ENSG00000143257,22.0,,,,3.1354942159291497
ENSG00000214548,8033.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',8.991437814919227
ENSG00000214548,8033.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',8.991437814919227
ENSG00000004142,3729.0,,,,8.224163512637862
ENSG00000178301,84.0,,,,4.442651256490317
ENSG00000232119,966.0,,,,6.874198495453294
ENSG00000127954,13866.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',9.537267195753865
ENSG00000127954,13866.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',9.537267195753865
ENSG00000127954,13866.0,E-GEOD-31138,-3.5,'invasive ductal carcinoma' vs 'normal',9.537267195753865
ENSG00000123473,151.0,,,,5.0238805208462765
ENSG00000182393,0.0,,,,0.0
ENSG00000037965,414.0,,,,6.028278520230698
ENSG00000265369,30.0,,,,3.4339872044851463
ENSG00000198121,2129.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.6638772587034705
ENSG00000198121,2129.0,E-GEOD-68086,-4.9,'breast carcinoma' vs 'normal',7.6638772587034705
ENSG00000155034,191.0,,,,5.2574953720277815
ENSG00000119231,1683.0,,,,7.428927194802272
ENSG00000063438,99.0,,,,4.605170185988092
ENSG00000164129,54.0,E-GEOD-68086,-5.2,'breast carcinoma' vs 'normal',4.007333185232471
ENSG00000162669,56.0,,,,4.04305126783455
ENSG00000229140,0.0,E-GEOD-52194,4.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000229140,0.0,E-GEOD-52194,6.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000168685,453.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',6.118097198041348
ENSG00000168685,453.0,E-GEOD-44408,2.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.118097198041348
ENSG00000168685,453.0,E-GEOD-25407,2.1,'breast cancer' vs 'normal',6.118097198041348
ENSG00000168685,453.0,E-GEOD-7377,-2.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.118097198041348
ENSG00000060718,30.0,E-MTAB-779,1.9,'breast carcinoma' vs 'normal',3.4339872044851463
ENSG00000060718,30.0,E-GEOD-52194,4.9,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',3.4339872044851463
ENSG00000060718,30.0,E-GEOD-20086,1.8,'breast cancer' vs 'normal',3.4339872044851463
ENSG00000060718,30.0,E-GEOD-54002,4.6,'breast cancer' vs 'normal',3.4339872044851463
ENSG00000060718,30.0,E-GEOD-10780,2.6,'breast carcinoma' vs 'normal',3.4339872044851463
ENSG00000060718,30.0,E-GEOD-31138,5.1,'invasive ductal carcinoma' vs 'normal',3.4339872044851463
ENSG00000060718,30.0,E-GEOD-52194,5.7,'triple-negative breast cancer; breast carcinoma' vs 'normal',3.4339872044851463
ENSG00000235703,407.0,,,,6.0112671744041615
ENSG00000225077,1.0,,,,0.6931471805599453
ENSG00000188064,45.0,,,,3.828641396489095
ENSG00000233966,7.0,,,,2.0794415416798357
ENSG00000112282,2130.0,,,,7.664346632098617
ENSG00000154144,2328.0,E-GEOD-38959,-1.3,'breast cancer; breast' vs 'normal; breast',7.753194269884341
ENSG00000153250,6177.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',8.728749873478527
ENSG00000249915,3121.0,,,,8.046229101075378
ENSG00000163291,646.0,,,,6.472346294500901
ENSG00000121454,115.0,,,,4.7535901911063645
ENSG00000178695,9189.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',9.125871215349733
ENSG00000178695,9189.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',9.125871215349733
ENSG00000187045,11.0,,,,2.4849066497880004
ENSG00000135457,1601.0,,,,7.379008127628304
ENSG00000185482,156.0,,,,5.056245805348308
ENSG00000246228,7.0,,,,2.0794415416798357
ENSG00000163659,1911.0,E-GEOD-52194,-5.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',7.555905093611346
ENSG00000104903,340.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.831882477283517
ENSG00000236289,0.0,,,,0.0
ENSG00000151725,108.0,E-GEOD-54002,2.0,'breast cancer' vs 'normal',4.6913478822291435
ENSG00000151725,108.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',4.6913478822291435
ENSG00000151725,108.0,E-MTAB-779,2.0,'breast carcinoma' vs 'normal',4.6913478822291435
ENSG00000278053,1085.0,,,,6.990256500493881
ENSG00000106689,0.0,,,,0.0
ENSG00000149634,54.0,,,,4.007333185232471
ENSG00000167232,953.0,,,,6.860663671448287
ENSG00000280890,0.0,,,,0.0
ENSG00000176046,5791.0,,,,8.664232934065552
ENSG00000105991,53.0,,,,3.9889840465642745
ENSG00000100987,2.0,,,,1.0986122886681098
ENSG00000109158,1.0,,,,0.6931471805599453
ENSG00000239732,8.0,,,,2.1972245773362196
ENSG00000143409,1393.0,,,,7.2399325913204695
ENSG00000223804,164.0,,,,5.10594547390058
ENSG00000237940,131.0,,,,4.882801922586371
ENSG00000186866,2571.0,,,,7.85243908535751
ENSG00000169302,126.0,,,,4.844187086458591
ENSG00000163961,1303.0,,,,7.1731917424865985
ENSG00000090534,62.0,,,,4.143134726391533
ENSG00000167968,33.0,,,,3.5263605246161616
ENSG00000183439,12.0,,,,2.5649493574615367
ENSG00000178919,3.0,,,,1.3862943611198906
ENSG00000261456,6.0,,,,1.9459101490553132
ENSG00000173930,16.0,,,,2.833213344056216
ENSG00000159788,1836.0,,,,7.515889085215125
ENSG00000122025,28.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.367295829986474
ENSG00000079387,835.0,,,,6.728628613084702
ENSG00000133048,2635.0,E-GEOD-54002,-3.4,'breast cancer' vs 'normal',7.877017895622398
ENSG00000125885,528.0,,,,6.270988431858299
ENSG00000151208,3171.0,E-GEOD-44408,-2.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.06211758275474
ENSG00000243264,2.0,,,,1.0986122886681098
ENSG00000164045,33.0,,,,3.5263605246161616
ENSG00000034510,20043.0,E-GEOD-38959,1.6,'breast cancer; breast' vs 'normal; breast',9.905685136079615
ENSG00000164109,118.0,E-GEOD-54002,1.7,'breast cancer' vs 'normal',4.77912349311153
ENSG00000164109,118.0,E-GEOD-31138,2.5,'invasive ductal carcinoma' vs 'normal',4.77912349311153
ENSG00000164109,118.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',4.77912349311153
ENSG00000164109,118.0,E-GEOD-10780,1.9,'breast carcinoma' vs 'normal',4.77912349311153
ENSG00000156384,197.0,,,,5.288267030694535
ENSG00000115946,787.0,,,,6.669498089857879
ENSG00000188211,96.0,,,,4.574710978503383
ENSG00000134595,0.0,,,,0.0
ENSG00000113070,1214.0,E-GEOD-52194,-5.5,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',7.102499355774649
ENSG00000113070,1214.0,E-GEOD-20086,1.3,'breast cancer' vs 'normal',7.102499355774649
ENSG00000113070,1214.0,E-GEOD-52194,-5.8,'triple-negative breast cancer; breast carcinoma' vs 'normal',7.102499355774649
ENSG00000113070,1214.0,E-GEOD-52194,-5.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',7.102499355774649
ENSG00000198417,227.0,,,,5.429345628954441
ENSG00000143753,3231.0,,,,8.080856419640986
ENSG00000173578,8.0,E-GEOD-52194,4.9,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',2.1972245773362196
ENSG00000101082,44.0,,,,3.8066624897703196
ENSG00000030582,8567.0,,,,9.055789612127585
ENSG00000084731,488.0,,,,6.192362489474872
ENSG00000244687,385.0,,,,5.955837369464831
ENSG00000165494,4115.0,,,,8.32263709695394
ENSG00000138755,51.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',3.9512437185814275
ENSG00000138755,51.0,E-GEOD-54002,2.5,'breast cancer' vs 'normal',3.9512437185814275
ENSG00000138755,51.0,E-GEOD-10780,1.9,'breast carcinoma' vs 'normal',3.9512437185814275
ENSG00000138755,51.0,E-GEOD-38959,2.0,'breast cancer; breast' vs 'normal; breast',3.9512437185814275
ENSG00000229656,4.0,,,,1.6094379124341003
ENSG00000120942,888.0,,,,6.790097235513905
ENSG00000198899,305663.0,,,,12.63024173843211
ENSG00000070770,3005.0,,,,8.00836557031292
ENSG00000203930,31.0,E-GEOD-52194,5.4,'triple-negative breast cancer; breast carcinoma' vs 'normal',3.4657359027997265
ENSG00000203930,31.0,E-GEOD-52194,5.6,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',3.4657359027997265
ENSG00000203930,31.0,E-MTAB-779,-2.0,'breast carcinoma' vs 'normal',3.4657359027997265
ENSG00000245526,1.0,E-GEOD-52194,6.2,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000185436,206.0,,,,5.332718793265369
ENSG00000188676,11.0,,,,2.4849066497880004
ENSG00000198542,288.0,E-GEOD-54002,-2.8,'breast cancer' vs 'normal',5.666426688112432
ENSG00000198542,288.0,E-GEOD-38959,-2.1,'breast cancer; breast' vs 'normal; breast',5.666426688112432
ENSG00000196611,3.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',1.3862943611198906
ENSG00000196611,3.0,E-GEOD-54002,2.4,'breast cancer' vs 'normal',1.3862943611198906
ENSG00000196611,3.0,E-GEOD-10780,1.7,'breast carcinoma' vs 'normal',1.3862943611198906
ENSG00000256223,666.0,,,,6.502790045915623
ENSG00000168594,2.0,,,,1.0986122886681098
ENSG00000265933,8.0,,,,2.1972245773362196
ENSG00000177410,3334.0,E-MTAB-779,1.2,'breast carcinoma' vs 'normal',8.112227958349724
ENSG00000225210,51.0,,,,3.9512437185814275
ENSG00000241697,0.0,,,,0.0
ENSG00000182048,15.0,,,,2.772588722239781
ENSG00000185737,6.0,,,,1.9459101490553132
ENSG00000244306,22.0,,,,3.1354942159291497
ENSG00000198033,1.0,,,,0.6931471805599453
ENSG00000136696,0.0,,,,0.0
ENSG00000126012,5424.0,,,,8.59877317840866
ENSG00000171711,0.0,,,,0.0
ENSG00000187912,3.0,,,,1.3862943611198906
ENSG00000221867,0.0,,,,0.0
ENSG00000131746,1636.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',7.400620577371135
ENSG00000131746,1636.0,E-GEOD-38959,-1.3,'breast cancer; breast' vs 'normal; breast',7.400620577371135
ENSG00000131746,1636.0,E-GEOD-52194,-4.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',7.400620577371135
ENSG00000164220,122.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',4.812184355372417
ENSG00000260691,2.0,,,,1.0986122886681098
ENSG00000100228,197.0,,,,5.288267030694535
ENSG00000189056,315.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.755742213586912
ENSG00000189056,315.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',5.755742213586912
ENSG00000189056,315.0,E-GEOD-20086,-1.1,'breast cancer' vs 'normal',5.755742213586912
ENSG00000183034,0.0,E-GEOD-52194,5.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000183034,0.0,E-GEOD-52194,4.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000230013,1.0,,,,0.6931471805599453
ENSG00000114346,438.0,E-GEOD-54002,1.7,'breast cancer' vs 'normal',6.0844994130751715
ENSG00000114346,438.0,E-GEOD-44408,-1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.0844994130751715
ENSG00000114346,438.0,E-MTAB-779,1.6,'breast carcinoma' vs 'normal',6.0844994130751715
ENSG00000114346,438.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.0844994130751715
ENSG00000114346,438.0,E-GEOD-10780,1.9,'breast carcinoma' vs 'normal',6.0844994130751715
ENSG00000114346,438.0,E-GEOD-31138,3.2,'invasive ductal carcinoma' vs 'normal',6.0844994130751715
ENSG00000114346,438.0,E-GEOD-38959,2.5,'breast cancer; breast' vs 'normal; breast',6.0844994130751715
ENSG00000245532,133364.0,,,,11.80084500922335
ENSG00000253552,358.0,,,,5.883322388488279
ENSG00000164287,3.0,,,,1.3862943611198906
ENSG00000171517,13.0,,,,2.6390573296152584
ENSG00000168615,3313.0,E-GEOD-7377,1.9,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.105911197986508
ENSG00000227036,15.0,,,,2.772588722239781
ENSG00000167992,342.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',5.8377304471659395
ENSG00000183918,29.0,E-GEOD-44408,2.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.4011973816621555
ENSG00000224209,0.0,E-GEOD-52194,4.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000160917,1547.0,,,,7.344719054149673
ENSG00000143674,95.0,,,,4.564348191467836
ENSG00000116132,4588.0,,,,8.431417414394833
ENSG00000072840,960.0,,,,6.8679744089702925
ENSG00000198718,916.0,,,,6.821107472256465
ENSG00000122643,1009.0,,,,6.917705609835305
ENSG00000123200,3543.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',8.173011311724972
ENSG00000250506,45.0,,,,3.828641396489095
ENSG00000182197,1901.0,,,,7.550661243105336
ENSG00000169750,307.0,,,,5.730099782973574
ENSG00000164221,295.0,,,,5.69035945432406
ENSG00000198925,3536.0,,,,8.17103418920548
ENSG00000170949,2549.0,,,,7.843848638152472
ENSG00000185650,31727.0,,,,10.364954850759577
ENSG00000166592,875.0,,,,6.775366090936392
ENSG00000162413,4648.0,,,,8.444407421690585
ENSG00000188171,283.0,,,,5.648974238161206
ENSG00000197712,2107.0,E-GEOD-44408,-1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.653494909661253
ENSG00000120149,116.0,E-GEOD-44408,-2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.762173934797756
ENSG00000120149,116.0,E-GEOD-7377,1.8,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',4.762173934797756
ENSG00000066427,2270.0,,,,7.7279755421055585
ENSG00000159388,10507.0,,,,9.259892150805431
ENSG00000167779,5019.0,E-MTAB-779,-2.2,'breast carcinoma' vs 'normal',8.521185212685776
ENSG00000167779,5019.0,E-GEOD-10780,-2.4,'breast carcinoma' vs 'normal',8.521185212685776
ENSG00000111554,651.0,,,,6.480044561926653
ENSG00000205336,4484.0,E-GEOD-44408,-2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.408493774492896
ENSG00000115525,1054.0,,,,6.961296045910167
ENSG00000204186,572.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',6.35088571671474
ENSG00000122550,1034.0,,,,6.942156705699469
ENSG00000198892,559.0,,,,6.327936783729195
ENSG00000111199,136.0,,,,4.919980925828125
ENSG00000243364,234.0,,,,5.459585514144159
ENSG00000012171,1277.0,E-GEOD-68086,-5.5,'breast carcinoma' vs 'normal',7.15305163493748
ENSG00000151117,309.0,,,,5.736572297479192
ENSG00000163464,27.0,,,,3.332204510175204
ENSG00000266412,7004.0,,,,8.854379458771108
ENSG00000088448,6761.0,,,,8.819073983267831
ENSG00000138615,2523.0,E-GEOD-54002,2.0,'breast cancer' vs 'normal',7.8336002236611035
ENSG00000138615,2523.0,E-GEOD-44408,-2.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.8336002236611035
ENSG00000161960,1806.0,,,,7.499423290592229
ENSG00000006459,3396.0,,,,8.130647968160584
ENSG00000104660,1416.0,,,,7.256297239690681
ENSG00000140285,1769.0,,,,7.478734825567875
ENSG00000127191,729.0,,,,6.593044534142437
ENSG00000134215,1138.0,E-GEOD-7377,2.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.037905963447182
ENSG00000137504,6259.0,,,,8.741935464094144
ENSG00000179632,5170.0,,,,8.550821372396221
ENSG00000089127,623.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',6.436150368369428
ENSG00000112333,0.0,,,,0.0
ENSG00000115507,4.0,,,,1.6094379124341003
ENSG00000152217,1970.0,E-GEOD-10780,-1.6,'breast carcinoma' vs 'normal',7.58629630715272
ENSG00000204564,608.0,,,,6.411818267709897
ENSG00000183513,1359.0,,,,7.215239978730097
ENSG00000262655,1655.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.412160334945205
ENSG00000262655,1655.0,E-GEOD-68086,-5.0,'breast carcinoma' vs 'normal',7.412160334945205
ENSG00000052344,529.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',6.272877006546167
ENSG00000052344,529.0,E-GEOD-44408,-3.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.272877006546167
ENSG00000122483,251.0,,,,5.529429087511423
ENSG00000110092,3104.0,E-GEOD-31138,2.3,'invasive ductal carcinoma' vs 'normal',8.040768994367578
ENSG00000110092,3104.0,E-GEOD-44408,-2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.040768994367578
ENSG00000135451,47.0,E-GEOD-54002,1.7,'breast cancer' vs 'normal',3.871201010907891
ENSG00000135451,47.0,E-MTAB-779,2.1,'breast carcinoma' vs 'normal',3.871201010907891
ENSG00000135451,47.0,E-GEOD-38959,1.9,'breast cancer; breast' vs 'normal; breast',3.871201010907891
ENSG00000198624,7487.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.921057018157429
ENSG00000198624,7487.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',8.921057018157429
ENSG00000140836,1641.0,,,,7.403670290012373
ENSG00000151475,0.0,,,,0.0
ENSG00000011422,602.0,,,,6.401917196727186
ENSG00000102218,593.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',6.386879319362645
ENSG00000009413,3357.0,,,,8.119100837637486
ENSG00000099800,1357.0,,,,7.213768308118642
ENSG00000088387,5630.0,,,,8.636042325254618
ENSG00000173171,833.0,,,,6.726233402358747
ENSG00000107242,305.0,E-GEOD-54002,-2.0,'breast cancer' vs 'normal',5.723585101952381
ENSG00000132432,1471.0,E-GEOD-38959,1.5,'breast cancer; breast' vs 'normal; breast',7.294377299288821
ENSG00000154124,1145.0,,,,7.044032897274685
ENSG00000005102,1615.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',7.38770923908104
ENSG00000106400,2606.0,,,,7.865955413933502
ENSG00000109475,20928.0,,,,9.948891035989977
ENSG00000111237,2717.0,,,,7.907651594711089
ENSG00000166603,0.0,,,,0.0
ENSG00000100416,1923.0,,,,7.562161631225652
ENSG00000146374,807.0,E-GEOD-10780,-1.7,'breast carcinoma' vs 'normal',6.694562058521095
ENSG00000125629,1076.0,,,,6.981934677156389
ENSG00000091656,917.0,,,,6.822197390620491
ENSG00000198056,185.0,,,,5.225746673713202
ENSG00000256683,501.0,,,,6.218600119691729
ENSG00000160293,1226.0,,,,7.112327444710911
ENSG00000138604,997.0,,,,6.905753276311464
ENSG00000085511,1890.0,,,,7.544861068658458
ENSG00000162702,633.0,,,,6.452048954437226
ENSG00000171189,37.0,,,,3.6375861597263857
ENSG00000221955,106.0,E-GEOD-44408,-1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.672828834461906
ENSG00000221955,106.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',4.672828834461906
ENSG00000186470,1482.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.301822342137932
ENSG00000196576,9187.0,,,,9.125653563808989
ENSG00000167601,3543.0,,,,8.173011311724972
ENSG00000109906,3280.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',8.0959035329611
ENSG00000109906,3280.0,E-MTAB-779,-2.7,'breast carcinoma' vs 'normal',8.0959035329611
ENSG00000109906,3280.0,E-GEOD-10780,-1.8,'breast carcinoma' vs 'normal',8.0959035329611
ENSG00000143921,1.0,,,,0.6931471805599453
ENSG00000130669,1359.0,,,,7.215239978730097
ENSG00000134779,1848.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.522400231387125
ENSG00000196639,376.0,,,,5.932245187448011
ENSG00000128534,1435.0,,,,7.269616749608169
ENSG00000131459,1682.0,,,,7.428333194190806
ENSG00000167123,1718.0,,,,7.449498005382849
ENSG00000268104,68.0,E-GEOD-54002,-4.7,'breast cancer' vs 'normal',4.23410650459726
ENSG00000268104,68.0,E-GEOD-68086,-5.3,'breast carcinoma' vs 'normal',4.23410650459726
ENSG00000268104,68.0,E-GEOD-10780,-1.9,'breast carcinoma' vs 'normal',4.23410650459726
ENSG00000129292,2396.0,,,,7.781973234434385
ENSG00000186281,471.0,,,,6.156978985585555
ENSG00000183814,153.0,E-GEOD-38959,1.5,'breast cancer; breast' vs 'normal; breast',5.0369526024136295
ENSG00000183814,153.0,E-GEOD-31138,3.1,'invasive ductal carcinoma' vs 'normal',5.0369526024136295
ENSG00000156052,3946.0,,,,8.280711075662847
ENSG00000196262,14885.0,E-GEOD-31138,2.0,'invasive ductal carcinoma' vs 'normal',9.608176452919857
ENSG00000175197,1340.0,,,,7.201170883281678
ENSG00000163840,1921.0,,,,7.561121589530238
ENSG00000173456,1121.0,,,,7.022868086082641
ENSG00000111404,371.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',5.918893854273146
ENSG00000163322,436.0,,,,6.07993319509559
ENSG00000118849,1359.0,E-GEOD-54002,-3.8,'breast cancer' vs 'normal',7.215239978730097
ENSG00000101187,2559.0,E-GEOD-31138,-2.3,'invasive ductal carcinoma' vs 'normal',7.847762537473608
ENSG00000101187,2559.0,E-GEOD-52194,-5.1,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',7.847762537473608
ENSG00000052126,1215.0,E-GEOD-44408,-1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.103322062526113
ENSG00000118946,131.0,E-GEOD-31138,4.3,'invasive ductal carcinoma' vs 'normal',4.882801922586371
ENSG00000159403,26987.0,,,,10.203147601747316
ENSG00000103222,2286.0,,,,7.734996194022781
ENSG00000154080,51.0,E-GEOD-54002,-2.9,'breast cancer' vs 'normal',3.9512437185814275
ENSG00000154080,51.0,E-GEOD-68086,-5.1,'breast carcinoma' vs 'normal',3.9512437185814275
ENSG00000149564,5167.0,,,,8.550241045462437
ENSG00000119508,622.0,E-GEOD-54002,-2.3,'breast cancer' vs 'normal',6.434546518787453
ENSG00000119508,622.0,E-GEOD-52194,-5.7,'triple-negative breast cancer; breast carcinoma' vs 'normal',6.434546518787453
ENSG00000153253,146.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.990432586778736
ENSG00000153253,146.0,E-GEOD-54002,-2.4,'breast cancer' vs 'normal',4.990432586778736
ENSG00000153253,146.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',4.990432586778736
ENSG00000198363,10947.0,E-GEOD-7377,1.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',9.30091207016057
ENSG00000104415,50.0,E-GEOD-54002,3.2,'breast cancer' vs 'normal',3.9318256327243257
ENSG00000104415,50.0,E-GEOD-20086,1.5,'breast cancer' vs 'normal',3.9318256327243257
ENSG00000172818,20.0,E-MTAB-779,1.6,'breast carcinoma' vs 'normal',3.044522437723423
ENSG00000163508,25.0,,,,3.258096538021482
ENSG00000126458,3802.0,,,,8.24354550792826
ENSG00000163430,27641.0,,,,10.227091634163973
ENSG00000101057,39.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',3.6888794541139363
ENSG00000187955,5756.0,E-MTAB-779,-1.7,'breast carcinoma' vs 'normal',8.65817178467581
ENSG00000187955,5756.0,E-GEOD-10780,-1.7,'breast carcinoma' vs 'normal',8.65817178467581
ENSG00000187955,5756.0,E-GEOD-38959,-2.5,'breast cancer; breast' vs 'normal; breast',8.65817178467581
ENSG00000073803,906.0,E-GEOD-31138,-2.4,'invasive ductal carcinoma' vs 'normal',6.810142450115136
ENSG00000111817,3474.0,,,,8.153349757998892
ENSG00000119203,1018.0,,,,6.926577033222725
ENSG00000197705,53.0,,,,3.9889840465642745
ENSG00000276409,480.0,,,,6.175867270105761
ENSG00000131174,2211.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',7.701652362642226
ENSG00000124356,1603.0,,,,7.38025578842646
ENSG00000115963,2834.0,E-GEOD-54002,-2.1,'breast cancer' vs 'normal',7.949797216161852
ENSG00000115963,2834.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',7.949797216161852
ENSG00000175591,111.0,,,,4.718498871295094
ENSG00000141219,828.0,,,,6.720220155135295
ENSG00000128039,657.0,,,,6.489204931325317
ENSG00000100209,470.0,,,,6.154858094016418
ENSG00000066468,665.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',6.501289670540389
ENSG00000066468,665.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',6.501289670540389
ENSG00000066468,665.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',6.501289670540389
ENSG00000151617,823.0,E-GEOD-31138,2.9,'invasive ductal carcinoma' vs 'normal',6.714170529909472
ENSG00000175643,37.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',3.6375861597263857
ENSG00000136603,1691.0,,,,7.433666540166168
ENSG00000185989,3540.0,E-GEOD-44408,1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.172164452111904
ENSG00000029153,197.0,,,,5.288267030694535
ENSG00000177082,398.0,,,,5.988961416889864
ENSG00000183508,402.0,E-GEOD-38959,-1.3,'breast cancer; breast' vs 'normal; breast',5.998936561946683
ENSG00000111206,88.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',4.48863636973214
ENSG00000111206,88.0,E-GEOD-54002,2.3,'breast cancer' vs 'normal',4.48863636973214
ENSG00000076344,534.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',6.282266746896006
ENSG00000134014,1231.0,,,,7.116394144093465
ENSG00000198382,2668.0,,,,7.889459149404524
ENSG00000004809,7.0,,,,2.0794415416798357
ENSG00000109436,3700.0,E-GEOD-38959,-2.3,'breast cancer; breast' vs 'normal; breast',8.216358332386156
ENSG00000109436,3700.0,E-GEOD-7377,1.7,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.216358332386156
ENSG00000165304,19.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',2.995732273553991
ENSG00000165304,19.0,E-GEOD-54002,3.4,'breast cancer' vs 'normal',2.995732273553991
ENSG00000165304,19.0,E-GEOD-10780,1.9,'breast carcinoma' vs 'normal',2.995732273553991
ENSG00000174444,62965.0,,,,11.050350177152948
ENSG00000110492,1394.0,E-GEOD-38959,2.0,'breast cancer; breast' vs 'normal; breast',7.240649694255466
ENSG00000130520,1614.0,,,,7.387090235656757
ENSG00000185633,1228.0,E-GEOD-20086,1.1,'breast cancer' vs 'normal',7.113956109566034
ENSG00000137959,773.0,E-GEOD-54002,1.8,'breast cancer' vs 'normal',6.651571873589727
ENSG00000137959,773.0,E-GEOD-10780,1.4,'breast carcinoma' vs 'normal',6.651571873589727
ENSG00000075303,657.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',6.489204931325317
ENSG00000151835,1376.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.227662498728654
ENSG00000151835,1376.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',7.227662498728654
ENSG00000151835,1376.0,E-GEOD-54002,-2.5,'breast cancer' vs 'normal',7.227662498728654
ENSG00000151835,1376.0,E-GEOD-31138,2.7,'invasive ductal carcinoma' vs 'normal',7.227662498728654
ENSG00000067057,2050.0,,,,7.62608275807238
ENSG00000145703,880.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',6.78105762593618
ENSG00000069509,385.0,E-GEOD-31138,3.0,'invasive ductal carcinoma' vs 'normal',5.955837369464831
ENSG00000077713,938.0,,,,6.844815479208263
ENSG00000140873,136.0,,,,4.919980925828125
ENSG00000169218,139.0,E-GEOD-52194,-5.6,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',4.941642422609304
ENSG00000118526,18.0,,,,2.9444389791664403
ENSG00000116213,1280.0,,,,7.155396301896734
ENSG00000100077,1774.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',7.4815557019095165
ENSG00000100077,1774.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',7.4815557019095165
ENSG00000100968,4726.0,,,,8.461046030793236
ENSG00000103067,621.0,E-GEOD-44408,-2.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.432940092739179
ENSG00000037897,435.0,,,,6.077642243349034
ENSG00000165675,588.0,,,,6.3784261836515865
ENSG00000158815,26.0,,,,3.295836866004329
ENSG00000155366,5591.0,,,,8.629092283913646
ENSG00000141506,472.0,,,,6.159095388491933
ENSG00000104371,4.0,,,,1.6094379124341003
ENSG00000141429,2717.0,,,,7.907651594711089
ENSG00000034713,3967.0,,,,8.286017468404763
ENSG00000123094,1199.0,,,,7.090076835776092
ENSG00000162711,132.0,,,,4.890349128221754
ENSG00000132781,756.0,,,,6.6293632534374485
ENSG00000126368,4208.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',8.344980368770571
ENSG00000174791,437.0,,,,6.082218910376446
ENSG00000140465,259.0,E-GEOD-52194,-4.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',5.560681631015528
ENSG00000170385,1104.0,E-GEOD-31138,2.2,'invasive ductal carcinoma' vs 'normal',7.007600613951853
ENSG00000134830,339.0,,,,5.8289456176102075
ENSG00000005243,1225.0,,,,7.111512116496157
ENSG00000156234,5.0,E-GEOD-54002,2.7,'breast cancer' vs 'normal',1.791759469228055
ENSG00000156234,5.0,E-GEOD-10780,1.5,'breast carcinoma' vs 'normal',1.791759469228055
ENSG00000156234,5.0,E-GEOD-52194,-4.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',1.791759469228055
ENSG00000156234,5.0,E-GEOD-44408,2.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',1.791759469228055
ENSG00000048052,750.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.621405651764134
ENSG00000100934,3523.0,E-GEOD-31138,3.2,'invasive ductal carcinoma' vs 'normal',8.16735198705607
ENSG00000131408,4182.0,,,,8.338783971442199
ENSG00000133812,2765.0,,,,7.925157512224703
ENSG00000187688,837.0,,,,6.731018100482083
ENSG00000038274,2812.0,,,,7.9420068084898565
ENSG00000169432,92.0,,,,4.532599493153256
ENSG00000127920,4863.0,E-GEOD-38959,-1.3,'breast cancer; breast' vs 'normal; breast',8.489616423646003
ENSG00000127920,4863.0,E-GEOD-10780,-1.5,'breast carcinoma' vs 'normal',8.489616423646003
ENSG00000170522,274.0,E-GEOD-44408,-1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.616771097666572
ENSG00000170522,274.0,E-GEOD-54002,1.7,'breast cancer' vs 'normal',5.616771097666572
ENSG00000109805,29.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',3.4011973816621555
ENSG00000109805,29.0,E-GEOD-31138,2.3,'invasive ductal carcinoma' vs 'normal',3.4011973816621555
ENSG00000109805,29.0,E-GEOD-54002,2.8,'breast cancer' vs 'normal',3.4011973816621555
ENSG00000109805,29.0,E-MTAB-779,2.1,'breast carcinoma' vs 'normal',3.4011973816621555
ENSG00000109805,29.0,E-GEOD-38959,2.8,'breast cancer; breast' vs 'normal; breast',3.4011973816621555
ENSG00000088832,8287.0,,,,9.022563964499264
ENSG00000167005,3224.0,,,,8.078688229229872
ENSG00000188706,2411.0,,,,7.788211557847076
ENSG00000180818,114.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',4.74493212836325
ENSG00000180818,114.0,E-GEOD-10780,1.5,'breast carcinoma' vs 'normal',4.74493212836325
ENSG00000180818,114.0,E-GEOD-7377,1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',4.74493212836325
ENSG00000169855,962.0,E-GEOD-31138,3.1,'invasive ductal carcinoma' vs 'normal',6.870053411798126
ENSG00000158555,2287.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',7.7354333524996886
ENSG00000162594,1.0,E-GEOD-68086,-5.0,'breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000183625,2.0,E-GEOD-52194,5.7,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000081087,2050.0,,,,7.62608275807238
ENSG00000196083,518.0,,,,6.251903883165888
ENSG00000266524,366.0,,,,5.905361848054571
ENSG00000164741,5436.0,E-GEOD-10780,-1.6,'breast carcinoma' vs 'normal',8.600982717145921
ENSG00000128342,201.0,E-GEOD-52194,-5.9,'triple-negative breast cancer; breast carcinoma' vs 'normal',5.308267697401205
ENSG00000128342,201.0,E-GEOD-52194,-6.6,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',5.308267697401205
ENSG00000128342,201.0,E-GEOD-52194,-5.9,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',5.308267697401205
ENSG00000101493,1840.0,E-GEOD-38959,-1.7,'breast cancer; breast' vs 'normal; breast',7.518064181233078
ENSG00000176597,425.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',6.054439346269371
ENSG00000176597,425.0,E-GEOD-54002,-2.7,'breast cancer' vs 'normal',6.054439346269371
ENSG00000182628,594.0,E-GEOD-38959,1.8,'breast cancer; breast' vs 'normal; breast',6.38856140554563
ENSG00000121898,1787.0,,,,7.488852955733459
ENSG00000131323,992.0,,,,6.900730664045173
ENSG00000184979,335.0,,,,5.817111159963204
ENSG00000111321,5423.0,,,,8.598588829620232
ENSG00000100330,651.0,,,,6.480044561926653
ENSG00000215012,893.0,,,,6.795705775173514
ENSG00000143590,65.0,,,,4.189654742026425
ENSG00000163545,119.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.787491742782046
ENSG00000269404,16.0,E-GEOD-44408,3.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',2.833213344056216
ENSG00000165794,6.0,,,,1.9459101490553132
ENSG00000174177,573.0,,,,6.352629396319567
ENSG00000131748,3202.0,,,,8.071843149609158
ENSG00000257365,416.0,,,,6.0330862217988015
ENSG00000138944,31.0,,,,3.4657359027997265
ENSG00000142102,7177.0,,,,8.878776071707552
ENSG00000023909,987.0,E-GEOD-31138,1.9,'invasive ductal carcinoma' vs 'normal',6.895682697747868
ENSG00000179388,756.0,E-GEOD-31138,-2.8,'invasive ductal carcinoma' vs 'normal',6.6293632534374485
ENSG00000179388,756.0,E-GEOD-54002,-3.7,'breast cancer' vs 'normal',6.6293632534374485
ENSG00000179388,756.0,E-GEOD-10780,-2.2,'breast carcinoma' vs 'normal',6.6293632534374485
ENSG00000179388,756.0,E-GEOD-52194,-6.3,'triple-negative breast cancer; breast carcinoma' vs 'normal',6.6293632534374485
ENSG00000003402,14616.0,,,,9.589940513889292
ENSG00000147883,827.0,E-GEOD-54002,1.6,'breast cancer' vs 'normal',6.71901315438526
ENSG00000147883,827.0,E-GEOD-38959,1.5,'breast cancer; breast' vs 'normal; breast',6.71901315438526
ENSG00000115825,2539.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.8399193600125825
ENSG00000115825,2539.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',7.8399193600125825
ENSG00000085831,352.0,E-MTAB-779,1.9,'breast carcinoma' vs 'normal',5.8664680569332965
ENSG00000085831,352.0,E-GEOD-7377,2.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',5.8664680569332965
ENSG00000085831,352.0,E-GEOD-44408,-3.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.8664680569332965
ENSG00000185666,26.0,,,,3.295836866004329
ENSG00000111961,8209.0,E-GEOD-7377,-2.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',9.013108202446475
ENSG00000166145,1827.0,E-GEOD-44408,-2.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.510977752014095
ENSG00000142089,24020.0,,,,10.086683726740743
ENSG00000152061,1373.0,,,,7.2254814727822945
ENSG00000142949,8346.0,E-GEOD-44408,-2.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.029657471850737
ENSG00000120332,437.0,,,,6.082218910376446
ENSG00000127329,3274.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',8.094073148069352
ENSG00000127329,3274.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',8.094073148069352
ENSG00000174600,616.0,,,,6.424869023905388
ENSG00000272325,763.0,,,,6.638567789166521
ENSG00000139344,45.0,,,,3.828641396489095
ENSG00000170606,3114.0,,,,8.043984431221553
ENSG00000165507,36778.0,E-GEOD-54002,-2.2,'breast cancer' vs 'normal',10.512682309099187
ENSG00000069966,914.0,,,,6.818924065275521
ENSG00000188488,525.0,E-GEOD-7377,1.7,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.26530121273771
ENSG00000134058,671.0,,,,6.51025834052315
ENSG00000162734,9759.0,,,,9.186047679407139
ENSG00000184634,4383.0,,,,8.385716828627851
ENSG00000231925,5895.0,,,,8.682029433869172
ENSG00000105976,1683.0,E-GEOD-31138,-2.3,'invasive ductal carcinoma' vs 'normal',7.428927194802272
ENSG00000105976,1683.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',7.428927194802272
ENSG00000105976,1683.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',7.428927194802272
ENSG00000105976,1683.0,E-GEOD-54002,-3.2,'breast cancer' vs 'normal',7.428927194802272
ENSG00000133800,3570.0,E-GEOD-44408,1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.18060094759445
ENSG00000133800,3570.0,E-GEOD-10780,-2.0,'breast carcinoma' vs 'normal',8.18060094759445
ENSG00000170445,2587.0,,,,7.858640655620791
ENSG00000039068,1811.0,E-GEOD-44408,-1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.502186486602924
ENSG00000039068,1811.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.502186486602924
ENSG00000187531,1058.0,,,,6.9650803456014065
ENSG00000072501,3346.0,,,,8.115819701211327
ENSG00000154447,1321.0,,,,7.186901020411631
ENSG00000147889,57.0,,,,4.060443010546419
ENSG00000163923,164.0,E-GEOD-38959,1.5,'breast cancer; breast' vs 'normal; breast',5.10594547390058
ENSG00000110693,184.0,,,,5.220355825078324
ENSG00000183665,427.0,,,,6.059123195581797
ENSG00000090889,16.0,E-GEOD-44408,-1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',2.833213344056216
ENSG00000090889,16.0,E-GEOD-10780,1.5,'breast carcinoma' vs 'normal',2.833213344056216
ENSG00000090889,16.0,E-GEOD-54002,3.1,'breast cancer' vs 'normal',2.833213344056216
ENSG00000275395,434.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',6.075346031088684
ENSG00000165409,24.0,,,,3.2188758248682006
ENSG00000234414,0.0,,,,0.0
ENSG00000178562,122.0,E-GEOD-44408,3.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.812184355372417
ENSG00000156675,831.0,E-GEOD-7377,2.0,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.723832440821209
ENSG00000170266,1516.0,,,,7.324489979348532
ENSG00000075891,1.0,,,,0.6931471805599453
ENSG00000117143,3531.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.16961956172385
ENSG00000223802,8.0,,,,2.1972245773362196
ENSG00000108091,2880.0,E-GEOD-31138,2.1,'invasive ductal carcinoma' vs 'normal',7.9658927350845286
ENSG00000138759,253.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',5.537334267018537
ENSG00000138759,253.0,E-GEOD-20086,-1.4,'breast cancer' vs 'normal',5.537334267018537
ENSG00000187098,1652.0,,,,7.410347097821024
ENSG00000110169,149.0,E-GEOD-68086,-5.9,'breast carcinoma' vs 'normal',5.0106352940962555
ENSG00000172216,5839.0,,,,8.672486075822272
ENSG00000164136,449.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.1092475827643655
ENSG00000164136,449.0,E-GEOD-31138,-3.3,'invasive ductal carcinoma' vs 'normal',6.1092475827643655
ENSG00000167397,701.0,,,,6.553933404025811
ENSG00000163960,2330.0,,,,7.754052639035757
ENSG00000117118,2497.0,,,,7.823245690685523
ENSG00000244731,220.0,,,,5.3981627015177525
ENSG00000179295,6010.0,,,,8.701346403039162
ENSG00000013441,12943.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.468387639298273
ENSG00000013441,12943.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',9.468387639298273
ENSG00000243955,23.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',3.1780538303479458
ENSG00000273749,5598.0,,,,8.630343289348893
ENSG00000125844,7392.0,,,,8.9082888855571
ENSG00000213853,4021.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.299534570332597
ENSG00000213853,4021.0,E-GEOD-44408,-2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.299534570332597
ENSG00000174175,1068.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.974478911025045
ENSG00000174175,1068.0,E-GEOD-31138,-3.5,'invasive ductal carcinoma' vs 'normal',6.974478911025045
ENSG00000183207,1836.0,,,,7.515889085215125
ENSG00000196588,2955.0,,,,7.991592282068092
ENSG00000115884,740.0,E-GEOD-10780,1.4,'breast carcinoma' vs 'normal',6.608000625296087
ENSG00000115884,740.0,E-MTAB-779,1.8,'breast carcinoma' vs 'normal',6.608000625296087
ENSG00000115884,740.0,E-GEOD-38959,1.7,'breast cancer; breast' vs 'normal; breast',6.608000625296087
ENSG00000143473,10.0,,,,2.3978952727983707
ENSG00000183684,1287.0,E-GEOD-38959,1.9,'breast cancer; breast' vs 'normal; breast',7.160845906664299
ENSG00000111962,687.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.5337888379333435
ENSG00000163914,1.0,,,,0.6931471805599453
ENSG00000104763,7656.0,,,,8.943375541113124
ENSG00000115761,1071.0,,,,6.977281341630747
ENSG00000204381,455.0,E-GEOD-54002,-2.0,'breast cancer' vs 'normal',6.1224928095143865
ENSG00000080822,2912.0,,,,7.976938756959434
ENSG00000140030,91.0,E-GEOD-44408,2.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.5217885770490405
ENSG00000197106,16.0,,,,2.833213344056216
ENSG00000164932,817.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',6.706862336602747
ENSG00000164932,817.0,E-GEOD-54002,5.9,'breast cancer' vs 'normal',6.706862336602747
ENSG00000164932,817.0,E-GEOD-10780,2.0,'breast carcinoma' vs 'normal',6.706862336602747
ENSG00000164932,817.0,E-GEOD-31138,4.2,'invasive ductal carcinoma' vs 'normal',6.706862336602747
ENSG00000164932,817.0,E-GEOD-38959,2.3,'breast cancer; breast' vs 'normal; breast',6.706862336602747
ENSG00000157827,2986.0,,,,8.00202481821611
ENSG00000132589,5991.0,,,,8.698180525197055
ENSG00000065534,9012.0,E-GEOD-54002,-3.2,'breast cancer' vs 'normal',9.10642325855641
ENSG00000065534,9012.0,E-GEOD-10780,-2.1,'breast carcinoma' vs 'normal',9.10642325855641
ENSG00000065534,9012.0,E-GEOD-38959,-2.0,'breast cancer; breast' vs 'normal; breast',9.10642325855641
ENSG00000166900,1530.0,,,,7.333676395657684
ENSG00000120253,1376.0,,,,7.227662498728654
ENSG00000153064,214.0,E-GEOD-44408,3.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.3706380281276624
ENSG00000163462,72.0,,,,4.290459441148391
ENSG00000196470,931.0,,,,6.837332814685591
ENSG00000132155,6717.0,,,,8.812545770172237
ENSG00000147654,914.0,,,,6.818924065275521
ENSG00000185745,606.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',6.408528791059498
ENSG00000108839,145.0,,,,4.983606621708336
ENSG00000100242,13091.0,,,,9.47975663562107
ENSG00000103855,2428.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',7.795234929002173
ENSG00000173482,7833.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',8.966228514225776
ENSG00000060237,11213.0,,,,9.324918276683619
ENSG00000182256,10.0,,,,2.3978952727983707
ENSG00000155438,1200.0,,,,7.0909098220799835
ENSG00000074603,2185.0,,,,7.689828668736484
ENSG00000159251,124.0,,,,4.8283137373023015
ENSG00000106991,12316.0,,,,9.418735700941484
ENSG00000159140,16300.0,,,,9.69898173460629
ENSG00000106624,19834.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.89520333294843
ENSG00000106624,19834.0,E-GEOD-54002,1.8,'breast cancer' vs 'normal',9.89520333294843
ENSG00000146414,909.0,,,,6.813444599510896
ENSG00000073754,1.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',0.6931471805599453
ENSG00000073754,1.0,E-GEOD-52194,5.7,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000185664,140.0,,,,4.948759890378168
ENSG00000117592,15090.0,,,,9.62185381861855
ENSG00000144648,188.0,,,,5.241747015059643
ENSG00000134853,4736.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',8.463159302923751
ENSG00000134853,4736.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',8.463159302923751
ENSG00000134853,4736.0,E-GEOD-10780,-1.6,'breast carcinoma' vs 'normal',8.463159302923751
ENSG00000134853,4736.0,E-GEOD-54002,-2.8,'breast cancer' vs 'normal',8.463159302923751
ENSG00000180879,3789.0,,,,8.240121298076472
ENSG00000127220,476.0,,,,6.1675164908883415
ENSG00000135535,12914.0,E-GEOD-31138,2.0,'invasive ductal carcinoma' vs 'normal',9.46614470552994
ENSG00000141510,1909.0,,,,7.554858521040676
ENSG00000023839,181.0,,,,5.204006687076795
ENSG00000147381,0.0,,,,0.0
ENSG00000046774,0.0,E-GEOD-52194,5.3,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000184378,60.0,,,,4.110873864173311
ENSG00000137752,977.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.885509670034818
ENSG00000160867,111.0,,,,4.718498871295094
ENSG00000140990,2342.0,,,,7.759187438507795
ENSG00000175866,1556.0,,,,7.350516171833998
ENSG00000109787,3365.0,E-GEOD-31138,2.2,'invasive ductal carcinoma' vs 'normal',8.121480374750751
ENSG00000134321,196.0,E-GEOD-54002,2.0,'breast cancer' vs 'normal',5.2832037287379885
ENSG00000134321,196.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',5.2832037287379885
ENSG00000134321,196.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',5.2832037287379885
ENSG00000115523,400.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.993961427306569
ENSG00000135312,9.0,,,,2.302585092994046
ENSG00000227507,38.0,E-GEOD-44408,2.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.6635616461296463
ENSG00000057252,1652.0,,,,7.410347097821024
ENSG00000187908,7.0,,,,2.0794415416798357
ENSG00000145675,13267.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',9.493110400066943
ENSG00000145675,13267.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',9.493110400066943
ENSG00000145675,13267.0,E-GEOD-38959,-1.6,'breast cancer; breast' vs 'normal; breast',9.493110400066943
ENSG00000099341,5841.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',8.672828482947686
ENSG00000162367,785.0,,,,6.666956792429207
ENSG00000141985,3881.0,,,,8.264105763728956
ENSG00000130164,2358.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',7.765993079407675
ENSG00000130164,2358.0,E-GEOD-52194,-4.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',7.765993079407675
ENSG00000113578,338.0,E-GEOD-54002,-2.5,'breast cancer' vs 'normal',5.82600010738045
ENSG00000113578,338.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',5.82600010738045
ENSG00000113578,338.0,E-GEOD-38959,-1.5,'breast cancer; breast' vs 'normal; breast',5.82600010738045
ENSG00000044524,356.0,E-GEOD-31138,2.3,'invasive ductal carcinoma' vs 'normal',5.877735781779639
ENSG00000044524,356.0,E-GEOD-20086,2.8,'breast cancer' vs 'normal',5.877735781779639
ENSG00000108953,13593.0,,,,9.517383797906584
ENSG00000165458,7341.0,,,,8.90136656405678
ENSG00000100105,1589.0,,,,7.371489295214277
ENSG00000126890,0.0,,,,0.0
ENSG00000189007,784.0,,,,6.665683717782408
ENSG00000069482,23.0,,,,3.1780538303479458
ENSG00000072803,2186.0,,,,7.690286020676768
ENSG00000076604,1437.0,,,,7.271008538280992
ENSG00000116903,720.0,E-GEOD-31138,3.7,'invasive ductal carcinoma' vs 'normal',6.580639137284949
ENSG00000196230,12725.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',9.451402423792738
ENSG00000182481,901.0,,,,6.804614520062624
ENSG00000182054,2598.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',7.8628820346414905
ENSG00000164885,240.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',5.484796933490655
ENSG00000132773,531.0,,,,6.2766434893416445
ENSG00000109854,1032.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',6.940222469119639
ENSG00000118729,569.0,,,,6.345636360828596
ENSG00000167193,4039.0,E-GEOD-31138,2.4,'invasive ductal carcinoma' vs 'normal',8.303999970955196
ENSG00000143575,2467.0,,,,7.811163385025279
ENSG00000091513,628.0,E-GEOD-54002,-2.9,'breast cancer' vs 'normal',6.444131256700441
ENSG00000091513,628.0,E-GEOD-10780,-2.2,'breast carcinoma' vs 'normal',6.444131256700441
ENSG00000091513,628.0,E-MTAB-779,-2.5,'breast carcinoma' vs 'normal',6.444131256700441
ENSG00000089356,740.0,,,,6.608000625296087
ENSG00000156869,216.0,,,,5.37989735354046
ENSG00000106546,4429.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',8.39615486303918
ENSG00000156219,28.0,,,,3.367295829986474
ENSG00000115128,1695.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',7.4360278163518485
ENSG00000134419,14461.0,,,,9.579279798734897
ENSG00000151651,372.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',5.921578419643816
ENSG00000132688,3804.0,E-MTAB-779,-1.2,'breast carcinoma' vs 'normal',8.244071270295786
ENSG00000132688,3804.0,E-GEOD-31138,-2.0,'invasive ductal carcinoma' vs 'normal',8.244071270295786
ENSG00000132688,3804.0,E-GEOD-20086,1.4,'breast cancer' vs 'normal',8.244071270295786
ENSG00000197635,905.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.80903930604298
ENSG00000173020,6246.0,,,,8.73985662749357
ENSG00000110395,2073.0,,,,7.637234388789473
ENSG00000123416,3373.0,,,,8.123854263105914
ENSG00000196365,3075.0,,,,8.031385330625534
ENSG00000109272,1.0,,,,0.6931471805599453
ENSG00000112473,4362.0,,,,8.38091517312361
ENSG00000115216,5276.0,,,,8.571113033405668
ENSG00000138622,1.0,,,,0.6931471805599453
ENSG00000100156,91.0,,,,4.5217885770490405
ENSG00000184937,1.0,E-GEOD-52194,5.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000184937,1.0,E-GEOD-52194,5.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000111540,7020.0,,,,8.85666093701725
ENSG00000147684,2597.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',7.862497197230545
ENSG00000171794,0.0,,,,0.0
ENSG00000158169,440.0,,,,6.089044875446846
ENSG00000164283,12.0,E-GEOD-31138,3.6,'invasive ductal carcinoma' vs 'normal',2.5649493574615367
ENSG00000142731,84.0,E-GEOD-31138,2.1,'invasive ductal carcinoma' vs 'normal',4.442651256490317
ENSG00000152583,31058.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',10.343643900434223
ENSG00000152583,31058.0,E-GEOD-54002,-2.2,'breast cancer' vs 'normal',10.343643900434223
ENSG00000152583,31058.0,E-GEOD-38959,-2.1,'breast cancer; breast' vs 'normal; breast',10.343643900434223
ENSG00000116497,1611.0,,,,7.385230923066573
ENSG00000102837,119.0,E-GEOD-52194,-4.8,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',4.787491742782046
ENSG00000102837,119.0,E-GEOD-54002,-3.9,'breast cancer' vs 'normal',4.787491742782046
ENSG00000102837,119.0,E-GEOD-38959,-1.9,'breast cancer; breast' vs 'normal; breast',4.787491742782046
ENSG00000102837,119.0,E-GEOD-52194,-6.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',4.787491742782046
ENSG00000102837,119.0,E-GEOD-52194,-7.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',4.787491742782046
ENSG00000102606,6804.0,,,,8.825412915085566
ENSG00000171862,7333.0,E-GEOD-38959,-1.3,'breast cancer; breast' vs 'normal; breast',8.900276348631271
ENSG00000104320,1775.0,,,,7.4821189235521155
ENSG00000197540,24.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.2188758248682006
ENSG00000256043,1912.0,,,,7.556427969440253
ENSG00000144730,872.0,E-GEOD-54002,-2.1,'breast cancer' vs 'normal',6.771935555839602
ENSG00000144730,872.0,E-GEOD-38959,-1.6,'breast cancer; breast' vs 'normal; breast',6.771935555839602
ENSG00000144730,872.0,E-GEOD-10780,-1.9,'breast carcinoma' vs 'normal',6.771935555839602
ENSG00000189283,317.0,,,,5.762051382780177
ENSG00000066739,3227.0,,,,8.07961802938984
ENSG00000148053,3198.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',8.070593539949519
ENSG00000148053,3198.0,E-GEOD-54002,-4.5,'breast cancer' vs 'normal',8.070593539949519
ENSG00000148053,3198.0,E-GEOD-10780,-3.2,'breast carcinoma' vs 'normal',8.070593539949519
ENSG00000148053,3198.0,E-GEOD-38959,-3.6,'breast cancer; breast' vs 'normal; breast',8.070593539949519
ENSG00000175104,772.0,,,,6.650279048587422
ENSG00000144566,2292.0,,,,7.737616282857904
ENSG00000106809,2201.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',7.697121317282625
ENSG00000106809,2201.0,E-GEOD-20086,-1.6,'breast cancer' vs 'normal',7.697121317282625
ENSG00000106809,2201.0,E-GEOD-10780,-2.7,'breast carcinoma' vs 'normal',7.697121317282625
ENSG00000133835,5957.0,,,,8.692490133273228
ENSG00000131470,141.0,,,,4.955827057601261
ENSG00000163468,5727.0,,,,8.653121708640482
ENSG00000267534,606.0,,,,6.408528791059498
ENSG00000124813,376.0,,,,5.932245187448011
ENSG00000072571,20.0,E-MTAB-779,1.7,'breast carcinoma' vs 'normal',3.044522437723423
ENSG00000072571,20.0,E-GEOD-31138,2.7,'invasive ductal carcinoma' vs 'normal',3.044522437723423
ENSG00000072571,20.0,E-GEOD-54002,3.0,'breast cancer' vs 'normal',3.044522437723423
ENSG00000072571,20.0,E-GEOD-38959,2.3,'breast cancer; breast' vs 'normal; breast',3.044522437723423
ENSG00000110934,247.0,E-GEOD-44408,2.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.5134287461649825
ENSG00000186260,5285.0,E-GEOD-7377,1.6,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.572817095164234
ENSG00000033178,2196.0,,,,7.69484807238461
ENSG00000112290,622.0,,,,6.434546518787453
ENSG00000103994,5212.0,,,,8.558910784768106
ENSG00000099994,790.0,,,,6.673297967767654
ENSG00000234906,6.0,,,,1.9459101490553132
ENSG00000174938,203.0,E-GEOD-44408,-1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.318119993844216
ENSG00000159184,1.0,E-GEOD-52194,6.3,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000159184,1.0,E-GEOD-52194,6.3,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000115947,1482.0,,,,7.301822342137932
ENSG00000103549,2201.0,,,,7.697121317282625
ENSG00000135333,38.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',3.6635616461296463
ENSG00000171596,114.0,E-MTAB-779,-1.8,'breast carcinoma' vs 'normal',4.74493212836325
ENSG00000067208,868.0,,,,6.767343125265392
ENSG00000204256,12738.0,,,,9.452423433109788
ENSG00000196924,65772.0,,,,11.093964698756729
ENSG00000168490,488.0,,,,6.192362489474872
ENSG00000101843,1130.0,,,,7.030857476116121
ENSG00000138109,4.0,,,,1.6094379124341003
ENSG00000170017,1694.0,E-GEOD-31138,2.0,'invasive ductal carcinoma' vs 'normal',7.43543801981455
ENSG00000170017,1694.0,E-GEOD-44408,-1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.43543801981455
ENSG00000170017,1694.0,E-GEOD-7377,1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.43543801981455
ENSG00000158125,87.0,E-GEOD-54002,-3.6,'breast cancer' vs 'normal',4.477336814478207
ENSG00000159640,447.0,,,,6.104793232414985
ENSG00000150782,158.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.0689042022202315
ENSG00000126583,2.0,,,,1.0986122886681098
ENSG00000104888,204.0,,,,5.3230099791384085
ENSG00000113441,3417.0,,,,8.136810863675537
ENSG00000196664,39.0,E-GEOD-52194,4.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',3.6888794541139363
ENSG00000096060,18396.0,,,,9.819942886825784
ENSG00000100427,10.0,E-GEOD-52194,5.3,'triple-negative breast cancer; breast carcinoma' vs 'normal',2.3978952727983707
ENSG00000109846,10061.0,E-GEOD-68086,-4.8,'breast carcinoma' vs 'normal',9.216521231051264
ENSG00000109846,10061.0,E-GEOD-54002,-3.6,'breast cancer' vs 'normal',9.216521231051264
ENSG00000109846,10061.0,E-GEOD-10780,-2.2,'breast carcinoma' vs 'normal',9.216521231051264
ENSG00000109846,10061.0,E-MTAB-779,-2.8,'breast carcinoma' vs 'normal',9.216521231051264
ENSG00000109689,1624.0,,,,7.393263094763838
ENSG00000080618,2.0,,,,1.0986122886681098
ENSG00000243709,7.0,,,,2.0794415416798357
ENSG00000165617,480.0,,,,6.175867270105761
ENSG00000131747,96.0,E-MTAB-779,1.7,'breast carcinoma' vs 'normal',4.574710978503383
ENSG00000131747,96.0,E-GEOD-54002,3.7,'breast cancer' vs 'normal',4.574710978503383
ENSG00000131747,96.0,E-GEOD-10780,2.6,'breast carcinoma' vs 'normal',4.574710978503383
ENSG00000131747,96.0,E-GEOD-31138,4.3,'invasive ductal carcinoma' vs 'normal',4.574710978503383
ENSG00000131747,96.0,E-GEOD-38959,2.8,'breast cancer; breast' vs 'normal; breast',4.574710978503383
ENSG00000112312,455.0,,,,6.1224928095143865
ENSG00000013297,1061.0,E-GEOD-10780,-2.8,'breast carcinoma' vs 'normal',6.967909201801884
ENSG00000013297,1061.0,E-GEOD-38959,-2.0,'breast cancer; breast' vs 'normal; breast',6.967909201801884
ENSG00000188612,4986.0,,,,8.514589805546123
ENSG00000115306,26308.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',10.177666364950163
ENSG00000115306,26308.0,E-MTAB-779,-1.9,'breast carcinoma' vs 'normal',10.177666364950163
ENSG00000185651,3523.0,,,,8.16735198705607
ENSG00000167244,4514.0,,,,8.415160465851086
ENSG00000068366,3349.0,E-GEOD-54002,-1.4,'breast cancer' vs 'normal',8.116715624819111
ENSG00000076770,633.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',6.452048954437226
ENSG00000117335,14195.0,,,,9.560715513766388
ENSG00000128191,2045.0,,,,7.6236419465115715
ENSG00000125780,16.0,,,,2.833213344056216
ENSG00000140575,12349.0,,,,9.421411342056123
ENSG00000273604,119.0,E-GEOD-31138,2.5,'invasive ductal carcinoma' vs 'normal',4.787491742782046
ENSG00000273604,119.0,E-GEOD-52194,-4.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',4.787491742782046
ENSG00000013725,88.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.48863636973214
ENSG00000123384,40256.0,,,,10.603039180769068
ENSG00000106852,730.0,,,,6.594413459749778
ENSG00000007372,76.0,E-GEOD-38959,1.7,'breast cancer; breast' vs 'normal; breast',4.343805421853684
ENSG00000124102,36.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',3.6109179126442243
ENSG00000143839,4.0,,,,1.6094379124341003
ENSG00000175206,71.0,,,,4.276666119016055
ENSG00000176393,2829.0,,,,7.948031990637284
ENSG00000138795,197.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.288267030694535
ENSG00000138795,197.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',5.288267030694535
ENSG00000138795,197.0,E-MTAB-779,1.7,'breast carcinoma' vs 'normal',5.288267030694535
ENSG00000102109,19.0,,,,2.995732273553991
ENSG00000019186,2.0,E-GEOD-52194,-5.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000038945,533.0,E-GEOD-44408,-1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.280395838960195
ENSG00000038945,533.0,E-GEOD-52194,4.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',6.280395838960195
ENSG00000005882,1221.0,,,,7.108244139731541
ENSG00000079257,602.0,E-GEOD-54002,-1.9,'breast cancer' vs 'normal',6.401917196727186
ENSG00000154640,1016.0,,,,6.92461239604856
ENSG00000168079,2844.0,E-MTAB-779,-2.9,'breast carcinoma' vs 'normal',7.953318346560431
ENSG00000168079,2844.0,E-GEOD-10780,-2.0,'breast carcinoma' vs 'normal',7.953318346560431
ENSG00000131737,0.0,,,,0.0
ENSG00000160014,6931.0,,,,8.843903650835497
ENSG00000166535,25.0,E-GEOD-52194,5.6,'triple-negative breast cancer; breast carcinoma' vs 'normal',3.258096538021482
ENSG00000132694,3085.0,,,,8.034631032923107
ENSG00000143631,70.0,,,,4.2626798770413155
ENSG00000134757,255.0,,,,5.545177444479562
ENSG00000173281,3434.0,E-GEOD-7377,1.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.14177220465645
ENSG00000183576,3044.0,,,,8.021256180143997
ENSG00000185100,491.0,,,,6.198478716492308
ENSG00000172232,52.0,,,,3.970291913552122
ENSG00000271425,372.0,,,,5.921578419643816
ENSG00000184887,3043.0,,,,8.020927718981577
ENSG00000176463,1617.0,,,,7.388946097618437
ENSG00000123364,2.0,,,,1.0986122886681098
ENSG00000162923,7070.0,,,,8.863757191604241
ENSG00000162337,4876.0,,,,8.492285555710053
ENSG00000168653,3688.0,,,,8.213110697596676
ENSG00000119280,3357.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',8.119100837637486
ENSG00000110107,3559.0,,,,8.177515823846075
ENSG00000170222,565.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.338594078203183
ENSG00000140992,2015.0,,,,7.60887062919126
ENSG00000113645,588.0,E-GEOD-44408,-1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.3784261836515865
ENSG00000136717,3504.0,E-GEOD-44408,2.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.16194579946869
ENSG00000116584,4086.0,,,,8.315566483564277
ENSG00000103642,912.0,,,,6.816735880594968
ENSG00000005421,11.0,,,,2.4849066497880004
ENSG00000177504,0.0,,,,0.0
ENSG00000138433,1844.0,,,,7.520234556474628
ENSG00000170323,81426.0,E-GEOD-10780,-2.5,'breast carcinoma' vs 'normal',11.307462192323593
ENSG00000170323,81426.0,E-GEOD-31138,-3.5,'invasive ductal carcinoma' vs 'normal',11.307462192323593
ENSG00000170323,81426.0,E-GEOD-52194,-5.9,'triple-negative breast cancer; breast carcinoma' vs 'normal',11.307462192323593
ENSG00000100294,486.0,,,,6.18826412308259
ENSG00000157613,602.0,,,,6.401917196727186
ENSG00000080503,5987.0,,,,8.69751274553952
ENSG00000135297,1155.0,,,,7.052721049232323
ENSG00000100243,17195.0,,,,9.752432077616172
ENSG00000135336,1037.0,,,,6.945051063725834
ENSG00000103343,399.0,,,,5.991464547107982
ENSG00000132970,1748.0,E-GEOD-54002,-2.2,'breast cancer' vs 'normal',7.466799475018602
ENSG00000132970,1748.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',7.466799475018602
ENSG00000156966,133.0,,,,4.897839799950911
ENSG00000166436,1377.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',7.228388451573604
ENSG00000166436,1377.0,E-GEOD-31138,-2.7,'invasive ductal carcinoma' vs 'normal',7.228388451573604
ENSG00000163209,55.0,,,,4.02535169073515
ENSG00000071994,1991.0,,,,7.596894438144544
ENSG00000170836,1049.0,,,,6.956545443151569
ENSG00000102125,2474.0,,,,7.813995675002791
ENSG00000108518,15931.0,,,,9.676084944301534
ENSG00000118900,3268.0,,,,8.092239406724211
ENSG00000110448,65.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.189654742026425
ENSG00000086205,35.0,,,,3.58351893845611
ENSG00000141485,59.0,,,,4.0943445622221
ENSG00000171467,1894.0,,,,7.546974117516527
ENSG00000135406,47.0,,,,3.871201010907891
ENSG00000111676,17412.0,E-GEOD-31138,-1.9,'invasive ductal carcinoma' vs 'normal',9.764972332679383
ENSG00000151090,1522.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',7.328437352895162
ENSG00000151090,1522.0,E-GEOD-20086,-1.1,'breast cancer' vs 'normal',7.328437352895162
ENSG00000151090,1522.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',7.328437352895162
ENSG00000156113,1181.0,E-GEOD-7377,1.9,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.074963197966044
ENSG00000164303,20.0,,,,3.044522437723423
ENSG00000150637,92.0,,,,4.532599493153256
ENSG00000157551,170.0,,,,5.14166355650266
ENSG00000136816,832.0,,,,6.725033642166843
ENSG00000105357,1224.0,,,,7.110696122978827
ENSG00000170476,124.0,,,,4.8283137373023015
ENSG00000138468,1938.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.569927655242652
ENSG00000015475,1044.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',6.951772164398911
ENSG00000147168,384.0,E-GEOD-44408,2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.953243334287785
ENSG00000147168,384.0,E-GEOD-36765,1.3,'breast carcinoma' vs 'normal' in 'peripheral blood',5.953243334287785
ENSG00000101966,1851.0,,,,7.524021415206125
ENSG00000072694,368.0,,,,5.910796644040527
ENSG00000124493,6.0,E-GEOD-52194,6.4,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.9459101490553132
ENSG00000124493,6.0,E-GEOD-52194,6.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',1.9459101490553132
ENSG00000140968,651.0,E-GEOD-44408,2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.480044561926653
ENSG00000221866,1662.0,E-MTAB-779,-1.8,'breast carcinoma' vs 'normal',7.416378479192928
ENSG00000162909,16187.0,,,,9.692025505995757
ENSG00000140750,4526.0,,,,8.417814747435958
ENSG00000116128,869.0,,,,6.76849321164863
ENSG00000166736,1.0,,,,0.6931471805599453
ENSG00000059377,361.0,,,,5.8916442118257715
ENSG00000156398,473.0,,,,6.161207321695077
ENSG00000103653,1737.0,,,,7.460490305825338
ENSG00000204713,2972.0,,,,7.997326822998097
ENSG00000158864,5032.0,,,,8.52377150677636
ENSG00000073792,657.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',6.489204931325317
ENSG00000124107,1101.0,E-GEOD-54002,-2.2,'breast cancer' vs 'normal',7.004881989712859
ENSG00000124107,1101.0,E-MTAB-779,-2.0,'breast carcinoma' vs 'normal',7.004881989712859
ENSG00000124107,1101.0,E-GEOD-7377,-1.7,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.004881989712859
ENSG00000087245,29031.0,E-GEOD-44408,-1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',10.276153948892906
ENSG00000146535,3187.0,,,,8.067149039910106
ENSG00000171747,91.0,,,,4.5217885770490405
ENSG00000008311,1948.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',7.575071699507561
ENSG00000008311,1948.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',7.575071699507561
ENSG00000008311,1948.0,E-GEOD-31138,-2.9,'invasive ductal carcinoma' vs 'normal',7.575071699507561
ENSG00000115866,3255.0,E-GEOD-31138,2.3,'invasive ductal carcinoma' vs 'normal',8.08825472712243
ENSG00000100731,4718.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',8.459352191726387
ENSG00000100731,4718.0,E-GEOD-54002,-1.9,'breast cancer' vs 'normal',8.459352191726387
ENSG00000100731,4718.0,E-GEOD-10780,-1.5,'breast carcinoma' vs 'normal',8.459352191726387
ENSG00000163902,6848.0,,,,8.831857935197906
ENSG00000107679,2059.0,,,,7.630461261783627
ENSG00000198911,4021.0,,,,8.299534570332597
ENSG00000075043,2.0,E-GEOD-52194,4.9,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000130396,7445.0,,,,8.915432254432663
ENSG00000160208,1443.0,,,,7.275172319452771
ENSG00000122863,2208.0,,,,7.700295203420117
ENSG00000148468,858.0,E-GEOD-7377,-1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.755768921984255
ENSG00000148468,858.0,E-GEOD-54002,-1.9,'breast cancer' vs 'normal',6.755768921984255
ENSG00000005483,5638.0,,,,8.637462023807181
ENSG00000141505,63.0,,,,4.1588830833596715
ENSG00000105376,57.0,,,,4.060443010546419
ENSG00000131871,2121.0,,,,7.660114319173928
ENSG00000141543,2978.0,,,,7.999342952713282
ENSG00000198873,2278.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.731492029245684
ENSG00000198873,2278.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',7.731492029245684
ENSG00000167749,14.0,,,,2.70805020110221
ENSG00000139219,11.0,,,,2.4849066497880004
ENSG00000154438,0.0,,,,0.0
ENSG00000138190,675.0,,,,6.516193076042964
ENSG00000211896,1178.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',7.072421900537371
ENSG00000211896,1178.0,E-GEOD-52194,4.9,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',7.072421900537371
ENSG00000103056,337.0,,,,5.823045895483019
ENSG00000188372,80.0,,,,4.394449154672439
ENSG00000132383,3443.0,E-GEOD-31138,2.8,'invasive ductal carcinoma' vs 'normal',8.144388865547622
ENSG00000048028,1001.0,,,,6.90975328164481
ENSG00000275126,0.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',0.0
ENSG00000275126,0.0,E-GEOD-52194,9.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000275126,0.0,E-GEOD-52194,8.7,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',0.0
ENSG00000275126,0.0,E-GEOD-52194,6.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000122884,2006.0,E-GEOD-31138,2.6,'invasive ductal carcinoma' vs 'normal',7.604396348796338
ENSG00000138095,5067.0,,,,8.53070154144103
ENSG00000134369,4083.0,,,,8.314832179284556
ENSG00000167513,52.0,,,,3.970291913552122
ENSG00000168872,1989.0,,,,7.595889917718538
ENSG00000169676,0.0,,,,0.0
ENSG00000125354,1299.0,E-GEOD-44408,2.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.170119543449628
ENSG00000164066,1028.0,,,,6.9363427358340495
ENSG00000058272,4693.0,,,,8.454040376410969
ENSG00000166136,1036.0,,,,6.9440872082295275
ENSG00000095139,6594.0,E-GEOD-31138,3.0,'invasive ductal carcinoma' vs 'normal',8.794067065151415
ENSG00000188986,2927.0,,,,7.982074875081202
ENSG00000184009,80983.0,,,,11.302006883278588
ENSG00000164251,91.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',4.5217885770490405
ENSG00000117560,5.0,,,,1.791759469228055
ENSG00000198846,93.0,E-GEOD-44408,2.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.543294782270004
ENSG00000077498,1.0,,,,0.6931471805599453
ENSG00000196091,905.0,E-GEOD-54002,-3.1,'breast cancer' vs 'normal',6.80903930604298
ENSG00000196091,905.0,E-GEOD-38959,-2.0,'breast cancer; breast' vs 'normal; breast',6.80903930604298
ENSG00000196091,905.0,E-GEOD-52194,-6.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',6.80903930604298
ENSG00000196091,905.0,E-GEOD-52194,-8.1,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',6.80903930604298
ENSG00000196091,905.0,E-GEOD-52194,-8.2,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',6.80903930604298
ENSG00000162545,1029.0,E-GEOD-31138,2.2,'invasive ductal carcinoma' vs 'normal',6.937314081223682
ENSG00000162545,1029.0,E-GEOD-44408,-2.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.937314081223682
ENSG00000162545,1029.0,E-GEOD-38959,-1.9,'breast cancer; breast' vs 'normal; breast',6.937314081223682
ENSG00000058085,1257.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',7.1372784372603855
ENSG00000058085,1257.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',7.1372784372603855
ENSG00000058085,1257.0,E-GEOD-54002,-2.3,'breast cancer' vs 'normal',7.1372784372603855
ENSG00000058085,1257.0,E-GEOD-38959,-1.5,'breast cancer; breast' vs 'normal; breast',7.1372784372603855
ENSG00000172175,1595.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.3752557780097545
ENSG00000090539,1564.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',7.355641102974253
ENSG00000243811,146.0,,,,4.990432586778736
ENSG00000164308,1186.0,,,,7.079184394609668
ENSG00000104365,5485.0,,,,8.60995467149755
ENSG00000125257,320.0,,,,5.771441123130016
ENSG00000104331,4007.0,,,,8.2960476427647
ENSG00000133106,375.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',5.929589143389895
ENSG00000160584,2981.0,,,,8.000349495324684
ENSG00000100216,1578.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',7.364547014255642
ENSG00000100216,1578.0,E-GEOD-31138,3.6,'invasive ductal carcinoma' vs 'normal',7.364547014255642
ENSG00000162745,1101.0,E-GEOD-44408,-1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.004881989712859
ENSG00000162745,1101.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',7.004881989712859
ENSG00000111737,2553.0,,,,7.845416036592485
ENSG00000161638,10171.0,,,,9.227394126542011
ENSG00000141027,5118.0,,,,8.540714386457584
ENSG00000104755,0.0,,,,0.0
ENSG00000090565,2437.0,,,,7.798933310041217
ENSG00000135341,2365.0,,,,7.768956044538332
ENSG00000169862,50.0,E-GEOD-7377,1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',3.9318256327243257
ENSG00000116455,1027.0,,,,6.93537044601511
ENSG00000147576,1292.0,,,,7.164720378771857
ENSG00000140939,1890.0,E-GEOD-44408,-1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.544861068658458
ENSG00000126803,471.0,E-GEOD-44408,-2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.156978985585555
ENSG00000147010,3377.0,,,,8.125039097367745
ENSG00000172500,1552.0,,,,7.347943823148687
ENSG00000170473,882.0,,,,6.78332520060396
ENSG00000117461,2723.0,E-GEOD-44408,-1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.909856667269403
ENSG00000186432,3876.0,,,,8.262816937670928
ENSG00000085276,1430.0,E-GEOD-20086,1.4,'breast cancer' vs 'normal',7.266128779556451
ENSG00000126545,24.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',3.2188758248682006
ENSG00000113739,4365.0,E-GEOD-54002,-2.3,'breast cancer' vs 'normal',8.38160253710989
ENSG00000113739,4365.0,E-GEOD-7377,1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.38160253710989
ENSG00000113739,4365.0,E-GEOD-38959,-2.1,'breast cancer; breast' vs 'normal; breast',8.38160253710989
ENSG00000113739,4365.0,E-GEOD-44408,-3.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.38160253710989
ENSG00000141753,44309.0,,,,10.698965664193535
ENSG00000138061,2884.0,,,,7.9672801789422
ENSG00000158406,19.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',2.995732273553991
ENSG00000158406,19.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',2.995732273553991
ENSG00000158406,19.0,E-GEOD-54002,2.8,'breast cancer' vs 'normal',2.995732273553991
ENSG00000145555,1647.0,E-GEOD-44408,-1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.4073177104694174
ENSG00000169032,2417.0,,,,7.790696031174738
ENSG00000142864,10649.0,E-GEOD-31138,3.0,'invasive ductal carcinoma' vs 'normal',9.273315171137572
ENSG00000112245,3980.0,,,,8.289288323000317
ENSG00000125967,1158.0,E-GEOD-44408,-1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.055312843339752
ENSG00000104881,2389.0,E-GEOD-44408,-1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.779048644925556
ENSG00000178950,5778.0,,,,8.661985936317778
ENSG00000122729,4269.0,E-GEOD-31138,2.3,'invasive ductal carcinoma' vs 'normal',8.35936910622267
ENSG00000122729,4269.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',8.35936910622267
ENSG00000036828,0.0,E-GEOD-52194,6.4,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000036828,0.0,E-GEOD-52194,5.3,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000108829,2768.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',7.926241523170962
ENSG00000108829,2768.0,E-GEOD-31138,2.3,'invasive ductal carcinoma' vs 'normal',7.926241523170962
ENSG00000108829,2768.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',7.926241523170962
ENSG00000108829,2768.0,E-MTAB-779,1.6,'breast carcinoma' vs 'normal',7.926241523170962
ENSG00000132002,3482.0,,,,8.155649270366002
ENSG00000134250,8075.0,,,,8.996651979432729
ENSG00000116981,1.0,,,,0.6931471805599453
ENSG00000171444,1901.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',7.550661243105336
ENSG00000274290,2.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000274290,2.0,E-GEOD-38959,1.7,'breast cancer; breast' vs 'normal; breast',1.0986122886681098
ENSG00000150093,26576.0,,,,10.187801459080141
ENSG00000109320,3176.0,,,,8.063692634269517
ENSG00000181143,70.0,,,,4.2626798770413155
ENSG00000166025,3546.0,E-GEOD-54002,-2.0,'breast cancer' vs 'normal',8.173857454773621
ENSG00000166025,3546.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',8.173857454773621
ENSG00000005381,29.0,,,,3.4011973816621555
ENSG00000215845,793.0,,,,6.677083461247136
ENSG00000239264,237.0,,,,5.472270673671475
ENSG00000110031,592.0,E-GEOD-44408,1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.385194398997726
ENSG00000155657,2234.0,E-GEOD-44408,1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.711996507047669
ENSG00000177889,2138.0,,,,7.668093709082406
ENSG00000141448,385.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',5.955837369464831
ENSG00000157765,239.0,,,,5.480638923341991
ENSG00000185811,354.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.872117789475416
ENSG00000051825,441.0,,,,6.091309882077698
ENSG00000112992,2347.0,,,,7.761319180947987
ENSG00000124486,5667.0,,,,8.64259160081057
ENSG00000167291,3952.0,E-GEOD-44408,-1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.282230063296685
ENSG00000121743,1.0,,,,0.6931471805599453
ENSG00000100220,3208.0,,,,8.073714641109857
ENSG00000130382,4345.0,,,,8.377011160816375
ENSG00000197548,1057.0,,,,6.964135612418245
ENSG00000004776,8080.0,,,,8.997270906233448
ENSG00000019169,237.0,E-MTAB-779,-1.2,'breast carcinoma' vs 'normal',5.472270673671475
ENSG00000019169,237.0,E-GEOD-44408,2.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.472270673671475
ENSG00000179796,9.0,,,,2.302585092994046
ENSG00000147274,8208.0,,,,9.012986392348266
ENSG00000100097,19365.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',9.871274230171476
ENSG00000165915,3017.0,,,,8.012349639327795
ENSG00000143882,200.0,,,,5.303304908059076
ENSG00000169035,83.0,E-GEOD-54002,-3.0,'breast cancer' vs 'normal',4.430816798843313
ENSG00000171056,480.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',6.175867270105761
ENSG00000171056,480.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',6.175867270105761
ENSG00000171056,480.0,E-GEOD-52194,-6.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',6.175867270105761
ENSG00000171056,480.0,E-GEOD-52194,-6.4,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',6.175867270105761
ENSG00000171056,480.0,E-GEOD-52194,-6.5,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',6.175867270105761
ENSG00000149418,1170.0,,,,7.065613363597717
ENSG00000130340,5763.0,E-GEOD-31138,2.6,'invasive ductal carcinoma' vs 'normal',8.659386957119413
ENSG00000166033,7628.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.93971205409023
ENSG00000166033,7628.0,E-GEOD-31138,2.4,'invasive ductal carcinoma' vs 'normal',8.93971205409023
ENSG00000118217,2653.0,,,,7.8838232148921525
ENSG00000070501,649.0,,,,6.476972362889683
ENSG00000136011,67.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.219507705176107
ENSG00000163909,661.0,,,,6.495265555937008
ENSG00000013588,1113.0,E-GEOD-54002,2.3,'breast cancer' vs 'normal',7.01571242048723
ENSG00000013588,1113.0,E-GEOD-38959,1.5,'breast cancer; breast' vs 'normal; breast',7.01571242048723
ENSG00000013588,1113.0,E-GEOD-7377,1.6,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.01571242048723
ENSG00000013588,1113.0,E-GEOD-25407,2.3,'breast cancer' vs 'normal',7.01571242048723
ENSG00000013588,1113.0,E-GEOD-10780,2.3,'breast carcinoma' vs 'normal',7.01571242048723
ENSG00000013588,1113.0,E-GEOD-44408,-4.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.01571242048723
ENSG00000121621,24.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',3.2188758248682006
ENSG00000184524,7.0,,,,2.0794415416798357
ENSG00000137845,3217.0,,,,8.076515327552329
ENSG00000153246,1226.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',7.112327444710911
ENSG00000153246,1226.0,E-GEOD-54002,-2.3,'breast cancer' vs 'normal',7.112327444710911
ENSG00000153246,1226.0,E-GEOD-7377,-1.6,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.112327444710911
ENSG00000081237,1000.0,E-GEOD-44408,2.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.90875477931522
ENSG00000155304,781.0,,,,6.661854740545311
ENSG00000108797,885.0,,,,6.786716950605081
ENSG00000184164,1494.0,,,,7.3098814858247865
ENSG00000211898,45.0,E-GEOD-44408,2.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.828641396489095
ENSG00000120913,999.0,,,,6.907755278982137
ENSG00000079819,6166.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',8.726967774991493
ENSG00000079819,6166.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',8.726967774991493
ENSG00000182533,10.0,,,,2.3978952727983707
ENSG00000139354,120.0,E-GEOD-54002,2.0,'breast cancer' vs 'normal',4.795790545596741
ENSG00000089159,12256.0,,,,9.413852481341165
ENSG00000123838,26.0,E-GEOD-52194,-4.7,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',3.295836866004329
ENSG00000123838,26.0,E-GEOD-54002,-3.1,'breast cancer' vs 'normal',3.295836866004329
ENSG00000196419,10239.0,,,,9.234056898593499
ENSG00000197275,47.0,,,,3.871201010907891
ENSG00000143319,1212.0,,,,7.10085190894405
ENSG00000101189,715.0,E-GEOD-31138,1.9,'invasive ductal carcinoma' vs 'normal',6.573680166960646
ENSG00000130724,3522.0,,,,8.167068178341237
ENSG00000162383,260.0,,,,5.564520407322694
ENSG00000146731,5289.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',8.573573524852344
ENSG00000146731,5289.0,E-MTAB-779,1.7,'breast carcinoma' vs 'normal',8.573573524852344
ENSG00000125686,1502.0,,,,7.315218389752975
ENSG00000140740,7127.0,,,,8.871785969150645
ENSG00000130234,136.0,,,,4.919980925828125
ENSG00000113721,19716.0,,,,9.889236486766269
ENSG00000141013,771.0,,,,6.648984550024776
ENSG00000157483,2097.0,,,,7.6487397889562425
ENSG00000123358,9456.0,E-GEOD-52194,-5.0,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',9.154510487015513
ENSG00000123358,9456.0,E-GEOD-52194,-4.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',9.154510487015513
ENSG00000123358,9456.0,E-GEOD-52194,-5.4,'triple-negative breast cancer; breast carcinoma' vs 'normal',9.154510487015513
ENSG00000160201,2106.0,,,,7.653020413804189
ENSG00000124762,8575.0,E-GEOD-52194,-5.2,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',9.056722883310583
ENSG00000096717,1452.0,,,,7.2813856635702825
ENSG00000089693,6116.0,,,,8.718827059242566
ENSG00000135046,22647.0,E-GEOD-38959,-1.4,'breast cancer; breast' vs 'normal; breast',10.027826826791735
ENSG00000135046,22647.0,E-MTAB-779,-1.7,'breast carcinoma' vs 'normal',10.027826826791735
ENSG00000135046,22647.0,E-GEOD-10780,-1.5,'breast carcinoma' vs 'normal',10.027826826791735
ENSG00000135046,22647.0,E-GEOD-54002,-3.5,'breast cancer' vs 'normal',10.027826826791735
ENSG00000107829,3133.0,,,,8.050065422915965
ENSG00000160072,1821.0,,,,7.507690077819904
ENSG00000103257,667.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',6.504288173536645
ENSG00000103257,667.0,E-GEOD-52194,-4.9,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',6.504288173536645
ENSG00000091409,5704.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',8.649098262296176
ENSG00000170677,1051.0,E-GEOD-31138,1.6,'invasive ductal carcinoma' vs 'normal',6.9584483932976555
ENSG00000170677,1051.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.9584483932976555
ENSG00000137673,507.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',6.230481447578482
ENSG00000137673,507.0,E-GEOD-54002,-4.0,'breast cancer' vs 'normal',6.230481447578482
ENSG00000137673,507.0,E-GEOD-52194,-5.7,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',6.230481447578482
ENSG00000099889,1030.0,,,,6.93828448401696
ENSG00000196502,832.0,,,,6.725033642166843
ENSG00000005007,5667.0,E-MTAB-779,1.9,'breast carcinoma' vs 'normal',8.64259160081057
ENSG00000173933,434.0,,,,6.075346031088684
ENSG00000158104,48.0,,,,3.8918202981106265
ENSG00000197632,14.0,,,,2.70805020110221
ENSG00000169946,662.0,,,,6.4967749901858625
ENSG00000173166,351.0,,,,5.863631175598097
ENSG00000144746,6153.0,,,,8.724857555881988
ENSG00000029993,312.0,E-GEOD-54002,1.7,'breast cancer' vs 'normal',5.746203190540153
ENSG00000029993,312.0,E-GEOD-44408,-1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.746203190540153
ENSG00000029993,312.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',5.746203190540153
ENSG00000029993,312.0,E-GEOD-38959,2.5,'breast cancer; breast' vs 'normal; breast',5.746203190540153
ENSG00000197471,117.0,,,,4.770684624465665
ENSG00000103035,2371.0,,,,7.771488760117616
ENSG00000160752,2269.0,,,,7.727535110475448
ENSG00000264424,10.0,,,,2.3978952727983707
ENSG00000139187,74.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.31748811353631
ENSG00000158796,1994.0,,,,7.598399329323964
ENSG00000114956,1332.0,,,,7.195187320178709
ENSG00000184254,857.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',6.754604099487962
ENSG00000184254,857.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',6.754604099487962
ENSG00000184254,857.0,E-GEOD-54002,-3.9,'breast cancer' vs 'normal',6.754604099487962
ENSG00000077348,508.0,,,,6.2324480165505225
ENSG00000145425,35541.0,,,,10.47847037474543
ENSG00000064012,1005.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.913737350659685
ENSG00000064012,1005.0,E-MTAB-779,1.2,'breast carcinoma' vs 'normal',6.913737350659685
ENSG00000110958,8980.0,E-GEOD-31138,1.8,'invasive ductal carcinoma' vs 'normal',9.10286651367095
ENSG00000164086,1248.0,,,,7.130098510125578
ENSG00000116752,1104.0,,,,7.007600613951853
ENSG00000135049,1058.0,,,,6.9650803456014065
ENSG00000169504,12371.0,,,,9.423191133804961
ENSG00000249437,866.0,,,,6.7650389767805414
ENSG00000162736,4665.0,,,,8.448057452581375
ENSG00000156345,351.0,,,,5.863631175598097
ENSG00000040731,1.0,E-GEOD-52194,5.2,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000148400,4749.0,,,,8.465899897028686
ENSG00000166863,1.0,,,,0.6931471805599453
ENSG00000123143,5366.0,,,,8.588024372176829
ENSG00000156709,1273.0,,,,7.149916836132109
ENSG00000166527,10.0,E-GEOD-52194,5.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',2.3978952727983707
ENSG00000131788,3277.0,E-GEOD-44408,-1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.094988759303774
ENSG00000116750,1127.0,,,,7.028201432058005
ENSG00000065371,15.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',2.772588722239781
ENSG00000065371,15.0,E-MTAB-779,-1.8,'breast carcinoma' vs 'normal',2.772588722239781
ENSG00000065371,15.0,E-GEOD-7377,-1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',2.772588722239781
ENSG00000065371,15.0,E-GEOD-54002,-4.0,'breast cancer' vs 'normal',2.772588722239781
ENSG00000162706,469.0,,,,6.152732694704104
ENSG00000131095,184.0,,,,5.220355825078324
ENSG00000104833,22.0,,,,3.1354942159291497
ENSG00000214944,1086.0,E-GEOD-54002,-2.0,'breast cancer' vs 'normal',6.99117688712121
ENSG00000214944,1086.0,E-GEOD-38959,-1.3,'breast cancer; breast' vs 'normal; breast',6.99117688712121
ENSG00000040933,1662.0,,,,7.416378479192928
ENSG00000178913,4562.0,,,,8.425735580927402
ENSG00000152137,1877.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',7.537962659768208
ENSG00000127472,102.0,,,,4.634728988229636
ENSG00000117519,8992.0,E-GEOD-7377,1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',9.104201775914515
ENSG00000185245,38.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.6635616461296463
ENSG00000185624,17465.0,,,,9.768011412973678
ENSG00000116830,822.0,,,,6.71295620067707
ENSG00000151150,574.0,E-GEOD-20086,1.1,'breast cancer' vs 'normal',6.354370040797351
ENSG00000136936,749.0,,,,6.620073206530356
ENSG00000162772,2672.0,E-GEOD-54002,-2.6,'breast cancer' vs 'normal',7.890956716138919
ENSG00000162772,2672.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',7.890956716138919
ENSG00000162772,2672.0,E-GEOD-52194,-6.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',7.890956716138919
ENSG00000162772,2672.0,E-GEOD-52194,-6.0,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',7.890956716138919
ENSG00000162772,2672.0,E-GEOD-52194,-6.1,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',7.890956716138919
ENSG00000092820,3426.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',8.139440521874608
ENSG00000092820,3426.0,E-GEOD-31138,2.4,'invasive ductal carcinoma' vs 'normal',8.139440521874608
ENSG00000162777,940.0,E-GEOD-44408,1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.846943139585379
ENSG00000100311,1581.0,,,,7.366445148327599
ENSG00000009307,26285.0,,,,10.176791757041954
ENSG00000078369,12760.0,,,,9.454148923733976
ENSG00000115138,93.0,,,,4.543294782270004
ENSG00000171401,184.0,E-GEOD-68086,-4.8,'breast carcinoma' vs 'normal',5.220355825078324
ENSG00000196092,5.0,E-GEOD-52194,5.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.791759469228055
ENSG00000196092,5.0,E-GEOD-44408,3.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',1.791759469228055
ENSG00000116574,2312.0,E-GEOD-31138,-1.7,'invasive ductal carcinoma' vs 'normal',7.746300662231439
ENSG00000116574,2312.0,E-GEOD-54002,-2.2,'breast cancer' vs 'normal',7.746300662231439
ENSG00000116574,2312.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',7.746300662231439
ENSG00000116574,2312.0,E-GEOD-25407,3.2,'breast cancer' vs 'normal',7.746300662231439
ENSG00000136628,3971.0,E-GEOD-31138,2.5,'invasive ductal carcinoma' vs 'normal',8.287025025165063
ENSG00000136628,3971.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',8.287025025165063
ENSG00000153310,1701.0,E-GEOD-38959,1.5,'breast cancer; breast' vs 'normal; breast',7.43955930913332
ENSG00000159723,2.0,,,,1.0986122886681098
ENSG00000130706,3033.0,,,,8.017637159908478
ENSG00000141469,70.0,,,,4.2626798770413155
ENSG00000187486,215.0,,,,5.375278407684165
ENSG00000271605,116.0,,,,4.762173934797756
ENSG00000005073,25.0,,,,3.258096538021482
ENSG00000181722,86.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',4.465908118654584
ENSG00000181722,86.0,E-GEOD-10780,-1.5,'breast carcinoma' vs 'normal',4.465908118654584
ENSG00000168646,512.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',6.240275845170769
ENSG00000013810,428.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',6.061456918928017
ENSG00000013810,428.0,E-GEOD-54002,2.2,'breast cancer' vs 'normal',6.061456918928017
ENSG00000073861,35.0,,,,3.58351893845611
ENSG00000115380,8073.0,E-GEOD-54002,-2.4,'breast cancer' vs 'normal',8.996404301412886
ENSG00000115380,8073.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',8.996404301412886
ENSG00000115380,8073.0,E-MTAB-779,-1.8,'breast carcinoma' vs 'normal',8.996404301412886
ENSG00000135114,88.0,,,,4.48863636973214
ENSG00000138757,3747.0,,,,8.228977643358313
ENSG00000149100,4529.0,,,,8.41847721847708
ENSG00000040275,333.0,,,,5.811140992976701
ENSG00000092148,7541.0,,,,8.928242677818302
ENSG00000162889,6080.0,,,,8.71292443512011
ENSG00000137841,744.0,,,,6.61338421837956
ENSG00000197746,49416.0,,,,10.808049773531675
ENSG00000100092,357.0,,,,5.8805329864007
ENSG00000160883,306.0,,,,5.726847747587197
ENSG00000165637,4495.0,,,,8.410943391573527
ENSG00000124812,0.0,,,,0.0
ENSG00000101346,2425.0,,,,7.793999089503996
ENSG00000101000,1165.0,,,,7.061334366910438
ENSG00000142002,2951.0,,,,7.990238185720363
ENSG00000203786,4.0,E-GEOD-68086,-5.1,'breast carcinoma' vs 'normal',1.6094379124341003
ENSG00000203786,4.0,E-GEOD-52194,5.6,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.6094379124341003
ENSG00000174903,5757.0,,,,8.65834547117212
ENSG00000012660,10548.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',9.263786347681808
ENSG00000012660,10548.0,E-GEOD-31138,4.0,'invasive ductal carcinoma' vs 'normal',9.263786347681808
ENSG00000012660,10548.0,E-GEOD-7377,2.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',9.263786347681808
ENSG00000169288,628.0,,,,6.444131256700441
ENSG00000186891,65.0,,,,4.189654742026425
ENSG00000144476,3241.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',8.08394570229562
ENSG00000144476,3241.0,E-GEOD-31138,3.0,'invasive ductal carcinoma' vs 'normal',8.08394570229562
ENSG00000134086,1293.0,,,,7.165493475060845
ENSG00000121634,0.0,,,,0.0
ENSG00000135766,3920.0,,,,8.27410200229233
ENSG00000154839,39.0,,,,3.6888794541139363
ENSG00000159167,1205.0,E-GEOD-44408,-2.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.095064377287131
ENSG00000112759,8180.0,,,,9.009569671513699
ENSG00000100867,40.0,,,,3.713572066704308
ENSG00000261150,115.0,,,,4.7535901911063645
ENSG00000179041,714.0,,,,6.5722825426940075
ENSG00000100139,1534.0,,,,7.336285660021297
ENSG00000102100,728.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.591673732008658
ENSG00000102100,728.0,E-GEOD-31138,3.0,'invasive ductal carcinoma' vs 'normal',6.591673732008658
ENSG00000178449,1718.0,,,,7.449498005382849
ENSG00000186395,1161.0,,,,7.057897937411856
ENSG00000137965,1083.0,,,,6.988413181999592
ENSG00000182180,1813.0,,,,7.503289630675082
ENSG00000105245,1783.0,,,,7.486613313139955
ENSG00000105185,2251.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',7.719573989259581
ENSG00000151364,89.0,E-GEOD-54002,-3.1,'breast cancer' vs 'normal',4.499809670330265
ENSG00000115935,3422.0,E-GEOD-44408,2.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.138272638530186
ENSG00000173436,956.0,,,,6.863803391452954
ENSG00000092295,93.0,,,,4.543294782270004
ENSG00000143862,2170.0,,,,7.682943169878292
ENSG00000142798,19793.0,,,,9.893134140456636
ENSG00000095951,1485.0,,,,7.303843225277705
ENSG00000058056,1548.0,,,,7.3453648404168685
ENSG00000104413,442.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',6.093569770045136
ENSG00000104413,442.0,E-GEOD-44408,-3.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.093569770045136
ENSG00000171049,37.0,,,,3.6375861597263857
ENSG00000128564,3.0,,,,1.3862943611198906
ENSG00000196090,107.0,,,,4.68213122712422
ENSG00000123562,7584.0,,,,8.933927891782632
ENSG00000138363,2105.0,,,,7.652545692693921
ENSG00000165799,16.0,,,,2.833213344056216
ENSG00000170835,92.0,,,,4.532599493153256
ENSG00000091879,845.0,,,,6.740519359606223
ENSG00000100614,3662.0,,,,8.206037762778815
ENSG00000143375,507.0,E-GEOD-31138,1.9,'invasive ductal carcinoma' vs 'normal',6.230481447578482
ENSG00000101384,6124.0,,,,8.720134035412928
ENSG00000011677,0.0,E-GEOD-52194,6.8,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000011677,0.0,E-GEOD-52194,5.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000165169,1334.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.19668657083435
ENSG00000181195,42.0,E-MTAB-779,-1.2,'breast carcinoma' vs 'normal',3.7612001156935624
ENSG00000181195,42.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',3.7612001156935624
ENSG00000181195,42.0,E-GEOD-52194,-6.4,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',3.7612001156935624
ENSG00000181195,42.0,E-GEOD-52194,-5.9,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',3.7612001156935624
ENSG00000181195,42.0,E-GEOD-7377,2.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',3.7612001156935624
ENSG00000203668,497.0,E-GEOD-31138,3.6,'invasive ductal carcinoma' vs 'normal',6.210600077024653
ENSG00000133083,2474.0,E-MTAB-779,-1.2,'breast carcinoma' vs 'normal',7.813995675002791
ENSG00000133083,2474.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',7.813995675002791
ENSG00000133083,2474.0,E-GEOD-38959,-1.6,'breast cancer; breast' vs 'normal; breast',7.813995675002791
ENSG00000133083,2474.0,E-GEOD-20086,-1.5,'breast cancer' vs 'normal',7.813995675002791
ENSG00000175305,64.0,E-GEOD-44408,-1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.174387269895637
ENSG00000175305,64.0,E-GEOD-38959,1.6,'breast cancer; breast' vs 'normal; breast',4.174387269895637
ENSG00000175305,64.0,E-GEOD-54002,3.3,'breast cancer' vs 'normal',4.174387269895637
ENSG00000175305,64.0,E-GEOD-31138,3.7,'invasive ductal carcinoma' vs 'normal',4.174387269895637
ENSG00000198015,1492.0,E-GEOD-31138,-2.0,'invasive ductal carcinoma' vs 'normal',7.30854279753919
ENSG00000136859,6234.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',8.737933858114136
ENSG00000136859,6234.0,E-MTAB-779,-1.9,'breast carcinoma' vs 'normal',8.737933858114136
ENSG00000176171,2777.0,E-GEOD-44408,-1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.9294865233142895
ENSG00000137267,619.0,E-GEOD-44408,-1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.429719478039138
ENSG00000127554,546.0,,,,6.304448802421981
ENSG00000130988,155.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',5.049856007249537
ENSG00000081051,2.0,E-GEOD-54002,-2.0,'breast cancer' vs 'normal',1.0986122886681098
ENSG00000126067,2895.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',7.971085753505607
ENSG00000114450,1292.0,E-GEOD-31138,2.0,'invasive ductal carcinoma' vs 'normal',7.164720378771857
ENSG00000114450,1292.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',7.164720378771857
ENSG00000122786,20731.0,E-GEOD-54002,-1.4,'breast cancer' vs 'normal',9.939433679309596
ENSG00000156299,433.0,,,,6.073044534100405
ENSG00000232810,16.0,E-GEOD-52194,-5.3,'triple-negative breast cancer; breast carcinoma' vs 'normal',2.833213344056216
ENSG00000232810,16.0,E-GEOD-52194,-5.6,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',2.833213344056216
ENSG00000232810,16.0,E-GEOD-52194,-5.7,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',2.833213344056216
ENSG00000165283,2769.0,,,,7.926602599181384
ENSG00000152348,351.0,,,,5.863631175598097
ENSG00000140718,2900.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.972810784121404
ENSG00000140718,2900.0,E-GEOD-38959,-1.5,'breast cancer; breast' vs 'normal; breast',7.972810784121404
ENSG00000204444,121.0,,,,4.804021044733257
ENSG00000136754,2941.0,,,,7.9868449011613825
ENSG00000043591,70.0,,,,4.2626798770413155
ENSG00000108387,1484.0,,,,7.3031700512368
ENSG00000130226,41.0,,,,3.7376696182833684
ENSG00000122545,7826.0,,,,8.965334573804839
ENSG00000131781,386.0,E-GEOD-38959,-2.0,'breast cancer; breast' vs 'normal; breast',5.958424693029782
ENSG00000134470,1428.0,,,,7.264730177929867
ENSG00000093010,3370.0,,,,8.12296471523406
ENSG00000258947,5.0,,,,1.791759469228055
ENSG00000186280,51.0,,,,3.9512437185814275
ENSG00000197594,1641.0,E-GEOD-44408,-2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.403670290012373
ENSG00000197594,1641.0,E-GEOD-20086,2.1,'breast cancer' vs 'normal',7.403670290012373
ENSG00000102934,399.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',5.991464547107982
ENSG00000136504,2566.0,,,,7.8504931808711405
ENSG00000147155,595.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',6.39024066706535
ENSG00000177106,2647.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.881559917056899
ENSG00000121552,360.0,E-GEOD-54002,-1.4,'breast cancer' vs 'normal',5.8888779583328805
ENSG00000185880,873.0,,,,6.773080375655535
ENSG00000178028,2448.0,,,,7.803435056952168
ENSG00000173542,1266.0,E-GEOD-31138,3.1,'invasive ductal carcinoma' vs 'normal',7.144407180321139
ENSG00000020577,2569.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',7.851661177889265
ENSG00000114739,515.0,,,,6.246106765481563
ENSG00000109944,227.0,,,,5.429345628954441
ENSG00000116044,5167.0,,,,8.550241045462437
ENSG00000119408,1081.0,,,,6.9865664594064265
ENSG00000153046,1380.0,,,,7.2305631534092925
ENSG00000124789,3198.0,,,,8.070593539949519
ENSG00000125285,1.0,,,,0.6931471805599453
ENSG00000042088,483.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',6.182084906716632
ENSG00000165238,603.0,,,,6.403574197934815
ENSG00000240694,122.0,E-GEOD-20086,-1.3,'breast cancer' vs 'normal',4.812184355372417
ENSG00000072274,2628.0,E-GEOD-31138,2.2,'invasive ductal carcinoma' vs 'normal',7.874358824729881
ENSG00000072274,2628.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',7.874358824729881
ENSG00000011426,39.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',3.6888794541139363
ENSG00000011426,39.0,E-GEOD-38959,1.5,'breast cancer; breast' vs 'normal; breast',3.6888794541139363
ENSG00000011426,39.0,E-GEOD-54002,3.8,'breast cancer' vs 'normal',3.6888794541139363
ENSG00000106804,482.0,,,,6.180016653652572
ENSG00000109814,1487.0,E-GEOD-31138,2.7,'invasive ductal carcinoma' vs 'normal',7.305188215393037
ENSG00000109814,1487.0,E-GEOD-44408,-2.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.305188215393037
ENSG00000109814,1487.0,E-GEOD-7377,2.0,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.305188215393037
ENSG00000124157,0.0,,,,0.0
ENSG00000173762,119.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.787491742782046
ENSG00000120659,1.0,E-GEOD-44408,3.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',0.6931471805599453
ENSG00000048740,5236.0,E-GEOD-44408,1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.563504094279487
ENSG00000048740,5236.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',8.563504094279487
ENSG00000048740,5236.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',8.563504094279487
ENSG00000146399,0.0,,,,0.0
ENSG00000122126,2192.0,,,,7.693025748417888
ENSG00000184216,4120.0,,,,8.323851131338817
ENSG00000082701,2189.0,,,,7.691656822810547
ENSG00000079689,24.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',3.2188758248682006
ENSG00000104824,7422.0,,,,8.912338567117548
ENSG00000149925,34044.0,,,,10.435438457917067
ENSG00000134460,46.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.8501476017100584
ENSG00000130175,8840.0,,,,9.087155271405804
ENSG00000124466,269.0,E-GEOD-7377,1.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',5.598421958998375
ENSG00000073331,1960.0,E-MTAB-779,2.0,'breast carcinoma' vs 'normal',7.581209826196346
ENSG00000117266,541.0,,,,6.295266001439646
ENSG00000164733,20886.0,E-GEOD-31138,1.8,'invasive ductal carcinoma' vs 'normal',9.946882234855318
ENSG00000164733,20886.0,E-MTAB-779,2.4,'breast carcinoma' vs 'normal',9.946882234855318
ENSG00000113525,2.0,,,,1.0986122886681098
ENSG00000134817,311.0,,,,5.7430031878094825
ENSG00000100697,5689.0,,,,8.646465527120377
ENSG00000165556,0.0,,,,0.0
ENSG00000165215,385.0,E-GEOD-44408,-2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.955837369464831
ENSG00000124092,3.0,E-GEOD-52194,5.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.3862943611198906
ENSG00000164434,17.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',2.8903717578961645
ENSG00000164434,17.0,E-GEOD-52194,-4.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',2.8903717578961645
ENSG00000164434,17.0,E-GEOD-54002,-3.5,'breast cancer' vs 'normal',2.8903717578961645
ENSG00000155897,2.0,,,,1.0986122886681098
ENSG00000077238,4118.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',8.323365694436081
ENSG00000014138,662.0,,,,6.4967749901858625
ENSG00000038382,5860.0,,,,8.676075516476429
ENSG00000198788,5.0,E-GEOD-52194,5.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.791759469228055
ENSG00000198788,5.0,E-GEOD-52194,5.1,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',1.791759469228055
ENSG00000157450,1613.0,,,,7.3864708488298945
ENSG00000171262,971.0,,,,6.879355804460439
ENSG00000153066,2430.0,,,,7.796057974316123
ENSG00000160886,99.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',4.605170185988092
ENSG00000170412,943.0,,,,6.8501261661455
ENSG00000133067,302.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',5.713732805509369
ENSG00000133067,302.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',5.713732805509369
ENSG00000133067,302.0,E-GEOD-38959,-1.5,'breast cancer; breast' vs 'normal; breast',5.713732805509369
ENSG00000110786,46.0,,,,3.8501476017100584
ENSG00000086570,217.0,E-GEOD-54002,-2.3,'breast cancer' vs 'normal',5.384495062789089
ENSG00000112319,69.0,E-GEOD-68086,-5.4,'breast carcinoma' vs 'normal',4.248495242049359
ENSG00000170581,8423.0,,,,9.03884005381381
ENSG00000179071,24.0,,,,3.2188758248682006
ENSG00000108821,20029.0,E-GEOD-44408,-2.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.904986428659864
ENSG00000108821,20029.0,E-GEOD-54002,3.8,'breast cancer' vs 'normal',9.904986428659864
ENSG00000142973,2088.0,,,,7.644440761556566
ENSG00000100359,3457.0,,,,8.148445666243235
ENSG00000141551,9024.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',9.107753783201082
ENSG00000132693,22.0,,,,3.1354942159291497
ENSG00000182247,1197.0,,,,7.088408778675395
ENSG00000126016,749.0,,,,6.620073206530356
ENSG00000148824,386.0,,,,5.958424693029782
ENSG00000211895,3464.0,E-GEOD-38959,-2.3,'breast cancer; breast' vs 'normal; breast',8.150467911624004
ENSG00000162434,12186.0,,,,9.408125088823502
ENSG00000105429,2269.0,,,,7.727535110475448
ENSG00000143603,153.0,,,,5.0369526024136295
ENSG00000075702,141.0,,,,4.955827057601261
ENSG00000185532,653.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',6.483107351457199
ENSG00000100739,22.0,,,,3.1354942159291497
ENSG00000135912,1185.0,,,,7.078341579557671
ENSG00000066422,1204.0,,,,7.094234845924755
ENSG00000163581,0.0,,,,0.0
ENSG00000138175,1004.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.912742820493176
ENSG00000119396,5230.0,,,,8.562357743370612
ENSG00000178372,33.0,,,,3.5263605246161616
ENSG00000070159,1137.0,E-GEOD-44408,-1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.037027614686276
ENSG00000055957,13.0,,,,2.6390573296152584
ENSG00000204305,420.0,,,,6.042632833682381
ENSG00000137992,1176.0,,,,7.0707241072602764
ENSG00000167286,39.0,E-GEOD-44408,2.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.6888794541139363
ENSG00000162409,322.0,,,,5.777652323222656
ENSG00000140682,3613.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',8.192570471152173
ENSG00000140682,3613.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',8.192570471152173
ENSG00000146085,1802.0,,,,7.497207223203318
ENSG00000102144,11667.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',9.364605330987612
ENSG00000108691,619.0,E-GEOD-52194,-4.9,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',6.429719478039138
ENSG00000161905,5.0,,,,1.791759469228055
ENSG00000118096,934.0,,,,6.840546529288687
ENSG00000183837,26.0,,,,3.295836866004329
ENSG00000204632,382.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',5.948034989180646
ENSG00000113569,1218.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',7.105786129481271
ENSG00000140464,7994.0,,,,8.986571625268054
ENSG00000009954,3972.0,,,,8.287276755814599
ENSG00000107957,4874.0,,,,8.491875383431948
ENSG00000068078,149.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',5.0106352940962555
ENSG00000068078,149.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',5.0106352940962555
ENSG00000215182,5.0,,,,1.791759469228055
ENSG00000114331,2646.0,,,,7.881182202227102
ENSG00000073605,1528.0,,,,7.332369205929062
ENSG00000103275,4083.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',8.314832179284556
ENSG00000165168,634.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.453624998892692
ENSG00000100522,550.0,,,,6.311734809152915
ENSG00000130758,833.0,,,,6.726233402358747
ENSG00000102977,1057.0,,,,6.964135612418245
ENSG00000088325,98.0,E-MTAB-779,1.2,'breast carcinoma' vs 'normal',4.59511985013459
ENSG00000088325,98.0,E-GEOD-54002,3.3,'breast cancer' vs 'normal',4.59511985013459
ENSG00000088325,98.0,E-GEOD-10780,1.9,'breast carcinoma' vs 'normal',4.59511985013459
ENSG00000088325,98.0,E-GEOD-31138,4.1,'invasive ductal carcinoma' vs 'normal',4.59511985013459
ENSG00000088325,98.0,E-GEOD-38959,2.5,'breast cancer; breast' vs 'normal; breast',4.59511985013459
ENSG00000100276,62.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',4.143134726391533
ENSG00000100276,62.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',4.143134726391533
ENSG00000108064,1288.0,,,,7.161622002939187
ENSG00000170748,0.0,,,,0.0
ENSG00000170325,708.0,,,,6.5638555265321274
ENSG00000122779,1137.0,,,,7.037027614686276
ENSG00000173546,2949.0,,,,7.989560449333865
ENSG00000196126,5520.0,E-GEOD-20086,1.1,'breast cancer' vs 'normal',8.616314282284044
ENSG00000197168,82.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',4.418840607796598
ENSG00000078747,2812.0,,,,7.9420068084898565
ENSG00000139291,566.0,E-GEOD-31138,3.3,'invasive ductal carcinoma' vs 'normal',6.340359303727752
ENSG00000139291,566.0,E-GEOD-7377,1.7,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.340359303727752
ENSG00000174405,552.0,,,,6.315358001522335
ENSG00000163221,42.0,,,,3.7612001156935624
ENSG00000174697,5016.0,E-MTAB-779,-2.2,'breast carcinoma' vs 'normal',8.520587424484253
ENSG00000174697,5016.0,E-GEOD-10780,-2.6,'breast carcinoma' vs 'normal',8.520587424484253
ENSG00000042493,2489.0,,,,7.820037989458753
ENSG00000163607,339.0,,,,5.8289456176102075
ENSG00000106628,2641.0,,,,7.879291485082271
ENSG00000095002,731.0,E-GEOD-31138,1.9,'invasive ductal carcinoma' vs 'normal',6.595780513961311
ENSG00000095002,731.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',6.595780513961311
ENSG00000073578,4685.0,,,,8.452334619067742
ENSG00000157540,4304.0,,,,8.367532416861831
ENSG00000104549,433.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.073044534100405
ENSG00000104549,433.0,E-GEOD-54002,2.0,'breast cancer' vs 'normal',6.073044534100405
ENSG00000104549,433.0,E-MTAB-779,2.2,'breast carcinoma' vs 'normal',6.073044534100405
ENSG00000104549,433.0,E-GEOD-38959,2.1,'breast cancer; breast' vs 'normal; breast',6.073044534100405
ENSG00000119917,835.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',6.728628613084702
ENSG00000119917,835.0,E-GEOD-20086,-1.2,'breast cancer' vs 'normal',6.728628613084702
ENSG00000103126,1644.0,,,,7.405495663199472
ENSG00000079459,4425.0,,,,8.395251520610994
ENSG00000213341,1238.0,,,,7.122059881629142
ENSG00000155792,1057.0,,,,6.964135612418245
ENSG00000085265,225.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.420534999272286
ENSG00000149547,3540.0,,,,8.172164452111904
ENSG00000070495,1682.0,,,,7.428333194190806
ENSG00000213928,461.0,,,,6.135564891081739
ENSG00000184033,0.0,,,,0.0
ENSG00000160796,5983.0,,,,8.696844519654313
ENSG00000161021,3198.0,,,,8.070593539949519
ENSG00000134184,473.0,E-GEOD-38959,-1.4,'breast cancer; breast' vs 'normal; breast',6.161207321695077
ENSG00000196950,902.0,E-GEOD-31138,3.5,'invasive ductal carcinoma' vs 'normal',6.805722553416985
ENSG00000115541,1248.0,,,,7.130098510125578
ENSG00000105609,1310.0,,,,7.1785454837637
ENSG00000165449,85.0,,,,4.454347296253507
ENSG00000054356,4.0,,,,1.6094379124341003
ENSG00000135480,5348.0,,,,8.58466490653125
ENSG00000123374,1520.0,,,,7.327123292259293
ENSG00000029364,2176.0,,,,7.685703061234547
ENSG00000167703,1518.0,,,,7.325807502595773
ENSG00000138398,3532.0,,,,8.169902647359145
ENSG00000100280,3775.0,,,,8.236420527265391
ENSG00000188157,3359.0,E-GEOD-44408,-1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.11969625295725
ENSG00000198435,239.0,,,,5.480638923341991
ENSG00000090316,3318.0,,,,8.107418811719974
ENSG00000070950,645.0,,,,6.470799503782602
ENSG00000166091,24.0,,,,3.2188758248682006
ENSG00000120658,132.0,,,,4.890349128221754
ENSG00000123405,25.0,,,,3.258096538021482
ENSG00000143156,380.0,,,,5.942799375126701
ENSG00000104921,40.0,E-GEOD-44408,2.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.713572066704308
ENSG00000115163,19.0,E-GEOD-38959,1.7,'breast cancer; breast' vs 'normal; breast',2.995732273553991
ENSG00000115163,19.0,E-GEOD-54002,3.0,'breast cancer' vs 'normal',2.995732273553991
ENSG00000095319,2778.0,,,,7.929846429742503
ENSG00000034677,3701.0,,,,8.216628493133443
ENSG00000103569,84.0,,,,4.442651256490317
ENSG00000164944,2589.0,,,,7.859413154693583
ENSG00000115170,1735.0,,,,7.459338895220296
ENSG00000167711,960.0,,,,6.8679744089702925
ENSG00000163072,1569.0,E-GEOD-31138,-2.0,'invasive ductal carcinoma' vs 'normal',7.358830898342354
ENSG00000163072,1569.0,E-GEOD-38959,-1.9,'breast cancer; breast' vs 'normal; breast',7.358830898342354
ENSG00000170965,0.0,,,,0.0
ENSG00000169347,137.0,,,,4.927253685157205
ENSG00000013573,1791.0,,,,7.491087593534876
ENSG00000100385,148.0,E-GEOD-44408,1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.003946305945459
ENSG00000173068,991.0,E-GEOD-68086,-5.1,'breast carcinoma' vs 'normal',6.899723107284872
ENSG00000185480,71.0,,,,4.276666119016055
ENSG00000174804,7837.0,E-MTAB-779,-1.9,'breast carcinoma' vs 'normal',8.966738978759576
ENSG00000186526,20.0,,,,3.044522437723423
ENSG00000166971,1556.0,,,,7.350516171833998
ENSG00000162607,1557.0,E-GEOD-31138,3.4,'invasive ductal carcinoma' vs 'normal',7.351158226430694
ENSG00000058673,9271.0,,,,9.134754385019587
ENSG00000160703,1063.0,,,,6.96979066990159
ENSG00000178127,295.0,,,,5.69035945432406
ENSG00000127152,82.0,E-GEOD-44408,3.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.418840607796598
ENSG00000111642,7892.0,,,,8.973731569708402
ENSG00000024526,11.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',2.4849066497880004
ENSG00000024526,11.0,E-GEOD-31138,2.4,'invasive ductal carcinoma' vs 'normal',2.4849066497880004
ENSG00000024526,11.0,E-GEOD-52194,5.3,'triple-negative breast cancer; breast carcinoma' vs 'normal',2.4849066497880004
ENSG00000024526,11.0,E-GEOD-54002,2.9,'breast cancer' vs 'normal',2.4849066497880004
ENSG00000107779,1848.0,,,,7.522400231387125
ENSG00000136826,5758.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',8.658519127506672
ENSG00000136826,5758.0,E-MTAB-779,-1.7,'breast carcinoma' vs 'normal',8.658519127506672
ENSG00000136826,5758.0,E-GEOD-10780,-1.7,'breast carcinoma' vs 'normal',8.658519127506672
ENSG00000136826,5758.0,E-GEOD-52194,-5.2,'triple-negative breast cancer; breast carcinoma' vs 'normal',8.658519127506672
ENSG00000136826,5758.0,E-GEOD-20086,-1.1,'breast cancer' vs 'normal',8.658519127506672
ENSG00000136826,5758.0,E-GEOD-31138,-3.1,'invasive ductal carcinoma' vs 'normal',8.658519127506672
ENSG00000136826,5758.0,E-GEOD-52194,-5.0,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',8.658519127506672
ENSG00000108654,45808.0,,,,10.73223585734761
ENSG00000112972,1332.0,,,,7.195187320178709
ENSG00000154265,4089.0,E-GEOD-54002,-2.1,'breast cancer' vs 'normal',8.316300249036848
ENSG00000154265,4089.0,E-GEOD-38959,-1.8,'breast cancer; breast' vs 'normal; breast',8.316300249036848
ENSG00000180828,108.0,,,,4.6913478822291435
ENSG00000178796,1.0,,,,0.6931471805599453
ENSG00000010322,9707.0,,,,9.180705566846491
ENSG00000153563,119.0,E-GEOD-44408,1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.787491742782046
ENSG00000239672,570.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',6.3473892096560105
ENSG00000167792,6291.0,,,,8.747034264178168
ENSG00000141568,2231.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',7.710653323501202
ENSG00000172530,702.0,,,,6.555356891810665
ENSG00000122882,1389.0,,,,7.237059026124737
ENSG00000104324,2156.0,,,,7.676473646389156
ENSG00000168397,3713.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',8.219864741912652
ENSG00000147955,2161.0,,,,7.6787889981991535
ENSG00000012061,2506.0,,,,7.826842098158293
ENSG00000198727,425909.0,,,,12.96198333532573
ENSG00000197576,164.0,,,,5.10594547390058
ENSG00000115966,2270.0,,,,7.7279755421055585
ENSG00000105655,1976.0,,,,7.589335823170617
ENSG00000070756,37185.0,,,,10.523687625340008
ENSG00000128573,354.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',5.872117789475416
ENSG00000157219,0.0,,,,0.0
ENSG00000100170,83.0,E-GEOD-54002,-1.4,'breast cancer' vs 'normal',4.430816798843313
ENSG00000159189,1767.0,,,,7.477604243197589
ENSG00000124140,8.0,,,,2.1972245773362196
ENSG00000170442,27.0,,,,3.332204510175204
ENSG00000037757,1335.0,,,,7.197435354096591
ENSG00000187736,27.0,,,,3.332204510175204
ENSG00000122971,2464.0,,,,7.80994708647679
ENSG00000198680,781.0,,,,6.661854740545311
ENSG00000182923,1511.0,,,,7.321188556739478
ENSG00000081189,2551.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.844632644464681
ENSG00000105383,204.0,,,,5.3230099791384085
ENSG00000184502,0.0,,,,0.0
ENSG00000074410,1491.0,E-MTAB-779,1.9,'breast carcinoma' vs 'normal',7.307872780763706
ENSG00000074410,1491.0,E-GEOD-38959,-1.6,'breast cancer; breast' vs 'normal; breast',7.307872780763706
ENSG00000074410,1491.0,E-GEOD-44408,-4.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.307872780763706
ENSG00000206172,218.0,E-MTAB-779,-2.2,'breast carcinoma' vs 'normal',5.389071729816501
ENSG00000131051,18542.0,,,,9.827847638327382
ENSG00000167081,984.0,,,,6.892641641172089
ENSG00000056097,4980.0,,,,8.513385953073284
ENSG00000138074,3984.0,,,,8.290292591224315
ENSG00000138768,4025.0,,,,8.300528606199737
ENSG00000163554,28.0,,,,3.367295829986474
ENSG00000138678,446.0,E-GEOD-54002,-2.0,'breast cancer' vs 'normal',6.102558594613569
ENSG00000070814,2569.0,,,,7.851661177889265
ENSG00000166847,2326.0,,,,7.752335163302292
ENSG00000099937,15.0,,,,2.772588722239781
ENSG00000107643,1841.0,,,,7.518607216815252
ENSG00000079215,1239.0,,,,7.122866658599083
ENSG00000151224,9.0,,,,2.302585092994046
ENSG00000140332,3424.0,,,,8.138856750696325
ENSG00000167034,125.0,,,,4.836281906951478
ENSG00000137073,1920.0,,,,7.560601162768557
ENSG00000102032,492.0,,,,6.20050917404269
ENSG00000137869,54.0,E-GEOD-52194,5.0,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',4.007333185232471
ENSG00000104327,26.0,E-GEOD-52194,4.8,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',3.295836866004329
ENSG00000104327,26.0,E-GEOD-52194,5.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',3.295836866004329
ENSG00000104327,26.0,E-GEOD-52194,4.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',3.295836866004329
ENSG00000076043,2030.0,,,,7.616283561580385
ENSG00000163466,10178.0,,,,9.22808205345234
ENSG00000070669,1164.0,,,,7.060476365999801
ENSG00000082898,5685.0,,,,8.645762292210945
ENSG00000081913,1073.0,,,,6.97914527506881
ENSG00000133466,497.0,,,,6.210600077024653
ENSG00000104765,7418.0,E-GEOD-31138,2.2,'invasive ductal carcinoma' vs 'normal',8.911799556189527
ENSG00000104765,7418.0,E-GEOD-7377,1.4,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.911799556189527
ENSG00000157456,64.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',4.174387269895637
ENSG00000157456,64.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',4.174387269895637
ENSG00000157456,64.0,E-GEOD-54002,2.8,'breast cancer' vs 'normal',4.174387269895637
ENSG00000157456,64.0,E-MTAB-779,2.1,'breast carcinoma' vs 'normal',4.174387269895637
ENSG00000196453,857.0,,,,6.754604099487962
ENSG00000198626,139.0,,,,4.941642422609304
ENSG00000153071,6944.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',8.845777255188445
ENSG00000168487,4112.0,,,,8.321907968230423
ENSG00000124784,1063.0,,,,6.96979066990159
ENSG00000050165,1988.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',7.5953872788539725
ENSG00000050165,1988.0,E-GEOD-54002,-3.0,'breast cancer' vs 'normal',7.5953872788539725
ENSG00000050165,1988.0,E-GEOD-38959,-2.5,'breast cancer; breast' vs 'normal; breast',7.5953872788539725
ENSG00000138821,819.0,,,,6.709304340258298
ENSG00000197614,3064.0,E-GEOD-54002,1.6,'breast cancer' vs 'normal',8.027802848370312
ENSG00000073921,12980.0,,,,9.471242028892995
ENSG00000104375,1435.0,E-GEOD-44408,-1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.269616749608169
ENSG00000055332,2194.0,,,,7.693937325509272
ENSG00000241360,17.0,,,,2.8903717578961645
ENSG00000171681,3551.0,,,,8.17526610411206
ENSG00000150760,3705.0,,,,8.217708406845306
ENSG00000149948,25.0,,,,3.258096538021482
ENSG00000185046,110.0,,,,4.709530201312334
ENSG00000103507,2565.0,,,,7.850103545175582
ENSG00000010810,3984.0,E-GEOD-44408,1.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.290292591224315
ENSG00000035862,28550.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',10.259447240740453
ENSG00000065361,1408.0,E-GEOD-31138,2.7,'invasive ductal carcinoma' vs 'normal',7.25063551189868
ENSG00000065361,1408.0,E-GEOD-44408,-4.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.25063551189868
ENSG00000160097,67.0,,,,4.219507705176107
ENSG00000143942,64.0,,,,4.174387269895637
ENSG00000163736,6.0,,,,1.9459101490553132
ENSG00000101311,48.0,E-GEOD-7377,-1.7,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',3.8918202981106265
ENSG00000197081,7416.0,,,,8.911529941736559
ENSG00000147475,2252.0,,,,7.720017940432244
ENSG00000153147,3727.0,,,,8.223627175805483
ENSG00000023572,237.0,,,,5.472270673671475
ENSG00000104147,17.0,E-GEOD-54002,2.0,'breast cancer' vs 'normal',2.8903717578961645
ENSG00000104147,17.0,E-MTAB-779,1.8,'breast carcinoma' vs 'normal',2.8903717578961645
ENSG00000104147,17.0,E-GEOD-38959,1.9,'breast cancer; breast' vs 'normal; breast',2.8903717578961645
ENSG00000168461,3101.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',8.039802343736485
ENSG00000168461,3101.0,E-GEOD-7377,1.7,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.039802343736485
ENSG00000017427,604.0,E-GEOD-10780,-1.6,'breast carcinoma' vs 'normal',6.405228458030842
ENSG00000017427,604.0,E-MTAB-779,-2.2,'breast carcinoma' vs 'normal',6.405228458030842
ENSG00000153292,34.0,,,,3.5553480614894135
ENSG00000122566,33950.0,,,,10.432673587634051
ENSG00000178999,27.0,,,,3.332204510175204
ENSG00000167900,182.0,E-GEOD-54002,2.1,'breast cancer' vs 'normal',5.209486152841421
ENSG00000167900,182.0,E-GEOD-10780,1.5,'breast carcinoma' vs 'normal',5.209486152841421
ENSG00000167900,182.0,E-MTAB-779,2.4,'breast carcinoma' vs 'normal',5.209486152841421
ENSG00000167900,182.0,E-GEOD-38959,1.9,'breast cancer; breast' vs 'normal; breast',5.209486152841421
ENSG00000128268,504.0,,,,6.22455842927536
ENSG00000099250,7578.0,,,,8.93313654381203
ENSG00000185420,109.0,E-GEOD-44408,-1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.700480365792417
ENSG00000113013,9266.0,,,,9.134214981586691
ENSG00000240184,766.0,,,,6.642486801367256
ENSG00000126787,12.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',2.5649493574615367
ENSG00000126787,12.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',2.5649493574615367
ENSG00000126787,12.0,E-GEOD-10780,1.5,'breast carcinoma' vs 'normal',2.5649493574615367
ENSG00000126787,12.0,E-GEOD-54002,3.1,'breast cancer' vs 'normal',2.5649493574615367
ENSG00000126787,12.0,E-GEOD-31138,3.6,'invasive ductal carcinoma' vs 'normal',2.5649493574615367
ENSG00000171476,173.0,,,,5.159055299214529
ENSG00000172977,1481.0,,,,7.301147805856032
ENSG00000070526,90.0,,,,4.51085950651685
ENSG00000162366,208.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',5.342334251964811
ENSG00000129071,1901.0,,,,7.550661243105336
ENSG00000145293,961.0,,,,6.8690144506657065
ENSG00000134013,1850.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',7.523481312573497
ENSG00000100664,8485.0,,,,9.04617302576227
ENSG00000125107,5347.0,,,,8.584477938221834
ENSG00000110628,596.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.391917113392602
ENSG00000120539,537.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',6.2878585601617845
ENSG00000123737,1199.0,,,,7.090076835776092
ENSG00000173757,7863.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.970050661827003
ENSG00000125676,3379.0,,,,8.125630988477065
ENSG00000134452,3345.0,,,,8.11552088154677
ENSG00000118260,2145.0,,,,7.671360923190644
ENSG00000157014,1142.0,,,,7.04141166379481
ENSG00000231852,47.0,,,,3.871201010907891
ENSG00000158019,1486.0,,,,7.304515946460155
ENSG00000132676,3134.0,,,,8.050384453067021
ENSG00000157110,11858.0,E-GEOD-38959,-1.4,'breast cancer; breast' vs 'normal; breast',9.380842351964795
ENSG00000150977,1641.0,,,,7.403670290012373
ENSG00000171940,2415.0,,,,7.789868559054706
ENSG00000148429,995.0,,,,6.903747257584598
ENSG00000127914,4610.0,,,,8.436200032206706
ENSG00000142173,52035.0,,,,10.85969106572145
ENSG00000130513,315.0,E-GEOD-54002,1.7,'breast cancer' vs 'normal',5.755742213586912
ENSG00000130513,315.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',5.755742213586912
ENSG00000130513,315.0,E-MTAB-779,1.5,'breast carcinoma' vs 'normal',5.755742213586912
ENSG00000130513,315.0,E-GEOD-44408,-2.9,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.755742213586912
ENSG00000145864,20.0,,,,3.044522437723423
ENSG00000124602,148.0,,,,5.003946305945459
ENSG00000108468,2053.0,,,,7.627544390488503
ENSG00000143256,1185.0,E-GEOD-38959,1.5,'breast cancer; breast' vs 'normal; breast',7.078341579557671
ENSG00000138778,51.0,E-GEOD-54002,2.4,'breast cancer' vs 'normal',3.9512437185814275
ENSG00000138778,51.0,E-GEOD-31138,2.8,'invasive ductal carcinoma' vs 'normal',3.9512437185814275
ENSG00000135506,9528.0,,,,9.162095059348188
ENSG00000137764,1044.0,,,,6.951772164398911
ENSG00000118271,4.0,,,,1.6094379124341003
ENSG00000134954,9829.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.193194213141211
ENSG00000055955,54.0,,,,4.007333185232471
ENSG00000187498,23417.0,E-GEOD-31138,3.2,'invasive ductal carcinoma' vs 'normal',10.06126023640867
ENSG00000165105,488.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',6.192362489474872
ENSG00000097007,7688.0,,,,8.94754601503218
ENSG00000148498,2252.0,E-GEOD-44408,-1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.720017940432244
ENSG00000148498,2252.0,E-GEOD-7377,-1.1,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.720017940432244
ENSG00000099337,653.0,,,,6.483107351457199
ENSG00000099804,1783.0,,,,7.486613313139955
ENSG00000197077,2781.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',7.930925372483388
ENSG00000050405,9345.0,,,,9.142703723260372
ENSG00000167972,985.0,,,,6.893656354602635
ENSG00000197467,74.0,,,,4.31748811353631
ENSG00000171953,541.0,,,,6.295266001439646
ENSG00000141959,8063.0,,,,8.99516499031115
ENSG00000197170,1858.0,,,,7.527793987721444
ENSG00000087095,855.0,,,,6.752270376141742
ENSG00000097021,396.0,,,,5.983936280687191
ENSG00000149256,130.0,,,,4.875197323201151
ENSG00000168137,7233.0,,,,8.886547412512042
ENSG00000111816,356.0,E-GEOD-31138,2.7,'invasive ductal carcinoma' vs 'normal',5.877735781779639
ENSG00000099956,2172.0,,,,7.6838639802564295
ENSG00000243646,1127.0,,,,7.028201432058005
ENSG00000132016,106.0,,,,4.672828834461906
ENSG00000071967,17606.0,E-GEOD-54002,-1.4,'breast cancer' vs 'normal',9.776051829226445
ENSG00000071967,17606.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',9.776051829226445
ENSG00000071967,17606.0,E-MTAB-779,-1.7,'breast carcinoma' vs 'normal',9.776051829226445
ENSG00000071967,17606.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',9.776051829226445
ENSG00000036672,257.0,E-GEOD-52194,-4.9,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',5.552959584921617
ENSG00000101680,342.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',5.8377304471659395
ENSG00000168884,1955.0,,,,7.578656850594762
ENSG00000067182,10320.0,,,,9.241935933565934
ENSG00000054267,2711.0,,,,7.905441649060286
ENSG00000147526,15162.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',9.62661352880094
ENSG00000173262,18.0,,,,2.9444389791664403
ENSG00000130529,2449.0,E-GEOD-44408,-1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.803843303538772
ENSG00000213465,1923.0,,,,7.562161631225652
ENSG00000105550,0.0,,,,0.0
ENSG00000176390,737.0,E-GEOD-31138,2.2,'invasive ductal carcinoma' vs 'normal',6.6039438246004725
ENSG00000176390,737.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.6039438246004725
ENSG00000163931,7777.0,,,,8.959054514715692
ENSG00000122335,482.0,,,,6.180016653652572
ENSG00000260314,1166.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',7.062191632286556
ENSG00000260314,1166.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.062191632286556
ENSG00000260314,1166.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',7.062191632286556
ENSG00000157087,21.0,,,,3.091042453358316
ENSG00000175166,6497.0,,,,8.779249716229046
ENSG00000025039,1056.0,E-GEOD-54002,-1.6,'breast cancer' vs 'normal',6.963189985870238
ENSG00000025039,1056.0,E-GEOD-7377,-1.6,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.963189985870238
ENSG00000107614,382.0,,,,5.948034989180646
ENSG00000174775,1202.0,,,,7.0925737159746784
ENSG00000008294,6842.0,,,,8.830981510952498
ENSG00000186827,220.0,,,,5.3981627015177525
ENSG00000054523,3281.0,,,,8.096208271650037
ENSG00000197756,30706.0,,,,10.332245920613584
ENSG00000170099,2.0,E-GEOD-52194,-6.9,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000170515,3824.0,,,,8.249313746260636
ENSG00000144406,32.0,,,,3.4965075614664802
ENSG00000198160,2028.0,,,,7.615298339825815
ENSG00000130066,19426.0,,,,9.874419130038781
ENSG00000113522,2580.0,,,,7.855932199718614
ENSG00000186868,1220.0,,,,7.107425474110705
ENSG00000157240,1333.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.195937226475569
ENSG00000090273,3956.0,,,,8.283241441385425
ENSG00000177301,14.0,,,,2.70805020110221
ENSG00000089685,52.0,E-GEOD-31138,2.4,'invasive ductal carcinoma' vs 'normal',3.970291913552122
ENSG00000089685,52.0,E-GEOD-54002,2.9,'breast cancer' vs 'normal',3.970291913552122
ENSG00000089685,52.0,E-MTAB-779,2.0,'breast carcinoma' vs 'normal',3.970291913552122
ENSG00000089685,52.0,E-GEOD-38959,3.3,'breast cancer; breast' vs 'normal; breast',3.970291913552122
ENSG00000176105,2199.0,,,,7.696212639346407
ENSG00000101938,5701.0,E-GEOD-20086,-2.2,'breast cancer' vs 'normal',8.648572269472618
ENSG00000101938,5701.0,E-MTAB-779,-2.1,'breast carcinoma' vs 'normal',8.648572269472618
ENSG00000101938,5701.0,E-GEOD-10780,-3.1,'breast carcinoma' vs 'normal',8.648572269472618
ENSG00000101938,5701.0,E-GEOD-31138,-4.0,'invasive ductal carcinoma' vs 'normal',8.648572269472618
ENSG00000026508,12656.0,,,,9.44596570079245
ENSG00000166965,539.0,,,,6.29156913955832
ENSG00000177963,3681.0,,,,8.211211361793023
ENSG00000005448,405.0,,,,6.0063531596017325
ENSG00000186010,574.0,,,,6.354370040797351
ENSG00000147316,944.0,,,,6.851184927493743
ENSG00000105205,1.0,,,,0.6931471805599453
ENSG00000171223,8028.0,,,,8.990815266184685
ENSG00000123243,5249.0,E-GEOD-54002,-2.6,'breast cancer' vs 'normal',8.565983355585669
ENSG00000123243,5249.0,E-GEOD-10780,-2.0,'breast carcinoma' vs 'normal',8.565983355585669
ENSG00000123243,5249.0,E-MTAB-779,-2.1,'breast carcinoma' vs 'normal',8.565983355585669
ENSG00000079277,2884.0,,,,7.9672801789422
ENSG00000172270,16503.0,,,,9.711358054751088
ENSG00000179588,283.0,,,,5.648974238161206
ENSG00000174669,958.0,,,,6.8658910748834385
ENSG00000100266,4969.0,,,,8.511175119090675
ENSG00000154736,3361.0,E-GEOD-38959,-1.5,'breast cancer; breast' vs 'normal; breast',8.120291313968561
ENSG00000154736,3361.0,E-GEOD-54002,-3.9,'breast cancer' vs 'normal',8.120291313968561
ENSG00000154736,3361.0,E-GEOD-20086,-1.4,'breast cancer' vs 'normal',8.120291313968561
ENSG00000154736,3361.0,E-MTAB-779,-2.5,'breast carcinoma' vs 'normal',8.120291313968561
ENSG00000154736,3361.0,E-GEOD-10780,-2.9,'breast carcinoma' vs 'normal',8.120291313968561
ENSG00000152556,2337.0,,,,7.757051142032013
ENSG00000187555,5796.0,,,,8.665095821339733
ENSG00000183840,15.0,E-GEOD-7377,1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',2.772588722239781
ENSG00000123989,1645.0,,,,7.406103381237015
ENSG00000131143,8567.0,,,,9.055789612127585
ENSG00000184840,3930.0,,,,8.27664912542186
ENSG00000204568,2191.0,E-GEOD-31138,2.2,'invasive ductal carcinoma' vs 'normal',7.692569648067906
ENSG00000100410,844.0,,,,6.739336627357174
ENSG00000134363,811.0,,,,6.699500340161678
ENSG00000162368,6190.0,,,,8.730851903519232
ENSG00000094631,3690.0,,,,8.213652703029998
ENSG00000107443,333.0,,,,5.811140992976701
ENSG00000142669,4537.0,,,,8.420241665339788
ENSG00000159871,69.0,,,,4.248495242049359
ENSG00000184205,6011.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',8.701512750872865
ENSG00000100288,382.0,,,,5.948034989180646
ENSG00000184897,5732.0,,,,8.653994232908383
ENSG00000111344,30.0,,,,3.4339872044851463
ENSG00000159128,3676.0,,,,8.209852481301272
ENSG00000010244,7952.0,,,,8.981304494957135
ENSG00000085840,41.0,,,,3.7376696182833684
ENSG00000109193,2.0,E-GEOD-68086,-5.3,'breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000178573,3363.0,E-GEOD-44408,1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.120886021092838
ENSG00000178573,3363.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',8.120886021092838
ENSG00000178573,3363.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',8.120886021092838
ENSG00000099875,11691.0,,,,9.366660126231137
ENSG00000096433,3909.0,,,,8.271292652979412
ENSG00000165646,50.0,,,,3.9318256327243257
ENSG00000103495,1166.0,,,,7.062191632286556
ENSG00000139324,784.0,E-GEOD-31138,2.4,'invasive ductal carcinoma' vs 'normal',6.665683717782408
ENSG00000142694,919.0,,,,6.824373670043086
ENSG00000169957,1567.0,,,,7.357556200910353
ENSG00000141086,4.0,,,,1.6094379124341003
ENSG00000163161,2933.0,,,,7.984121958702927
ENSG00000113163,2730.0,,,,7.912423121473705
ENSG00000171132,747.0,,,,6.617402977974478
ENSG00000138777,1789.0,E-MTAB-779,1.8,'breast carcinoma' vs 'normal',7.489970898834801
ENSG00000125207,14.0,E-GEOD-68086,-4.9,'breast carcinoma' vs 'normal',2.70805020110221
ENSG00000140398,2349.0,E-GEOD-38959,-1.8,'breast cancer; breast' vs 'normal; breast',7.762170607138205
ENSG00000184428,974.0,,,,6.882437470997847
ENSG00000183718,992.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.900730664045173
ENSG00000204977,1264.0,,,,7.142827401161621
ENSG00000172350,12.0,,,,2.5649493574615367
ENSG00000152952,1761.0,E-GEOD-31138,3.0,'invasive ductal carcinoma' vs 'normal',7.474204806496124
ENSG00000152952,1761.0,E-GEOD-44408,-2.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.474204806496124
ENSG00000116731,3526.0,,,,8.168202930236053
ENSG00000240972,500.0,,,,6.2166061010848646
ENSG00000102359,1335.0,,,,7.197435354096591
ENSG00000152422,238.0,,,,5.476463551931511
ENSG00000213741,10678.0,,,,9.276034475171546
ENSG00000164736,1349.0,E-MTAB-779,-1.9,'breast carcinoma' vs 'normal',7.2078598714324755
ENSG00000164736,1349.0,E-GEOD-52194,-7.4,'triple-negative breast cancer; breast carcinoma' vs 'normal',7.2078598714324755
ENSG00000164736,1349.0,E-GEOD-52194,-6.5,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',7.2078598714324755
ENSG00000164736,1349.0,E-GEOD-52194,-6.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',7.2078598714324755
ENSG00000163812,3395.0,,,,8.130353547431238
ENSG00000166164,2153.0,,,,7.675081857716334
ENSG00000185008,16.0,,,,2.833213344056216
ENSG00000143799,3491.0,,,,8.158229916959494
ENSG00000086062,6898.0,,,,8.839131752546109
ENSG00000132514,237.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.472270673671475
ENSG00000173273,2401.0,,,,7.784057002639929
ENSG00000115419,3748.0,E-GEOD-44408,1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.229244416735913
ENSG00000142082,1296.0,,,,7.167809184316444
ENSG00000135537,144.0,,,,4.976733742420574
ENSG00000198286,113.0,,,,4.736198448394496
ENSG00000139874,80.0,,,,4.394449154672439
ENSG00000166796,5.0,,,,1.791759469228055
ENSG00000168010,2581.0,,,,7.856319571406588
ENSG00000132466,5003.0,,,,8.517992871586802
ENSG00000170075,17.0,,,,2.8903717578961645
ENSG00000010610,974.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.882437470997847
ENSG00000010610,974.0,E-GEOD-36765,1.1,'breast carcinoma' vs 'normal' in 'peripheral blood',6.882437470997847
ENSG00000133063,43.0,,,,3.784189633918261
ENSG00000167862,632.0,,,,6.450470422144176
ENSG00000143514,1536.0,,,,7.337587743538596
ENSG00000160633,5379.0,,,,8.59044365315583
ENSG00000060656,1277.0,,,,7.15305163493748
ENSG00000141646,4187.0,,,,8.339978571990427
ENSG00000090339,1871.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.534762657037537
ENSG00000090339,1871.0,E-GEOD-52194,-5.6,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',7.534762657037537
ENSG00000070718,918.0,,,,6.823286122355687
ENSG00000153187,13519.0,,,,9.511925349596956
ENSG00000013275,2445.0,,,,7.802209316247118
ENSG00000133121,1997.0,E-GEOD-44408,-1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.599901959208498
ENSG00000131507,5133.0,,,,8.543640361431086
ENSG00000130985,12576.0,E-GEOD-36765,1.4,'breast carcinoma' vs 'normal' in 'peripheral blood',9.439625028047155
ENSG00000172572,795.0,,,,6.679599185844383
ENSG00000167701,612.0,,,,6.418364935936212
ENSG00000163349,3555.0,E-GEOD-31138,2.1,'invasive ductal carcinoma' vs 'normal',8.176391596633795
ENSG00000010438,7.0,,,,2.0794415416798357
ENSG00000075624,159237.0,,,,11.978155217377003
ENSG00000109163,5.0,E-GEOD-52194,5.5,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',1.791759469228055
ENSG00000170421,4255.0,,,,8.35608503102148
ENSG00000163319,418.0,,,,6.037870919922137
ENSG00000158485,1.0,,,,0.6931471805599453
ENSG00000138071,6551.0,,,,8.787525625532906
ENSG00000114480,4641.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',8.442900586834382
ENSG00000111727,1322.0,,,,7.187657164114956
ENSG00000100836,5691.0,,,,8.646816959209742
ENSG00000214050,21.0,,,,3.091042453358316
ENSG00000153823,1861.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.529406457837013
ENSG00000153823,1861.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',7.529406457837013
ENSG00000153823,1861.0,E-GEOD-10780,-1.9,'breast carcinoma' vs 'normal',7.529406457837013
ENSG00000079337,6661.0,E-GEOD-31138,-2.5,'invasive ductal carcinoma' vs 'normal',8.804175018753625
ENSG00000173698,210.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.351858133476067
ENSG00000181610,969.0,E-GEOD-31138,2.6,'invasive ductal carcinoma' vs 'normal',6.877296071497429
ENSG00000145388,1023.0,,,,6.931471805599453
ENSG00000177565,5093.0,,,,8.535818655539403
ENSG00000142676,37108.0,,,,10.52161480677699
ENSG00000115484,5135.0,,,,8.544029845369797
ENSG00000158828,1692.0,,,,7.4342573821331355
ENSG00000131495,1541.0,,,,7.340835554123275
ENSG00000101665,1999.0,,,,7.600902459542082
ENSG00000116288,6478.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.776321456449958
ENSG00000085563,463.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.139884552226255
ENSG00000147162,23103.0,E-GEOD-44408,1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',10.047761041692553
ENSG00000165092,3479.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.15478757276852
ENSG00000165092,3479.0,E-MTAB-779,-1.8,'breast carcinoma' vs 'normal',8.15478757276852
ENSG00000165092,3479.0,E-GEOD-20086,-2.6,'breast cancer' vs 'normal',8.15478757276852
ENSG00000165092,3479.0,E-GEOD-10780,-1.9,'breast carcinoma' vs 'normal',8.15478757276852
ENSG00000197921,5.0,,,,1.791759469228055
ENSG00000171872,0.0,,,,0.0
ENSG00000167748,23.0,,,,3.1780538303479458
ENSG00000165806,1493.0,,,,7.309212365692763
ENSG00000110680,2.0,,,,1.0986122886681098
ENSG00000132646,1321.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',7.186901020411631
ENSG00000132646,1321.0,E-GEOD-38959,1.5,'breast cancer; breast' vs 'normal; breast',7.186901020411631
ENSG00000132646,1321.0,E-GEOD-31138,3.6,'invasive ductal carcinoma' vs 'normal',7.186901020411631
ENSG00000069399,2953.0,E-GEOD-52194,-4.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',7.9909154630913255
ENSG00000088205,3317.0,,,,8.10711747075039
ENSG00000006756,1782.0,,,,7.48605261786314
ENSG00000119689,6852.0,,,,8.832441791585824
ENSG00000110876,356.0,E-GEOD-44408,1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.877735781779639
ENSG00000135517,1.0,,,,0.6931471805599453
ENSG00000115705,824.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',6.715383386334681
ENSG00000196878,1959.0,E-GEOD-54002,-2.7,'breast cancer' vs 'normal',7.580699752224563
ENSG00000196878,1959.0,E-MTAB-779,-1.9,'breast carcinoma' vs 'normal',7.580699752224563
ENSG00000196878,1959.0,E-GEOD-10780,-1.9,'breast carcinoma' vs 'normal',7.580699752224563
ENSG00000196878,1959.0,E-GEOD-38959,-2.2,'breast cancer; breast' vs 'normal; breast',7.580699752224563
ENSG00000086598,6249.0,E-GEOD-31138,2.6,'invasive ductal carcinoma' vs 'normal',8.740336742730447
ENSG00000027869,101.0,,,,4.624972813284271
ENSG00000143452,6.0,E-GEOD-38959,1.9,'breast cancer; breast' vs 'normal; breast',1.9459101490553132
ENSG00000143452,6.0,E-GEOD-52194,7.6,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.9459101490553132
ENSG00000143452,6.0,E-GEOD-52194,7.9,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',1.9459101490553132
ENSG00000134871,26278.0,E-GEOD-31138,3.0,'invasive ductal carcinoma' vs 'normal',10.17652542012418
ENSG00000117139,2537.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.839131648274333
ENSG00000056558,1432.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.267525427828172
ENSG00000163630,1.0,,,,0.6931471805599453
ENSG00000161610,0.0,,,,0.0
ENSG00000175220,7473.0,,,,8.91918561004543
ENSG00000099840,233.0,,,,5.455321115357702
ENSG00000177663,2298.0,,,,7.740229524763182
ENSG00000049656,3603.0,,,,8.189799618728228
ENSG00000204370,2776.0,E-GEOD-31138,2.7,'invasive ductal carcinoma' vs 'normal',7.9291264873067995
ENSG00000060762,1617.0,,,,7.388946097618437
ENSG00000153395,2281.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',7.732807530422021
ENSG00000119535,1570.0,,,,7.359467638255621
ENSG00000168062,86.0,,,,4.465908118654584
ENSG00000185022,4851.0,E-GEOD-54002,-2.4,'breast cancer' vs 'normal',8.48714627006394
ENSG00000185022,4851.0,E-GEOD-10780,-1.8,'breast carcinoma' vs 'normal',8.48714627006394
ENSG00000185022,4851.0,E-GEOD-52194,-6.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',8.48714627006394
ENSG00000185022,4851.0,E-GEOD-52194,-6.9,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',8.48714627006394
ENSG00000185022,4851.0,E-GEOD-52194,-6.7,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',8.48714627006394
ENSG00000117593,660.0,,,,6.493753839851686
ENSG00000113643,2203.0,,,,7.698029170272805
ENSG00000143995,1646.0,,,,7.4067107301776405
ENSG00000075426,15532.0,,,,9.650722071987907
ENSG00000151729,1685.0,,,,7.430114138561801
ENSG00000110651,28986.0,,,,10.274602732600881
ENSG00000179914,5.0,,,,1.791759469228055
ENSG00000110171,1578.0,,,,7.364547014255642
ENSG00000167323,4792.0,,,,8.474911799159631
ENSG00000167114,970.0,,,,6.878326468291325
ENSG00000133706,4944.0,,,,8.506132244056813
ENSG00000023445,905.0,E-GEOD-44408,2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.80903930604298
ENSG00000109072,40.0,,,,3.713572066704308
ENSG00000170035,2458.0,,,,7.807510042216193
ENSG00000140350,3958.0,E-GEOD-31138,2.4,'invasive ductal carcinoma' vs 'normal',8.28374674710613
ENSG00000253293,461.0,,,,6.135564891081739
ENSG00000223865,3417.0,,,,8.136810863675537
ENSG00000274618,0.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',0.0
ENSG00000274618,0.0,E-GEOD-52194,7.7,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000274618,0.0,E-GEOD-52194,7.8,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',0.0
ENSG00000274618,0.0,E-GEOD-52194,5.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000119541,2392.0,,,,7.780303087908373
ENSG00000179163,942.0,E-GEOD-44408,1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.849066282633458
ENSG00000123136,2801.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',7.938088726896952
ENSG00000137166,2534.0,,,,7.837948916025283
ENSG00000163565,7713.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.950792138768174
ENSG00000168003,7165.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',8.8771028978649
ENSG00000105695,6.0,,,,1.9459101490553132
ENSG00000159840,17117.0,,,,9.747885820441555
ENSG00000196781,3050.0,,,,8.02322468471667
ENSG00000109381,2414.0,,,,7.789454566086673
ENSG00000006128,28.0,E-GEOD-52194,-5.4,'triple-negative breast cancer; breast carcinoma' vs 'normal',3.367295829986474
ENSG00000174915,1301.0,,,,7.171656822768514
ENSG00000067715,65.0,,,,4.189654742026425
ENSG00000214367,878.0,,,,6.778784897685177
ENSG00000128918,635.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',6.455198563340122
ENSG00000164096,6303.0,,,,8.748939631537715
ENSG00000062485,7574.0,,,,8.93260863037757
ENSG00000180353,2582.0,E-GEOD-44408,2.0,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.8567067930958405
ENSG00000183495,3756.0,,,,8.231376045573969
ENSG00000258643,17.0,,,,2.8903717578961645
ENSG00000150753,4296.0,E-GEOD-31138,3.2,'invasive ductal carcinoma' vs 'normal',8.365672383774996
ENSG00000049759,1886.0,E-GEOD-44408,-1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.54274354536855
ENSG00000049759,1886.0,E-GEOD-38959,-2.5,'breast cancer; breast' vs 'normal; breast',7.54274354536855
ENSG00000170276,147.0,E-MTAB-779,-2.1,'breast carcinoma' vs 'normal',4.997212273764115
ENSG00000102898,2392.0,,,,7.780303087908373
ENSG00000113658,2975.0,,,,7.998335395952982
ENSG00000164061,60.0,,,,4.110873864173311
ENSG00000172115,2648.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',7.88193748927207
ENSG00000178597,2.0,E-GEOD-52194,6.4,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000178597,2.0,E-GEOD-52194,5.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000161544,2817.0,,,,7.943782692458625
ENSG00000171051,296.0,,,,5.6937321388027
ENSG00000025708,3390.0,,,,8.128880142125638
ENSG00000101443,517.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',6.249975242259483
ENSG00000101443,517.0,E-GEOD-52194,-5.9,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',6.249975242259483
ENSG00000169554,5330.0,E-MTAB-779,-1.6,'breast carcinoma' vs 'normal',8.581294116822761
ENSG00000082438,2169.0,,,,7.682482446534506
ENSG00000186847,9017.0,E-GEOD-31138,-2.1,'invasive ductal carcinoma' vs 'normal',9.106977858981029
ENSG00000186847,9017.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',9.106977858981029
ENSG00000186847,9017.0,E-GEOD-52194,-6.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',9.106977858981029
ENSG00000186847,9017.0,E-GEOD-54002,-6.3,'breast cancer' vs 'normal',9.106977858981029
ENSG00000186847,9017.0,E-GEOD-10780,-3.8,'breast carcinoma' vs 'normal',9.106977858981029
ENSG00000133256,103.0,,,,4.6443908991413725
ENSG00000107249,308.0,,,,5.733341276897746
ENSG00000128052,3308.0,,,,8.104401307921613
ENSG00000185386,1644.0,,,,7.405495663199472
ENSG00000101405,15.0,,,,2.772588722239781
ENSG00000066044,2735.0,E-GEOD-31138,2.3,'invasive ductal carcinoma' vs 'normal',7.914252278742441
ENSG00000088808,1636.0,,,,7.400620577371135
ENSG00000087191,5299.0,,,,8.575462099540212
ENSG00000112576,4503.0,,,,8.412721169819527
ENSG00000118058,4915.0,,,,8.500250470685925
ENSG00000117751,1540.0,,,,7.340186835320115
ENSG00000181449,8.0,E-GEOD-52194,5.4,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',2.1972245773362196
ENSG00000157064,447.0,,,,6.104793232414985
ENSG00000006327,692.0,E-GEOD-44408,-1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.541029999189903
ENSG00000006327,692.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',6.541029999189903
ENSG00000197442,1720.0,,,,7.450660796211539
ENSG00000165813,1519.0,,,,7.326465613840322
ENSG00000120833,2753.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',7.9208096792886
ENSG00000120833,2753.0,E-GEOD-54002,-2.7,'breast cancer' vs 'normal',7.9208096792886
ENSG00000127947,6148.0,,,,8.724044745953469
ENSG00000221963,2984.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',8.001355025826703
ENSG00000047188,2664.0,,,,7.887959336599945
ENSG00000064835,1.0,,,,0.6931471805599453
ENSG00000196743,1685.0,,,,7.430114138561801
ENSG00000138115,31.0,,,,3.4657359027997265
ENSG00000158270,1430.0,,,,7.266128779556451
ENSG00000170893,2.0,,,,1.0986122886681098
ENSG00000198886,714597.0,,,,13.479475425798988
ENSG00000165312,1021.0,,,,6.92951677076365
ENSG00000170498,1.0,,,,0.6931471805599453
ENSG00000109606,7070.0,,,,8.863757191604241
ENSG00000206075,302.0,E-GEOD-52194,-5.1,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',5.713732805509369
ENSG00000198077,6.0,,,,1.9459101490553132
ENSG00000176387,251.0,,,,5.529429087511423
ENSG00000233276,7812.0,,,,8.963544291996744
ENSG00000178896,378.0,,,,5.937536205082426
ENSG00000164694,184.0,E-GEOD-54002,2.2,'breast cancer' vs 'normal',5.220355825078324
ENSG00000164694,184.0,E-GEOD-10780,1.8,'breast carcinoma' vs 'normal',5.220355825078324
ENSG00000164694,184.0,E-GEOD-31138,3.2,'invasive ductal carcinoma' vs 'normal',5.220355825078324
ENSG00000198730,1990.0,,,,7.596392304064196
ENSG00000078237,305.0,,,,5.723585101952381
ENSG00000008018,5833.0,,,,8.671458150427666
ENSG00000145041,1935.0,,,,7.568379267836522
ENSG00000149295,33.0,,,,3.5263605246161616
ENSG00000101224,2981.0,E-GEOD-38959,1.6,'breast cancer; breast' vs 'normal; breast',8.000349495324684
ENSG00000122707,1806.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.499423290592229
ENSG00000122707,1806.0,E-GEOD-10780,-1.7,'breast carcinoma' vs 'normal',7.499423290592229
ENSG00000170486,3.0,E-GEOD-68086,-5.3,'breast carcinoma' vs 'normal',1.3862943611198906
ENSG00000158850,2024.0,,,,7.613324979540639
ENSG00000101972,4110.0,,,,8.321421586897879
ENSG00000196154,8324.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',9.027018314848645
ENSG00000198742,2693.0,,,,7.898782356970309
ENSG00000047056,1396.0,,,,7.242082359256962
ENSG00000112118,2615.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',7.86940171257709
ENSG00000112118,2615.0,E-GEOD-31138,2.5,'invasive ductal carcinoma' vs 'normal',7.86940171257709
ENSG00000178921,1325.0,,,,7.189922170745808
ENSG00000139372,1166.0,,,,7.062191632286556
ENSG00000113384,4195.0,,,,8.341886969516187
ENSG00000005889,1917.0,,,,7.559038255443384
ENSG00000136098,957.0,E-GEOD-31138,-2.0,'invasive ductal carcinoma' vs 'normal',6.86484777797086
ENSG00000136098,957.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',6.86484777797086
ENSG00000142235,97.0,,,,4.584967478670572
ENSG00000175564,119.0,,,,4.787491742782046
ENSG00000154928,167.0,,,,5.123963979403259
ENSG00000161888,51.0,E-GEOD-38959,1.9,'breast cancer; breast' vs 'normal; breast',3.9512437185814275
ENSG00000167914,27.0,,,,3.332204510175204
ENSG00000073584,2790.0,,,,7.934155233536322
ENSG00000104812,2915.0,,,,7.977968093128549
ENSG00000124256,47.0,,,,3.871201010907891
ENSG00000031691,200.0,,,,5.303304908059076
ENSG00000137709,92.0,,,,4.532599493153256
ENSG00000011028,3662.0,,,,8.206037762778815
ENSG00000162851,514.0,,,,6.244166900663736
ENSG00000116703,4.0,,,,1.6094379124341003
ENSG00000155066,1316.0,E-GEOD-68086,-5.1,'breast carcinoma' vs 'normal',7.183111701743281
ENSG00000163661,1236.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',7.1204443723924875
ENSG00000163661,1236.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',7.1204443723924875
ENSG00000163661,1236.0,E-GEOD-52194,-4.9,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',7.1204443723924875
ENSG00000163661,1236.0,E-GEOD-54002,-4.2,'breast cancer' vs 'normal',7.1204443723924875
ENSG00000078061,3907.0,,,,8.270781013162674
ENSG00000142149,130.0,,,,4.875197323201151
ENSG00000134824,748.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',6.618738983517219
ENSG00000134824,748.0,E-GEOD-38959,3.7,'breast cancer; breast' vs 'normal; breast',6.618738983517219
ENSG00000074047,237.0,,,,5.472270673671475
ENSG00000162599,3099.0,E-MTAB-779,-1.3,'breast carcinoma' vs 'normal',8.039157390473237
ENSG00000162599,3099.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',8.039157390473237
ENSG00000162599,3099.0,E-GEOD-38959,-1.8,'breast cancer; breast' vs 'normal; breast',8.039157390473237
ENSG00000175029,3126.0,E-GEOD-44408,-1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.047829357457841
ENSG00000096395,1.0,,,,0.6931471805599453
ENSG00000057608,7630.0,,,,8.939974177289633
ENSG00000167874,392.0,,,,5.973809611869261
ENSG00000105668,7.0,,,,2.0794415416798357
ENSG00000034152,2736.0,E-GEOD-52194,-5.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',7.914617709040679
ENSG00000034152,2736.0,E-GEOD-52194,-5.2,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',7.914617709040679
ENSG00000112541,360.0,,,,5.8888779583328805
ENSG00000091483,2127.0,,,,7.662937850461535
ENSG00000114166,1617.0,,,,7.388946097618437
ENSG00000141570,175.0,,,,5.170483995038151
ENSG00000168386,2409.0,E-GEOD-7377,1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.787382026484701
ENSG00000101098,65.0,E-GEOD-52194,5.8,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',4.189654742026425
ENSG00000119335,8001.0,E-GEOD-31138,2.2,'invasive ductal carcinoma' vs 'normal',8.98744678941718
ENSG00000184752,1122.0,,,,7.023758954738443
ENSG00000101126,4129.0,,,,8.326032685955079
ENSG00000134324,4939.0,,,,8.505120610181969
ENSG00000106245,1149.0,,,,7.047517221357296
ENSG00000186810,6.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',1.9459101490553132
ENSG00000186810,6.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',1.9459101490553132
ENSG00000105392,18.0,,,,2.9444389791664403
ENSG00000111276,4529.0,,,,8.41847721847708
ENSG00000074266,860.0,,,,6.7580945044277305
ENSG00000154889,933.0,,,,6.839476438228843
ENSG00000182326,31433.0,,,,10.355645388636274
ENSG00000169083,2439.0,E-GEOD-44408,-2.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.799753318287247
ENSG00000169083,2439.0,E-GEOD-38959,-2.2,'breast cancer; breast' vs 'normal; breast',7.799753318287247
ENSG00000257017,285.0,,,,5.655991810819852
ENSG00000128266,507.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',6.230481447578482
ENSG00000145192,2.0,E-GEOD-52194,5.7,'triple-negative breast cancer; breast carcinoma' vs 'normal',1.0986122886681098
ENSG00000050820,2565.0,,,,7.850103545175582
ENSG00000163347,256.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',5.54907608489522
ENSG00000115758,1965.0,,,,7.583756300707112
ENSG00000179144,1178.0,,,,7.072421900537371
ENSG00000041982,3172.0,,,,8.062432791583195
ENSG00000087111,2473.0,,,,7.813591552952433
ENSG00000173890,444.0,E-GEOD-10780,1.4,'breast carcinoma' vs 'normal',6.09807428216624
ENSG00000135373,581.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',6.366470447731438
ENSG00000135373,581.0,E-GEOD-68086,-5.5,'breast carcinoma' vs 'normal',6.366470447731438
ENSG00000135373,581.0,E-GEOD-7377,-2.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.366470447731438
ENSG00000102678,21.0,E-GEOD-20086,-1.3,'breast cancer' vs 'normal',3.091042453358316
ENSG00000109452,1617.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',7.388946097618437
ENSG00000109452,1617.0,E-GEOD-38959,-1.4,'breast cancer; breast' vs 'normal; breast',7.388946097618437
ENSG00000143515,2738.0,,,,7.915348169263078
ENSG00000011465,83271.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',11.329867637195305
ENSG00000149269,1418.0,,,,7.257707677160043
ENSG00000143437,4321.0,,,,8.371473537066832
ENSG00000136273,708.0,,,,6.5638555265321274
ENSG00000136108,288.0,E-GEOD-54002,1.6,'breast cancer' vs 'normal',5.666426688112432
ENSG00000136108,288.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',5.666426688112432
ENSG00000136108,288.0,E-GEOD-10780,1.4,'breast carcinoma' vs 'normal',5.666426688112432
ENSG00000065559,1394.0,,,,7.240649694255466
ENSG00000143314,1657.0,,,,7.4133673356952405
ENSG00000168961,1059.0,,,,6.966024187106113
ENSG00000119013,742.0,E-GEOD-7377,1.2,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.610696044717759
ENSG00000029363,6999.0,,,,8.85366542803745
ENSG00000161513,321.0,,,,5.7745515455444085
ENSG00000145431,1184.0,E-GEOD-54002,-1.9,'breast cancer' vs 'normal',7.077498053569231
ENSG00000145431,1184.0,E-GEOD-7377,-1.6,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.077498053569231
ENSG00000183813,32.0,,,,3.4965075614664802
ENSG00000187514,34865.0,,,,10.45926742130316
ENSG00000125245,9.0,E-GEOD-52194,5.6,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',2.302585092994046
ENSG00000125245,9.0,E-GEOD-44408,3.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',2.302585092994046
ENSG00000128383,30.0,,,,3.4339872044851463
ENSG00000132530,1211.0,E-GEOD-7377,-1.7,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.10002716662926
ENSG00000213918,879.0,,,,6.779921907472252
ENSG00000134057,165.0,E-GEOD-44408,-1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.111987788356544
ENSG00000134057,165.0,E-MTAB-779,1.4,'breast carcinoma' vs 'normal',5.111987788356544
ENSG00000134057,165.0,E-GEOD-54002,2.2,'breast cancer' vs 'normal',5.111987788356544
ENSG00000134057,165.0,E-GEOD-10780,2.0,'breast carcinoma' vs 'normal',5.111987788356544
ENSG00000134057,165.0,E-GEOD-38959,1.8,'breast cancer; breast' vs 'normal; breast',5.111987788356544
ENSG00000143641,3055.0,,,,8.024862150286411
ENSG00000063015,3.0,E-GEOD-68086,-4.9,'breast carcinoma' vs 'normal',1.3862943611198906
ENSG00000105854,2407.0,E-GEOD-44408,-1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.786551806428712
ENSG00000116874,684.0,,,,6.529418838262226
ENSG00000130203,5457.0,,,,8.604837701268284
ENSG00000103152,967.0,,,,6.875232087276577
ENSG00000254986,990.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',6.898714534329988
ENSG00000079739,4280.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',8.361941906144946
ENSG00000079739,4280.0,E-GEOD-31138,2.6,'invasive ductal carcinoma' vs 'normal',8.361941906144946
ENSG00000101191,4577.0,,,,8.429017500512511
ENSG00000170458,1835.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',7.515344571180436
ENSG00000004478,3394.0,E-GEOD-31138,2.4,'invasive ductal carcinoma' vs 'normal',8.130059039992796
ENSG00000004478,3394.0,E-GEOD-44408,-2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.130059039992796
ENSG00000173402,3998.0,E-GEOD-44408,-1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.293799608846818
ENSG00000182568,1819.0,E-GEOD-54002,-2.1,'breast cancer' vs 'normal',7.506591780070841
ENSG00000182568,1819.0,E-GEOD-44408,2.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.506591780070841
ENSG00000099769,21.0,,,,3.091042453358316
ENSG00000164163,2362.0,,,,7.767687277186908
ENSG00000154269,50.0,,,,3.9318256327243257
ENSG00000196139,3077.0,E-MTAB-779,-2.6,'breast carcinoma' vs 'normal',8.032035314398824
ENSG00000196139,3077.0,E-GEOD-10780,-1.7,'breast carcinoma' vs 'normal',8.032035314398824
ENSG00000204103,2986.0,,,,8.00202481821611
ENSG00000184047,260.0,,,,5.564520407322694
ENSG00000126698,3695.0,,,,8.215006432761575
ENSG00000135218,50630.0,E-GEOD-38959,-1.3,'breast cancer; breast' vs 'normal; breast',10.832319315904593
ENSG00000135218,50630.0,E-GEOD-31138,-2.9,'invasive ductal carcinoma' vs 'normal',10.832319315904593
ENSG00000135218,50630.0,E-MTAB-779,-2.5,'breast carcinoma' vs 'normal',10.832319315904593
ENSG00000135218,50630.0,E-GEOD-10780,-2.9,'breast carcinoma' vs 'normal',10.832319315904593
ENSG00000137601,750.0,,,,6.621405651764134
ENSG00000105398,4.0,,,,1.6094379124341003
ENSG00000182492,6143.0,E-GEOD-44408,-2.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.723231274827508
ENSG00000182492,6143.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',8.723231274827508
ENSG00000182492,6143.0,E-GEOD-54002,3.1,'breast cancer' vs 'normal',8.723231274827508
ENSG00000169914,953.0,,,,6.860663671448287
ENSG00000065243,3151.0,,,,8.05579245097777
ENSG00000153162,882.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',6.78332520060396
ENSG00000073150,87.0,,,,4.477336814478207
ENSG00000116649,2467.0,,,,7.811163385025279
ENSG00000132669,2476.0,,,,7.814803429489359
ENSG00000119514,166.0,,,,5.117993812416755
ENSG00000137710,3143.0,,,,8.053251153549096
ENSG00000104635,4332.0,,,,8.374015421739909
ENSG00000183831,8.0,,,,2.1972245773362196
ENSG00000110090,4078.0,,,,8.313607139317558
ENSG00000100393,5335.0,,,,8.58223158759546
ENSG00000265681,2279.0,,,,7.731930721948486
ENSG00000248487,346.0,,,,5.849324779946859
ENSG00000162139,704.0,,,,6.558197802812269
ENSG00000167580,2.0,,,,1.0986122886681098
ENSG00000077264,298.0,E-GEOD-54002,-2.3,'breast cancer' vs 'normal',5.700443573390687
ENSG00000077264,298.0,E-GEOD-7377,-1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',5.700443573390687
ENSG00000153904,832.0,E-GEOD-44408,-2.1,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.725033642166843
ENSG00000125733,7810.0,,,,8.963288275610298
ENSG00000149591,29693.0,E-GEOD-54002,-2.6,'breast cancer' vs 'normal',10.29870028417994
ENSG00000149591,29693.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',10.29870028417994
ENSG00000118705,7918.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',8.977020214210413
ENSG00000213523,1416.0,,,,7.256297239690681
ENSG00000165138,933.0,,,,6.839476438228843
ENSG00000137804,109.0,,,,4.700480365792417
ENSG00000000938,1374.0,E-GEOD-31138,-2.1,'invasive ductal carcinoma' vs 'normal',7.226209010100671
ENSG00000000938,1374.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.226209010100671
ENSG00000270882,2.0,,,,1.0986122886681098
ENSG00000144802,4108.0,E-GEOD-7377,-1.8,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.32093496888341
ENSG00000112655,1409.0,,,,7.251344983372214
ENSG00000128585,2800.0,,,,7.937731775260109
ENSG00000121691,10112.0,E-MTAB-779,-1.4,'breast carcinoma' vs 'normal',9.221577003902171
ENSG00000136522,693.0,E-GEOD-38959,2.1,'breast cancer; breast' vs 'normal; breast',6.542471960506805
ENSG00000111640,35131.0,,,,10.466867675037008
ENSG00000130561,43.0,E-GEOD-52194,6.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',3.784189633918261
ENSG00000130561,43.0,E-GEOD-52194,5.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',3.784189633918261
ENSG00000152670,1.0,,,,0.6931471805599453
ENSG00000136527,6086.0,,,,8.713910628493924
ENSG00000152518,22962.0,E-GEOD-52194,-4.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',10.041639503918871
ENSG00000161692,407.0,,,,6.0112671744041615
ENSG00000165912,1067.0,,,,6.97354301952014
ENSG00000076685,1503.0,,,,7.315883504509785
ENSG00000011600,857.0,,,,6.754604099487962
ENSG00000083799,2558.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.847371836159788
ENSG00000116478,3619.0,E-GEOD-31138,2.4,'invasive ductal carcinoma' vs 'normal',8.194229304819817
ENSG00000159166,243.0,,,,5.497168225293202
ENSG00000155100,665.0,,,,6.501289670540389
ENSG00000100028,2061.0,,,,7.631431664576906
ENSG00000169021,2307.0,,,,7.744136627627991
ENSG00000134294,12864.0,,,,9.462265724715845
ENSG00000170561,1115.0,E-GEOD-54002,-1.9,'breast cancer' vs 'normal',7.017506142941256
ENSG00000170561,1115.0,E-GEOD-10780,-1.7,'breast carcinoma' vs 'normal',7.017506142941256
ENSG00000170561,1115.0,E-GEOD-38959,-2.2,'breast cancer; breast' vs 'normal; breast',7.017506142941256
ENSG00000171867,4314.0,E-GEOD-44408,1.2,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.36985260351753
ENSG00000171867,4314.0,E-GEOD-54002,-2.2,'breast cancer' vs 'normal',8.36985260351753
ENSG00000171867,4314.0,E-GEOD-10780,-1.4,'breast carcinoma' vs 'normal',8.36985260351753
ENSG00000175854,569.0,,,,6.345636360828596
ENSG00000101160,7017.0,,,,8.85623355614316
ENSG00000064393,4252.0,,,,8.355379895253634
ENSG00000117586,51.0,E-GEOD-20086,2.4,'breast cancer' vs 'normal',3.9512437185814275
ENSG00000119638,6374.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',8.760139370026627
ENSG00000265491,3225.0,,,,8.078998258685154
ENSG00000115594,11429.0,E-GEOD-20086,-1.1,'breast cancer' vs 'normal',9.343996756788856
ENSG00000106305,456.0,,,,6.124683390894205
ENSG00000183484,105.0,,,,4.663439094112067
ENSG00000059804,6197.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.731981938347694
ENSG00000059804,6197.0,E-GEOD-52194,-4.4,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',8.731981938347694
ENSG00000157873,6410.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.765770543987257
ENSG00000157017,39.0,,,,3.6888794541139363
ENSG00000003756,9628.0,E-GEOD-38959,-1.4,'breast cancer; breast' vs 'normal; breast',9.172534657240284
ENSG00000116663,374.0,E-GEOD-54002,1.4,'breast cancer' vs 'normal',5.926926025970411
ENSG00000116663,374.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',5.926926025970411
ENSG00000163206,0.0,,,,0.0
ENSG00000157193,216.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',5.37989735354046
ENSG00000144366,1046.0,E-GEOD-54002,-2.1,'breast cancer' vs 'normal',6.953684210870537
ENSG00000144366,1046.0,E-GEOD-10780,-1.8,'breast carcinoma' vs 'normal',6.953684210870537
ENSG00000154040,103.0,,,,4.6443908991413725
ENSG00000125968,1722.0,E-MTAB-779,-1.5,'breast carcinoma' vs 'normal',7.45182223652793
ENSG00000125968,1722.0,E-GEOD-10780,-1.2,'breast carcinoma' vs 'normal',7.45182223652793
ENSG00000035499,14.0,E-GEOD-54002,1.9,'breast cancer' vs 'normal',2.70805020110221
ENSG00000120868,831.0,,,,6.723832440821209
ENSG00000100448,159.0,,,,5.075173815233827
ENSG00000183770,1.0,,,,0.6931471805599453
ENSG00000132170,4259.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',8.357024439263416
ENSG00000132170,4259.0,E-MTAB-779,-2.3,'breast carcinoma' vs 'normal',8.357024439263416
ENSG00000163071,258.0,E-GEOD-54002,-2.0,'breast cancer' vs 'normal',5.556828061699537
ENSG00000163071,258.0,E-GEOD-38959,-1.7,'breast cancer; breast' vs 'normal; breast',5.556828061699537
ENSG00000077092,308.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',5.733341276897746
ENSG00000137076,31106.0,,,,10.345188153226388
ENSG00000073050,1355.0,,,,7.212294468500341
ENSG00000070087,1448.0,E-GEOD-38959,1.1,'breast cancer; breast' vs 'normal; breast',7.278628942320682
ENSG00000070087,1448.0,E-GEOD-44408,-2.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.278628942320682
ENSG00000036257,2566.0,,,,7.8504931808711405
ENSG00000162692,770.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.647688373563329
ENSG00000162692,770.0,E-GEOD-20086,1.9,'breast cancer' vs 'normal',6.647688373563329
ENSG00000132591,1520.0,,,,7.327123292259293
ENSG00000138385,3829.0,,,,8.250620082174692
ENSG00000153956,965.0,E-GEOD-10780,-1.3,'breast carcinoma' vs 'normal',6.873163834212518
ENSG00000155659,1577.0,,,,7.363913501405819
ENSG00000155827,1820.0,,,,7.507141079727608
ENSG00000164039,2008.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',7.605392364814935
ENSG00000164039,2008.0,E-GEOD-38959,-1.2,'breast cancer; breast' vs 'normal; breast',7.605392364814935
ENSG00000137975,42.0,,,,3.7612001156935624
ENSG00000149485,1057.0,E-GEOD-54002,1.7,'breast cancer' vs 'normal',6.964135612418245
ENSG00000149485,1057.0,E-GEOD-38959,1.8,'breast cancer; breast' vs 'normal; breast',6.964135612418245
ENSG00000152661,3315.0,E-GEOD-38959,-1.5,'breast cancer; breast' vs 'normal; breast',8.106514516255185
ENSG00000152661,3315.0,E-MTAB-779,1.8,'breast carcinoma' vs 'normal',8.106514516255185
ENSG00000137936,1589.0,,,,7.371489295214277
ENSG00000205542,61746.0,,,,11.03080067031408
ENSG00000154310,328.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',5.796057750765372
ENSG00000163754,2526.0,,,,7.834788107388194
ENSG00000012779,1346.0,E-GEOD-44408,1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.205635176410364
ENSG00000012779,1346.0,E-GEOD-54002,-2.1,'breast cancer' vs 'normal',7.205635176410364
ENSG00000136689,101.0,E-GEOD-7377,1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',4.624972813284271
ENSG00000138448,4091.0,E-GEOD-31138,2.5,'invasive ductal carcinoma' vs 'normal',8.316789127071518
ENSG00000133816,1197.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',7.088408778675395
ENSG00000133816,1197.0,E-GEOD-54002,1.7,'breast cancer' vs 'normal',7.088408778675395
ENSG00000133816,1197.0,E-GEOD-10780,1.3,'breast carcinoma' vs 'normal',7.088408778675395
ENSG00000134780,423.0,,,,6.049733455231958
ENSG00000101336,404.0,E-GEOD-44408,1.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.003887067106539
ENSG00000141564,1389.0,,,,7.237059026124737
ENSG00000123191,427.0,E-GEOD-7377,2.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.059123195581797
ENSG00000198492,3161.0,,,,8.058960017769417
ENSG00000106299,2597.0,,,,7.862497197230545
ENSG00000022840,8466.0,,,,9.043931533642278
ENSG00000184545,685.0,E-GEOD-52194,-5.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',6.530877627725885
ENSG00000136068,10708.0,,,,9.278839788400875
ENSG00000171843,597.0,E-GEOD-7377,1.6,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.393590753950631
ENSG00000198670,1.0,,,,0.6931471805599453
ENSG00000120949,281.0,,,,5.641907070938114
ENSG00000186185,24.0,E-GEOD-54002,2.1,'breast cancer' vs 'normal',3.2188758248682006
ENSG00000186185,24.0,E-GEOD-38959,2.2,'breast cancer; breast' vs 'normal; breast',3.2188758248682006
ENSG00000130311,1387.0,,,,7.23561914106675
ENSG00000163932,2410.0,,,,7.787796878181171
ENSG00000117450,6008.0,E-GEOD-38959,1.2,'breast cancer; breast' vs 'normal; breast',8.701013624333928
ENSG00000179583,1304.0,E-GEOD-31138,-1.7,'invasive ductal carcinoma' vs 'normal',7.173958319756794
ENSG00000140009,120.0,,,,4.795790545596741
ENSG00000097046,165.0,E-GEOD-54002,1.7,'breast cancer' vs 'normal',5.111987788356544
ENSG00000097046,165.0,E-GEOD-10780,1.2,'breast carcinoma' vs 'normal',5.111987788356544
ENSG00000097046,165.0,E-GEOD-38959,1.5,'breast cancer; breast' vs 'normal; breast',5.111987788356544
ENSG00000097046,165.0,E-GEOD-31138,4.8,'invasive ductal carcinoma' vs 'normal',5.111987788356544
ENSG00000120802,2104.0,,,,7.652070746116482
ENSG00000162341,1533.0,,,,7.335633981927201
ENSG00000197530,2839.0,,,,7.951559331155252
ENSG00000135069,149.0,E-GEOD-38959,1.4,'breast cancer; breast' vs 'normal; breast',5.0106352940962555
ENSG00000159322,3088.0,,,,8.035602692918582
ENSG00000159377,7241.0,,,,8.887652690325586
ENSG00000196616,68437.0,E-GEOD-10780,-2.9,'breast carcinoma' vs 'normal',11.133683504902342
ENSG00000196616,68437.0,E-GEOD-20086,-3.7,'breast cancer' vs 'normal',11.133683504902342
ENSG00000118515,4743.0,E-GEOD-54002,-2.5,'breast cancer' vs 'normal',8.464635940677562
ENSG00000151748,3096.0,E-GEOD-54002,-1.4,'breast cancer' vs 'normal',8.038189179973203
ENSG00000164587,32033.0,,,,10.374553117728242
ENSG00000121879,2062.0,E-GEOD-31138,3.2,'invasive ductal carcinoma' vs 'normal',7.631916513071252
ENSG00000071082,25140.0,,,,10.132255258600559
ENSG00000137275,2416.0,,,,7.790282380703483
ENSG00000076662,25.0,E-GEOD-44408,1.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',3.258096538021482
ENSG00000164683,1061.0,E-GEOD-38959,-1.4,'breast cancer; breast' vs 'normal; breast',6.967909201801884
ENSG00000152413,183.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',5.214935757608986
ENSG00000152413,183.0,E-GEOD-44408,-1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.214935757608986
ENSG00000122705,5175.0,,,,8.551787836180736
ENSG00000162493,1183.0,,,,7.076653815443951
ENSG00000131467,3239.0,,,,8.083328608786376
ENSG00000111254,36.0,,,,3.6109179126442243
ENSG00000012124,105.0,E-GEOD-44408,1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.663439094112067
ENSG00000166454,2170.0,E-GEOD-31138,2.4,'invasive ductal carcinoma' vs 'normal',7.682943169878292
ENSG00000102524,159.0,,,,5.075173815233827
ENSG00000115956,573.0,E-GEOD-44408,1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.352629396319567
ENSG00000159217,7.0,E-GEOD-52194,5.0,'triple-negative breast cancer; breast carcinoma' vs 'normal',2.0794415416798357
ENSG00000159217,7.0,E-GEOD-52194,5.2,'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal',2.0794415416798357
ENSG00000165376,20.0,,,,3.044522437723423
ENSG00000107438,12600.0,E-GEOD-54002,-1.5,'breast cancer' vs 'normal',9.441531454869693
ENSG00000107438,12600.0,E-GEOD-7377,1.4,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',9.441531454869693
ENSG00000100784,891.0,,,,6.79346613258001
ENSG00000177595,1778.0,,,,7.483806687665835
ENSG00000163235,97.0,E-GEOD-54002,-1.8,'breast cancer' vs 'normal',4.584967478670572
ENSG00000162688,1611.0,E-GEOD-7377,1.3,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',7.385230923066573
ENSG00000198805,1337.0,E-GEOD-54002,1.5,'breast cancer' vs 'normal',7.198931240688173
ENSG00000198805,1337.0,E-GEOD-10780,1.1,'breast carcinoma' vs 'normal',7.198931240688173
ENSG00000198805,1337.0,E-GEOD-38959,1.9,'breast cancer; breast' vs 'normal; breast',7.198931240688173
ENSG00000143858,64.0,,,,4.174387269895637
ENSG00000158773,2522.0,,,,7.833203948641057
ENSG00000171903,39.0,E-GEOD-38959,-1.4,'breast cancer; breast' vs 'normal; breast',3.6888794541139363
ENSG00000205937,4417.0,,,,8.393442383980062
ENSG00000174885,35.0,,,,3.58351893845611
ENSG00000165775,3238.0,,,,8.08301991917133
ENSG00000033327,2371.0,,,,7.771488760117616
ENSG00000132600,1886.0,,,,7.54274354536855
ENSG00000080573,5807.0,,,,8.666991556504632
ENSG00000004700,1138.0,,,,7.037905963447182
ENSG00000170180,1.0,,,,0.6931471805599453
ENSG00000120725,1473.0,,,,7.295735072749282
ENSG00000110717,2254.0,,,,7.720905251936779
ENSG00000067369,1931.0,,,,7.566311014772463
ENSG00000184292,4538.0,E-GEOD-44408,-4.5,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.420462002456466
ENSG00000139641,10479.0,,,,9.257223957875032
ENSG00000105048,51.0,E-GEOD-54002,2.0,'breast cancer' vs 'normal',3.9512437185814275
ENSG00000105048,51.0,E-MTAB-779,1.7,'breast carcinoma' vs 'normal',3.9512437185814275
ENSG00000172613,1020.0,,,,6.928537818164665
ENSG00000163818,753.0,,,,6.625392368007956
ENSG00000162600,493.0,,,,6.202535517187923
ENSG00000143226,874.0,,,,6.774223886357614
ENSG00000101365,3735.0,,,,8.225770799348734
ENSG00000121577,318.0,,,,5.765191102784844
ENSG00000167986,8840.0,,,,9.087155271405804
ENSG00000118513,374.0,E-GEOD-38959,-1.5,'breast cancer; breast' vs 'normal; breast',5.926926025970411
ENSG00000118513,374.0,E-GEOD-44408,-2.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',5.926926025970411
ENSG00000118513,374.0,E-MTAB-779,2.1,'breast carcinoma' vs 'normal',5.926926025970411
ENSG00000118513,374.0,E-GEOD-7377,2.7,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',5.926926025970411
ENSG00000085832,4108.0,,,,8.32093496888341
ENSG00000112182,450.0,E-GEOD-44408,2.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.111467339502679
ENSG00000077943,308.0,,,,5.733341276897746
ENSG00000117480,882.0,,,,6.78332520060396
ENSG00000182866,105.0,E-GEOD-44408,2.8,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',4.663439094112067
ENSG00000151846,12.0,,,,2.5649493574615367
ENSG00000158604,3411.0,,,,8.13505390861157
ENSG00000173218,528.0,E-GEOD-44408,-1.6,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.270988431858299
ENSG00000010704,572.0,,,,6.35088571671474
ENSG00000173660,3050.0,,,,8.02322468471667
ENSG00000156508,273732.0,E-GEOD-10780,-1.1,'breast carcinoma' vs 'normal',12.519908457727913
ENSG00000156508,273732.0,E-GEOD-54002,-1.9,'breast cancer' vs 'normal',12.519908457727913
ENSG00000164050,5906.0,E-GEOD-44408,-1.4,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',8.683893367307235
ENSG00000182944,13608.0,,,,9.518486617560317
ENSG00000135829,6164.0,,,,8.726643415598444
ENSG00000123595,1181.0,,,,7.074963197966044
ENSG00000132005,991.0,,,,6.899723107284872
ENSG00000100577,653.0,,,,6.483107351457199
ENSG00000139190,923.0,E-GEOD-44408,1.7,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',6.828712071641684
ENSG00000087086,84913.0,,,,11.349394258587163
ENSG00000107819,2962.0,,,,7.993957547573565
ENSG00000116977,3259.0,,,,8.089482474360754
ENSG00000120742,5508.0,E-MTAB-779,1.3,'breast carcinoma' vs 'normal',8.614138397472717
ENSG00000174827,30.0,,,,3.4339872044851463
ENSG00000033170,879.0,E-GEOD-7377,1.5,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',6.779921907472252
ENSG00000142156,34719.0,E-GEOD-44408,-1.3,'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation',10.455071168774287
ENSG00000139970,528.0,E-GEOD-54002,-1.7,'breast cancer' vs 'normal',6.270988431858299
ENSG00000135387,7256.0,,,,8.889721799278137
ENSG00000160688,1412.0,,,,7.253470382684528
ENSG00000125753,4038.0,,,,8.303752415563412
ENSG00000213903,1168.0,,,,7.063903961472068
ENSG00000133112,104495.0,,,,11.556904072142439
ENSG00000008513,3115.0,,,,8.044305406990638
ENSG00000225921,1730.0,,,,7.456454555176209
ENSG00000131171,4922.0,E-GEOD-38959,-1.1,'breast cancer; breast' vs 'normal; breast',8.5016733797582
ENSG00000131171,4922.0,E-GEOD-31138,2.7,'invasive ductal carcinoma' vs 'normal',8.5016733797582
ENSG00000131171,4922.0,E-GEOD-7377,2.0,'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit',8.5016733797582
ENSG00000040199,728.0,,,,6.591673732008658
ENSG00000182578,1282.0,,,,7.1569563646156364
ENSG00000151240,1930.0,,,,7.565793282428515
ENSG00000108774,3529.0,,,,8.169053149927343
ENSG00000178075,359.0,E-GEOD-31138,-1.9,'invasive ductal carcinoma' vs 'normal',5.886104031450156
ENSG00000178075,359.0,E-GEOD-54002,-2.1,'breast cancer' vs 'normal',5.886104031450156
ENSG00000178075,359.0,E-GEOD-38959,-1.5,'breast cancer; breast' vs 'normal; breast',5.886104031450156
ENSG00000197646,255.0,,,,5.545177444479562
ENSG00000135047,4183.0,E-GEOD-38959,1.3,'breast cancer; breast' vs 'normal; breast',8.339023005744759
ENSG00000166848,3572.0,,,,8.181160858023409
ENSG00000197885,417.0,,,,6.035481432524756
ENSG00000144560,1897.0,,,,7.5485559791698735
ENSG00000243509,0.0,,,,0.0
ENSG00000227925,0.0,,,,0.0
ENSG00000224586,0.0,E-GEOD-52194,5.3,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.0
ENSG00000164299,0.0,,,,0.0
ENSG00000236534,0.0,,,,0.0
ENSG00000225366,1.0,,,,0.6931471805599453
ENSG00000255192,1.0,,,,0.6931471805599453
ENSG00000253603,0.0,,,,0.0
ENSG00000125363,0.0,,,,0.0
ENSG00000179407,1.0,E-GEOD-52194,6.1,'triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000179407,1.0,E-GEOD-52194,5.0,'non-triple-negative breast cancer; breast carcinoma' vs 'normal',0.6931471805599453
ENSG00000221845,2.0,,,,1.0986122886681098
ENSG00000170516,0.0,,,,0.0
ENSG00000166884,0.0,,,,0.0
ENSG00000184321,0.0,,,,0.0
ENSG00000253513,0.0,,,,0.0
ENSG00000279284,0.0,,,,0.0
ENSG00000225768,0.0,E-GEOD-68086,-4.9,'breast carcinoma' vs 'normal',0.0
ENSG00000242385,0.0,,,,0.0
ENSG00000132446,0.0,E-MTAB-779,1.9,'breast carcinoma' vs 'normal',0.0
ENSG00000164399,0.0,,,,0.0
ENSG00000236481,0.0,,,,0.0
ENSG00000215262,1.0,,,,0.6931471805599453
ENSG00000167346,0.0,,,,0.0
